Science.gov

Sample records for administration a-821-819 magnesium

  1. Magnesium sulfate administration in subarachnoid hemorrhage.

    PubMed

    Suarez, Jose I

    2011-09-01

    Magnesium offers theoretic vascular and neuroprotective benefits for patients with subarachnoid hemorrhage. An electronic literature search was conducted to identify original research studies describing intravenous magnesium treatment in patients with SAH published in English between January 1990 and October 2010. Seventeen articles were identified and reviewed, including one phase III randomized-controlled clinical trial and six phase II randomized-controlled trials. Study quality was low for most of the included studies, with the phase III trial considered to be of moderate quality. Due to inconsistently reported benefits and the occurrence of side effects, phase II data suggested that intravenous magnesium for SAH provided either no overall net benefit or uncertain trade-offs. Benefit was likewise not supported in the single phase III clinical trial. PMID:21748496

  2. The effect of oral aspartame administration on the balance of magnesium in the rat.

    PubMed

    Kovatsi, L; Tsouggas, M

    2001-09-01

    The aim of the present work was to determine the effect of aspartame administration on the excretion of magnesium and its distribution in the various rat tissues and organs. The present results have shown that aspartame administration influences the balance of magnesium in the organism, since in some organs and tissues (heart, lungs, kidneys, adrenals, jejunum, hair and blood) it is accumulated, while other organs (liver and testes) are deprived of it. Aspartame administration also affects the excretion of magnesium from the organism, since it decreases the concentration of magnesium in both urine and feces.

  3. Magnesium

    MedlinePlus

    ... after taking a dietary supplement that contains magnesium. Diuretics can either increase or decrease the loss of magnesium through urine, depending on the type of diuretic. Prescription drugs used to ease symptoms of acid ...

  4. 75 FR 56989 - Magnesium Metal From the Russian Federation: Final Results of Antidumping Duty Administrative Review

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-09-17

    ... Duty Administrative Review, 75 FR 26922 (May 13, 2010) (Preliminary Results). We invited interested... Magnesium in Granular Form From the People's Republic of China, 66 FR 49345 (September 27, 2001), Notice of Final Determination of Sales at Less Than Fair Value: Pure Magnesium From Israel, 66 FR 49349...

  5. Oral administration of lithium increases tissue magnesium contents but not plasma magnesium level in rats.

    PubMed

    Kiełczykowska, Małgorzata; Musik, Irena; Hordyjewska, Anna; Boguszewska, Anna; Lewandowska, Anna; Pasternak, Kazimierz

    2007-01-01

    The aim of this work was to determine the influence of different doses of lithium on magnesium concentration in plasma and tissues of rats. For a period of eight weeks rats had been provided with aqueous solutions of Li(2)CO(3) whose concentrations were established as follows: 0.7; 1.4; 2.6; 3.6; 7.1; 10.7 mmol Li(+)/l. Magnesium concentration was determined in plasma and tissue supernatants. Lithium caused no changes in magnesium concentration in plasma, whereas Mg concentration in tissues was found to be enhanced, although the degree of the increment depended on the studied tissue. In the liver, brain and heart muscle, the increase was statistically insignificant vs. control. In the kidney, the higher Li doses were required to result in the significant Mg enhancement, whereas in femoral muscle all the used doses caused well-marked Mg increase vs. control. Positive correlations between average daily Li intake and tissue Mg concentration in the kidney (r = 0.650) and femoral muscle (r = 0.696) were found. In conclusion, the present study indicates that the different Li doses disturbed tissue homeostasis of magnesium. The increase in Mg tissue concentration, observed in groups receiving higher Li doses can influence nervous-muscular excitability.

  6. 76 FR 7813 - Amended Final Results of the 2008-2009 Antidumping Duty Administrative Review: Pure Magnesium...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-02-11

    ...-2009 Antidumping Duty Administrative Review of the Antidumping Duty Order, 75 FR 80791 (December 23... chemistry, form or size, unless expressly excluded from the scope of this order. Pure magnesium is a metal... materials into magnesium metal. Pure primary magnesium is used primarily as a chemical in the...

  7. 76 FR 53408 - Pure Magnesium From the People's Republic of China: Rescission of Antidumping Duty Administrative...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-08-26

    ... Countervailing Duty Administrative Reviews and Request for Revocation in Part, 76 FR 37781 (June 28, 2011... Department certifying that it did not export pure magnesium for consumption in the United States during the...; Opportunity To Request Administrative Review, 76 FR 24458 (May 2, 2011). \\4\\ See letter from U.S....

  8. The influence of chosen metals administration in drinking water on magnesium balance in rats.

    PubMed

    Kiełczykowska, Małgorzata; Pasternak, Kazimierz; Boguszewska, Anna; Musik, Irena

    2004-01-01

    The aim of our study was to estimate the influence of chromium, lead and aluminium on the magnesium level in serum and tissues of rats. Male Wistar rats received Cr, Pb and Al at the concentration of 500 mg of metal x dm(-3) in the form of drinking water for three or six weeks. After the period of administration the animals were sacrificed under ketamine narcosis and blood from the heart as well as the tissues of the liver, kidney, brain, spleen, femoral muscle and heart muscle were collected. Magnesium concentration was measured in serum and tissue homogenates. Chromium caused the increase of Mg level in some tissues after six weeks and no changes in serum. Lead influenced Mg level in serum and tissues mainly after six weeks but the changes were more diverse and depending on the tissue. After six weeks' administration aluminium caused the magnesium release from serum and its storage in tissues.

  9. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects.

    PubMed

    Paolisso, G; Sgambato, S; Pizza, G; Passariello, N; Varricchio, M; D'Onofrio, F

    1989-04-01

    In eight aged non-insulin-dependent diabetes mellitus (NIDDM) subjects, insulin response and action were studied before and after chronic magnesium supplementation (2 g/day) to diet. Chronic magnesium supplementation to diet versus placebo produced 1) a significant increase in plasma (0.83 +/- 0.05 vs. 0.78 +/- 0.06 mM, P less than .05) and erythrocyte (2.03 +/- 0.06 vs. 1.88 +/- 0.09 mM, P less than .01) magnesium levels, 2) an increase in acute insulin response (AIR) (4.0 +/- 0.6 vs. -1.6 +/- 0.6 mU/L, P less than .05) to glucose pulse, and 3) an increase in glucose infusion rate (GIR) (3.6 +/- 0.6 vs. 2.9 +/- 0.5 mg.kg-1.min-1, P less than .025) calculated in the last 60 min of a euglycemic-hyperinsulinemic (100 mU.m2.min-1 during 180 min) glucose clamp. Net increase in AIR, glucose disappearance rate after glucose pulse, and GIR were significantly and positively correlated to the net increase in erythrocyte magnesium content calculated after chronic magnesium supplementation to diet. In conclusion, our data suggest that NIDDM subjects may benefit from therapeutic chronic administration of magnesium salts.

  10. Long-term administration of magnesium after acoustic trauma caused by gunshot noise in guinea pigs.

    PubMed

    Abaamrane, L; Raffin, F; Gal, M; Avan, P; Sendowski, I

    2009-01-01

    In a previous study we observed that a 7-day post-trauma magnesium treatment significantly reduced auditory threshold shifts measured 7 days after gunshot noise exposure. However this improvement was only temporary, suggesting that it could be potentially beneficial to prolong this treatment. The aim of the present study was to evaluate the efficacy of a long-term (1 month) magnesium treatment after an impulse noise trauma, in comparison with either a 7-day magnesium treatment, an administration of methylprednisolone (conventional treatment), or a placebo (NaCl). Guinea pigs were exposed to impulse noise (three blank gunshots, 170 dB SPL peak). They received one of the four treatments, 1 h after the noise exposure. Auditory function was explored by recording the auditory brainstem response (ABR) and measuring the distortion product otoacoustic emissions (DPOAE) over a 3-month recovery period after the gunshot exposure. The functional hearing study was supplemented by a histological analysis. The results showed that a 1-month treatment with magnesium was the most effective treatment in terms of hair cell preservation. The DPOAE confirmed this effectiveness. Methylprednisolone accelerated recovery but its final efficacy remained moderate. It is probable that magnesium acts on the later metabolic processes that occur after noise exposure. Multiple mechanisms could be involved: calcium antagonism, anti-ischaemic effect or NMDA channel blockage. Regardless of the specific mechanism, a 1-month treatment with magnesium clearly attenuates NIHL, and presents the advantage of being safe for use in humans. PMID:19084059

  11. NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801.

    PubMed

    Decollogne, S; Tomas, A; Lecerf, C; Adamowicz, E; Seman, M

    1997-09-01

    The ion channel of the N-methyl-D-aspartate (NMDA) receptor complex is subject to a voltage-dependent regulation by Mg2+ cations. Under physiological conditions, this channel is supposed to be blocked by a high concentration of magnesium in extracellular fluids. A single dose of magnesium organic salts (i.e., aspartate, pyroglutamate, and lactate) given orally to normal mice rapidly increases the plasma Mg2+ level and reveals a significant dose-dependent antagonist effect of magnesium on the latency of NMDA-induced convulsions; this effect is similar to that seen after administration of the dizocilpine (MK-801) channel blocker. An anticonvulsant effect of Mg2+ treatment is also observed with strychnine-induced convulsions but not with bicuculline-, picrotoxin-, or pentylenetetrazol-induced convulsions. In the forced swimming test, Mg2+ salts reduce the immobility time in a way similar to imipramine and thus resemble the antidepressant-like activity of MK-801. This activity is masked at high doses of magnesium by a myorelaxant effect that is comparable to MK-801-induced ataxia. Potentiation of yohimbine fatal toxicity is another test commonly used to evaluate putative antidepressant drugs. Administration of Mg2+ salts, like administration of imipramine strongly potentiates yohimbine lethality in contrast to MK-801, which is only poorly active in this test. Neither Mg2+ nor MK-801 treatment can prevent reserpine-induced hypothermia. These data demonstrate that oral administration of magnesium to normal animals can antagonize NMDA-mediated responses and lead to antidepressant-like effects that are comparable to those of MK-801. This important regulatory role of Mg2+ in the central nervous system needs further investigation to evaluate the potential therapeutic advantages of magnesium supplementation in psychiatric disorders. PMID:9264101

  12. 76 FR 56396 - Magnesium Metal from the Russian Federation: Final Results of Antidumping Duty Administrative Review

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-09-13

    ... of Antidumping Duty Administrative Review, 76 FR 26247 (May 6, 2011) (Preliminary Results). We... FR 13128 (March 10, 2011). The subject merchandise includes the following pure and alloy magnesium... Granular Form From the People's Republic of China, 66 FR 49345 (September 27, 2001), Notice of...

  13. Magnesium

    NASA Astrophysics Data System (ADS)

    Bechtel, H.; Bulian, W.; Bungardt, K.; Gürs, K.; Gürs, U.; Helling, W.; Kyri, H.; Laue, H. J.; Mahler, W.; Matting, A.; Meyer, F. R.; Mialki, W.; Ritter, F.; Ruge, J.; Saur, G.; Simon, W.; Strnat, K.; Weber, R.; Weigand, H. H.; Weik, H.; Ziesler, H.; Borchers, Heinz; Schmidt, Ernst

    Magnesium wird überwiegend durch Schmelzflußelektrolyse hergestellt. Das dabei anfallende Reinmagnesium hat einen Mg-Gehalt von etwa 99,9%. Hauptbeimengung ist das Eisen; Silizium und Aluminium sind nur in Spuren vorhanden. Der Anwendungsumfang des Reinmagnesiums ist gering; dagegen werden Magnesiumlegierungen zunehmend, insbesondere für den Druckguß verwendet. Neben den bis etwa zum Jahre 1950 allein gebräuchlichen Mg-Mn-, Mg-Al- und Mg-Al-Zn-Legierungen werden heute mehr und mehr die besonders warmfesten Legierungen mit Zusätzen von Zirkon, Thorium und Seltenen Erden hergestellt (siehe dazu auch Abschnitt Seltene Erden). Als Umhüllungsmaterial für Uranstäbe dient die Legierung Magnox A 12, die nach [H 3] neben 1 % Al noch geringe Mengen an Ca und Ba enthält. In den in Deutschland üblichen Kurzzeichen (DIN 1729) werden die chemischen Symbole und der ungefähre Gehalt der wichtigsten Legierungselemente angegeben. Gußlegierungen werden zusätzlich durch ein G (Sandguß oder Kokillenguß) oder ein D (Druckguß) gekennzeichnet (siehe Tab. 5).

  14. [COMPARATIVE CEREBROPROTECTIVE EFFECT OF PREVENTIVE ADMINISTRATION OF MAGNESIUM HYDROXYBUTYRATE VERSUS MAGNESIUM SULFATE AND CAVINTON IN RATS WITH COMMON CAROTID ARTERY OCCLUSION].

    PubMed

    Tyurenkov, I N; Litvinov, A A; Kurkin, D V; Volotova, E V; Darmanyan, A P; Ozerov, A A

    2016-01-01

    Dose-dependent cerebroprotective effect of magnesium hydroxybutyrate (MHB) on common carotid artery occlusion model in rats was established. Administration of 150 mg/kg MHB led to significant decrease in animal mortality (up to 9.3 times) in comparison to control (p < 0.05). This MHB dose also produced significant decrease of neurological deficit on the McGraw scale in comparison to control and magnesium sulfate (50% and 20%, respectively). The MHB treated animals also showed improved locomotor and exploratory performance in the open-field test and retained memory performance in the passive avoidance test and extrapolation escape task test. The administration of 150 mg/kg MHB produced three-fold (p < 0.05) decrease of brain edema in animals with cerebral blood flow impairment in comparison to animals treated with magnesium sulfate and cavinton. PMID:27455571

  15. [COMPARATIVE CEREBROPROTECTIVE EFFECT OF PREVENTIVE ADMINISTRATION OF MAGNESIUM HYDROXYBUTYRATE VERSUS MAGNESIUM SULFATE AND CAVINTON IN RATS WITH COMMON CAROTID ARTERY OCCLUSION].

    PubMed

    Tyurenkov, I N; Litvinov, A A; Kurkin, D V; Volotova, E V; Darmanyan, A P; Ozerov, A A

    2016-01-01

    Dose-dependent cerebroprotective effect of magnesium hydroxybutyrate (MHB) on common carotid artery occlusion model in rats was established. Administration of 150 mg/kg MHB led to significant decrease in animal mortality (up to 9.3 times) in comparison to control (p < 0.05). This MHB dose also produced significant decrease of neurological deficit on the McGraw scale in comparison to control and magnesium sulfate (50% and 20%, respectively). The MHB treated animals also showed improved locomotor and exploratory performance in the open-field test and retained memory performance in the passive avoidance test and extrapolation escape task test. The administration of 150 mg/kg MHB produced three-fold (p < 0.05) decrease of brain edema in animals with cerebral blood flow impairment in comparison to animals treated with magnesium sulfate and cavinton.

  16. Effect of oral magnesium sulfate administration on blood pressure and lipid profile in streptozocin diabetic rat.

    PubMed

    Soltani, Nepton; Keshavarz, Manssor; Dehpour, Ahmad Reza

    2007-04-10

    Approximately one-third of patients with type 1 diabetes develop a variety of complications as a result of mechanisms that are not completely understood. However, insufficient metabolic control seems to play a major role. Other factors such as magnesium (Mg) could also be of importance. We designed this study to elucidate the effect of oral magnesium administration on plasma lipid profile and mesenteric fat in male Wistar rats. Animals were divided into 4 groups (n=10 in each group): one group served as control, while the other groups were made diabetic with a single i.v. injection of 40 mg/kg streptozocin. Animals in which the diabetic state lasted for 10 days were referred as acute diabetic rats, whereas those in which the diabetes lasted for 8 weeks were defined as chronic diabetics. Mg-treated chronic diabetic received 10 g/l of MgSO(4) added to the drinking water (0.46 g/24 h) for eight weeks following which the left common carotid artery was cannulated for continuous recording of blood pressure. Blood glucose, magnesium and lipid profiles levels were also determined. Diabetes induction caused plasma glucose, high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL), total cholesterol and triglyceride concentrations to increase, however plasma Mg level was decreased. Administration of MgSO(4) for eight weeks caused the return of the above factors to their normal levels. Mg concentrations also increased but failed to reach normal levels. Diabetes induction caused mesenteric fat/body weight ratio to increase, but administration of MgSO(4) reduced the ratio to normal levels. In addition, Mg administration returned systolic blood pressure to the normal level. Our results support the hypothesis that Mg may play a part in the management of diabetes and the prevention of its vascular complications in streptozocin-induced diabetic rats and it may be useful in the treatment of hyperlipidaemia in diabetic case. PMID:17292879

  17. Alcohol-induced vascular damage of brain can be ameliorated by administration of magnesium

    SciTech Connect

    Altura, B.M.; Altura, B.T.; Gebrewold, A.

    1986-03-01

    Long-term as well as short-term administration of alcohol can cause neuronal and vascular damage in the brain. The authors have reported that acute administration of ethyl alcohol (ALC), either directly into the rat brain, IV or locally, can produce concentration-dependent spasms of cerebral arterioles, venules, arteries and veins followed by irreversible rupture of capillaries and veins followed by irreversible rupture of capillaries and venules. Several experiments have suggested that administration of magnesium ions (Mg/sup 2 +/) can modify vascular tone. Whether Mg/sup 2 +/ can exert direct actions on the intact cerebral microcirculation is not known. Using the above intact rat brain model, and TV-image intensification, the authors determine whether administration of Mg/sup 2 +/ : 1) exerts actions on cerebral (coritical) arterioles (A) and venules (V) (12-40..mu..m); 2) directly into the brain alters arterial blood pressure (BP); and 3) could ameliorate or prevent some of the detrimental cerebral-vascular actions ALC exerts in the brain. The data show that infusion of Mg/sup 7 +/ : 1) into the rat brain result in a rapid dose-dependent lowering of systolic and diastolic and BP; 2) IV or intra-arterially (IA) produces dose-dependent vaso-dilation of A and V; 3) IV or IA prevents spasms and rupture of A and V induced by 10% ALC. The cerebral vascular actions of Mg/sup 2 +/ may prove to be useful in treatment and prevention of ALC-induced brain damage.

  18. The effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes

    PubMed Central

    Horton, Amanda L.; Lai, Yinglei; Rouse, Dwight J.; Spong, Catherine Y.; Leveno, Kenneth J.; Varner, Michael W.; Mercer, Brian M.; Iams, Jay D.; Wapner, Ronald J.; Sorokin, Yoram; Thorp, John M.; Ramin, Susan M.; Malone, Fergal D.; O'Sullivan, Mary J.; Hankins, Gary D. V.; Caritis, Steve N.

    2015-01-01

    Objective To evaluate whether magnesium sulfate administration for neuroprotection prolongs latency in women with preterm premature rupture of membranes between 24 and 31 6/7 weeks' gestation. Study Design This is a secondary analysis of a randomized controlled trial of magnesium sulfate for prevention of cerebral palsy. Gravid women with a singleton pregnancy between 24 and 31 6/7 weeks' gestation with preterm premature rupture of membranes (pPROM) without evidence of labor were randomized to receive magnesium sulfate, administered intravenously as a 6-g bolus followed by a constant infusion of 2 g per hour up to 12 hours, or placebo. Maternal outcomes for this analysis were delivery in less than 48 hours and in less than 7 days from randomization. Neonatal outcomes included a composite of respiratory distress, interventricular hemorrhage grades 3 or 4, periventricular leukomalacia, sepsis, necrotizing enterocolitis, retinopathy of prematurity, or death. Results A total of 1259 women were included. The rate of delivery < 48 hours was not different in the magnesium sulfate and the placebo groups (22.2% and 20.7%, p=0.51). Delivery < 7 days was similar between groups (55.4% and 51.4%, p=0.16). Median latency was also similar between groups (median [interquartile range] 6.0 days [2.4–13.8] and 6.6 days [2.4–15.1], p =0.29). Composite neonatal outcomes did not differ between groups. Conclusion: Magnesium sulfate administration given for neuroprotection in women with a singleton gestation with preterm premature rupture of membranes and without labor before 32 weeks does not impact latency. PMID:25241107

  19. 77 FR 73979 - Magnesium Metal From the Russian Federation: Notice of Reinstated Final Results of Administrative...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-12-12

    ... Russian Federation: Final Results of Antidumping Duty Administrative Review, 73 FR 52642 (September 10... period April 1, 2006, through March 31, 2007. See Final Results, 73 FR at 52643. The CIT remanded the... Administrative Review Pursuant to Court Decision, 76 FR 13355 (March 11, 2011). On July 27, 2012, the...

  20. Magnesium Gluconate

    MedlinePlus

    Magnesium gluconate is used to treat low blood magnesium. Low blood magnesium is caused by gastrointestinal disorders, prolonged vomiting or ... disease, or certain other conditions. Certain drugs lower magnesium levels as well.This medication is sometimes prescribed ...

  1. Absorption of magnesium from orally administered magnesium sulfate in man.

    PubMed

    Morris, M E; LeRoy, S; Sutton, S C

    1987-01-01

    The use of magnesium sulfate (Epsom salt) as a cathartic in patients with impaired renal function can lead to severe toxicity due to hypermagnesemia. Although toxicity is uncommon in healthy subjects, little is known concerning the extent of absorption of magnesium after a cathartic dose of magnesium sulfate. The bioavailability of magnesium following a large oral dose of magnesium sulfate in normal volunteers was examined in the present investigation. Baseline 24-hour urinary excretion rates of magnesium and creatinine were determined over 3 consecutive days in 6 healthy men. The oral administration of 13.9 g (56.5 mmoles) magnesium sulfate U.S.P., in 4 equal hourly increments, resulted in the urinary excretion (corrected for baseline excretion rate) of 4.0 +/- 2.9% (mean +/- SD) of the dose of magnesium during the first 24 hours and 6.9 +/- 7.0% of the dose during a 72-hour interval. Magnesium sulfate administration had no effect on the 24-hour urinary excretion rate of creatinine. The baseline excretion rate of magnesium was significantly correlated with that of creatinine (r = 0.875) and inorganic sulfate (r = 0.921). All of the subjects experienced mild or moderate diarrhea. Therefore, magnesium is absorbed to a limited and variable extent in healthy adults following a cathartic dose of magnesium sulfate. PMID:3430654

  2. [Magnesium in skin allergy].

    PubMed

    Błach, Joanna; Nowacki, Wojciech; Mazur, Andrzej

    2007-10-08

    Magnesium is involved in many biological processes within the body. Magnesium deficiency causes many disorders, including impairment of immunity. This review summarizes present knowledge on the relationship between magnesium and skin allergy reactions. Special focus is on allergy types I and IV. At present the best knowledge is on allergy I. Magnesium deficiency in experimental animals, mainly rats, leads to characteristic hyperemia, an increase in IgE, neutrophilia and eosinophilia, an increase in the level of proinflammatory cytokines, mastocyte degranulation, histaminemia, and splenomegaly. These symptoms observed in hypomagnesemic rats are similar to those in atopic patients. Data on the relationship between magnesium and other types of allergy are scarce. Clinical observations show the beneficial effect of topical and oral administration of magnesium salts in patients with skin allergy. All the presented data point to an important role of magnesium in allergy reactions. Other studies are needed to better understand the mechanism of magnesium's action. Well-controlled clinical protocols should also be conducted to assess the efficiency of magnesium supplementation in patients with skin allergy.

  3. Selected haematological and biochemical parameters of blood in rats after subchronic administration of vanadium and/or magnesium in drinking water.

    PubMed

    Scibior, Agnieszka; Zaporowska, Halina; Ostrowski, Jarosław

    2006-08-01

    The purpose of these studies was to evaluate the effect of selected vanadium and magnesium doses on certain haematological and biochemical blood parameters in rats. Outbred 2-month-old, albino male Wistar rats received for a period of 6 weeks, as a sole drinking liquid, the following water solutions: group II, sodium metavanadate (SMV) at a concentration of 0.125 mg V/mL; group III, magnesium sulphate (MS) at a concentration of 0.06 mg Mg/mL; and group IV, SMV-MS solution at the same concentrations. The control group received at this time deionized water to drink. It was calculated that group II ingested with drinking water about 10.7 mg V/kg b. w./24 h, group III 6 mg Mg/kg b. w./24 h, and group IV about 9 mg V and 4.5 mg Mg/kg b. w./24 h. The exposure to vanadium alone (group II) led to a statistically significant decrease in body weight gain, food and fluid intakes. Moreover, in the same group of rats a statistically significant decrease in the RBC count, Hb concentration, MCV, and MCH values was demonstrated. Additionally, a statistically significant decrease in the plasma L-ascorbic acid concentration and a significant increase in MDA concentration in blood in this group were found. Instead, after the administration of magnesium alone (group III), a statistically significant decrease in the fluid intake and in the L-ascorbic acid concentration in plasma was noted. Furthermore, in the same group of rats a statistically significant increase in Hb level and in the plasma magnesium concentration was demonstrated. Two-way analysis of variance (ANOVA) did not reveal the interactions between V and Mg.

  4. Magnesium basics

    PubMed Central

    Ketteler, Markus

    2012-01-01

    As a cofactor in numerous enzymatic reactions, magnesium fulfils various intracellular physiological functions. Thus, imbalance in magnesium status—primarily hypomagnesaemia as it is seen more often than hypermagnesaemia—might result in unwanted neuromuscular, cardiac or nervous disorders. Measuring total serum magnesium is a feasible and affordable way to monitor changes in magnesium status, although it does not necessarily reflect total body magnesium content. The following review focuses on the natural occurrence of magnesium and its physiological function. The absorption and excretion of magnesium as well as hypo- and hypermagnesaemia will be addressed. PMID:26069819

  5. 75 FR 9160 - Initiation of Five-Year (“Sunset”) Review

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-03-01

    ... Duty Orders, 63 FR 13516 (March 20, 1998) and 70 FR 62061 (October 28, 2005). Guidance on... Antidumping and Countervailing Duty Orders: Policy Bulletin, 63 FR 18871 (April 16, 1998). Initiation of... China Magnesium Metal....... Jennifer Moats (202) 482-5047. A-821-819 731-TA-1072 Russia Magnesium...

  6. 75 FR 5037 - Antidumping or Countervailing Duty Order, Finding, or Suspended Investigation; Advance...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-02-01

    ... (``Sunset'') Reviews of Antidumping and Countervailing Duty Orders; Policy Bulletin, 63 FR 18871 (April 16... Department contact Magnesium Metal from the People's Republic Jennifer Moats; (202) 482- of China (A-570-896). 5047. Magnesium Metal from Russia (A-821-819)... Dana Mermelstein; (202) 482- 1391. Countervailing...

  7. Exogenous magnesium chloride-adenosine triphosphate administration during reperfusion reduces the extent of necrosis in previously ischemic skeletal muscle.

    PubMed

    Hayes, P G; Liauw, S; Smith, A; Romaschin, A D; Walker, P M

    1990-03-01

    The lower extremity may be exposed to prolonged periods of ischemia, resulting in depletion of intracellular energy stores in the affected skeletal muscle. The role of adenine nucleotide reduction and failure of resynthesis on reperfusion in determining the extent of muscle necrosis was investigated in this study, in addition to the possible beneficial effects of the addition of exogenous adenosine triphosphate-magnesium chloride during early reperfusion. The isolated paired canine gracilis muscle model was used. After 4 hours of normothermic ischemia in group I, a perfusate Krebs-Henseleit solution plus the gradual reintroduction of oxygenated blood flow was compared to standard reperfusion. In group II, a similar infusion protocol was used, with the addition of 2 mmol/L adenosine triphosphate-magnesium chloride and compared to normal reperfusion. Adenosine triphosphate-magnesium chloride resulted in the salvage of skeletal muscle, 57% +/- 12% versus 44% +/- 14% (p less than 0.05, n = 6 pairs). Reperfusion with the solution alone increased the resulting necrosis (42% +/- 13% vs 60% +/- 20%, n = 6 pairs). Adenine nucleotide stores were not increased, but oxygen consumption was increased by magnesium chloride-adenosine triphosphate (p less than 0.05, analysis of variance [ANOVA]). A clear relationship was demonstrated between the fall in energy stores, as measured by a change in energy charge potential from preischemia to end ischemia levels, and the extent of resulting necrosis (p less than 0.01). In summary, the addition of 2 mmol/L to an infusion of Krebs-Henseleit solution during reperfusion results in significant salvage of skeletal muscle.(ABSTRACT TRUNCATED AT 250 WORDS)

  8. Magnesium Hydroxide

    MedlinePlus

    Magnesium hydroxide is used on a short-term basis to treat constipation.This medication is sometimes prescribed ... Magnesium hydroxide come as a tablet and liquid to take by mouth. It usually is taken as ...

  9. 21 CFR 582.2437 - Magnesium silicate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Magnesium silicate. 582.2437 Section 582.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations,...

  10. 21 CFR 582.2437 - Magnesium silicate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 6 2012-04-01 2012-04-01 false Magnesium silicate. 582.2437 Section 582.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations,...

  11. 21 CFR 182.2437 - Magnesium silicate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium silicate. 182.2437 Section 182.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) FOOD FOR... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations,...

  12. 21 CFR 182.2437 - Magnesium silicate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium silicate. 182.2437 Section 182.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) FOOD FOR... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations,...

  13. 21 CFR 582.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 6 2012-04-01 2012-04-01 false Magnesium hydroxide. 582.1428 Section 582.1428 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1428 Magnesium hydroxide. (a) Product. Magnesium hydroxide. (b) Conditions of use....

  14. 21 CFR 582.1431 - Magnesium oxide.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 6 2011-04-01 2011-04-01 false Magnesium oxide. 582.1431 Section 582.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance...

  15. 21 CFR 582.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 6 2011-04-01 2011-04-01 false Magnesium carbonate. 582.1425 Section 582.1425 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1425 Magnesium carbonate. (a) Product. Magnesium carbonate. (b) Conditions of use....

  16. 21 CFR 582.1431 - Magnesium oxide.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 6 2012-04-01 2012-04-01 false Magnesium oxide. 582.1431 Section 582.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance...

  17. 21 CFR 582.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 6 2013-04-01 2013-04-01 false Magnesium carbonate. 582.1425 Section 582.1425 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1425 Magnesium carbonate. (a) Product. Magnesium carbonate. (b) Conditions of use....

  18. 21 CFR 582.1431 - Magnesium oxide.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Magnesium oxide. 582.1431 Section 582.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance...

  19. 21 CFR 182.2437 - Magnesium silicate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Magnesium silicate. 182.2437 Section 182.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) FOOD FOR... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations,...

  20. 21 CFR 582.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Magnesium hydroxide. 582.1428 Section 582.1428 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1428 Magnesium hydroxide. (a) Product. Magnesium hydroxide. (b) Conditions of use....

  1. 21 CFR 582.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 6 2014-04-01 2014-04-01 false Magnesium carbonate. 582.1425 Section 582.1425 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1425 Magnesium carbonate. (a) Product. Magnesium carbonate. (b) Conditions of use....

  2. 21 CFR 582.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 6 2013-04-01 2013-04-01 false Magnesium hydroxide. 582.1428 Section 582.1428 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1428 Magnesium hydroxide. (a) Product. Magnesium hydroxide. (b) Conditions of use....

  3. 21 CFR 582.2437 - Magnesium silicate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 6 2013-04-01 2013-04-01 false Magnesium silicate. 582.2437 Section 582.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations,...

  4. 21 CFR 582.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 6 2012-04-01 2012-04-01 false Magnesium carbonate. 582.1425 Section 582.1425 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1425 Magnesium carbonate. (a) Product. Magnesium carbonate. (b) Conditions of use....

  5. 21 CFR 582.2437 - Magnesium silicate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 6 2011-04-01 2011-04-01 false Magnesium silicate. 582.2437 Section 582.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations,...

  6. 21 CFR 582.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 6 2011-04-01 2011-04-01 false Magnesium hydroxide. 582.1428 Section 582.1428 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1428 Magnesium hydroxide. (a) Product. Magnesium hydroxide. (b) Conditions of use....

  7. 21 CFR 582.1431 - Magnesium oxide.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 6 2013-04-01 2013-04-01 false Magnesium oxide. 582.1431 Section 582.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance...

  8. 21 CFR 582.1431 - Magnesium oxide.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Magnesium oxide. 582.1431 Section 582.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This substance...

  9. 21 CFR 582.2437 - Magnesium silicate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Magnesium silicate. 582.2437 Section 582.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations,...

  10. 21 CFR 582.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Magnesium hydroxide. 582.1428 Section 582.1428 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1428 Magnesium hydroxide. (a) Product. Magnesium hydroxide. (b) Conditions of use....

  11. 21 CFR 182.2437 - Magnesium silicate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Magnesium silicate. 182.2437 Section 182.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) FOOD FOR... Magnesium silicate. (a) Product. Magnesium silicate. (b) Tolerance. 2 percent. (c) Limitations,...

  12. 21 CFR 582.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 6 2010-04-01 2010-04-01 false Magnesium carbonate. 582.1425 Section 582.1425 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) ANIMAL... Additives § 582.1425 Magnesium carbonate. (a) Product. Magnesium carbonate. (b) Conditions of use....

  13. Administration of lithium and magnesium chloride inhibited tolerance to the anticonvulsant effect of morphine on pentylenetetrazole-induced seizures in mice.

    PubMed

    Ghasemi, Abbas; Saberi, Mohammad; Ghasemi, Mehdi; Shafaroodi, Hamed; Moezi, Leila; Bahremand, Arash; Montaser-Kouhsari, Laleh; Ziai, Pouya; Dehpour, Ahmad Reza

    2010-12-01

    Although morphine has an anticonvulsant effect in several animal models of seizures, its potential clinical application in epilepsy may be hindered by its adverse effects like opioid tolerance. The present study evaluated the development of tolerance to the anticonvulsant effect of morphine in a model of clonic seizures induced with pentylenetetrazole (PTZ) in male Swiss mice. We also examined whether administration of either lithium chloride (LiCl) or magnesium chloride (MgCl(2)) was able to prevent the probable tolerance. Our data demonstrated that the anticonvulsant effect of a potent dose of morphine (1mg/kg) was abolished in chronic morphine-treated mice (mice administered the same dose of morphine intraperitoneally twice daily for 4 days). Four days of pretreatment with low and noneffective doses of MgCl(2) (2 and 5mg/kg) and LiCl (5mg/kg) inhibited the development of tolerance to the anticonvulsant effect of morphine (1mg/kg, ip). Moreover, a single acute injection of the aforementioned agents at the same doses reversed the expression of tolerance to the anticonvulsant effects of morphine (1mg/kg, ip). Chronic 17-day treatment with LiCl (600 mg/L in drinking water) also inhibited the development of tolerance to the anticonvulsant effects of 1mg/kg morphine. These results demonstrate that the anticonvulsant effect of morphine is subject to tolerance after repeated administration. Both development and expression of tolerance are inhibited by either LiCl or MgCl(2). As both LiCl and MgCl(2) can modulate the function of N-methyl-d-aspartate (NMDA) receptors, we discuss how NMDA receptor functioning might be involved in the effects of LiCl and MgCl(2) on the development of tolerance to the anticonvulsant effect of morphine.

  14. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2010-01-01

    Seawater and natural brines accounted for about 40 percent of U.S. magnesium compounds production in 2009. Dead-burned magnesia was produced by Martin Marietta Magnesia Specialties from well brines in Michigan. Caustic-calcined magnesia was recovered from seawater by Premier Chemicals in Florida, from well brines in Michigan by Martin Marietta and from magnesite in Nevada by Premier Chemicals. Intrepid Potash-Wendover, and Great Salt Lake Minerals Corp. recovered magnesium chloride brines from the Great Salt Lake in Utah. Magnesium hydroxide was produced from seawater by SPI Pharma in Delaware and Premier Chemicals in Florida, and by Martin Marietta from its operation mentioned above.

  15. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2011-01-01

    Seawater and natural brines accounted for about 54 percent of U.S. magnesium compounds production in 2010. Dead-burned magnesia was produced by Martin Marietta Magnesia Specialties from well brines in Michigan. Caustic-calcined magnesia was recovered from seawater by Premier Magnesia in Florida, from well brines in Michigan by Martin Marietta and from magnesite in Nevada by Premier Magnesia. Intrepid Potash-Wendover and Great Salt Lake Minerals Corp. recovered magnesium chloride brines from the Great Salt Lake in Utah. Magnesium hydroxide was produced from seawater by SPI Pharma in Delaware and Premier Magnesia in Florida, and by Martin Marietta from its operation mentioned above.

  16. Magnesium Oxide

    MedlinePlus

    ... different reasons. Some people use it as an antacid to relieve heartburn, sour stomach, or acid indigestion. ... stomach.Do not take magnesium oxide as an antacid for longer than 2 weeks unless your doctor ...

  17. Production of magnesium metal

    DOEpatents

    Blencoe, James G [Harriman, TN; Anovitz, Lawrence M [Knoxville, TN; Palmer, Donald A [Oliver Springs, TN; Beard, James S [Martinsville, VA

    2010-02-23

    A process of producing magnesium metal includes providing magnesium carbonate, and reacting the magnesium carbonate to produce a magnesium-containing compound and carbon dioxide. The magnesium-containing compound is reacted to produce magnesium metal. The carbon dioxide is used as a reactant in a second process. In another embodiment of the process, a magnesium silicate is reacted with a caustic material to produce magnesium hydroxide. The magnesium hydroxide is reacted with a source of carbon dioxide to produce magnesium carbonate. The magnesium carbonate is reacted to produce a magnesium-containing compound and carbon dioxide. The magnesium-containing compound is reacted to produce magnesium metal. The invention further relates to a process for production of magnesium metal or a magnesium compound where an external source of carbon dioxide is not used in any of the reactions of the process. The invention also relates to the magnesium metal produced by the processes described herein.

  18. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2012-01-01

    Seawater and natural brines accounted for about 57 percent of magnesium compounds produced in the United States in 2011. Dead-burned magnesia was produced by Martin Marietta Magnesia Specialties LLC from well brines in Michigan. Caustic-calcined magnesia was recovered from seawater by Premier Magnesia LLC in Florida, from well brines in Michigan by Martin Marietta and from magnesite in Nevada by Premier Magnesia. Intrepid Potash Wendover LLC and Great Salt Lake Minerals Corp. recovered magnesium chloride brines from the Great Salt Lake in Utah. Magnesium hydroxide was produced from seawater by SPI Pharma Inc. in Delaware and Premier Magnesia in Florida, and by Martin Marietta from its brine operation in Michigan.

  19. Intravenous magnesium sulfate does not increase ventricular CSF ionized magnesium concentration of patients with intracranial hypertension.

    PubMed

    Brewer, R P; Parra, A; Borel, C O; Hopkins, M B; Reynolds, J D

    2001-01-01

    Magnesium sulfate has attracted interest as a potential neuroprotectant but passage of magnesium ion into the central nervous system has not been well documented. For this study, we quantified plasma and cerebrospinal fluid (CSF) ionized magnesium concentration after systemic magnesium sulfate infusion in patients with intracranial hypertension. Patients ( N = 9) received an intravenous infusion of 5 g/20 mmol magnesium sulfate (125 mL of a 4% wt/vol solution) over 30 minutes. Before and after dosing, CSF (from an indwelling ventricular catheter) and blood samples were collected at hourly intervals. Ionized magnesium concentration in all samples was determined using an electrolyte analyzer. Baseline plasma and CSF ionized magnesium concentrations were 0.58 +/- 0.05 and 0.82 +/- 0.06 mmol/L, respectively. Intravenous magnesium sulfate infusion significantly increased plasma ionized magnesium concentration (peak, 0.89 +/- 0.11 mmol/L), but CSF magnesium levels did not change during the 4-hour study. Systemic administration of magnesium sulfate failed to increase CSF ionized magnesium concentration in patients with intracranial hypertension despite increasing plasma magnesium levels by >50%.

  20. Production of magnesium metal

    DOEpatents

    Blencoe, James G.; Anovitz, Lawrence M.; Palmer, Donald A.; Beard, James S.

    2012-04-10

    A process of producing magnesium metal includes providing magnesium carbonate, and reacting the magnesium carbonate to produce a magnesium-containing compound and carbon dioxide. The magnesium-containing compound is reacted to produce magnesium metal. The carbon dioxide is used as a reactant in a second process. In another embodiment of the process, a magnesium silicate is reacted with a caustic material to produce magnesium hydroxide. The magnesium hydroxide is reacted with a source of carbon dioxide to produce magnesium carbonate. The magnesium carbonate is reacted to produce a magnesium-containing compound and carbon dioxide. The magnesium-containing compound is reacted to produce magnesium metal. The invention also relates to the magnesium metal produced by the processes described herein.

  1. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2002-01-01

    Seawater and natural brines accounted for about 60% of US magnesium compounds production in 2001. Dead-burned and caustic-calcined magnesias were recovered from seawater in Florida by Premier Chemicals. They were also recovered from Michigan well brines by Dow Chemical, Martin Marietta Magnesia Specialties and Rohm & Haas. And Premier Chemicals recovered dead-burned and caustic-calcined magnesias from magnesite in Nevada. Reilly Industries and Great Salt Lake Minerals recovered magnesium chloride brines from the Great Salt Lake in Utah.

  2. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2007-01-01

    Seawater and natural brines accounted for about 52 percent of U.S. magnesium compounds production in 2006. Dead-burned magnesia was produced by Martin Marietta Magnesia Specialties from well brines in Michigan. Caustic-calcined magnesia was recovered from sea-water by Premier Chemicals in Florida; from well brines in Michigan by Martin Marietta and Rohm and Haas; and from magnesite in Nevada by Premier Chemicals. Intrepid Potash-Wendover and Great Salt Lake Minerals recovered magnesium chloride brines from the Great Salt Lake in Utah. Magnesium hydroxide was produced from brucite by Applied Chemical Magnesias in Texas, from seawater by SPI Pharma in Delaware and Premier Chemicals in Florida, and by Martin Marietta and Rohm and Haas from their operations mentioned above. About 59 percent of the magnesium compounds consumed in the United States was used for refractories that are used mainly to line steelmaking furnaces. The remaining 41 percent was consumed in agricultural, chemical, construction, environmental and industrial applications.

  3. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2004-01-01

    Dead-burned and caustic-calcined magnesias were recovered from seawater by Premier Chemicals in Florida; from well brines in Michigan by Dow Chemical, Martin Marietta Magnesia Specialties, and Rohm & Haas; and from magnesite in Nevada by Premier Chemicals. Reilly Industries and Great Salt Lake Minerals recovered magnesium chloride brines from the Great Salt Lake in Utah.

  4. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2001-01-01

    Seawater and natural brines accounted for about 63% of US magnesium compounds production during 2000. Premier Services in Florida, Dow Chemical in Michigan, Martin Marietta Magnesia Specialties, and Rohm & Haas recovered dead-burned and caustic-calcined magnesias from seawater. And Premier Services' recoveries, in Nevada, were from magnasite.

  5. High-Dose Pyridoxine and Magnesium Administration in Children with Autistic Disorder: An Absence of Salutary Effects in a Double-Blind, Placebo-Controlled Study.

    ERIC Educational Resources Information Center

    Findling, Robert L.; Maxwell, Kathleen; Scotese-Wojtila, Lynette; Huang, Jie; Yamashita, Toyoko; Wiznitzer, Max

    1997-01-01

    Evaluation of high doses of pyridoxine and magnesium in a 10-week double-blind placebo-controlled trial with 10 patients (mean age 6 years) having autism concluded that the high doses used were ineffective in ameliorating autistic behaviors. (DB)

  6. 21 CFR 182.2437 - Magnesium silicate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium silicate. 182.2437 Section 182.2437 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) SUBSTANCES GENERALLY RECOGNIZED AS SAFE Anticaking Agents § 182.2437 Magnesium silicate. (a) Product....

  7. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2006-01-01

    In 2005, seawater and natural brines accounted for 51% of US magnesium compounds production. World magnesia production was estimated to be 14.5 Mt. Most of the production came from China, North Korea, Russia and Turkey. Although no specific production figures are available, Japan and the United States are estimated to account for almost one-half of the world's capacity from seawater and brines.

  8. Magnesium compounds

    USGS Publications Warehouse

    Kramer, D.A.

    2003-01-01

    Seawater and natural brines accounted for about 60 percent of U.S. magnesium compounds production during 2002. Dead-burned and caustic-calcined magnesias were recovered from seawater by Premier Chemicals in Florida. They were also recovered from well brines in Michigan by Dow Chemical, Martin Marietta Magnesia Specialties and Rohm & Haas. And they were recovered from magnesite in Nevada by Premier Chemicals.

  9. Magnesium in diet

    MedlinePlus

    Diet - magnesium ... Magnesium is needed for more than 300 biochemical reactions in the body. It helps to maintain normal ... There is ongoing research into the role of magnesium in preventing and managing disorders such as high ...

  10. Use of magnesium in traumatic brain injury.

    PubMed

    Sen, Ananda P; Gulati, Anil

    2010-01-01

    Depletion of magnesium is observed in animal brain and in human blood after brain injury. Treatment with magnesium attenuates the pathological and behavioral changes in rats with brain injury; however, the therapeutic effect of magnesium has not been consistently observed in humans with traumatic brain injury (TBI). Secondary brain insults are observed in patients with brain injury, which adversely affect clinical outcome. Systemic administration studies in rats have shown that magnesium enters the brain; however, inducing hypermagnesemia in humans did not concomitantly increase magnesium levels in the CSF. We hypothesize that the neuroprotective effects of magnesium in TBI patients could be observed by increasing its brain bioavailability with mannitol. Here, we review the role of magnesium in brain injury, preclinical studies in brain injury, clinical safety and efficacy studies in TBI patients, brain bioavailability studies in rat, and pharmacokinetic studies in humans with brain injury. Neurodegeneration after brain injury involves multiple biochemical pathways. Treatment with a single agent has often resulted in poor efficacy at a safe dose or toxicity at a therapeutic dose. A successful neuroprotective therapy needs to be aimed at homeostatic control of these pathways with multiple agents. Other pharmacological agents, such as dexanabinol and progesterone, and physiological interventions, with hypothermia and hyperoxia, have been studied for the treatment of brain injury. Treatment with magnesium and hypothermia has shown favorable outcome in rats with cerebral ischemia. We conclude that coadministration of magnesium and mannitol with pharmacological and physiological agents could be an effective neuroprotective regimen for the treatment of TBI. PMID:20129501

  11. Magnesium influence on nicotine pharmacodependence and smoking.

    PubMed

    Nechifor, Mihai; Chelarescu, Dan; Mândreci, Ioan; Cartas, Nicoleta

    2004-09-01

    We followed the magnesium effect (Magne B(6)R, Sanofi-Synthelabo) with internal administration in 53 adult neurotic smoking patients (more than 10 cigarettes/day) of both genders admitted into psychiatric hospital. The nicotine dependence was assessed by the Fagerstrom test, initially and after 28 days of magnesium intake. Plasmatic magnesium level was determined before any therapy and at 28 days. All patients received benzodiazepines during the trial. Our data show that patients that received magnesium therapy showed a significant decrease in the number of cigarettes smoked and Fagerstrom test after 4 weeks [Fagerstrom score 7.93 +/- 0.17 before magnesium therapy versus 6.78 +/- 0.18 (P < 0.05) after 28 days of magnesium therapy]. In the group of smokers who did not receive magnesium, the Fagerstrom score did not change significantly [Fagerstrom score 7.48 +/- 0.22 initial versus 7.24 +/- 0.19 after 28 days]. Magnesium supplementation raised plasmatic levels (17.2 +/- 1.2 mg/L before versus 26.1 +/- 1.6 mg/L after 28 days of magnesium intake, P < 0.01). The results suggest that this cation might be a useful adjuvant in treatment of nicotine pharmacodependence.

  12. Micronized Organic Magnesium Salts Enhance Opioid Analgesia in Rats

    PubMed Central

    Bujalska-Zadrożny, Magdalena; Kulik, Kamila; Ordak, Michał; Sasinowska-Motyl, Małgorzata; Gąsińska, Emilia; de Corde, Anna; Kowalczyk, Agnieszka; Sacharczuk, Mariusz; Naruszewicz, Marek

    2016-01-01

    Purpose As previously reported, magnesium sulphate administered parenterally significantly increased an opioid antinociception in different kinds of pain. Since the typical form of magnesium salts are poorly and slowly absorbed from the gastrointestinal tract we examined whether their micronized form could increase opioids induced antinociception. Methods In behavioural studies on rats morphine, tramadol and oxycodone together with magnesium (lactate dihydrate, hydroaspartate, chloride) in micronized (particles of size D90 < 50 μm) and conventional forms were used. Changes in pain thresholds were determined using mechanical stimuli. The intestinal absorption of two forms of magnesium lactate dihydrate (at the doses of 7.5 or 15 mg ions) in the porcine gut sac model were also compared. Results Micronized form of magnesium lactate dihydrate or hydroaspartate but not chloride (15 mg of magnesium ions kg-1) enhanced the analgesic activity of orally administered opioids, significantly faster and more effective in comparison to the conventional form of magnesium salts (about 40% for oxycodone administered together with a micronized form of magnesium hydroaspartate). Moreover, in vitro studies of transport across porcine intestines of magnesium ions showed that magnesium salts administered in micronized form were absorbed from the intestines to a greater extent than the normal form of magnesium salts. Conclusions The co-administration of micronized magnesium organic salts with opioids increased their synergetic analgesic effect. This may suggest an innovative approach to the treatment of pain in clinical practice. PMID:27792736

  13. Choline Magnesium Trisalicylate

    MedlinePlus

    Choline magnesium trisalicylate is used to relieve the pain, tenderness, inflammation (swelling), and stiffness caused by arthritis and painful ... used to relieve pain and lower fever. Choline magnesium trisalicylate is in a class of nonsteroidal anti- ...

  14. Magnesium and Space Flight

    PubMed Central

    Smith, Scott M.; Zwart, Sara R.

    2015-01-01

    Magnesium is an essential nutrient for muscle, cardiovascular, and bone health on Earth, and during space flight. We sought to evaluate magnesium status in 43 astronauts (34 male, 9 female; 47 ± 5 years old, mean ± SD) before, during, and after 4–6-month space missions. We also studied individuals participating in a ground analog of space flight (head-down-tilt bed rest; n = 27 (17 male, 10 female), 35 ± 7 years old). We evaluated serum concentration and 24-h urinary excretion of magnesium, along with estimates of tissue magnesium status from sublingual cells. Serum magnesium increased late in flight, while urinary magnesium excretion was higher over the course of 180-day space missions. Urinary magnesium increased during flight but decreased significantly at landing. Neither serum nor urinary magnesium changed during bed rest. For flight and bed rest, significant correlations existed between the area under the curve of serum and urinary magnesium and the change in total body bone mineral content. Tissue magnesium concentration was unchanged after flight and bed rest. Increased excretion of magnesium is likely partially from bone and partially from diet, but importantly, it does not come at the expense of muscle tissue stores. While further study is needed to better understand the implications of these findings for longer space exploration missions, magnesium homeostasis and tissue status seem well maintained during 4–6-month space missions. PMID:26670248

  15. Magnesium and Space Flight

    NASA Technical Reports Server (NTRS)

    Smith, Scott M.; Zwart, Sara R.

    2016-01-01

    Magnesium is an essential nutrient for muscle, cardiovascular, and bone health on Earth, and during space flight. We sought to evaluate magnesium status in astronauts before, during, and after space missions, in 43 astronauts (34 male, 9 female) on 4-6 month space flight missions. We also studied individuals participating in a ground analog of space flight, (head-down tilt bed rest, n=27, 35 +/- 7 y). We evaluated serum concentration and 24-hour urinary excretion of magnesium along with estimates of tissue magnesium status from sublingual cells. Serum magnesium increased late in flight, while urinary magnesium excretion was higher over the course of 180-d space missions. Urinary magnesium increased during flight but decreased significantly at landing. Neither serum nor urinary magnesium changed during bed rest. For flight and bed rest, significant correlations existed between the area under the curve of serum and urinary magnesium and the change in total body bone mineral content. Tissue magnesium concentration was unchanged after flight and bed rest. Increased excretion of magnesium is likely partially from bone and partially from diet, but importantly, it does not come at the expense of muscle tissue stores. While further study is needed to better understand the implications of these findings for longer space exploration missions, magnesium homeostasis and tissue status seem well maintained during 4- to 6-month space missions.

  16. Magnesium and Space Flight.

    PubMed

    Smith, Scott M; Zwart, Sara R

    2015-12-08

    Magnesium is an essential nutrient for muscle, cardiovascular, and bone health on Earth, and during space flight. We sought to evaluate magnesium status in 43 astronauts (34 male, 9 female; 47 ± 5 years old, mean ± SD) before, during, and after 4-6-month space missions. We also studied individuals participating in a ground analog of space flight (head-down-tilt bed rest; n = 27 (17 male, 10 female), 35 ± 7 years old). We evaluated serum concentration and 24-h urinary excretion of magnesium, along with estimates of tissue magnesium status from sublingual cells. Serum magnesium increased late in flight, while urinary magnesium excretion was higher over the course of 180-day space missions. Urinary magnesium increased during flight but decreased significantly at landing. Neither serum nor urinary magnesium changed during bed rest. For flight and bed rest, significant correlations existed between the area under the curve of serum and urinary magnesium and the change in total body bone mineral content. Tissue magnesium concentration was unchanged after flight and bed rest. Increased excretion of magnesium is likely partially from bone and partially from diet, but importantly, it does not come at the expense of muscle tissue stores. While further study is needed to better understand the implications of these findings for longer space exploration missions, magnesium homeostasis and tissue status seem well maintained during 4-6-month space missions.

  17. Magnesium and Space Flight.

    PubMed

    Smith, Scott M; Zwart, Sara R

    2015-12-01

    Magnesium is an essential nutrient for muscle, cardiovascular, and bone health on Earth, and during space flight. We sought to evaluate magnesium status in 43 astronauts (34 male, 9 female; 47 ± 5 years old, mean ± SD) before, during, and after 4-6-month space missions. We also studied individuals participating in a ground analog of space flight (head-down-tilt bed rest; n = 27 (17 male, 10 female), 35 ± 7 years old). We evaluated serum concentration and 24-h urinary excretion of magnesium, along with estimates of tissue magnesium status from sublingual cells. Serum magnesium increased late in flight, while urinary magnesium excretion was higher over the course of 180-day space missions. Urinary magnesium increased during flight but decreased significantly at landing. Neither serum nor urinary magnesium changed during bed rest. For flight and bed rest, significant correlations existed between the area under the curve of serum and urinary magnesium and the change in total body bone mineral content. Tissue magnesium concentration was unchanged after flight and bed rest. Increased excretion of magnesium is likely partially from bone and partially from diet, but importantly, it does not come at the expense of muscle tissue stores. While further study is needed to better understand the implications of these findings for longer space exploration missions, magnesium homeostasis and tissue status seem well maintained during 4-6-month space missions. PMID:26670248

  18. Magnesium industry overview

    SciTech Connect

    Clow, B.B.

    1996-10-01

    Magnesium products provide an excellent strength-to-weight ratio, good fatigue strength, high impact strength, good corrosion resistance, high-speed machinability, and good thermal and electrical conductivities. As a result, applications are expanding in almost every industry. Dozens of automotive components are now made of magnesium, including steering wheels, valve covers, and seat frames. Magnesium alloys are also used in computer housings, in-line roller skates, golf clubs, tennis racquets, and baseball bats. Good strength and stiffness at both room and elevated temperatures make magnesium alloys especially valuable for aerospace applications. This article presents an overview of magnesium technology, world production, increasing demand, and recycling.

  19. Magnesium and the Athlete.

    PubMed

    Volpe, Stella Lucia

    2015-01-01

    Magnesium is the fourth most abundant mineral and the second most abundant intracellular divalent cation in the body. It is a required mineral that is involved in more than 300 metabolic reactions in the body. Magnesium helps maintain normal nerve and muscle function, heart rhythm (cardiac excitability), vasomotor tone, blood pressure, immune system, bone integrity, and blood glucose levels and promotes calcium absorption. Because of magnesium's role in energy production and storage, normal muscle function, and maintenance of blood glucose levels, it has been studied as an ergogenic aid for athletes. This article will cover the general roles of magnesium, magnesium requirements, and assessment of magnesium status as well as the dietary intake of magnesium and its effects on exercise performance. The research articles cited were limited from those published in 2003 through 2014. PMID:26166051

  20. Magnesium and the Athlete.

    PubMed

    Volpe, Stella Lucia

    2015-01-01

    Magnesium is the fourth most abundant mineral and the second most abundant intracellular divalent cation in the body. It is a required mineral that is involved in more than 300 metabolic reactions in the body. Magnesium helps maintain normal nerve and muscle function, heart rhythm (cardiac excitability), vasomotor tone, blood pressure, immune system, bone integrity, and blood glucose levels and promotes calcium absorption. Because of magnesium's role in energy production and storage, normal muscle function, and maintenance of blood glucose levels, it has been studied as an ergogenic aid for athletes. This article will cover the general roles of magnesium, magnesium requirements, and assessment of magnesium status as well as the dietary intake of magnesium and its effects on exercise performance. The research articles cited were limited from those published in 2003 through 2014.

  1. The influence of combined magnesium and vanadate administration on the level of some elements in selected rat organs: V-Mg interactions and the role of iron-essential protein (DMT-1) in the mechanism underlying altered tissues iron level.

    PubMed

    Scibior, Agnieszka; Adamczyk, Agnieszka; Gołębiowska, Dorota; Niedźwiecka, Irmina; Fornal, Emilia

    2014-04-01

    The effect of 12 week co-administration of sodium metavanadate (SMV) and magnesium sulfate (MS) on the levels of some elements in selected rats' organs and an attempt to elucidate a role of divalent metal transporter 1 (DMT-1) in the mechanism(s) of the SMV-induced disorders in some tissue Fe homeostasis were studied. SMV taken up separately or in combination with MS may pose a risk of the rise and shortage of the total hepatic and splenic Fe and Cu contents, respectively, cerebral Fe deficiency, splenic Ca deposition, and the hepatic, renal, and cerebral DMT-1 down-regulation. When administered alone, SMV may also cause the decrease in the total renal Fe and Cu contents. A visible protective effect of Mg against the renal and cerebral V accumulation and the decrease in the renal Fe and Cu contents during the SMV-MS co-administration together with our previous findings suggest a beneficial role of Mg at SMV exposure. Further, the SMV-induced fall in total iron binding capacity (TIBC), reported previously, and its correlations with the hepatic, splenic, and cerebral Fe levels allow us to suggest that diminished TIBC could be partly involved in the mechanism(s) responsible for the dramatic redistribution of Fe in those tissues. Finally, DMT-1, which potentially could participate in the hepatic non-transferrin Fe-bound uptake, does not play a significant role in this process indicating the need for studying other Fe transporters to more precisely elucidate molecular mechanism(s) underlying the hepatic Fe loading in our experimental conditions.

  2. Magnesium degradation products: effects on tissue and human metabolism.

    PubMed

    Seitz, J-M; Eifler, R; Bach, Fr-W; Maier, H J

    2014-10-01

    Owing to their mechanical properties, metallic materials present a promising solution in the field of resorbable implants. The magnesium metabolism in humans differs depending on its introduction. The natural, oral administration of magnesium via, for example, food, essentially leads to an intracellular enrichment of Mg(2+) . In contrast, introducing magnesium-rich substances or implants into the tissue results in a different decomposition behavior. Here, exposing magnesium to artificial body electrolytes resulted in the formation of the following products: magnesium hydroxide, magnesium oxide, and magnesium chloride, as well as calcium and magnesium apatites. Moreover, it can be assumed that Mg(2+) , OH(-) ions, and gaseous hydrogen are also present and result from the reaction for magnesium in an aqueous environment. With the aid of physiological metabolic processes, the organism succeeds in either excreting the above mentioned products or integrating them into the natural metabolic process. Only a burst release of these products is to be considered a problem. A multitude of general tissue effects and responses from the Mg's degradation products is considered within this review, which is not targeting specific implant classes. Furthermore, common alloying elements of magnesium and their hazardous potential in vivo are taken into account.

  3. [Magnesium and exercise].

    PubMed

    Bielinski, R W

    2006-07-26

    The determination of the magnesium status is difficult, since a cheep, sensitive and usable test remains to be found. Serum magnesium only signals severe deficiencies, which are in athletes. Blood cell magnesium may detect a subclinical deficiency, the significance of which is however very controversial. The "magnesium loading test" is the standard method, but it is too complex for the practice. A mixed diet with sufficient energy covers the needs of athletes of all levels. When the plasma magnesium levels are in normal range, supplements offer no significant benefits in terms of performance. The usefulness of magnesium in the treatment of exercise related muscle cramps is most probably widely exaggerated. Various other electrolyte dysbalances as well as venous insufficiency are certainly more important factors.

  4. Magnesium in pregnancy.

    PubMed

    Dalton, Lynne M; Ní Fhloinn, Deirdre M; Gaydadzhieva, Gergana T; Mazurkiewicz, Ola M; Leeson, Heather; Wright, Ciara P

    2016-09-01

    Magnesium deficiency is prevalent in women of childbearing age in both developing and developed countries. The need for magnesium increases during pregnancy, and the majority of pregnant women likely do not meet this increased need. Magnesium deficiency or insufficiency during pregnancy may pose a health risk for both the mother and the newborn, with implications that may extend into adulthood of the offspring. The measurement of serum magnesium is the most widely used method for determining magnesium levels, but it has significant limitations that have both hindered the assessment of deficiency and affected the reliability of studies in pregnant women. Thus far, limited studies have suggested links between magnesium inadequacy and certain conditions in pregnancy associated with high mortality and morbidity, such as gestational diabetes, preterm labor, preeclampsia, and small for gestational age or intrauterine growth restriction. This review provides recommendations for further study and improved testing using measurement of red cell magnesium. Pregnant women should be counseled to increase their intake of magnesium-rich foods such as nuts, seeds, beans, and leafy greens and/or to supplement with magnesium at a safe level. PMID:27445320

  5. Magnesium in pregnancy.

    PubMed

    Dalton, Lynne M; Ní Fhloinn, Deirdre M; Gaydadzhieva, Gergana T; Mazurkiewicz, Ola M; Leeson, Heather; Wright, Ciara P

    2016-09-01

    Magnesium deficiency is prevalent in women of childbearing age in both developing and developed countries. The need for magnesium increases during pregnancy, and the majority of pregnant women likely do not meet this increased need. Magnesium deficiency or insufficiency during pregnancy may pose a health risk for both the mother and the newborn, with implications that may extend into adulthood of the offspring. The measurement of serum magnesium is the most widely used method for determining magnesium levels, but it has significant limitations that have both hindered the assessment of deficiency and affected the reliability of studies in pregnant women. Thus far, limited studies have suggested links between magnesium inadequacy and certain conditions in pregnancy associated with high mortality and morbidity, such as gestational diabetes, preterm labor, preeclampsia, and small for gestational age or intrauterine growth restriction. This review provides recommendations for further study and improved testing using measurement of red cell magnesium. Pregnant women should be counseled to increase their intake of magnesium-rich foods such as nuts, seeds, beans, and leafy greens and/or to supplement with magnesium at a safe level.

  6. 21 CFR 184.1431 - Magnesium oxide.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Magnesium oxide. 184.1431 Section 184.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) FOOD FOR HUMAN CONSUMPTION (CONTINUED) DIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE Listing of...

  7. 21 CFR 184.1431 - Magnesium oxide.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium oxide. 184.1431 Section 184.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) DIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE Listing of Specific Substances Affirmed...

  8. 21 CFR 184.1431 - Magnesium oxide.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium oxide. 184.1431 Section 184.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) FOOD FOR HUMAN CONSUMPTION (CONTINUED) DIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE Listing...

  9. 21 CFR 184.1431 - Magnesium oxide.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium oxide. 184.1431 Section 184.1431 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) FOOD FOR HUMAN CONSUMPTION (CONTINUED) DIRECT FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE Listing...

  10. Effect of 12-week vanadate and magnesium co-administration on chosen haematological parameters as well as on some indices of iron and copper metabolism and biomarkers of oxidative stress in rats.

    PubMed

    Scibior, Agnieszka; Adamczyk, Agnieszka; Gołębiowska, Dorota; Niedźwiecka, Irmina

    2012-09-01

    Changes in some blood parameters after 12-week administration of sodium metavanadate (SMV; 0.125mgV/ml) or/and magnesium sulphate (MS; 0.06mgMg/ml) in drinking water were studied in outbred male Wistar rats (16 rats/each group) to explore the probable mechanism(s) underlying SMV toxicity and check whether Mg at the level selected during SMV co-administration can protect, at least in part, from a possible deleterious action of SMV. Exposure to SMV alone and in combination with MS (a) led to a decrease in fluid and food intake and body weight gain; (b) predisposed the animals to the development of microcytic-hypochromic anaemia (with excessive liver and spleen Fe deposition, unaltered plasma Fe level and enhanced Zn concentration in the erythrocytes (RBCs) characterized by a reduced haematocrit (Ht) index and haemoglobin (Hb) level, unchanged erythrocyte and reticulocyte count, anisocytosis, lowered total iron binding capacity (TIBC) and elevated transferrin saturation (TS); (c) disturbed Cu homeostasis, but (d) did not influence the leukocyte count and the plasma total antioxidant status (TAS). We suggest that abnormal metabolism and accumulation of Fe as well as an altered Cu status and the RBC Zn level might lead to defective Fe utilization and be a factor promoting the development of Fe-utilization anaemia. The disturbances in the antioxidative capacity reported previously in rats' RBCs after SMV intoxication (Ścibior, Zaporowska, Environ. Toxicol. Pharmacol. 30 (2010) 153-161) may suggest that oxidative stress (OS) could also be, in part, involved in the mechanism responsible for the development of anaemia. The Mg dose ingested in combination with V under SMV-MS co-administration (a) was able to decrease, to some extent, the V concentration in the blood, (b) normalized the RBC Mg and Fe levels and (c) restored the values of some parameters of the Fe status near the control values. These results allow a supposition that a higher Mg dose consumed during SMV

  11. Magnesium deficiency: what's our status?

    Technology Transfer Automated Retrieval System (TEKTRAN)

    Low magnesium intake has been implicated in a broad range of cardiometabolic conditions, including diabetes, hypertension, and cardiovascular disease. Dietary magnesium and total body magnesium status have a widely-used but imperfect biomarker in serum magnesium. Despite serum magnesium’s limitation...

  12. Method for production of magnesium

    DOEpatents

    Diaz, A.F.; Howard, J.B.; Modestino, A.J.; Peters, W.A.

    1998-07-21

    A continuous process for the production of elemental magnesium is described. Magnesium is made from magnesium oxide and a light hydrocarbon gas. In the process, a feed stream of the magnesium oxide and gas is continuously fed into a reaction zone. There the magnesium oxide and gas are reacted at a temperature of about 1400 C or greater in the reaction zone to provide a continuous product stream of reaction products, which include elemental magnesium. The product stream is continuously quenched after leaving the reaction zone, and the elemental magnesium is separated from other reaction products. 12 figs.

  13. Method for production of magnesium

    DOEpatents

    Diaz, Alexander F.; Howard, Jack B.; Modestino, Anthony J.; Peters, William A.

    1998-01-01

    A continuous process for the production of elemental magnesium is described. Magnesium is made from magnesium oxide and a light hydrocarbon gas. In the process, a feed stream of the magnesium oxide and gas is continuously fed into a reaction zone. There the magnesium oxide and gas are reacted at a temperature of about 1400.degree. C. or greater in the reaction zone to provide a continuous product stream of reaction products, which include elemental magnesium. The product stream is continuously quenched after leaving the reaction zone, and the elemental magnesium is separated from other reaction products.

  14. Magnesium battery disposal characteristics

    NASA Astrophysics Data System (ADS)

    Soffer, Louis; Atwater, Terrill

    1994-12-01

    This study assesses the disposal characteristics of U.S. Army procured military magnesium batteries under current Resource Conservation and Recovery Act (RCRA) hazardous waste identification regulations administered by the U.S. Environmental Protection Agency. Magnesium batteries were tested at 100, 50, 10 and 0 percent remaining state of charge. Present findings indicate that magnesium batteries with less than 50 percent remaining charge do not exceed the federal regulatory limit of 5.0 mg/L for chromium. All other RCRA contaminates were below regulatory limits at all levels of remaining charge. Assay methods, findings, disposal requirements and design implications are discussed.

  15. Magnesium blood test

    MedlinePlus

    Magnesium - blood ... A blood sample is needed. ... When the needle is inserted to draw blood, some people feel slight pain. Others feel a prick or stinging. Afterward, there may be some throbbing or a slight bruise. This soon ...

  16. Magnesium for automotive applications

    SciTech Connect

    VanFleteren, R.

    1996-05-01

    Die cast magnesium parts are rapidly replacing steel and aluminum structural components in automotive applications, as design engineers seek to reduce assembly costs, raise fuel efficiency, and improve safety. Dozens of automotive components are now die cast from magnesium alloys, including seat stanchions, valve covers, steering wheels, and a variety of steering column components. Because of their excellent castability, complex magnesium die castings can sometimes consolidate several components and eliminate assembly steps. Highly ductile magnesium alloys such as AM60B (6% aluminum) and AM50A (5% aluminum) are important in helping to meet automotive industry crash-energy requirements for car seating and steering components. AZ91D (9% aluminum, 1% zinc) alloys are making removable rear seats in new minivans much easier to handle.

  17. 78 FR 1834 - Magnesium Metal From the People's Republic of China: Preliminary Results of Antidumping Duty...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-01-09

    ... Notice of Antidumping Duty Order: Magnesium Metal From the People's Republic of China, 70 FR 19928 (April... Order, Finding, or Suspended Investigation; Opportunity To Request Administrative Review, 77 FR 19621... Countervailing Duty Administrative Review, 77 FR 31568 (May 29, 2012). \\4\\ See letter from TMI, ``Magnesium...

  18. Interstellar magnesium abundances

    NASA Technical Reports Server (NTRS)

    Murray, M. J.; Dufton, P. L.; Hibbert, A.; York, D. G.

    1984-01-01

    An improved evaluation of the Mg II 1240 A doublet oscillator strength is used in conjunction with recently published Copernicus observations to derive accurate Mg II column densities toward 74 stars. These imply an average of 40 percent of interstellar magnesium is in the gaseous phase. Magnesium depletion is examined as a function of various interstellar extinction and density parameters, and the results are briefly discussed in terms of current depletion theories.

  19. Rechargeable Magnesium Power Cells

    NASA Technical Reports Server (NTRS)

    Koch, Victor R.; Nanjundiah, Chenniah; Orsini, Michael

    1995-01-01

    Rechargeable power cells based on magnesium anodes developed as safer alternatives to high-energy-density cells like those based on lithium and sodium anodes. At cost of some reduction in energy density, magnesium-based cells safer because less susceptible to catastrophic meltdown followed by flames and venting of toxic fumes. Other advantages include ease of handling, machining, and disposal, and relatively low cost.

  20. Electrodeposition of magnesium and magnesium/aluminum alloys

    DOEpatents

    Mayer, A.

    1988-01-21

    Electrolytes and plating solutions for use in processes for electroplating and electroforming pure magnesium and alloys of aluminum and magnesium and also electrodeposition processes. An electrolyte of this invention is comprised of an alkali metal fluoride or a quaternary ammonium halide, dimethyl magnesium and/or diethyl magnesium, and triethyl aluminum and/or triisobutyl aluminum. An electrolyte may be dissolved in an aromatic hydrocarbon solvent to form a plating solution. The proportions of the component compounds in the electrolyte are varied to produce essentially pure magnesium or magnesium/aluminum alloys having varying selected compositions.

  1. Electrodeposition of magnesium and magnesium/aluminum alloys

    DOEpatents

    Mayer, Anton

    1988-01-01

    Electrolytes and plating solutions for use in processes for electroplating and electroforming pure magnesium and alloys of aluminum and magnesium and also electrodeposition processes. An electrolyte of this invention is comprised of an alkali metal fluoride or a quaternary ammonium halide, dimethyl magnesium and/or diethyl magnesium, and triethyl aluminum and/or triisobutyl aluminum. An electrolyte may be dissolved in an aromatic hydrocarbon solvent to form a plating solution. The proportions of the component compounds in the electrolyte are varied to produce essentially pure magnesium or magnesium/aluminum alloys having varying selected compositions.

  2. 75 FR 78968 - Magnesium Metal From the Russian Federation: Extension of Time Limit for Preliminary Results of...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-12-17

    ... Antidumping and Countervailing Duty Administrative Reviews, 75 FR 29976 (May 28, 2010). The preliminary... International Trade Administration Magnesium Metal From the Russian Federation: Extension of Time Limit for... a notice of initiation of an administrative review of the antidumping duty order on magnesium...

  3. 21 CFR 184.1434 - Magnesium phosphate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Magnesium phosphate. 184.1434 Section 184.1434... Listing of Specific Substances Affirmed as GRAS § 184.1434 Magnesium phosphate. (a) Magnesium phosphate includes both magnesium phosphate, dibasic, and magnesium phosphate, tribasic. Magnesium phosphate,...

  4. 21 CFR 184.1434 - Magnesium phosphate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium phosphate. 184.1434 Section 184.1434... Listing of Specific Substances Affirmed as GRAS § 184.1434 Magnesium phosphate. (a) Magnesium phosphate includes both magnesium phosphate, dibasic, and magnesium phosphate, tribasic. Magnesium phosphate,...

  5. 21 CFR 184.1434 - Magnesium phosphate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium phosphate. 184.1434 Section 184.1434... Listing of Specific Substances Affirmed as GRAS § 184.1434 Magnesium phosphate. (a) Magnesium phosphate includes both magnesium phosphate, dibasic, and magnesium phosphate, tribasic. Magnesium phosphate,...

  6. 21 CFR 184.1434 - Magnesium phosphate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium phosphate. 184.1434 Section 184.1434... GRAS § 184.1434 Magnesium phosphate. (a) Magnesium phosphate includes both magnesium phosphate, dibasic, and magnesium phosphate, tribasic. Magnesium phosphate, dibasic (MgHPO4·3H2O, CAS Reg. No....

  7. 21 CFR 184.1434 - Magnesium phosphate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Magnesium phosphate. 184.1434 Section 184.1434 Food... Specific Substances Affirmed as GRAS § 184.1434 Magnesium phosphate. (a) Magnesium phosphate includes both magnesium phosphate, dibasic, and magnesium phosphate, tribasic. Magnesium phosphate, dibasic...

  8. Aluminum Hydroxide and Magnesium Hydroxide

    MedlinePlus

    Aluminum Hydroxide, Magnesium Hydroxide are antacids used together to relieve heartburn, acid indigestion, and upset stomach. They ... They combine with stomach acid and neutralize it. Aluminum Hydroxide, Magnesium Hydroxide are available without a prescription. ...

  9. Calcium carbonate with magnesium overdose

    MedlinePlus

    The combination of calcium carbonate and magnesium is commonly found in antacids. These medicines provide heartburn relief. Calcium carbonate with magnesium overdose occurs when someone takes more than the ...

  10. Corrosion in Magnesium and a Magnesium Alloy

    NASA Astrophysics Data System (ADS)

    Akavipat, Sanay

    Magnesium and a magnesium alloy (AZ91C) have been ion implanted over a range of ions energies (50 to 150 keV) and doses (1 x 10('16) to 2 x 10('17) ions/cm('2)) to modify the corrosion properties of the metals. The corrosion tests were done by anodic polarization in chloride -free and chloride-containing aqueous solutions of a borated -boric acid with a pH of 9.3. Anodic polarization measurements showed that some implantations could greatly reduce the corrosion current densities at all impressed voltages and also increased slightly the pitting potential, which indicated the onset of the chloride attack. These improvements in corrosion resistance were caused by boron implantations into both types of samples. However, iron implantations were found to improve only the magnesium alloy. To study the corrosion in more detail, Scanning Auger Microprobe Spectrometer (SAM), Scanning Electron Microscope (SEM) with an X-ray Energy Spectrometry (XES) attachment, and Transmission Electron Microscope (TEM) measurements were used to analyze samples before, after, and at various corrosion stages. In both the unimplanted pure magnesium and AZ91C samples, anodic polarization results revealed that there were three active corrosion stages (Stages A, C, and E) and two passivating stages (Stages B and D). Examination of Stages A and B in both types of samples showed that only a mild, generalized corrosion had occurred. In Stage C of the TD samples, a pitting breakdown in the initial oxide film was observed. In Stage C of the AZ91C samples, galvanic and intergranular attack around the Mg(,17)Al(,12) intermetallic islands and along the matrix grain boundaries was observed. Stage D of both samples showed the formation of a thick, passivating oxygen containing, probably Mg(OH)(,2) film. In Stage E, this film was broken down by pits, which formed due to the presence of the chloride ions in both types of samples. Stages A through D of the unimplanted samples were not seen in the boron or iron

  11. Effects of thyroid status on renal calcium and magnesium handling.

    PubMed Central

    McCaffrey, C; Quamme, G A

    1984-01-01

    Renal calcium and magnesium handling was studied in rats with chronic thyroid hormone deficiency or excess, hyperthyroidism. Mean kidney weight of the thyroid deficient rats was 42% of age matched, euthyroid and hyperthyroid animals and glomerular filtration rate was 71% of normal. Fractional sodium excretion was consistently elevated in thyroid deficient rats (0.26%) as compared to euthyroid (0.07%) and hyperthyroid animals (0.07%). Urinary calcium excretion (0.39%) was also elevated and parallel to sodium excretion in thyroid deficiency. Despite this renal leak of sodium and calcium, thyroid deficient animals conserved magnesium much more efficiently than either euthyroid or hyperthyroid rats (5.7% vs 17.4% respectively). Plasma magnesium concentration was elevated by acute MgCl2 infusions to determine the reabsorptive capacity of magnesium. Thyroid deficient rats reabsorbed 15-30% more of the filtered magnesium at any given plasma concentration. Although these effects on electrolyte reabsorption are modest compared to the hemodynamic alterations, the data suggest that thyroid hormone has a direct effect on the tubule which if chronically absent results in subtle sodium and calcium wasting and renal retention of magnesium. Administration of thyroid hormone to euthyroid or thyroid deficient rats twenty-four hours prior to experimentation had no effect on calcium and magnesium handling. PMID:6713257

  12. Magnesium Research and Technology Development

    SciTech Connect

    Nyberg, Eric A.; Joost, William; Smith, Mark T.

    2009-12-30

    The Magnesium Research and Technical Development (MR&TD) project supports efforts to increase using magnesium in automotive applications, including improving technology, lowering costs and increasing the knowledge needed to enable alloy and manufacturing process optimization. MR&TD supports the U.S. Department of Energy (DOE)/United States Automotive Materials Partnership (USAMP) Magnesium Front End Research and Development (MFERD) project in collaboration with China and Canada. The MR&TD projects also maintains the magnesium bibliographic database at magnesium.pnl.gov.

  13. Oral magnesium supplementation in type II diabetic patients

    PubMed Central

    Solati, Mehrdad; Ouspid, Elham; Hosseini, Saeedeh; Soltani, Nepton; Keshavarz, Mansoor; Dehghani, Mohsen

    2014-01-01

    Background: Magnesium is the second most abundant intracellular cation. It plays an important role in insulin homeostasis and glucose metabolism through multiple enzymatic reactions. With increasing data on magnesium deficiency in diabetic patients and epidemiological studies demonstrating magnesium deficiency as a risk factor for diabetes, it is logical to search for its possible beneficial effects on diabetes control and prevention. We aimed to determine whether oral magnesium supplementation improves metabolic control, lipid profile and blood pressure in patients with type II diabetes. Methods: Fifty four patients with type II diabetes were included in a randomized double blind placebocontrolled clinical trial.Patients received either placebo or 300 mg elemental magnesium (as magnesium sulfate -MgSo4-) daily, for 3 months. Metabolic control, lipid profile, blood pressure, magnesium status, hepatic enzymes, hemoglobin concentration, and anthropometric indices were determined in the beginning and at the end of the study. Results: Daily administration of 300 mg elemental magnesium for 3 months, significantly improved fasting blood glucose (183.9±15.43 to 125.8±6.52 vs. 196.5±28.12 to 136.5±7.94, p< 0.0001), 2-hour post prandial glucose (239.1±74.75 to 189.1±60mg/dl vs. 246.4±97.37 to 247.8±86.74mg/dl, p< 0.01), lipid profile, blood pressure and hepatic enzymes. Conclusion: Oral magnesium supplementation with proper dosage has beneficial effects on blood glucose, lipid profile, and blood pressure in patients with type II diabetes. PMID:25405132

  14. Effect of magnesium ion upon the calcitonin content of rat thyroid.

    PubMed

    Gozariu, L; Orbai, P; Barabas, E

    1984-01-01

    Thyroid calcitonin level was assayed in male rats after administration of magnesium gluconolactate. The resulting acute hypermagnesemia caused a significant decrease in calcitonin. However, calcemia showed unimportant changes, which suggests that the inhibitory action of magnesium is exerted directly on calcitonin secretion and is not affected by the calcium ion. PMID:6494785

  15. 21 CFR 201.312 - Magnesium sulfate heptahydrate; label declaration on drug products.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 4 2011-04-01 2011-04-01 false Magnesium sulfate heptahydrate; label declaration on drug products. 201.312 Section 201.312 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF... Drug Products § 201.312 Magnesium sulfate heptahydrate; label declaration on drug products....

  16. 21 CFR 201.312 - Magnesium sulfate heptahydrate; label declaration on drug products.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 4 2012-04-01 2012-04-01 false Magnesium sulfate heptahydrate; label declaration on drug products. 201.312 Section 201.312 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF... Drug Products § 201.312 Magnesium sulfate heptahydrate; label declaration on drug products....

  17. 21 CFR 201.312 - Magnesium sulfate heptahydrate; label declaration on drug products.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 4 2013-04-01 2013-04-01 false Magnesium sulfate heptahydrate; label declaration on drug products. 201.312 Section 201.312 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF... Drug Products § 201.312 Magnesium sulfate heptahydrate; label declaration on drug products....

  18. 21 CFR 201.312 - Magnesium sulfate heptahydrate; label declaration on drug products.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 4 2014-04-01 2014-04-01 false Magnesium sulfate heptahydrate; label declaration on drug products. 201.312 Section 201.312 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF... Drug Products § 201.312 Magnesium sulfate heptahydrate; label declaration on drug products....

  19. 21 CFR 201.312 - Magnesium sulfate heptahydrate; label declaration on drug products.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 4 2010-04-01 2010-04-01 false Magnesium sulfate heptahydrate; label declaration on drug products. 201.312 Section 201.312 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF... Drug Products § 201.312 Magnesium sulfate heptahydrate; label declaration on drug products....

  20. 75 FR 63440 - Pure Magnesium From the People's Republic of China: Extension of Time for the Final Results of...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-10-15

    ..., 2009. See Pure Magnesium from the People's Republic of China: Preliminary Results of the 2008-2009 Antidumping Duty Administrative Review, 75 FR 34689 (June 18, 2010). The final results of review are currently... International Trade Administration Pure Magnesium From the People's Republic of China: Extension of Time for...

  1. 75 FR 2108 - Pure Magnesium from the People's Republic of China: Extension of Time for the Preliminary Results...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-01-14

    ... Request Administrative Review, 74 FR 20278 (May 1, 2009). Respondent, Tianjin Magnesium International Co... Reviews and Requests for Revocation in Part, 74 FR 30052 (June 24, 2009). Currently, the preliminary... International Trade Administration Pure Magnesium from the People's Republic of China: Extension of Time for...

  2. 75 FR 50992 - Magnesium Metal from the People's Republic of China: Extension of Time for the Final Results of...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-08-18

    ..., 2009. See Magnesium Metal from the People's Republic of China: Preliminary Results of the 2008-2009 Antidumping Duty Administrative Review, 75 FR 20817 (April 21, 2010). The final results of review are... International Trade Administration Magnesium Metal from the People's Republic of China: Extension of Time...

  3. Inhaled magnesium fluoride reverse bronchospasma.

    PubMed

    Gandia, Fedoua; Rouatbi, Sonia; Latiri, Imed; Guénard, Hervé; Tabka, Zouhair

    2010-01-01

    Asthma is a global health problem. Asthma attacks are becoming more severe and more resistant to usual treatment by beta(2) agonists nebulisation. The search for a new product that could reduce the morbidity of asthmatic disease seems necessary. The objective of this study was to compare the effectiveness of inhaled magnesium fluoride (MgF(2)) with that of magnesium sulphate (MgSO(4)) 15% alone and sodium fluoride (NaF) 0.5 M alone in rats pre-contracted by methacholine (MeCh). Fifty six adult male Wistar rats of medium weight 259 +/- 15 g were divided randomly into five groups. They inhaled respectively: MeCh, MgF(2) + NaCl 0.9%, MgF(2) + acetic acid, MgSO(4) 15% single and NaF (0.5 M) single. Airway resistances were measured after each dose of MeCh by pneumomultitest equipment. Results indicated that (1) MgF(2) + NaCl 0.9%, MgF(2) + acetic acid and MgSO(4) reversed significantly the methacholine-induced bronchial constriction in rats and had a bronchodilating effect at the moment of its administration (2) MgF(2) + acetic acid led to a greater decrease (P<0.05) of bronchial resistances when compared to that obtained from MgF(2) + NaCl 0.9%, NaF exclusively and MgSO(4) alone (3) inhaled NaF alone led to a significant bronchorelaxing effect (P<0.05) that starts at the sixth dose of MeCh (17 mg/L). As a matter of fact, MgF(2) dissolved in acetic acid and delivered in aerosol form reduces significantly bronchial spasm. In conclusion, MgF(2) can be used as a bronchodilator for diseases with bronchospasma such as asthma and chronic obstructive pulmonary disease (COPD).

  4. Suppression of exercise-induced angina by magnesium sulfate in patients with variant angina

    SciTech Connect

    Kugiyama, K.; Yasue, H.; Okumura, K.; Goto, K.; Minoda, K.; Miyagi, H.; Matsuyama, K.; Kojima, A.; Koga, Y.; Takahashi, M.

    1988-11-01

    The effects of intravenous magnesium on exercise-induced angina were examined in 15 patients with variant angina and in 13 patients with stable effort angina and were compared with those of placebo. Symptom-limited bicycle exercise and thallium-201 myocardial scintigraphy were performed after intravenous administration of 0.27 mmol/kg body weight of magnesium sulfate and after placebo on different days. In all patients, serum magnesium levels after administration of magnesium sulfate were about twofold higher than levels after placebo. Exercise-induced angina associated with transient ST segment elevation occurred in 11 patients with variant angina receiving placebo and in only 2 of these patients receiving magnesium (p less than 0.005). On the other hand, exercise-induced angina was not suppressed by magnesium in any patient with stable effort angina. In these patients there was no significant difference in exercise duration after administration of placebo versus after administration of magnesium. The size of the perfusion defect as measured by thallium-201 scintigraphy was significantly less in patients with variant angina receiving magnesium than that in those receiving placebo (p less than 0.001), whereas it was not significantly different in patients with stable effort angina receiving placebo versus magnesium. In conclusion, exercise-induced angina is suppressed by intravenous magnesium in patients with variant angina but not in patients with stable effort angina. This beneficial effect of magnesium in patients with variant angina is most likely due to improvement of regional myocardial blood flow by suppression of coronary artery spasm.

  5. Nondestructive spot test method for magnesium and magnesium alloys

    NASA Technical Reports Server (NTRS)

    Wilson, M. L. (Inventor)

    1973-01-01

    A method for spot test identification of magnesium and various magnesium alloys commonly used in aerospace applications is described. The spot test identification involves color codes obtained when several drops of 3 M hydrochloric acid are placed on the surface to be tested. After approximately thirty seconds, two drops of this reacted acid is transferred to each of two depressions in a spot plate for additions of other chemicals with subsequent color changes indicating magnesium or its alloy.

  6. Highly Soluble Alkoxide Magnesium Salts for Rechargeable Magnesium Batteries

    SciTech Connect

    Liao, Chen; Guo, Bingkun; Jiang, Deen; Custelcean, Radu; Mahurin, Shannon Mark; Sun, Xiao-Guang; Dai, Sheng

    2014-01-01

    A unique class of air-stable and non-pyrophoric magnesium electrolytes has been developed based on alkoxide magnesium compounds. The crystals obtained from this class of electrolytes exhibit a unique structure of tri-magnesium cluster, [Mg3Cl3(OR)2(THF)6]+ [(THF)MgCl3] . High reversible capacities and good rate capabilities were obtained in Mg-Mo6S8 batteries using these new electrolytes at both 20 and 50 oC.

  7. Magnesium fluoride recovery method

    DOEpatents

    Gay, Richard L.; McKenzie, Donald E.

    1989-01-01

    A method of obtaining magnesium fluoride substantially free from radioactive uranium from a slag containing the same and having a radioactivity level of at least about 7000 pCi/gm. The slag is ground to a particle size of about 200 microns or less. The ground slag is contacted with an acid under certain prescribed conditions to produce a liquid product and a particulate solid product. The particulate solid product is separated from the liquid and treated at least two more times with acid to produce a solid residue consisting essentially of magnesium fluoride substantially free of uranium and having a residual radioactivity level of less than about 1000 pCi/gm. In accordance with a particularly preferred embodiment of the invention a catalyst and an oxidizing agent are used during the acid treatment and preferably the acid is sulfuric acid having a strength of about 1.0 Normal.

  8. [Magnesium and pregnancy].

    PubMed

    Yamasaki, Mineo

    2012-08-01

    Blood levels of total Mg, ionized Mg and intracellular ionized Mg of platelet were lowered in the 2nd trimester of gestation and thereafter. Urinary excretion of Mg does not change during the whole period of pregnancy. According to our results of animal experiments, intestinal absorption of Mg does not increase during pregnancy compared with non-pregnant state. These data suggest pregnant women tend to become magnesium deficiency. This is reflected in the fact that Mg metabolic parameters of pregnant women with preeclampsia are relatively reduced compared with those of healthy gravidae. In the obstetrical practice Mg has other significance, because magnesium sulfate is frequently used as a drug of choice in the therapy of threatened premature delivery and eclampsia. Mg plays important roles in physiology and pharmacology during gestation. PMID:22846356

  9. Constraining magnesium cycling in marine sediments using magnesium isotopes

    NASA Astrophysics Data System (ADS)

    Higgins, J. A.; Schrag, D. P.

    2010-09-01

    Magnesium concentrations in deep-sea sediment pore-fluids typically decrease down core due to net precipitation of dolomite or clay minerals in the sediments or underlying crust. To better characterize and differentiate these processes, we have measured magnesium isotopes in pore-fluids and sediment samples from Ocean Drilling Program sites (1082, 1086, 1012, 984, 1219, and 925) that span a range of oceanographic settings. At all sites, magnesium concentrations decrease with depth. At sites where diagenetic reactions are dominated by the respiration of organic carbon, pore-fluid δ 26Mg values increase with depth by as much as 2‰. Because carbonates preferentially incorporate 24Mg (low δ 26Mg), the increase in pore-fluid δ 26Mg values at these sites is consistent with the removal of magnesium in Mg-carbonate (dolomite). In contrast, at sites where the respiration of organic carbon is not important and/or weatherable minerals are abundant, pore-fluid δ 26Mg values decrease with depth by up to 2‰. The decline in pore-fluid δ 26Mg at these sites is consistent with a magnesium sink that is isotopically enriched relative to the pore-fluid. The identity of this enriched magnesium sink is likely clay minerals. Using a simple 1D diffusion-advection-reaction model of pore-fluid magnesium, we estimate rates of net magnesium uptake/removal and associated net magnesium isotope fractionation factors for sources and sinks at all sites. Independent estimates of magnesium isotope fractionation during dolomite precipitation from measured δ 26Mg values of dolomite samples from sites 1082 and 1012 are very similar to modeled net fractionation factors at these sites, suggesting that local exchange of magnesium between sediment and pore-fluid at these sites can be neglected. Our results indicate that the magnesium incorporated in dolomite is 2.0-2.7‰ depleted in δ 26Mg relative to the precipitating fluid. Assuming local exchange of magnesium is minor at the rest of the

  10. Magnesium in Prevention and Therapy.

    PubMed

    Gröber, Uwe; Schmidt, Joachim; Kisters, Klaus

    2015-09-23

    Magnesium is the fourth most abundant mineral in the body. It has been recognized as a cofactor for more than 300 enzymatic reactions, where it is crucial for adenosine triphosphate (ATP) metabolism. Magnesium is required for DNA and RNA synthesis, reproduction, and protein synthesis. Moreover, magnesium is essential for the regulation of muscular contraction, blood pressure, insulin metabolism, cardiac excitability, vasomotor tone, nerve transmission and neuromuscular conduction. Imbalances in magnesium status-primarily hypomagnesemia as it is seen more common than hypermagnesemia-might result in unwanted neuromuscular, cardiac or nervous disorders. Based on magnesium's many functions within the human body, it plays an important role in prevention and treatment of many diseases. Low levels of magnesium have been associated with a number of chronic diseases, such as Alzheimer's disease, insulin resistance and type-2 diabetes mellitus, hypertension, cardiovascular disease (e.g., stroke), migraine headaches, and attention deficit hyperactivity disorder (ADHD).

  11. Low brain magnesium in migraine

    SciTech Connect

    Ramadan, N.M.; Halvorson, H.; Vande-Linde, A.; Levine, S.R.; Helpern, J.A.; Welch, K.M.

    1989-10-01

    Brain magnesium was measured in migraine patients and control subjects using in vivo 31-Phosphorus Nuclear Magnetic Resonance Spectroscopy. pMg and pH were calculated from the chemical shifts between Pi, PCr and ATP signals. Magnesium levels were low during a migraine attack without changes in pH. We hypothesize that low brain magnesium is an important factor in the mechanism of the migraine attack.

  12. Mineral of the month: magnesium

    USGS Publications Warehouse

    Kramer, Deborah A.

    2005-01-01

    Magnesium, often confused with last month’s mineral of the month manganese, is valued primarily because of its light weight and high strength-to-weight ratio. Magnesium is the eighth most abundant element and constitutes about 2 percent of the Earth’s crust. It is the third most plentiful element dissolved in seawater, with a concentration averaging 0.13 percent. Magnesium is found in over 60 minerals, and also is recovered from seawater, wells, and lake brines and bitterns.

  13. Magnesium metabolism: a brief review.

    PubMed Central

    Paymaster, N. J.

    1976-01-01

    The important role played by the magnesium ion in the body is not generally recognized. The action of numerous enzyme systems critical to cellular metabolism is regulated by it and it contributes importantly to macromolecular structure. Magnesium defiency occurs more often than is generally suspected; magnesium excess, though uncommon, is of special interest to the anaesthetist because it produces a curare-like effect on neuromuscular transmission. It is hoped that this brief review of magnesium metabolism will draw attention to its importance and relevance in everyday practice. PMID:942168

  14. Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid

    MedlinePlus

    ... sheet (Medication Guide) when you begin treatment with sodium picosulfate, magnesium oxide, and anhydrous citric acid. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda. ...

  15. Magnesium Hall Thruster

    NASA Technical Reports Server (NTRS)

    Szabo, James J.

    2015-01-01

    This Phase II project is developing a magnesium (Mg) Hall effect thruster system that would open the door for in situ resource utilization (ISRU)-based solar system exploration. Magnesium is light and easy to ionize. For a Mars- Earth transfer, the propellant mass savings with respect to a xenon Hall effect thruster (HET) system are enormous. Magnesium also can be combusted in a rocket with carbon dioxide (CO2) or water (H2O), enabling a multimode propulsion system with propellant sharing and ISRU. In the near term, CO2 and H2O would be collected in situ on Mars or the moon. In the far term, Mg itself would be collected from Martian and lunar regolith. In Phase I, an integrated, medium-power (1- to 3-kW) Mg HET system was developed and tested. Controlled, steady operation at constant voltage and power was demonstrated. Preliminary measurements indicate a specific impulse (Isp) greater than 4,000 s was achieved at a discharge potential of 400 V. The feasibility of delivering fluidized Mg powder to a medium- or high-power thruster also was demonstrated. Phase II of the project evaluated the performance of an integrated, highpower Mg Hall thruster system in a relevant space environment. Researchers improved the medium power thruster system and characterized it in detail. Researchers also designed and built a high-power (8- to 20-kW) Mg HET. A fluidized powder feed system supporting the high-power thruster was built and delivered to Busek Company, Inc.

  16. ? - ? Double twinning in magnesium

    NASA Astrophysics Data System (ADS)

    Jäger, Aleš; Ostapovets, Andriy; Molnár, Peter; Lejček, Pavel

    2011-08-01

    It is demonstrated that metalworking processes performed at different temperatures can lead to the ? - ? double twinning. This twinning mode has been observed during direct extrusion of the coarse-grained Mg-0.3at.%Al alloy at 433 K and analysed in detail on room-temperature rolled magnesium single crystal with the c-axis parallel to transverse direction and the a-axis parallel to rolling direction. The ? - ? double twins originated during initial stage of the formation on coarse-grained and single-crystalline structure.

  17. Magnesium in Prevention and Therapy

    PubMed Central

    Gröber, Uwe; Schmidt, Joachim; Kisters, Klaus

    2015-01-01

    Magnesium is the fourth most abundant mineral in the body. It has been recognized as a cofactor for more than 300 enzymatic reactions, where it is crucial for adenosine triphosphate (ATP) metabolism. Magnesium is required for DNA and RNA synthesis, reproduction, and protein synthesis. Moreover, magnesium is essential for the regulation of muscular contraction, blood pressure, insulin metabolism, cardiac excitability, vasomotor tone, nerve transmission and neuromuscular conduction. Imbalances in magnesium status—primarily hypomagnesemia as it is seen more common than hypermagnesemia—might result in unwanted neuromuscular, cardiac or nervous disorders. Based on magnesium’s many functions within the human body, it plays an important role in prevention and treatment of many diseases. Low levels of magnesium have been associated with a number of chronic diseases, such as Alzheimer’s disease, insulin resistance and type-2 diabetes mellitus, hypertension, cardiovascular disease (e.g., stroke), migraine headaches, and attention deficit hyperactivity disorder (ADHD). PMID:26404370

  18. Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

    PubMed Central

    2013-01-01

    Background The aim of this study was to assess the cost-effectiveness of administering magnesium sulphate to patients in whom preterm birth at < 32+0 weeks gestation is either imminent or threatened for the purpose of fetal neuroprotection. Methods Multiple decision tree models and probabilistic sensitivity analyses were used to compare the administration of magnesium sulphate with the alternative of no treatment. Two separate cost perspectives were utilized in this series of analyses: a health system and a societal perspective. In addition, two separate measures of effectiveness were utilized: cases of cerebral palsy (CP) averted and quality-adjusted life years (QALYs). Results From a health system and a societal perspective, respectively, a savings of $2,242 and $112,602 is obtained for each QALY gained and a savings of $30,942 and $1,554,198 is obtained for each case of CP averted when magnesium sulphate is administered to patients in whom preterm birth is imminent. From a health system perspective and a societal perspective, respectively, a cost of $2,083 is incurred and a savings of $108,277 is obtained for each QALY gained and a cost of $28,755 is incurred and a savings of $1,494,500 is obtained for each case of CP averted when magnesium sulphate is administered to patients in whom preterm birth is threatened. Conclusions Administration of magnesium sulphate to patients in whom preterm birth is imminent is a dominant (i.e. cost-effective) strategy, no matter what cost perspective or measure of effectiveness is used. Administration of magnesium sulphate to patients in whom preterm birth is threatened is a dominant strategy from a societal perspective and is very likely to be cost-effective from a health system perspective. PMID:24350635

  19. Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer's model.

    PubMed

    Xu, Zhi-Peng; Li, Li; Bao, Jian; Wang, Zhi-Hao; Zeng, Juan; Liu, En-Jie; Li, Xiao-Guang; Huang, Rong-Xi; Gao, Di; Li, Meng-Zhu; Zhang, Yao; Liu, Gong-Ping; Wang, Jian-Zhi

    2014-01-01

    Alzheimer's disease (AD) is characterized by profound synapse loss and impairments of learning and memory. Magnesium affects many biochemical mechanisms that are vital for neuronal properties and synaptic plasticity. Recent studies have demonstrated that the serum and brain magnesium levels are decreased in AD patients; however, the exact role of magnesium in AD pathogenesis remains unclear. Here, we found that the intraperitoneal administration of magnesium sulfate increased the brain magnesium levels and protected learning and memory capacities in streptozotocin-induced sporadic AD model rats. We also found that magnesium sulfate reversed impairments in long-term potentiation (LTP), dendritic abnormalities, and the impaired recruitment of synaptic proteins. Magnesium sulfate treatment also decreased tau hyperphosphorylation by increasing the inhibitory phosphorylation of GSK-3β at serine 9, thereby increasing the activity of Akt at Ser473 and PI3K at Tyr458/199, and improving insulin sensitivity. We conclude that magnesium treatment protects cognitive function and synaptic plasticity by inhibiting GSK-3β in sporadic AD model rats, which suggests a potential role for magnesium in AD therapy. PMID:25268773

  20. Magnesium Protects Cognitive Functions and Synaptic Plasticity in Streptozotocin-Induced Sporadic Alzheimer’s Model

    PubMed Central

    Bao, Jian; Wang, Zhi-Hao; Zeng, Juan; Liu, En-Jie; Li, Xiao-Guang; Huang, Rong-Xi; Gao, Di; Li, Meng-Zhu; Zhang, Yao; Liu, Gong-Ping; Wang, Jian-Zhi

    2014-01-01

    Alzheimer’s disease (AD) is characterized by profound synapse loss and impairments of learning and memory. Magnesium affects many biochemical mechanisms that are vital for neuronal properties and synaptic plasticity. Recent studies have demonstrated that the serum and brain magnesium levels are decreased in AD patients; however, the exact role of magnesium in AD pathogenesis remains unclear. Here, we found that the intraperitoneal administration of magnesium sulfate increased the brain magnesium levels and protected learning and memory capacities in streptozotocin-induced sporadic AD model rats. We also found that magnesium sulfate reversed impairments in long-term potentiation (LTP), dendritic abnormalities, and the impaired recruitment of synaptic proteins. Magnesium sulfate treatment also decreased tau hyperphosphorylation by increasing the inhibitory phosphorylation of GSK-3β at serine 9, thereby increasing the activity of Akt at Ser473 and PI3K at Tyr458/199, and improving insulin sensitivity. We conclude that magnesium treatment protects cognitive function and synaptic plasticity by inhibiting GSK-3β in sporadic AD model rats, which suggests a potential role for magnesium in AD therapy. PMID:25268773

  1. Evidence for magnesium deficiency in the pathogenesis of bronchopulmonary dysplasia (BPD).

    PubMed

    Caddell, J L

    1996-10-01

    Bronchopulmonary dysplasia (BPD) has been defined as a requirement for oxygen for more than 28 days because of chronic pulmonary changes, usually in a premature infant. About 50 per cent of very low birth weight (VLBW) infants who weigh 1 kg at birth and who survive 28 days will develop BPD. Since 80 per cent of fetal accretion of magnesium occurs during the third trimester, this population is also at risk for magnesium deficiency. This paper reviews evidence for a role of magnesium deficiency in the pathogenesis of BPD. Pathology in BPD that may be caused or aggravated by magnesium deficiency is noted. Agents or mediators that are increased in BPD and in BPD include: oxygen free radicals; the inflammatory cytokines interleukin (IL)-1 and IL-6, and tumour necrosis factor-alpha; vaso- and bronchoconstrictors thromboxane A2 (TXA2) and serotonin: vasoconstrictor, endothelin-1 (ET-1); and bronchoconstrictor, histamine. Magnesium deficiency increases the susceptibility of cells and tissues to peroxidation, worsens the inflammatory reaction, reduces the immune response, exaggerates catecholamine release in stress, and diminishes energy metabolism. Possibly because of the danger of magnesium toxicity and the difficulty in studying the preterm VLBW neonate, little is known about magnesium supplementation in this group. Such information must be gained through controlled studies on the effect of antepartum exposure to maternally administered magnesium sulphate on the VLBW infant, through carefully monitored postnatal administration of magnesium in an intensive care setting, or through evaluations of combined pre- and postnatal supplementation. PMID:9140865

  2. Synthesis of magnesium diboride by magnesium vapor infiltration process (MVIP)

    DOEpatents

    Serquis, Adriana C.; Zhu, Yuntian T.; Mueller, Frederick M.; Peterson, Dean E.; Liao, Xiao Zhou

    2003-01-01

    A process of preparing superconducting magnesium diboride powder by heating an admixture of solid magnesium and amorphous boron powder or pellet under an inert atmosphere in a Mg:B ratio of greater than about 0.6:1 at temperatures and for time sufficient to form said superconducting magnesium diboride. The process can further include exposure to residual oxygen at high synthesis temperatures followed by slow cooling. In the cooling process oxygen atoms dissolved into MgB.sub.2 segregated to form nanometer-sized coherent Mg(B,O) precipitates in the MgB.sub.2 matrix, which can act as flux pinning centers.

  3. 21 CFR 184.1426 - Magnesium chloride.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium chloride. 184.1426 Section 184.1426 Food... Specific Substances Affirmed as GRAS § 184.1426 Magnesium chloride. (a) Magnesium chloride (MgC12·6H2O, CAS... mineral bischofite. It is prepared by dissolving magnesium oxide, hydroxide, or carbonate in...

  4. 21 CFR 184.1443 - Magnesium sulfate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Magnesium sulfate. 184.1443 Section 184.1443 Food... Specific Substances Affirmed as GRAS § 184.1443 Magnesium sulfate. (a) Magnesium sulfate (MgSO4·7H2O, CAS... magnesium oxide, hydroxide, or carbonate with sulfuric acid and evaporating the solution to...

  5. 21 CFR 184.1426 - Magnesium chloride.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium chloride. 184.1426 Section 184.1426 Food... Specific Substances Affirmed as GRAS § 184.1426 Magnesium chloride. (a) Magnesium chloride (MgC12·6H2O, CAS... mineral bischofite. It is prepared by dissolving magnesium oxide, hydroxide, or carbonate in...

  6. 21 CFR 184.1426 - Magnesium chloride.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Magnesium chloride. 184.1426 Section 184.1426 Food... Specific Substances Affirmed as GRAS § 184.1426 Magnesium chloride. (a) Magnesium chloride (MgC12·6H2O, CAS... mineral bischofite. It is prepared by dissolving magnesium oxide, hydroxide, or carbonate in...

  7. 21 CFR 184.1431 - Magnesium oxide.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Magnesium oxide. 184.1431 Section 184.1431 Food... Specific Substances Affirmed as GRAS § 184.1431 Magnesium oxide. (a) Magnesium oxide (MgO, CAS Reg. No... bulky white powder (light) or a relatively dense white powder (heavy) by heating magnesium hydroxide...

  8. 21 CFR 184.1443 - Magnesium sulfate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium sulfate. 184.1443 Section 184.1443 Food... Specific Substances Affirmed as GRAS § 184.1443 Magnesium sulfate. (a) Magnesium sulfate (MgSO4·7H2O, CAS... magnesium oxide, hydroxide, or carbonate with sulfuric acid and evaporating the solution to...

  9. 21 CFR 184.1443 - Magnesium sulfate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium sulfate. 184.1443 Section 184.1443 Food... Specific Substances Affirmed as GRAS § 184.1443 Magnesium sulfate. (a) Magnesium sulfate (MgSO4·7H2O, CAS... magnesium oxide, hydroxide, or carbonate with sulfuric acid and evaporating the solution to...

  10. Mineral resource of the month: magnesium

    USGS Publications Warehouse

    Kramer, Deborah A.

    2012-01-01

    Magnesium is the eighthmost abundant element in Earth’s crust, and the second-most abundant metal ion in seawater. Although magnesium is found in more than 60 minerals, only brucite, dolomite, magnesite and carnallite are commercially important for their magnesium content. Magnesium and its compounds also are recovered from seawater, brines found in lakes and wells, and bitterns (salts).

  11. 21 CFR 184.1443 - Magnesium sulfate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Magnesium sulfate. 184.1443 Section 184.1443 Food... Specific Substances Affirmed as GRAS § 184.1443 Magnesium sulfate. (a) Magnesium sulfate (MgSO4·7H2O, CAS... magnesium oxide, hydroxide, or carbonate with sulfuric acid and evaporating the solution to...

  12. 21 CFR 184.1426 - Magnesium chloride.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Magnesium chloride. 184.1426 Section 184.1426 Food... Specific Substances Affirmed as GRAS § 184.1426 Magnesium chloride. (a) Magnesium chloride (MgC12·6H2O, CAS... mineral bischofite. It is prepared by dissolving magnesium oxide, hydroxide, or carbonate in...

  13. Magnesium homeostasis and aging.

    PubMed

    Barbagallo, Mario; Belvedere, Mario; Dominguez, Ligia J

    2009-12-01

    Aging is very often associated with magnesium (Mg) deficit. Total plasma magnesium concentrations are remarkably constant in healthy subjects throughout life, while total body Mg and Mg in the intracellular compartment tend to decrease with age. Dietary Mg deficiencies are common in the elderly population. Other frequent causes of Mg deficits in the elderly include reduced Mg intestinal absorption, reduced Mg bone stores, and excess urinary loss. Secondary Mg deficit in aging may result from different conditions and diseases often observed in the elderly (i.e. insulin resistance and/or type 2 diabetes mellitus) and drugs (i.e. use of hypermagnesuric diuretics). Chronic Mg deficits have been linked to an increased risk of numerous preclinical and clinical outcomes, mostly observed in the elderly population, including hypertension, stroke, atherosclerosis, ischemic heart disease, cardiac arrhythmias, glucose intolerance, insulin resistance, type 2 diabetes mellitus, endothelial dysfunction, vascular remodeling, alterations in lipid metabolism, platelet aggregation/thrombosis, inflammation, oxidative stress, cardiovascular mortality, asthma, chronic fatigue, as well as depression and other neuropsychiatric disorders. Both aging and Mg deficiency have been associated to excessive production of oxygen-derived free radicals and low-grade inflammation. Chronic inflammation and oxidative stress are also present in several age-related diseases, such as many vascular and metabolic conditions, as well as frailty, muscle loss and sarcopenia, and altered immune responses, among others. Mg deficit associated to aging may be at least one of the pathophysiological links that may help to explain the interactions between inflammation and oxidative stress with the aging process and many age-related diseases.

  14. Lack of Response in an Autistic Population to a Low Dose Clinical Trial of Pyridoxine Plus Magnesium.

    ERIC Educational Resources Information Center

    Tolbert, Lelland; And Others

    1993-01-01

    As some therapeutic benefits for autistic persons have been reported from combined high doses of pyridoxine and magnesium, this study evaluated long-term administration of low doses (to minimize adverse effects) to 15 subjects with autism. Findings indicated that, at this dosage level, pyridoxine and magnesium had no effect on the severity of…

  15. 76 FR 62040 - Pure Magnesium From the People's Republic of China: Final Results of Expedited Third Sunset...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-10-06

    ... Value: Antidumping Duty Investigation of Pure Magnesium From the Russian Federation, 60 FR 25691 (May 12..., pursuant to section 751(c) of the Act. See Initiation of Five-Year ``Sunset'' Review, 76 FR 31588 (June 1... International Trade Administration Pure Magnesium From the People's Republic of China: Final Results...

  16. Nutritional Aspects of Magnesium Metabolism

    PubMed Central

    Flink, Edmund B.

    1980-01-01

    The absolute necessity for magnesium in plant and animal nutrition is easily appreciated when one realizes that magnesium is found in high concentration in cells. It is necessary for photosynthesis in plants and for all reactions involving adenosine triphosphate in plant and animal cells. Although it is abundant in nature in general, deficiencies occur in both plants and animals. Human beings need about 5 mg of magnesium per kg of body weight per day. Infants and young children need twice as much. Children and women during pregnancy or lactation require significantly greater amounts than normal adults. Various diseases result in a deficiency of magnesium because of interruption of food intake or intestinal or renal wasting of the mineral. PMID:7347045

  17. Magnesium Alloys and their Applications

    NASA Astrophysics Data System (ADS)

    Kainer, Karl U.

    1999-04-01

    In the recent years there has been a dramatic increase in research activity and also applications of magnesium alloys. The driving force is the growing demand by the automobile industry resulting from the pressure to reduce weight and hence to reduce the fuel consumption. The U.S. car industry incorporates the largest amount of magnesium at the present time. In Europe, Volkswagen had a history of using magnesium in the VW Beetle. Volkswagen, in common with other major car producers has initiated a major research and development programme for advanced magnesium materials. The main emphasis of this book is in the field of general physical metallurgy and alloy development refelcting the need to provide a wider range of alloys both casting and wrought alloys to meet the increasing demands of industry. Other topics are nevertheless well represented such as casting, recycling, joining, corrosion, and surface treatment.

  18. Magnesium and Dialysis: The Neglected Cation.

    PubMed

    Alhosaini, Mohamad; Leehey, David J

    2015-09-01

    Disorders of magnesium homeostasis are very common in dialysis patients but have received scant attention. In this review, we address measurement of plasma magnesium, magnesium balance and the factors that affect magnesium flux during dialysis, the prevalence of hypo- and hypermagnesemia in dialysis patients, and the potential clinical significance of hypo- and hypermagnesemia in dialysis patients. Many factors can affect plasma magnesium concentration, including diet, nutritional status (including plasma albumin level), medications (such as proton pump inhibitors), and dialysis prescription. Further interventional studies to determine the effect of normalization of plasma magnesium concentration on clinical outcomes are needed. At the present time, we recommend that predialysis plasma magnesium be measured on a regular basis, with the dialysate magnesium concentration adjusted to maintain plasma magnesium concentration within the normal range.

  19. Magnesium and fetal growth

    SciTech Connect

    Weaver, K.

    1988-01-01

    Fetal growth retardation and premature labor are major problems in perinatal medicine today and account for a great deal of the observed fetal morbidity. While the neonatal death rate has steadily declined over the past decade, there has been a lack of concommitant decrease in these two leading problems. Magnesium (Mg/sup ++/) plays a major role in both of these areas of concern. The fact that it is used as a treatment for premature labor has led investigators to look at low Mg/sup ++/ as a possible cause of this poorly understood phenomenon. The second major cause of small for gestational age infants is intrauterine growth retardation, a condition which may be of either fetal or maternal origin. In either case, Mg/sup ++/ may be implicated since it exerts a strong influence on the underlying pathophysiology of placental failure and maternal hypertension. Both of these conditions are mediated by vascular and platelet hyperactivity as well as by and increase in the ration of thromboxane to prostacyclin. Studies in both the human and animal species are beginning to show how Mg/sup ++/ interacts in these conditions to produce such a damaging fetal outcome. The recent use of Doppler velocimetry of the developing fetus has shown reduced fetal vascular and maternal uterine vascular compliance as early as 14 weeks of gestation in those who would be so affected.

  20. Magnesium and healthy aging.

    PubMed

    Veronese, Nicola; Zanforlini, Bruno Micael; Manzato, Enzo; Sergi, Giuseppe

    2015-01-01

    Magnesium (Mg) is relatively stable in the intracellular compartment, although decreases linearly with advancing age. This begs the question as to whether Mg could be used as biomarker of aging. A biomarker of aging is a biological parameter of an organism that, in the absence of disease, better predicts functional capability at a later age than the chronological age. Bone and muscle Mg content might be useful biomarkers, but the need for biopsies and the heterogeneous distribution of Mg in bones and muscles strongly limit the application of these methods in clinical practice. Similar considerations can be made for urinary Mg assessment, particularly after a loading test. Markers of Mg in blood seem fairly unreliable as biomarkers of aging since they are strongly dependent upon renal function, do not reflect the intracellular Mg status, and, in some investigations, are within normal ranges although other Mg parameters are not. Other investigations (e.g. nuclear magnetic resonance with fluorescent probes) seem to be promising, but their availability remains limited. PMID:26446714

  1. Thiazide treatment of systemic hypertension: effects on serum magnesium and ventricular ectopic activity.

    PubMed

    Hollifield, J W

    1989-04-18

    Clinical and investigational evidence has proved an association between thiazide-induced electrolyte imbalances and ventricular arrhythmias. It is hypothesized that this increases the potential for sudden unexplained death. Elderly hypertensive patients are at particular risk because of their tendency to have significantly depressed serum magnesium levels, which decrease even further when treated with thiazide diuretics. Potassium supplementation does not effectively restore electrolyte balance unless accompanied by magnesium. Therefore, concomitant administration of potassium and magnesium supplementation appears to be an approach to reducing the risk of arrhythmias and death in thiazide-treated hypertensive patients.

  2. The influence of lithium on calcium and magnesium homeostasis in serum and tissues of rats.

    PubMed

    Kiełczykowska, Małgorzata; Pasternak, Kazimierz; Musik, Irena

    2003-01-01

    Lithium is used in medicine. However, its administration can have negative side effects, disturb the water-electrolyte equilibrium and affect the level of essential elements. For these reasons the influence of oral lithium intoxication at the dose of 150 mg Li dm(-3) on magnesium and calcium levels in serum and tissues of rats was investigated. The concentration of Mg and Ca in serum increased throughout the experiment. The concentration of magnesium in tissues decreased after three weeks in liver, kidney, brain and femoral muscle. The trend of the changes of calcium tissue concentration was opposite to the one observed in the case of magnesium.

  3. Magnesium silicide intermetallic alloys

    NASA Astrophysics Data System (ADS)

    Li, Gh.; Gill, H. S.; Varin, R. A.

    1993-11-01

    Methods of induction melting an ultra-low-density magnesium silicide (Mg2Si) intermetallic and its alloys and the resulting microstructure and microhardness were studied. The highest quality ingots of Mg2Si alloys were obtained by triple melting in a graphite crucible coated with boron nitride to eliminate reactivity, under overpressure of high-purity argon (1.3 X 105 Pa), at a temperature close to but not exceeding 1105 °C ± 5 °C to avoid excessive evaporation of Mg. After establishing the proper induction-melting conditions, the Mg-Si binary alloys and several Mg2Si alloys macroalloyed with 1 at. pct of Al, Ni, Co, Cu, Ag, Zn, Mn, Cr, and Fe were induction melted and, after solidification, investigated by optical microscopy and quantitative X-ray energy dispersive spectroscopy (EDS). Both the Mg-rich and Si-rich eutectic in the binary alloys exhibited a small but systematic increase in the Si content as the overall composition of the binary alloy moved closer toward the Mg2Si line compound. The Vickers microhardness (VHN) of the as-solidified Mg-rich and Si-rich eutectics in the Mg-Si binary alloys decreased with increasing Mg (decreasing Si) content in the eutectic. This behavior persisted even after annealing for 75 hours at 0.89 pct of the respective eutectic temperature. The Mg-rich eutectic in the Mg2Si + Al, Ni, Co, Cu, Ag, and Zn alloys contained sections exhibiting a different optical contrast and chemical composition than the rest of the eutectic. Some particles dispersed in the Mg2Si matrix were found in the Mg2Si + Cr, Mn, and Fe alloys. The EDS results are presented and discussed and compared with the VHN data.

  4. 21 CFR 582.5434 - Magnesium phosphate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5434 Magnesium phosphate. (a) Product. Magnesium phosphate (di- and tribasic)....

  5. 21 CFR 582.5431 - Magnesium oxide.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This...

  6. 21 CFR 582.5431 - Magnesium oxide.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This...

  7. 21 CFR 582.5431 - Magnesium oxide.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This...

  8. 21 CFR 582.5443 - Magnesium sulfate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5443 Magnesium sulfate. (a) Product. Magnesium sulfate. (b) Conditions of use....

  9. 21 CFR 582.5434 - Magnesium phosphate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5434 Magnesium phosphate. (a) Product. Magnesium phosphate (di- and tribasic)....

  10. 21 CFR 582.5431 - Magnesium oxide.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This...

  11. 21 CFR 582.5443 - Magnesium sulfate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5443 Magnesium sulfate. (a) Product. Magnesium sulfate. (b) Conditions of use....

  12. 21 CFR 582.5434 - Magnesium phosphate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5434 Magnesium phosphate. (a) Product. Magnesium phosphate (di- and tribasic)....

  13. 21 CFR 582.5443 - Magnesium sulfate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5443 Magnesium sulfate. (a) Product. Magnesium sulfate. (b) Conditions of use....

  14. 21 CFR 582.5443 - Magnesium sulfate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5443 Magnesium sulfate. (a) Product. Magnesium sulfate. (b) Conditions of use....

  15. 21 CFR 582.5434 - Magnesium phosphate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5434 Magnesium phosphate. (a) Product. Magnesium phosphate (di- and tribasic)....

  16. 21 CFR 582.5431 - Magnesium oxide.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5431 Magnesium oxide. (a) Product. Magnesium oxide. (b) Conditions of use. This...

  17. 21 CFR 582.5434 - Magnesium phosphate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5434 Magnesium phosphate. (a) Product. Magnesium phosphate (di- and tribasic)....

  18. 21 CFR 582.5443 - Magnesium sulfate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... DRUGS, FEEDS, AND RELATED PRODUCTS SUBSTANCES GENERALLY RECOGNIZED AS SAFE Nutrients and/or Dietary Supplements 1 § 582.5443 Magnesium sulfate. (a) Product. Magnesium sulfate. (b) Conditions of use....

  19. Magnesium/Calcium Competition at Excitable Membranes.

    ERIC Educational Resources Information Center

    Belzer, Bill; Fry, Panni

    1998-01-01

    Considers some consequences of altering intracellular calcium supply by magnesium concentration changes. Focuses on using this procedure as an exercise with allied health students as they witness therapeutic uses of magnesium and other calcium entry inhibitors. (DDR)

  20. 75 FR 26922 - Magnesium Metal From the Russian Federation: Preliminary Results of Antidumping Duty...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-05-13

    ...: Magnesium Metal From the Russian Federation, 70 FR 19930 (April 15, 2005) (Antidumping Duty Order). On April... Administrative Review, 74 FR 14771 (April 1, 2009). On April 30, 2009, AVISMA, a Russian Federation producer of... Administrative Reviews, 74 FR 25711 (May 29, 2009). On December 16, 2009, the Department extended the...

  1. 76 FR 26247 - Magnesium Metal From the Russian Federation: Preliminary Results of Antidumping Duty...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-05-06

    ...: Magnesium Metal From the Russian Federation, 70 FR 19930 (April 15, 2005). On April 1, 2010, the Department..., or Suspended Investigation; Opportunity To Request Administrative Review, 75 FR 16426 (April 1, 2010... Countervailing Duty Administrative Reviews, 75 FR 29976 (May 28, 2010). We have extended the deadline for...

  2. 76 FR 61342 - Magnesium Metal from the Russian Federation: Amended Final Results of Antidumping Duty...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-10-04

    ... Results of Antidumping Duty Administrative Review, 76 FR 56396 (September 13, 2011) (Final Results). We... Antidumping and Countervailing Duty Proceedings: Assessment of Antidumping Duties, 68 FR 23954 (May 6, 2003... International Trade Administration Magnesium Metal from the Russian Federation: Amended Final Results...

  3. An anticorrosive magnesium/carbon nanotube composite

    NASA Astrophysics Data System (ADS)

    Endo, M.; Hayashi, T.; Itoh, I.; Kim, Y. A.; Shimamoto, D.; Muramatsu, H.; Shimizu, Y.; Morimoto, S.; Terrones, M.; Iinou, S.; Koide, S.

    2008-02-01

    Here, we report a drastically improved anticorrosive characteristic of magnesium alloy composites with the introduction of multiwalled carbon nanotubes. Highly depressed corrosion of nanotube-filled magnesium composite in salt water is due to the formation of stable oxide films along the grain boundaries of magnesium. Our results indicate that carbon nanotube acted as effective multifunctional filler to improve both mechanical and anticorrosive performances of magnesium alloy.

  4. 21 CFR 184.1440 - Magnesium stearate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 21 Food and Drugs 3 2011-04-01 2011-04-01 false Magnesium stearate. 184.1440 Section 184.1440 Food... Specific Substances Affirmed as GRAS § 184.1440 Magnesium stearate. (a) Magnesium stearate (Mg(C17H34COO)2, CAS Reg. No. 557-04-0) is the magnesium salt of stearic acid. It is produced as a white precipitate...

  5. 21 CFR 184.1426 - Magnesium chloride.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium chloride. 184.1426 Section 184.1426 Food... GRAS § 184.1426 Magnesium chloride. (a) Magnesium chloride (MgC12·6H2O, CAS Reg. No. 7786-30-3) is a... prepared by dissolving magnesium oxide, hydroxide, or carbonate in aqueous hydrochloric acid solution...

  6. 21 CFR 184.1440 - Magnesium stearate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 3 2012-04-01 2012-04-01 false Magnesium stearate. 184.1440 Section 184.1440 Food... Specific Substances Affirmed as GRAS § 184.1440 Magnesium stearate. (a) Magnesium stearate (Mg(C17H34COO)2, CAS Reg. No. 557-04-0) is the magnesium salt of stearic acid. It is produced as a white precipitate...

  7. 21 CFR 184.1440 - Magnesium stearate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium stearate. 184.1440 Section 184.1440 Food... GRAS § 184.1440 Magnesium stearate. (a) Magnesium stearate (Mg(C17H34COO)2, CAS Reg. No. 557-04-0) is the magnesium salt of stearic acid. It is produced as a white precipitate by the addition of...

  8. 21 CFR 184.1443 - Magnesium sulfate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 3 2014-04-01 2014-04-01 false Magnesium sulfate. 184.1443 Section 184.1443 Food... GRAS § 184.1443 Magnesium sulfate. (a) Magnesium sulfate (MgSO4·7H2O, CAS Reg. No. 10034-99-8) occurs naturally as the mineral epsomite. It is prepared by neutralization of magnesium oxide, hydroxide,...

  9. 21 CFR 184.1440 - Magnesium stearate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 3 2013-04-01 2013-04-01 false Magnesium stearate. 184.1440 Section 184.1440 Food... Specific Substances Affirmed as GRAS § 184.1440 Magnesium stearate. (a) Magnesium stearate (Mg(C17H34COO)2, CAS Reg. No. 557-04-0) is the magnesium salt of stearic acid. It is produced as a white precipitate...

  10. 21 CFR 184.1440 - Magnesium stearate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 3 2010-04-01 2009-04-01 true Magnesium stearate. 184.1440 Section 184.1440 Food... Specific Substances Affirmed as GRAS § 184.1440 Magnesium stearate. (a) Magnesium stearate (Mg(C17H34COO)2, CAS Reg. No. 557-04-0) is the magnesium salt of stearic acid. It is produced as a white precipitate...

  11. Solid-state rechargeable magnesium battery

    DOEpatents

    Shao, Yuyan; Liu, Jun; Liu, Tianbiao; Li, Guosheng

    2016-09-06

    Embodiments of a solid-state electrolyte comprising magnesium borohydride, polyethylene oxide, and optionally a Group IIA or transition metal oxide are disclosed. The solid-state electrolyte may be a thin film comprising a dispersion of magnesium borohydride and magnesium oxide nanoparticles in polyethylene oxide. Rechargeable magnesium batteries including the disclosed solid-state electrolyte may have a coulombic efficiency .gtoreq.95% and exhibit cycling stability for at least 50 cycles.

  12. Dislocation Creep in Magnesium Calcite

    NASA Astrophysics Data System (ADS)

    Xu, L.; Xiao, X.; Evans, B. J.

    2003-12-01

    To investigate the effect of dissolved Mg on plastic deformation of calcite, we performed triaxial deformation experiments on synthetic calcite with varying amount of Mg content. Mixtures of powders of calcite and dolomite were isostatically hot pressed (HIP) at 850° C and 300 MPa confining pressure for different intervals (2 to 20hrs) resulting in homogeneous aggregates of high-magnesium calcite; Mg content varied from 0.07 to 0.17 mol%. Creep tests were performed at differential stresses from 20 to 160 MPa at 700 to 800° C. Grain sizes before and after deformation were determined from the images obtained from scanning electron microscope (SEM) and optical microscope. Grain sizes are in the range of 5 to 20 microns depending on the HIP time, and decrease with increasing magnesium content. Both BSE images and chemical analysis suggest that all dolomite are dissolved and the Mg distribution is homogeneous through the sample, after 2 hrs HIP. At stresses below 40 MPa, the samples deformed in diffusion region (Coble creep), as described previously by Herwegh. The strength decreases with increasing magnesium content, owing to the difference of grain size. At stresses above 80 MPa, the stress exponent is greater than 3, indicating an increased contribution of dislocation creep. The transition between diffusion to dislocation creep occurs at higher stresses for the samples with higher magnesium content and smaller grain size. Preliminary data suggests a slight increase in strength with increasing magnesium content, but more tests are needed to verify this effect. In a few samples, some strain weakening may have been evident. The activation energy in the transition region (at 80 MPa) is ˜200 KJ/mol with no dependence on magnesium content, agreeing with previous measurements of diffusion creep in natural and synthetic marbles.

  13. Committee Opinion No. 652 Summary: Magnesium Sulfate Use in Obstetrics.

    PubMed

    2016-01-01

    The U.S. Food and Drug Administration advises against the use of magnesium sulfate injections for more than 5-7 days to stop preterm labor in pregnant women. Based on this, the drug classification was changed from Category A to Category D, and the labeling was changed to include this new warning information. However, the U.S. Food and Drug Administration's change in classification addresses an unindicated and nonstandard use of magnesium sulfate in obstetric care. The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine continue to support the short-term (usually less than 48 hours) use of magnesium sulfate in obstetric care for appropriate conditions and for appropriate durations of treatment, which includes the prevention and treatment of seizures in women with preeclampsia or eclampsia, fetal neuroprotection before anticipated early preterm (less than 32 weeks of gestation) delivery, and short-term prolongation of pregnancy (up to 48 hours) to allow for the administration of antenatal corticosteroids in pregnant women who are at risk of preterm delivery within 7 days.

  14. Committee Opinion No 652: Magnesium Sulfate Use in Obstetrics.

    PubMed

    2016-01-01

    The U.S. Food and Drug Administration advises against the use of magnesium sulfate injections for more than 5-7 days to stop preterm labor in pregnant women. Based on this, the drug classification was changed from Category A to Category D, and the labeling was changed to include this new warning information. However, the U.S. Food and Drug Administration's change in classification addresses an unindicated and nonstandard use of magnesium sulfate in obstetric care. The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine continue to support the short-term (usually less than 48 hours) use of magnesium sulfate in obstetric care for appropriate conditions and for appropriate durations of treatment, which includes the prevention and treatment of seizures in women with preeclampsia or eclampsia, fetal neuroprotection before anticipated early preterm (less than 32 weeks of gestation) delivery, and short-term prolongation of pregnancy (up to 48 hours) to allow for the administration of antenatal corticosteroids in pregnant women who are at risk of preterm delivery within 7 days.

  15. Intravenous magnesium for acute asthma?

    PubMed

    2003-10-01

    Each year in the UK, around 1,500 people die from asthma. Standard treatment has been based on bronchodilators (e.g. beta 2-stimulants) and anti-inflammatory drugs (corticosteroids). The recently revised British Guideline on the Management of Asthma suggests also using a single dose of i.v. magnesium sulphate in patients with acute severe asthma, an unlicensed indication. Here we discuss the rationale for giving i.v. magnesium and whether it offers any advantage for patients with acute severe asthma.

  16. Primary magnesium production costs for automotive applications

    NASA Astrophysics Data System (ADS)

    Das, Sujit

    2008-11-01

    Focusing on primary magnesium production cost estimates, this paper provides a forecast of the long-term competitiveness of magnesium in automotive applications. Competing magnesium production technologies are considered, with particular emphasis on the long-term viability of cheap supplies using Chinese production technology. Also considered are two yet-to-be commercialized production processes.

  17. Synthesis of superconducting magnesium diboride objects

    DOEpatents

    Finnemore, Douglas K.; Canfield, Paul C.; Bud'ko, Sergey L.; Ostenson, Jerome E.; Petrovic, Cedomir; Cunningham, Charles E.; Lapertot, Gerard

    2003-08-15

    A process to produce magnesium diboride objects from boron objects with a similar form is presented. Boron objects are reacted with magnesium vapor at a predetermined time and temperature to form magnesium diboride objects having a morphology similar to the boron object's original morphology.

  18. Synthesis Of Superconducting Magnesium Diboride Objects.

    DOEpatents

    Finnemore, Douglas K.; Canfield, Paul C.; Bud'ko, Sergey L.; Ostenson, Jerome E.; Petrovic, Cedomir; Cunningham, Charles E.; Lapertot, Gerard

    2003-07-08

    A process to produce magnesium diboride objects from boron objects with a similar form is presented. Boron objects are reacted with magnesium vapor at a predetermined time and temperature to form magnesium diboride objects having a morphology similar to the boron object's original morphology.

  19. 76 FR 69284 - Pure Magnesium From China

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-11-08

    ... COMMISSION Pure Magnesium From China Determination On the basis of the record \\1\\ developed in the subject... order on pure magnesium from China would be likely to lead to continuation or recurrence of material... USITC Publication 4274 (October 2011), entitled Pure Magnesium from China: Investigation No....

  20. 21 CFR 201.71 - Magnesium labeling.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 21 Food and Drugs 4 2012-04-01 2012-04-01 false Magnesium labeling. 201.71 Section 201.71 Food and... LABELING Labeling Requirements for Over-the-Counter Drugs § 201.71 Magnesium labeling. (a) The labeling of over-the-counter (OTC) drug products intended for oral ingestion shall contain the magnesium...

  1. 21 CFR 201.71 - Magnesium labeling.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 21 Food and Drugs 4 2013-04-01 2013-04-01 false Magnesium labeling. 201.71 Section 201.71 Food and... LABELING Labeling Requirements for Over-the-Counter Drugs § 201.71 Magnesium labeling. (a) The labeling of over-the-counter (OTC) drug products intended for oral ingestion shall contain the magnesium...

  2. 21 CFR 201.71 - Magnesium labeling.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 21 Food and Drugs 4 2014-04-01 2014-04-01 false Magnesium labeling. 201.71 Section 201.71 Food and... LABELING Labeling Requirements for Over-the-Counter Drugs § 201.71 Magnesium labeling. (a) The labeling of over-the-counter (OTC) drug products intended for oral ingestion shall contain the magnesium...

  3. 21 CFR 184.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... GRAS § 184.1428 Magnesium hydroxide. (a) Magnesium hydroxide (Mg(OH)2, CAS Reg. No. 1309-42-8) occurs... magnesium oxide. (b) The ingredient meets the specifications of the Food Chemicals Codex, 3d Ed. (1981), p...: (1) The ingredient is used as a nutrient supplement as defined in § 170.3(o)(20) of this chapter; a...

  4. Magnesium Diboride Current Leads

    NASA Technical Reports Server (NTRS)

    Panek, John

    2010-01-01

    A recently discovered superconductor, magnesium diboride (MgB2), can be used to fabricate conducting leads used in cryogenic applications. Dis covered to be superconducting in 2001, MgB2 has the advantage of remaining superconducting at higher temperatures than the previously used material, NbTi. The purpose of these leads is to provide 2 A of electricity to motors located in a 1.3 K environment. The providing environment is a relatively warm 17 K. Requirements for these leads are to survive temperature fluctuations in the 5 K and 11 K heat sinks, and not conduct excessive heat into the 1.3 K environment. Test data showed that each lead in the assembly could conduct 5 A at 4 K, which, when scaled to 17 K, still provided more than the required 2 A. The lead assembly consists of 12 steelclad MgB2 wires, a tensioned Kevlar support, a thermal heat sink interface at 4 K, and base plates. The wires are soldered to heavy copper leads at the 17 K end, and to thin copper-clad NbTi leads at the 1.3 K end. The leads were designed, fabricated, and tested at the Forschungszentrum Karlsruhe - Institut foer Technische Physik before inclusion in Goddard's XRS (X-Ray Spectrometer) instrument onboard the Astro-E2 spacecraft. A key factor is that MgB2 remains superconducting up to 30 K, which means that it does not introduce joule heating as a resistive wire would. Because the required temperature ranges are 1.3-17 K, this provides a large margin of safety. Previous designs lost superconductivity at around 8 K. The disadvantage to MgB2 is that it is a brittle ceramic, and making thin wires from it is challenging. The solution was to encase the leads in thin steel tubes for strength. Previous designs were so brittle as to risk instrument survival. MgB2 leads can be used in any cryogenic application where small currents need to be conducted at below 30 K. Because previous designs would superconduct only at up to 8 K, this new design would be ideal for the 8-30 K range.

  5. Magnesium treatment palliates noise-induced behavioral deficits by normalizing DAergic and 5-HTergic metabolism in adult male rats.

    PubMed

    Haider, Saida; Sadir, Sadia; Naqvi, Fizza; Batool, Zehra; Tabassum, Saiqa; Khaliq, Saima; Anis, Lubna; Sajid, Irfan; Haleem, Darakhshan J

    2016-08-01

    Magnesium (Mg) is the fourth most abundant biological mineral essential for good health. Neuroprotective, anxiolytic and antidepressant effects of magnesium following stress and brain injuries are well established. In present study, we analyzed the protective effects of magnesium in rats exposed to sub-chronic noise stress. Magnesium Chloride (MgCl2, 100 mg/kg) was administered intraperitoneally once daily for 15 days prior exposure to noise stress. Rats were exposed to noise stress for 4 h after administration of magnesium for 15 days. At the end of treatment behavioral alterations were assessed. Animals were decapitated following behavioral testing and the brains were dissected out for neurochemical estimations by HPLC-EC. Improvement in noise-induced memory deficits as assessed by novel object recognition (NOR) test and elevated plus maze (EPM) test was found in magnesium treated rats. This improvement in noise-induced behavioral deficits following treatment with magnesium may be attributed to a significant decrease (p < 0.01) in dopamine (DA) and serotonin (5-hydroxytryptamine; 5-HT) turnover as compared to control rats observed in present work. These results suggest that treatment with magnesium can attenuate the noise-induced deficits and may be used as a therapy against noise-induced neurodegeneration. Moreover an adequate amount of magnesium in daily diet may help to develop the ability to resist against or cope up with stressful conditions encountered in daily life.

  6. Effect of magnesium supplementation on blood rheology in NOS inhibition-induced hypertension model.

    PubMed

    Cengiz, Melike; Ülker, Pinar; Üyüklü, Mehmet; Yaraş, Nazmi; Özen, Nur; Aslan, Mutay; Özyurt, Dilek; Basralı, Filiz

    2016-01-27

    This study investigated the effects of magnesium on blood rheological properties and blood pressure in nitric oxide synthase (NOS) inhibition-induced hypertension model. Hypertension was induced by oral administration of the nonselective NOS inhibitor N-nitro-L-arginine methyl ester (L-NAME, 25 mg/kg/day) for 6 weeks and systolic blood pressure was measured by the tail-cuff method. The groups receiving magnesium supplementation were fed with rat chow containing 0.8% magnesium oxide during the experiment. At the end of experiment, blood samples were obtained from abdominal aorta, using ether anesthesia. Plasma and erythrocyte magnesium levels were determined by the atomic absorption spectrometer. RBC deformability and aggregation were determined by rotational ektacytometry. Plasma fibrinogen concentration was evaluated by ELISA. Whole blood and plasma viscosities were determined by viscometer and intracellular free Ca++ level was measured by using spectroflurometric method. Blood pressure was elevated in hypertensive groups and suppressed by magnesium therapy. Plasma viscosity and RBC aggregation were found to be higher in hypertensive rats than control animals and these parameters significantly decreased in magnesium supplemented hypertensive animals. Other measurements were not different between experimental groups. These results confirm that blood pressure, plasma viscosity and RBC aggregation increased in NOS inhibition-induced hypertension model and oral magnesium supplementation improved these parameters. PMID:26890104

  7. Superoxide radicals scavenging and xanthine oxidase inhibitory activity of magnesium lithospermate B from Salvia miltiorrhiza.

    PubMed

    Liu, Xiaoyu; Chen, Ruohua; Shang, Yanjun; Jiao, Binghua; Huang, Caiguo

    2009-06-01

    In this study we investigated the superoxide radicals scavenging effect and xanthine oxidase inhibitory activity by magnesium lithospermate B, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine. Superoxide radicals were generated both in beta-NADH/PMS system and xanthine/ xanthine oxidase system. Magnesium lithospermate B significantly inhibited the reduction of NBT induced by superoxide radicals with an IC(50) of 29.8 microg/mL and 4.06 microg/mL respectively in the two systems. Further study suggested that magnesium lithospermate B can directly inhibit xanthine oxidase and exhibits competitive inhibition. Magnesium lithospermate B was also found to have the hypouricemic activity in vivo against potassium oxonate-induced hyperuricaemia in mice. After oral administration of magnesium lithospermate B at doses of 10, 20 and 30 mg/kg, there was a significant decrease in the serum urate level when compared to the hyperuricemia control. In addition, magnesium lithospermate B significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the xanthine/ xanthine oxidase reactions. This study provided evidence that magnesium lithospermate B exhibits direct superoxide radicals scavenging and xanthine oxidase inhibitory activity.

  8. Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles.

    PubMed

    Lu, J F; Nightingale, C H

    2000-04-01

    Magnesium sulfate (MgSO4) is the agent most commonly used for treatment of eclampsia and prophylaxis of eclampsia in patients with severe pre-eclampsia. It is usually given by either the intramuscular or intravenous routes. The intramuscular regimen is most commonly a 4 g intravenous loading dose, immediately followed by 10 g intramuscularly and then by 5 g intramuscularly every 4 hours in alternating buttocks. The intravenous regimen is given as a 4 g dose, followed by a maintenance infusion of 1 to 2 g/h by controlled infusion pump. After administration, about 40% of plasma magnesium is protein bound. The unbound magnesium ion diffuses into the extravascular-extracellular space, into bone, and across the placenta and fetal membranes and into the fetus and amniotic fluid. In pregnant women, apparent volumes of distribution usually reach constant values between the third and fourth hours after administration, and range from 0.250 to 0.442 L/kg. Magnesium is almost exclusively excreted in the urine, with 90% of the dose excreted during the first 24 hours after an intravenous infusion of MgSO4. The pharmacokinetic profile of MgSO4 after intravenous administration can be described by a 2-compartment model with a rapid distribution (a) phase, followed by a relative slow beta phase of elimination. The clinical effect and toxicity of MgSO4 can be linked to its concentration in plasma. A concentration of 1.8 to 3.0 mmol/L has been suggested for treatment of eclamptic convulsions. The actual magnesium dose and concentration needed for prophylaxis has never been estimated. Maternal toxicity is rare when MgSO4 is carefully administered and monitored. The first warning of impending toxicity in the mother is loss of the patellar reflex at plasma concentrations between 3.5 and 5 mmol/L. Respiratory paralysis occurs at 5 to 6.5 mmol/L. Cardiac conduction is altered at greater than 7.5 mmol/L, and cardiac arrest can be expected when concentrations of magnesium exceed 12.5 mmol

  9. Major Minerals - Calcium, Magnesium, Phosphorus

    Technology Transfer Automated Retrieval System (TEKTRAN)

    Calcium, magnesium and phosphorus are essential elements critically important for the function of the musculoskeletal system, including the formation and transduction of energy and the maintenance of healthy bone. The major calcium concern for physically active healthy middle-aged adults is to consu...

  10. Sodium picosulfate/magnesium citrate: a review of its use as a colorectal cleanser.

    PubMed

    Hoy, Sheridan M; Scott, Lesley J; Wagstaff, Antona J

    2009-01-01

    Oral sodium picosulfate/magnesium citrate (CitraFleet; Picolax), consisting of sodium picosulfate (a stimulant laxative) and magnesium citrate (an osmotic laxative), is approved for use in adults (CitraFleet; Picolax) and/or adolescents and children (Picolax) as a colorectal cleansing agent prior to any diagnostic procedure (e.g. colonoscopy or x-ray examination) requiring a clean bowel and/or surgery. It is dispensed in powder form (sodium picosulfate 0.01 g, magnesium oxide 3.5 g, citric acid 12.0 g per sachet), with the magnesium oxide and citric acid components forming magnesium citrate when the powder is dissolved in water. In adult patients, two sachets of sodium picosulfate/magnesium citrate was at least as effective and well tolerated as oral magnesium citrate 17.7 or 35.4 g, or oral polyethylene glycol 236 g in adult patients undergoing a double-contrast barium enema procedure in three large, randomized, comparative clinical studies. In contrast, sodium picosulfate/magnesium citrate was less effective than a sodium phosphate enema preparation in two studies in patients undergoing flexible sigmoidoscopy. A similar number of patients receiving two sachets of sodium picosulfate/magnesium citrate or two 45 mL doses of oral sodium phosphate the day before a double-contrast barium enema procedure achieved satisfactory barium coating and none/minimal faecal residue in one study. However, the data from three of these studies should be interpreted with caution because the administrative regimens used differed from that recommended. Sodium picosulfate/magnesium citrate is also an effective and generally well tolerated colorectal cleansing agent in children and adolescents; the preparation was more effective than oral bisacodyl 0.01 or 0.02 g plus a sodium phosphate enema preparation in this population. Further research is thus required to accurately position sodium picosulfate/magnesium citrate and fully establish its efficacy and tolerability prior to various

  11. Comparative effects of lactulose and magnesium sulfate on urea metabolism and nitrogen excretion in cirrhotic subjects.

    PubMed

    Weber, F L; Fresard, K M

    1981-05-01

    In previous studies with cirrhotic subjects administration of oral lactulose caused a reduction in the urea production rate associated with an increase in fecal nitrogen excretion. The change in urea production rate in response to lactulose therapy was an indirect measure of a reduction in total gut ammonia production. In this study, the effect of magnesium sulfate administration was compared with lactulose therapy in 5 cirrhotic subjects to determine whether the effects of lactulose on nitrogen metabolism might be attributed to a nonspecific, cathartic effect. Both magnesium sulfate (5-15 g/day) and lactulose (40-80 g/day) caused significant and comparable increases in stool weight, solids, and total nitrogen. Only lactulose caused a reduction in fecal pH. Magnesium sulfate had no significant effect on the urea production rate or urinary nitrogen excretion, whereas lactulose caused a 25% reduction in the urea production rate and an 18% reduction in urinary nitrogen excretion. The latter was accounted for by a fall in urinary urea. Nitrogen balance was more negative during magnesium sulfate than during control or lactulose periods since magnesium sulfate increased fecal nitrogen without altering urinary nitrogen excretion. These data demonstrated that the effects of lactulose on nitrogen excretion and urea metabolism were not duplicated by equivalent cathartic doses of magnesium sulfate. PMID:7202981

  12. A SEARCH FOR MAGNESIUM IN EUROPA'S ATMOSPHERE

    SciTech Connect

    Hoerst, S. M.; Brown, M. E.

    2013-02-20

    Europa's tenuous atmosphere results from sputtering of the surface. The trace element composition of its atmosphere is therefore related to the composition of Europa's surface. Magnesium salts are often invoked to explain Galileo Near Infrared Mapping Spectrometer spectra of Europa's surface, thus magnesium may be present in Europa's atmosphere. We have searched for magnesium emission in the Hubble Space Telescope Faint Object Spectrograph archival spectra of Europa's atmosphere. Magnesium was not detected and we calculate an upper limit on the magnesium column abundance. This upper limit indicates that either Europa's surface is depleted in magnesium relative to sodium and potassium, or magnesium is not sputtered as efficiently resulting in a relative depletion in its atmosphere.

  13. Effects of magnesium supplementation on electrophysiological remodeling of cardiac myocytes in L-NAME induced hypertensive rats.

    PubMed

    Ozturk, Nihal; Olgar, Yusuf; Aslan, Mutay; Ozdemir, Semir

    2016-08-01

    Hypertension is one of the major risk factors of cardiac hypertrophy and magnesium deficiency is suggested to be a contributing factor in the progression of this complication. In this study, we aimed to investigate the relationship between intracellular free Mg(2+) levels and electrophysiological changes developed in the myocardium of L-NAME induced hypertensive rats. Hypertension was induced by administration of 40 mg/kg of L-NAME for 6 weeks, while magnesium treated rats fed with a diet supplemented with 1 g/kg of MgO for the same period. L-NAME administration for 6 weeks elicited a significant increase in blood pressure which was corrected with MgO treatment; thereby cardiac hypertrophy developing secondary to hypertension was prevented. Cytosolic free magnesium levels of ventricular myocytes were significantly decreased with hypertension and magnesium administration restored these changes. Hypertension significantly decreased the fractional shortening with slowing of shortening kinetics in left ventricular myocytes whereas magnesium treatment was capable of restoring hypertension-induced contractile dysfunction. Long-term magnesium treatment significantly restored the hypertension-induced prolongation in action potentials of ventricular myocytes and suppressed Ito and Iss currents. In contrast, hypertension dependent decrement in intracellular Mg(2+) level did not cause a significant change in L-type Ca(2+) currents, SR Ca(2+) content and NCX activity. Nevertheless, hypertension mediated increase in superoxide anion, hydrogen peroxide and protein oxidation mitigated with magnesium treatment. In conclusion, magnesium administration improves mechanical abnormalities observed in hypertensive rat ventricular myocytes due to reduced oxidative stress. It is likely that, changes in intracellular magnesium balance may contribute to the pathophysiology of chronic heart diseases.

  14. Effects of magnesium supplementation on electrophysiological remodeling of cardiac myocytes in L-NAME induced hypertensive rats.

    PubMed

    Ozturk, Nihal; Olgar, Yusuf; Aslan, Mutay; Ozdemir, Semir

    2016-08-01

    Hypertension is one of the major risk factors of cardiac hypertrophy and magnesium deficiency is suggested to be a contributing factor in the progression of this complication. In this study, we aimed to investigate the relationship between intracellular free Mg(2+) levels and electrophysiological changes developed in the myocardium of L-NAME induced hypertensive rats. Hypertension was induced by administration of 40 mg/kg of L-NAME for 6 weeks, while magnesium treated rats fed with a diet supplemented with 1 g/kg of MgO for the same period. L-NAME administration for 6 weeks elicited a significant increase in blood pressure which was corrected with MgO treatment; thereby cardiac hypertrophy developing secondary to hypertension was prevented. Cytosolic free magnesium levels of ventricular myocytes were significantly decreased with hypertension and magnesium administration restored these changes. Hypertension significantly decreased the fractional shortening with slowing of shortening kinetics in left ventricular myocytes whereas magnesium treatment was capable of restoring hypertension-induced contractile dysfunction. Long-term magnesium treatment significantly restored the hypertension-induced prolongation in action potentials of ventricular myocytes and suppressed Ito and Iss currents. In contrast, hypertension dependent decrement in intracellular Mg(2+) level did not cause a significant change in L-type Ca(2+) currents, SR Ca(2+) content and NCX activity. Nevertheless, hypertension mediated increase in superoxide anion, hydrogen peroxide and protein oxidation mitigated with magnesium treatment. In conclusion, magnesium administration improves mechanical abnormalities observed in hypertensive rat ventricular myocytes due to reduced oxidative stress. It is likely that, changes in intracellular magnesium balance may contribute to the pathophysiology of chronic heart diseases. PMID:27193439

  15. Magnesium: its role in nutrition and carcinogenesis.

    PubMed

    Blaszczyk, Urszula; Duda-Chodak, Aleksandra

    2013-01-01

    Magnesium (Mg2+) plays a key role in many essential cellular processes such as intermediary metabolism, DNA replication and repair, transporting potassium and calcium ions, cell proliferation together with signalling transduction. Dietary sources rich in magnesium are whole and unrefined grains, seeds, cocoa, nuts, almonds and green leafy vegetables. Hard water is also considered to be an important source of magnesium beneficial to human health. The daily dietary intake of magnesium is however frequently found to be below that recommended in Western countries. Indeed, it is recognised that magnesium deficiency may lead to many disorders of the human body, where for instance magnesium depletion is believed to play an important role in the aetiology of the following; cardiovascular disease (including thrombosis, atherosclerosis, ishaemic heart disease, myocardial infarction, hypertension, arrhythmias and congestive heart failure in human), as well as diabetes mellitus, gastrointestinal (GI) tract disease, liver cirrhosis and diseases of the thyroid and parathyroid glands. Insufficient dietary intake of magnesium may also significantly affect the development and exacerbation ofADHD (Attention Deficit- Hyperactivity Disorder) symptoms in children. The known links between magnesium and carcinogenesis still remain unclear and complex, with conflicting results being reported from many experimental, epidemiological and clinical studies; further knowledge is thus required. Mg2+ ions are enzyme cofactors involved in DNA repair mechanisms that maintain genomic stability and fidelity. Any magnesium deficiencies could thereby cause a dysfunction of these systems to occur leading to DNA mutations. Magnesium deficiency may also be associated with inflammation and increased levels of free radicals where both inflammatory mediators and free radicals so arising could cause oxidative DNA damage and therefore tumour formation. The presented review article now provides a summary

  16. The effect of intravenous magnesium hypophosphite in calcium borogluconate solution on the serum concentration of inorganic phosphorus in healthy cows.

    PubMed

    Braun, U; Jehle, W

    2007-03-01

    The goal of this study was to determine the effect of intravenous (IV) administration of phosphite on the serum concentration of inorganic phosphorus in cows. Twelve clinically healthy cows were divided into four groups of three. All cows received 600 mL of a 40% calcium borogluconate solution; three cows each received this as a rapid (20 min) IV infusion with and without 6% magnesium hypophosphite, and three other cows each received this as a slow IV infusion (8 h) with and without 6% magnesium hypophosphite. Samples of blood were collected for the determination of serum concentrations of calcium, inorganic phosphorus and magnesium before and 10, 20, 40, 60 and 90 min and 2, 3, 4, 5, 6, 7, 8, 24, 48 and 72 h after the start of treatment. The concentration of calcium increased after treatment in all cows but the increase was most rapid in cows that received the rapid infusion. In cows that received the rapid IV infusion containing magnesium hypophosphite, the mean concentration of inorganic phosphorus decreased significantly 3-4 h after treatment compared with initial serum levels. The serum concentration of inorganic phosphorus did not change significantly in cows that received the rapid IV solution without magnesium hypophosphite or the slow IV infusion with or without magnesium hypophosphite. The serum concentration of magnesium increased after treatment in all cows receiving magnesium hypophosphite but remained unchanged in the others. The rapid infusion of calcium borogluconate without magnesium hypophosphite made all three cows anorexic and hypercalcaemic and the slow infusion made 1/3 anorexic. It is concluded that the IV administration of a calcium solution containing magnesium hypophosphite does not increase the serum concentration of inorganic phosphorus.

  17. Method for magnesium sulfate recovery

    DOEpatents

    Gay, R.L.; Grantham, L.F.

    1987-08-25

    A method is described for obtaining magnesium sulfate substantially free from radioactive uranium from a slag containing the same and having a radioactivity level of at least about 7,000 pCi/gm. The slag is ground to a particle size of about 200 microns or less. The ground slag is then contacted with a concentrated sulfuric acid under certain prescribed conditions to produce a liquid product and a solid product. The particulate solid product and a minor amount of the liquid is then treated to produce a solid residue consisting essentially of magnesium sulfate substantially free of uranium and having a residual radioactivity level of less than 1,000 pCi/gm. In accordance with the preferred embodiment of the invention, a catalyst and an oxidizing agent are used during the initial acid treatment and a final solid residue has a radioactivity level of less than about 50 pCi/gm.

  18. Method for magnesium sulfate recovery

    DOEpatents

    Gay, Richard L.; Grantham, LeRoy F.

    1987-01-01

    A method of obtaining magnesium sulfate substantially free from radioactive uranium from a slag containing the same and having a radioactivity level of at least about 7000 pCi/gm. The slag is ground to a particle size of about 200 microns or less. The ground slag is then contacted with a concentrated sulfuric acid under certain prescribed conditions to produce a liquid product and a solid product. The particulate solid product and a minor amount of the liquid is then treated to produce a solid residue consisting essentially of magnesium sulfate substantially free of uranium and having a residual radioactivity level of less than 1000 pCi/gm. In accordance with the preferred embodiment of the invention, a catalyst and an oxidizing agent are used during the initial acid treatment and a final solid residue has a radioactivity level of less than about 50 pCi/gm.

  19. Method for removing magnesium from aluminum-magnesium alloys with engineered scavenger compound

    SciTech Connect

    Riley, W.D.; Jong, B.W.

    1994-12-31

    The invention relates to a method for removal and production of high purity magnesium from aluminum-magnesium alloys using an engineered scanvenger compound. In particular, the invention relates to a method for removal and production of high purity magnesium from aluminum-magnesium alloys using the engineered scanvenger compound (ESC) lithium titanate (Li2O3TiO2). The removal of magnesium from the aluminum-magnesium alloys is performed at about 600-750 C in a molten salt bath of KCl or KCl-MgCl2 using lithium titanate (Li2O3TiO2) as the engineered scavenger compound (ESC). Electrode deposition of magnesium from the loaded ESC onto a stainless steel electrode is accomplished in a second step, and provides a clean magnesium electrode deposit for recycling. The second step also prepares the ESC for reuse.

  20. Substrate and method for the formation of continuous magnesium diboride and doped magnesium diboride wire

    DOEpatents

    Suplinskas, Raymond J.; Finnemore, Douglas; Bud'ko, Serquei; Canfield, Paul

    2007-11-13

    A chemically doped boron coating is applied by chemical vapor deposition to a silicon carbide fiber and the coated fiber then is exposed to magnesium vapor to convert the doped boron to doped magnesium diboride and a resultant superconductor.

  1. Lightweight Heat Pipes Made from Magnesium

    NASA Technical Reports Server (NTRS)

    Rosenfeld, John N.; Zarembo, Sergei N.; Eastman, G. Yale

    2010-01-01

    Magnesium has shown promise as a lighter-weight alternative to the aluminum alloys now used to make the main structural components of axially grooved heat pipes that contain ammonia as the working fluid. Magnesium heat-pipe structures can be fabricated by conventional processes that include extrusion, machining, welding, and bending. The thermal performances of magnesium heat pipes are the same as those of equal-sized aluminum heat pipes. However, by virtue of the lower mass density of magnesium, the magnesium heat pipes weigh 35 percent less. Conceived for use aboard spacecraft, magnesium heat pipes could also be attractive as heat-transfer devices in terrestrial applications in which minimization of weight is sought: examples include radio-communication equipment and laptop computers.

  2. IMPROVED MAGNESIUM OXIDE SLIP CASTING METHOD

    DOEpatents

    Stoddard, S.D.; Nuckolls, D.E.

    1963-12-31

    A process for making an aqueous magnesium oxide slip casting slurry comprising the steps of mixing finely ground fused magnesium oxide with water, milling the slurry for at least 30 hours at a temperature of 2-10 deg C (the low temperature during milling inhibiting the formation of hydrated magnesium oxide), discharging the slurry from the mill, adding hydrochloric acid as a deflocculent, and adding a scum inhibitor is presented. (AEC)

  3. Magnesium: a versatile drug for anesthesiologists.

    PubMed

    Do, Sang-Hwan

    2013-07-01

    Magnesium sulfate has been used in preeclampsia patients in order to prevent seizure. It is also used for the treatment of arrhythmia and asthma and as an anesthetic adjunct in patients undergoing surgery for pheochromocytoma. However, its potentiating effects on perioperative analgesia and muscle relaxation have drawn attention recently. These characteristics of magnesium (anesthetic- and analgesic-sparing effect) enable anesthesiologists to reduce the use of anesthetics during surgery and the use of analgesics after surgery. Magnesium sulfate has a high therapeutic index and cost-effectiveness. Considering these diverse characteristics useful for anesthesia, appropriate use of magnesium sulfate would improve surgical outcome and patients' satisfaction. PMID:23904932

  4. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats.

    PubMed

    Ram, Z; Sadeh, M; Shacked, I; Sahar, A; Hadani, M

    1991-07-01

    We induced experimental delayed cerebral vasospasm by the intracisternal injection of greater than 0.5 ml blood in 30 rats. Seventy-two hours later the basilar artery was exposed via the transclival approach and photographed at high-power magnification through an operating microscope. We then evaluated the effect of topical (n = 30) and intravenous (n = 20) magnesium sulfate on the spastic artery by computerized image analysis. A greater than 50% reduction in baseline diameter of the basilar artery was observed in the rats subjected to subarachnoid hemorrhage compared with the 10 controls (p less than 0.0001). Intravenous magnesium sulfate dilated the spastic artery to approximately 75% of the baseline diameter in control rats (p less than 0.0001). Topical magnesium sulfate caused dramatic dilation of the basilar artery in both the control and the subarachnoid hemorrhage groups to near 150% of the baseline diameter in the controls (p less than 0.001). All rats receiving intravenous magnesium sulfate reached therapeutic plasma levels of the ion. Hemodynamic effects were mild and immediately reversible upon cessation of magnesium sulfate administration. We suggest that magnesium has a role in the treatment of subarachnoid hemorrhage-induced vasospasm in humans.

  5. 21 CFR 862.1495 - Magnesium test system.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... magnesium levels in serum and plasma. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels...

  6. 21 CFR 862.1495 - Magnesium test system.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... magnesium levels in serum and plasma. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels...

  7. 21 CFR 862.1495 - Magnesium test system.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... magnesium levels in serum and plasma. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels...

  8. 21 CFR 862.1495 - Magnesium test system.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... magnesium levels in serum and plasma. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels...

  9. 21 CFR 862.1495 - Magnesium test system.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... magnesium levels in serum and plasma. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels...

  10. Serum calcitonin-lowering effect of magnesium in patients with medullary carcinoma of the thyroid.

    PubMed Central

    Anast, C; David, L; Winnacker, J; Glass, R; Baskin, W; Brubaker, L; Burns, T

    1975-01-01

    The effect of magnesium chloride or magnesium sulfate infusion on circulating levels of immunoreactive calcitonin (iCT) was evaluated on nine occasions in three patients with metastatic medullary carcinoma of the thyroid. One patient was normocalcemic and had normal circulating levels of immunoreactive parathyroid hormone (iPTH), one patient was hypocalcemic and had surgical hypoparathyroidism, and one patient had mild to moderate hypercalcemia associated with bone metastases. The basal serum iPTH levels were undetectable in the latter two patients. In every instance magnesium administration produced a rapid and striking fall in circulating iCT and usually a detectable fall in serum calcium. During the hypermagnesemic state, serum iPTH fell from normal to undetectable in the patient with normal parathyroid function, while serum iPTH levels remained undetectable in the hypoparathyroid patient and in the patient with hypercalcemia associated with bone metastases. The results of these studies indicate that: (a) contrary to what has been reported in normal experimental animals, magnesium administration lowers circulating iCT in human subjects with thyroid medullary carcinoma and (b) the calcium-lowering effect produced by magnesium in patients with medullary carcinoma may, in part at least, be due to a redistribution of body calcium that is not mediated by the actions of either parathyroid hormone or clacitonin. PMID:1202087

  11. The TMS Magnesium Committee: Committed to the Advancement of Global Magnesium Technology

    SciTech Connect

    Sillekens, Wim H.; Nyberg, Eric A.

    2011-04-21

    The TMS Magnesium Committee was established in the year 2000 as a spin-off of the Reactive Metals Committee, triggered by the strong global growth of magnesium being used in a variety of structural lightweight applications since the mid-1990’s. Since then the committee has seen a distinct development in terms of size, participation and focus. The article at hand outlines this development by recapitulating the output of its two main activities: the annual Magnesium Technology Symposia and the JOM Special Issues dedicated to magnesium research and development. Further records on the Magnesium Committee are available from the committee homepage (accessible through http://members.tms.org).

  12. Iatrogenic magnesium toxicity following intravenous infusion of magnesium sulfate: risks and strategies for prevention.

    PubMed

    Cavell, Gillian F; Bryant, Catherine; Jheeta, Seetal

    2015-07-31

    A 65-year-old man being treated with radiotherapy and chemotherapy for recurrent colonic adenocarcinoma was admitted for management of hypokalaemia and hypomagnesaemia secondary to diarrhoea. He was treated with intravenous infusions of potassium chloride and magnesium sulfate. Following an infusion of magnesium sulfate, he experienced a sudden neurological deterioration. A CT of the head revealed no haemorrhage or evidence of acute ischaemic injury. Results of serum biochemistry later that day revealed an elevated magnesium level. Iatrogenic magnesium toxicity was suspected. Further discussions between the pharmacist and ward staff confirmed that a medication error had been made in the preparation of the infusion resulting in an overdose of intravenous magnesium.

  13. 75 FR 65450 - Magnesium Metal From the People's Republic of China: Final Results of the 2008-2009 Antidumping...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-10-25

    ... China: Preliminary Results of the 2008-2009 Administrative Review of the Antidumping Duty Order, 75 FR...; Extension of Time for the Final Results of the Antidumping Duty Administrative Review, 75 FR 50992 (August... Federation, 60 FR 25691 (May 12, 1995); and Antidumping Duty Order: Pure Magnesium in Granular Form from...

  14. 76 FR 33194 - Pure Magnesium From the People's Republic of China: Preliminary Results of the 2009-2010...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-06-08

    ... Fair Value: Antidumping Duty Investigation of Pure Magnesium From the Russian Federation, 60 FR 25691...; Opportunity To Request Administrative Review, 75 FR 23236 (May 3, 2010). \\3\\ See Initiation of Antidumping and Countervailing Duty Administrative Reviews and Requests for Revocation in Part, 75 FR 37759 (June 30, 2010)....

  15. 77 FR 71578 - Pure Magnesium in Granular Form From the People's Republic of China; Final Results of Antidumping...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-12-03

    ... Administrative Review, 77 FR 46030 (August 2, 2012) (``Preliminary Results''). We invited interested parties to... Administrative Determination Deadlines Pursuant to the Tariff Act of 1930, As Amended, 70 FR 24533 (May 10, 2005... Antidumping Duty Order: Pure Magnesium in Granular Form from the People's Republic of China, 66 FR...

  16. 75 FR 13489 - Magnesium Metal from the People's Republic of China: Extension of Time for the Preliminary...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-03-22

    ..., 74 FR 25711 (May 29, 2009). \\3\\ See Magnesium Metal from the People's Republic of China: Extension of Time for the Preliminary Results of the Antidumping Duty Administrative Review, 74 FR 68227 (December... Duty Order, Finding, or Suspended Investigation; Opportunity to Request Administrative Review, 74...

  17. Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits.

    PubMed

    Pochwat, Bartłomiej; Szewczyk, Bernadeta; Sowa-Kucma, Magdalena; Siwek, Agata; Doboszewska, Urszula; Piekoszewski, Wojciech; Gruca, Piotr; Papp, Mariusz; Nowak, Gabriel

    2014-03-01

    Recent data suggests that the glutamatergic system is involved in the pathophysiology and treatment of major depressive disorder (MDD) and that the N-methyl-D-aspartate (NMDA) receptor is a potential target for antidepressant drugs. The magnesium ion blocks the ion channel of the NMDA receptor and prevents its excessive activation. Some preclinical and clinical evidence suggests also that magnesium may be useful in the treatment of depression. The present study investigated the effect of magnesium treatment (10, 15 and 20 mg/kg, given as magnesium hydroaspartate) in the chronic mild stress (CMS) model of depression in rats. Moreover, the effect of CMS and magnesium (with an effective dose) on the level of the proteins related to the glutamatergic system (GluN1, GluN2A, GluN2B and PSD-95) in the hippocampus, prefrontal cortex (PFC) and amygdala were examined. A significant reduction in the sucrose intake induced by CMS was increased by magnesium treatment at a dose of 15 mg/kg, beginning from the third week of administration. Magnesium did not affect this behavioural parameter in the control animals. CMS significantly increased the level of the GluN1 subunit in the amygdala (by 174%) and GluN2A in the hippocampus (by 191%), both of which were significantly attenuated by magnesium treatment. Moreover, magnesium treatment in CMS animals increased the level of GluN2B (by 116%) and PSD-95 (by 150%) in the PFC. The present results for the first time demonstrate the antidepressant-like activity of magnesium in the animal model of anhedonia (CMS), thus indicating the possible involvement of the NMDA/glutamatergic receptors in this activity.

  18. Nanostructured magnesium increases bone cell density

    NASA Astrophysics Data System (ADS)

    Weng, Lucy; Webster, Thomas J.

    2012-12-01

    Magnesium has attracted some attention in orthopedics due to its biodegradability and mechanical properties. Since magnesium is an essential natural mineral for bone growth, it can be expected that as a biomaterial, it would support bone formation. However, upon degradation in the body, magnesium releases OH- which results in an alkaline pH that can be detrimental to cell density (for example, osteoblasts or bone forming cells). For this reason, modification of magnesium may be necessary to compensate for such detrimental effects to cells. This study created biologically inspired nanoscale surface features on magnesium by soaking magnesium in various concentrations of NaOH (from 1 to 10 N) and for various periods of time (from 10 to 30 min). The results provided the first evidence of increased roughness, surface energy, and consequently greater osteoblast adhesion, after 4 h as well as density up to 7 days on magnesium treated with any concentration of NaOH for any length of time compared to untreated controls. For these reasons, this study suggests that soaking magnesium in NaOH could be an inexpensive, simple and effective manner to promote osteoblast functions for numerous orthopedic applications and, thus, should be further studied.

  19. Imparting passivity to vapor deposited magnesium alloys

    NASA Astrophysics Data System (ADS)

    Wolfe, Ryan C.

    Magnesium has the lowest density of all structural metals. Utilization of low density materials is advantageous from a design standpoint, because lower weight translates into improved performance of engineered products (i.e., notebook computers are more portable, vehicles achieve better gas mileage, and aircraft can carry more payload). Despite their low density and high strength to weight ratio, however, the widespread implementation of magnesium alloys is currently hindered by their relatively poor corrosion resistance. The objective of this research dissertation is to develop a scientific basis for the creation of a corrosion resistant magnesium alloy. The corrosion resistance of magnesium alloys is affected by several interrelated factors. Among these are alloying, microstructure, impurities, galvanic corrosion effects, and service conditions, among others. Alloying and modification of the microstructure are primary approaches to controlling corrosion. Furthermore, nonequilibrium alloying of magnesium via physical vapor deposition allows for the formation of single-phase magnesium alloys with supersaturated concentrations of passivity-enhancing elements. The microstructure and surface morphology is also modifiable during physical vapor deposition through the variation of evaporation power, pressure, temperature, ion bombardment, and the source-to-substrate distance. Aluminum, titanium, yttrium, and zirconium were initially chosen as candidates likely to impart passivity on vapor deposited magnesium alloys. Prior to this research, alloys of this type have never before been produced, much less studied. All of these metals were observed to afford some degree of corrosion resistance to magnesium. Due to the especially promising results from nonequilibrium alloying of magnesium with yttrium and titanium, the ternary magnesium-yttrium-titanium system was investigated in depth. While all of the alloys are lustrous, surface morphology is observed under the scanning

  20. Imparting passivity to vapor deposited magnesium alloys

    NASA Astrophysics Data System (ADS)

    Wolfe, Ryan C.

    Magnesium has the lowest density of all structural metals. Utilization of low density materials is advantageous from a design standpoint, because lower weight translates into improved performance of engineered products (i.e., notebook computers are more portable, vehicles achieve better gas mileage, and aircraft can carry more payload). Despite their low density and high strength to weight ratio, however, the widespread implementation of magnesium alloys is currently hindered by their relatively poor corrosion resistance. The objective of this research dissertation is to develop a scientific basis for the creation of a corrosion resistant magnesium alloy. The corrosion resistance of magnesium alloys is affected by several interrelated factors. Among these are alloying, microstructure, impurities, galvanic corrosion effects, and service conditions, among others. Alloying and modification of the microstructure are primary approaches to controlling corrosion. Furthermore, nonequilibrium alloying of magnesium via physical vapor deposition allows for the formation of single-phase magnesium alloys with supersaturated concentrations of passivity-enhancing elements. The microstructure and surface morphology is also modifiable during physical vapor deposition through the variation of evaporation power, pressure, temperature, ion bombardment, and the source-to-substrate distance. Aluminum, titanium, yttrium, and zirconium were initially chosen as candidates likely to impart passivity on vapor deposited magnesium alloys. Prior to this research, alloys of this type have never before been produced, much less studied. All of these metals were observed to afford some degree of corrosion resistance to magnesium. Due to the especially promising results from nonequilibrium alloying of magnesium with yttrium and titanium, the ternary magnesium-yttrium-titanium system was investigated in depth. While all of the alloys are lustrous, surface morphology is observed under the scanning

  1. Analysis Methods of Magnesium Chips

    NASA Astrophysics Data System (ADS)

    Ohmann, Sven; Ditze, André; Scharf, Christiane

    2015-11-01

    The quality of recycled magnesium from chips depends strongly on their exposure to inorganic and organic impurities that are added during the production processes. Different kinds of magnesium chips from these processes were analyzed by several methods. In addition, the accuracy and effectiveness of the methods are discussed. The results show that the chips belong either to the AZ91, AZ31, AM50/60, or AJ62 alloy. Some kinds of chips show deviations from the above-mentioned normations. Different impurities result mainly from transition metals and lime. The water and oil content does not exceed 25%, and the chip size is not more than 4 mm in the diameter. The sieve analysis shows good results for oily and wet chips. The determination of oil and water shows better results for the application of a Soxhlet compared with the addition of lime and vacuum distillation. The most accurate values for the determination of water and oil are obtained by drying at 110°C (for water) and washing with acetone (for oil) by hand.

  2. Tape casting of magnesium oxide.

    SciTech Connect

    Ayala, Alicia; Corral, Erica L.; Loehman, Ronald E.; Bencoe, Denise Nora; Reiterer, Markus; Shah, Raja A.

    2008-02-01

    A tape casting procedure for fabricating ceramic magnesium oxide tapes has been developed as a method to produce flat sheets of sintered MgO that are thin and porous. Thickness of single layer tapes is in the range of 200-400 {micro}m with corresponding surface roughness values in the range of 10-20 {micro}m as measured by laser profilometry. Development of the tape casting technique required optimization of pretreatment for the starting magnesium oxide (MgO) powder as well as a detailed study of the casting slurry preparation and subsequent heat treatments for sintering and final tape flattening. Milling time of the ceramic powder, plasticizer, and binder mixture was identified as a primary factor affecting surface morphology of the tapes. In general, longer milling times resulted in green tapes with a noticeably smoother surface. This work demonstrates that meticulous control of the entire tape casting operation is necessary to obtain high-quality MgO tapes.

  3. What we learned about the role of antenatal magnesium sulfate for the prevention of cerebral palsy.

    PubMed

    Rouse, Dwight J; Hirtz, Deborah

    2016-08-01

    Based on the convincing case control study of Nelson and Grether which suggested that the administration of magnesium sulfate to mothers prior to early preterm birth might protect their offspring from cerebral palsy, and a pilot study by John Hauth et al. at the University of Alabama at Birmingham, the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, with co-funding from the National Institute of Neurologic Disorders and Stroke embarked on the Beneficial Effects of Antenatal Magnesium (BEAM) Trial in 1997. PMID:27117179

  4. Magnesium Lowers the Incidence of Postoperative Junctional Ectopic Tachycardia in Congenital Heart Surgical Patients: Is There a Relationship to Surgical Procedure Complexity?

    PubMed

    He, Dingchao; Sznycer-Taub, Nathaniel; Cheng, Yao; McCarter, Robert; Jonas, Richard A; Hanumanthaiah, Sridhar; Moak, Jeffrey P

    2015-08-01

    Magnesium sulfate was given to pediatric cardiac surgical patients during cardiopulmonary bypass period in an attempt to reduce the occurrence of postoperative junctional ectopic tachycardia (PO JET). We reviewed our data to evaluate the effect of magnesium on the occurrence of JET and assess a possible relationship between PO JET and procedure complexity. A total of 1088 congenital heart surgeries (CHS), performed from 2005 to 2010, were reviewed. A total of 750 cases did not receive magnesium, and 338 cases received magnesium (25 mg/kg). All procedures were classified according to Aristotle score from 1 to 4. Overall, there was a statistically significant decrease in PO JET occurrence between the two groups regardless of the Aristotle score, 15.3 % (115/750) in non-magnesium group versus 7.1 % (24/338) in magnesium group, P < 0.001. In the absence of magnesium, the risk of JET increased with increasing Aristotle score, P = 0.01. Following magnesium administration and controlling for body weight, surgical and aortic cross-clamp times in the analyses, reduction in adjusted risk of JET was significantly greater with increasing Aristotle level of complexity (JET in non-magnesium vs. magnesium group, Aristotle level 1: 9.8 vs. 14.3 %, level 4: 11.5 vs. 3.2 %; odds ratio 0.54, 95 % CI 0.31-0.94, P = 0.028). Our data confirmed that intra-operative usage of magnesium reduced the occurrence of PO JET in a larger number and more diverse group of CHS patients than has previously been reported. Further, our data suggest that magnesium's effect on PO JET occurrence seemed more effective in CHS with higher levels of Aristotle complexity.

  5. Magnesium: its role in nutrition and carcinogenesis.

    PubMed

    Blaszczyk, Urszula; Duda-Chodak, Aleksandra

    2013-01-01

    Magnesium (Mg2+) plays a key role in many essential cellular processes such as intermediary metabolism, DNA replication and repair, transporting potassium and calcium ions, cell proliferation together with signalling transduction. Dietary sources rich in magnesium are whole and unrefined grains, seeds, cocoa, nuts, almonds and green leafy vegetables. Hard water is also considered to be an important source of magnesium beneficial to human health. The daily dietary intake of magnesium is however frequently found to be below that recommended in Western countries. Indeed, it is recognised that magnesium deficiency may lead to many disorders of the human body, where for instance magnesium depletion is believed to play an important role in the aetiology of the following; cardiovascular disease (including thrombosis, atherosclerosis, ishaemic heart disease, myocardial infarction, hypertension, arrhythmias and congestive heart failure in human), as well as diabetes mellitus, gastrointestinal (GI) tract disease, liver cirrhosis and diseases of the thyroid and parathyroid glands. Insufficient dietary intake of magnesium may also significantly affect the development and exacerbation ofADHD (Attention Deficit- Hyperactivity Disorder) symptoms in children. The known links between magnesium and carcinogenesis still remain unclear and complex, with conflicting results being reported from many experimental, epidemiological and clinical studies; further knowledge is thus required. Mg2+ ions are enzyme cofactors involved in DNA repair mechanisms that maintain genomic stability and fidelity. Any magnesium deficiencies could thereby cause a dysfunction of these systems to occur leading to DNA mutations. Magnesium deficiency may also be associated with inflammation and increased levels of free radicals where both inflammatory mediators and free radicals so arising could cause oxidative DNA damage and therefore tumour formation. The presented review article now provides a summary

  6. Magnesium absorption in mature ewes infused intrarumenally with magnesium chloride.

    PubMed

    McLean, A F; Buchan, W; Scott, D

    1984-11-01

    The effects of magnesium supplementation on Mg absorption proximal and distal to the pylorus in ewes maintained on a grass diet were investigated using a combination of balance, digesta flow and electropotential measurements. Three mature ewes each received by intrarumenal infusion a supplement of 0, 1, 2 and 3 g Mg/d in sequence over four 10-d periods. Net Mg absorption distal to the pylorus took place down its electrochemical gradient, although the quantity absorbed remained small during the control and first infusion periods. The bulk of Mg absorption occurred before the pylorus and, during the control and first infusion periods, took place against its electrochemical gradient. The net Mg absorption proximal to the pylorus rose with declining efficiency as Mg intake was increased. It is suggested that saturation of the absorption process at this site was occurring.

  7. Intestinal absorption of magnesium from food and supplements.

    PubMed Central

    Fine, K D; Santa Ana, C A; Porter, J L; Fordtran, J S

    1991-01-01

    The purpose of this study was to measure magnesium absorption over the wide range of intakes to which the intestine may be exposed from food and/or magnesium-containing medications. Net magnesium absorption was measured in normal subjects after they ingested a standard meal supplemented with 0, 10, 20, 40, and 80 mEq of magnesium acetate. Although absorption increased with each increment in intake, fractional magnesium absorption fell progressively (from 65% at the lowest to 11% at the highest intake) so that absorption as a function of intake was curvilinear. This absorption-intake relationship was almost perfectly represented by an equation containing a hyperbolic function plus a linear function. Our results are statistically compatible with a magnesium absorption process that simultaneously uses a mechanism that reaches an absorptive maximum, plus a mechanism that endlessly absorbs a defined fraction (7%) of ingested magnesium. Compared to previous studies of calcium absorption, much less magnesium that calcium was absorbed at intakes above 8 mEq/meal, apparently due to greater restriction of intestinal permeability to magnesium. We also found that magnesium from a high magnesium-containing food source, almonds, was just as bioavailable as from soluble magnesium acetate. In contrast, magnesium absorption from commercially available enteric-coated magnesium chloride was much less than from magnesium acetate, suggesting that enteric coating can impair magnesium bioavailability. PMID:1864954

  8. Magnesium bicarbonate as an in situ uranium lixiviant

    SciTech Connect

    Sibert, J.W.

    1984-09-25

    In the subsurface solution mining of mineral values, especially uranium, in situ, magnesium bicarbonate leaching solution is used instead of sodium, potassium and ammonium carbonate and bicarbonates. The magnesium bicarbonate solution is formed by combining carbon dioxide with magnesium oxide and water. The magnesium bicarbonate lixivant has four major advantages over prior art sodium, potassium and ammonium bicarbonates.

  9. Monitoring Biodegradation of Magnesium Implants with Sensors

    NASA Astrophysics Data System (ADS)

    Zhao, Daoli; Wang, Tingting; Guo, Xuefei; Kuhlmann, Julia; Doepke, Amos; Dong, Zhongyun; Shanov, Vesselin N.; Heineman, William R.

    2016-04-01

    Magnesium and its alloys exhibit properties such as high strength, light weight, and in vivo corrosion that make them promising candidates for the development of biodegradable metallic implant materials for bone repair, stents and other medical applications. Sensors have been used to monitor the corrosion of magnesium and its alloys by measuring the concentrations of the following corrosion products: magnesium ions, hydroxyl ions and hydrogen gas. The corrosion characterization system with home-made capillary pH and Mg2+ microsensors has been developed for real-time detection of magnesium corrosion in vitro. A hydrogen gas sensor was used to monitor the corrosion of magnesium by measuring the concentration of the hydrogen gas reaction product in vivo. The high permeability of hydrogen through skin allows transdermal monitoring of the biodegradation of a magnesium alloy implanted beneath the skin by detecting hydrogen gas at the skin surface. The sensor was used to map hydrogen concentration in the vicinity of an implanted magnesium alloy.

  10. Computational micromechanics of bioabsorbable magnesium stents.

    PubMed

    Grogan, J A; Leen, S B; McHugh, P E

    2014-06-01

    Magnesium alloys are a promising candidate material for an emerging generation of absorbable metal stents. Due to its hexagonal-close-packed lattice structure and tendency to undergo twinning, the deformation behaviour of magnesium is quite different to that of conventional stent materials, such as stainless steel 316L and cobalt chromium L605. In particular, magnesium exhibits asymmetric plastic behaviour (i.e. different yield behaviours in tension and compression) and has lower ductility than these conventional alloys. In the on-going development of absorbable metal stents it is important to assess how the unique behaviour of magnesium affects device performance. The mechanical behaviour of magnesium stent struts is investigated in this study using computational micromechanics, based on finite element analysis and crystal plasticity theory. The plastic deformation in tension and bending of textured and non-textured magnesium stent struts with different numbers of grains through the strut dimension is investigated. It is predicted that, unlike 316L and L605, the failure risk and load bearing capacity of magnesium stent struts during expansion is not strongly affected by the number of grains across the strut dimensions; however texturing, which may be introduced and controlled in the manufacturing process, is predicted to have a significant influence on these measures of strut performance.

  11. Magnesium and disturbances in carbohydrate metabolism.

    PubMed

    Mooren, Frank C

    2015-09-01

    Magnesium is actively involved in a number of metabolic reactions as an important co-factor, with special emphasis on carbohydrate metabolism. After a brief overview of the regulation of intra- and extracellular magnesium, the present review first describes the regulatory role of magnesium in important metabolic pathways involved in energy metabolism and glycaemic control. Next the clinical significance of hypomagnesaemic conditions with regard to the management of glucose in prediabetic stages, such as insulin resistance/impaired glucose tolerance and in type 2 diabetes mellitus are characterized. Cross-sectional as well as longitudinal studies suggest that a reduced dietary magnesium intake serves as a risk factor for the incidence of both impaired glucose regulation and type 2 diabetes. Mechanisms that might be responsible for diabetes-associated hypomagnesaemia are discussed. Furthermore, the role of hypomagnesaemia in the development and progression of chronic diabetic complications are addressed. Finally, the available literature on the effects of magnesium supplementation on glycaemic control parameters during prediabetic conditions (preventive approach) as well as type 2 diabetes mellitus (therapeutic approach) are reviewed systematically. There is considerable evidence that chronic magnesium supplementation may delay the progression from impaired glucose regulation to type 2 diabetes; however, the effects of oral magnesium supplementation as an adjunct therapy for type 2 diabetes are quite heterogeneous with respect to the various measures of glycaemic control. The results of this review suggest a requirement for critical consideration of the pros and cons of magnesium replacement therapy, based on variables such as magnesium status, stage of disease and glycaemic control.

  12. Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia.

    PubMed

    Bujalska, Magdalena; Malinowska, Ewelina; Makulska-Nowak, Helena; Gumułka, Stanisław Witold

    2008-01-01

    Streptozotocin-induced hyperglycemia accompanied by a chronic decrease in the nociceptive threshold is considered a useful model of experimental hyperalgesia. We examined (1) the effect of the opioid receptor agonists and (2) the effect of the magnesium ions (Mg(2+)) on the antinociceptive action of opioid agonists in a diabetic neuropathic pain model. When administered alone, opioid agonists like morphine (5 mg/kg i.p.) and fentanyl (0.0625 mg/kg i.p.), as well as the partial agonist buprenorphine (0.075 mg/kg) had only little effect on streptozotocin-induced hyperalgesia. However, pretreatment with Mg(2+) at a dose of 40 mg magnesium sulfate/kg i.p. markedly enhanced the analgesic activity of all three investigated opioids. Practical aspects of co-administration of magnesium and opioids in diabetic neuropathy are discussed. PMID:18701828

  13. Magnesium doping of boron nitride nanotubes

    DOEpatents

    Legg, Robert; Jordan, Kevin

    2015-06-16

    A method to fabricate boron nitride nanotubes incorporating magnesium diboride in their structure. In a first embodiment, magnesium wire is introduced into a reaction feed bundle during a BNNT fabrication process. In a second embodiment, magnesium in powder form is mixed into a nitrogen gas flow during the BNNT fabrication process. MgB.sub.2 yarn may be used for superconducting applications and, in that capacity, has considerably less susceptibility to stress and has considerably better thermal conductivity than these conventional materials when compared to both conventional low and high temperature superconducting materials.

  14. Effect of magnesium sulfate on ventricular refractoriness and its efficacy for torsade de pointes.

    PubMed

    Bando, S; Yamamoto, H; Nishikado, A; Hamai, K; Fujino, K; Nakaya, Y; Shinohara, A

    1990-12-01

    The effect of magnesium sulfate on ventricular refractoriness and its efficacy for torsade de pointes (TdP) were studied in nineteen dogs. After the administration of quinidine sulfate (30 mg/kg), TdP was induced by ventricular pacing in ten of 19 dogs (52.6%), polymorphic ventricular tachycardia in seven (36.8%), ventricular fibrillation in two (10.5%). Quinidine sulfate caused significant increases in QTc interval, ventricular effective refractory period (ERP) and dispersion of ERP(dERP), and decrease in ERP/QT. Magnesium sulfate significantly increased ERP (p less than 0.01), but it did not change QT interval, resulting in significant increasing of ERP/QT (0.41 +/- 0.05 to 0.61 +/- 0.05, p less than 0.01). It decreased dERP but not significantly. Magnesium sulfate prevented the induction of TdP in eight of 10 dogs (80.0%) (30 mg/kg in four and 60 mg/kg in four). In conclusion, magnesium sulfate has value as first aid therapy for drug-induced TdP. If patients have ischemic heart disease or hypertension, we recommend infusion of magnesium for the initial therapy of TdP. PMID:2094063

  15. Magnesium Recycling of Partially Oxidized, Mixed Magnesium-Aluminum Scrap through Combined Refining and Solid Oxide Membrane Electrolysis Processes

    SciTech Connect

    Xiaofei Guan; Peter A. Zink; Uday B. Pal; Adam C. Powell

    2012-01-01

    Pure magnesium (Mg) is recycled from 19g of partially oxidized 50.5wt.% Mg-Aluminum (Al) alloy. During the refining process, potentiodynamic scans (PDS) were performed to determine the electrorefining potential for magnesium. The PDS show that the electrorefining potential increases over time as the magnesium content inside the Mg-Al scrap decreases. Up to 100% percent of magnesium is refined from the Mg-Al scrap by a novel refining process of dissolving magnesium and its oxide into a flux followed by vapor phase removal of dissolved magnesium and subsequently condensing the magnesium vapor. The solid oxide membrane (SOM) electrolysis process is employed in the refining system to enable additional recycling of magnesium from magnesium oxide (MgO) in the partially oxidized Mg-Al scrap. The combination of the refining and SOM processes yields 7.4g of pure magnesium.

  16. Magnesium Recycling of Partially Oxidized, Mixed Magnesium-Aluminum Scrap Through Combined Refining and Solid Oxide Membrane (SOM) Electrolysis Processes

    SciTech Connect

    Guan, Xiaofei; Zink, Peter; Pal, Uday

    2012-03-11

    Pure magnesium (Mg) is recycled from 19g of partially oxidized 50.5wt.%Mg-Aluminum (Al) alloy. During the refining process, potentiodynamic scans (PDS) were performed to determine the electrorefining potential for magnesium. The PDS show that the electrorefining potential increases over time as the Mg content inside the Mg-Al scrap decreases. Up to 100% percent of magnesium is refined from the Mg-Al scrap by a novel refining process of dissolving magnesium and its oxide into a flux followed by vapor phase removal of dissolved magnesium and subsequently condensing the magnesium vapors in a separate condenser. The solid oxide membrane (SOM) electrolysis process is employed in the refining system to enable additional recycling of magnesium from magnesium oxide (MgO) in the partially oxidized Mg-Al scrap. The combination of the refining and SOM processes yields 7.4g of pure magnesium; could not collect and weigh all of the magnesium recovered.

  17. LOST FOAM CASTING OF MAGNESIUM ALLOYS

    SciTech Connect

    Han, Qingyou; Dinwiddie, Ralph Barton; Sklad, Philip S; Currie, Kenneth; Abdelrahman, Mohamed; Vondra, Fred; Walford, Graham; Nolan, Dennis J

    2007-01-01

    The lost foam casting process has been successfully used for making aluminum and cast iron thin walled castings of complex geometries. Little work has been carried out on cast magnesium alloys using the lost foam process. The article describes the research activities at Oak Ridge National Laboratory and Tennessee Technological University on lost foam casting of magnesium alloys. The work was focused on castings of simple geometries such as plate castings and window castings. The plate castings were designed to investigate the mold filling characteristics of magnesium and aluminum alloys using an infrared camera. The pate castings were then characterized for porosity distribution. The window castings were made to test the castability of the alloys under lost foam conditions. Significant differences between lost foam aluminum casting and lost foam magnesium casting have been observed.

  18. Magnesium silicates adsorbents of organic compounds

    NASA Astrophysics Data System (ADS)

    Ciesielczyk, Filip; Krysztafkiewicz, Andrzej; Jesionowski, Teofil

    2007-08-01

    Studies were presented on production of highly dispersed magnesium silicate at a pilote scale. The process of silicate adsorbent production involved precipitation reaction using water glass (sodium metasilicate) solution and appropriate magnesium salt, preceded by an appropriate optimization stage. Samples of best physicochemical parameters were in addition modified (in order to introduce to silica surface of several functional groups) using the dry technique and various amounts of 3-isocyanatepropyltrimethoxysilane, 3-thiocyanatepropyltrimethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane. The so prepared samples were subjected to a comprehensive physicochemical analysis. At the terminal stage of studies attempts were made to adsorb phenol from its aqueous solutions on the surface of unmodified and modified magnesium silicates. Particle size distributions were determined using the ZetaSizer Nano ZS apparatus. In order to define adsorptive properties of studied magnesium silicates isotherms of nitrogen adsorption/desorption on their surfaces were established. Efficiency of phenol adsorption was tested employing analysis of post-adsorption solution.

  19. Dietary intake of magnesium may modulate depression.

    PubMed

    Yary, Teymoor; Aazami, Sanaz; Soleimannejad, Kourosh

    2013-03-01

    Depressive symptoms are frequent in students and may lead to countless problems. Several hypotheses associate magnesium with depression because of the presence of this mineral in several enzymes, hormones, and neurotransmitters, which may play a key role in the pathological pathways of depression. The aim of this study was to assess whether magnesium intake could modulate depressive symptoms. A cross-sectional study was conducted on a convenience sample of 402 Iranian postgraduate students studying in Malaysia to assess the relationship between magnesium intake and depressive symptoms. The mean age of the participants was 32.54 ± 6.22 years. The results of the study demonstrated an inverse relationship between magnesium intake and depressive symptoms, which persisted even after adjustments for sex, age, body mass index, monthly expenses, close friends, living on campus, smoking (current and former), education, physical activity, and marital status.

  20. Magnesium is a cerebrovasodilator in newborn piglets.

    PubMed

    Kim, C R; Oh, W; Stonestreet, B S

    1997-01-01

    We tested the hypothesis that, in newborn piglets, magnesium results in a dose-dependent prostanoid-mediated cerebrovasodilation. Pial arterioles (50-200 microns in diameter) were serially measured, and cortical subarachnoid cerebrospinal fluid (CSF) was collected for radioimmunoassay of 6-ketoprostaglandin F1 alpha (6-keto-PGF1 alpha, hydrolysis product of prostacyclin) and thromboxane B2 (TxB2, metabolite of thromboxane A2) before and after CSF containing 1.2, 2.4, 4.8, and 9.6 mM MgCl2 was suffused over the parietal cortex under a closed cranial window in twelve 2- to 4-day-old piglets. Magnesium suffusion resulted (P < 0.05) in a dose-dependent pial arteriolar vasodilation. The increase in vessel diameter was greater (P < 0.001) with 2.4, 4.8, and 9.6 mM than with 1.2 mM concentration of magnesium. The increase in vessel diameter with 9.6 mM was also greater (P < 0.001) than with the 2.4 mM concentration of magnesium. Magnesium suffusion did not result in changes in cortical CSF prostanoid concentrations. The effect of intravenous indomethacin (5 mg/kg) on cyclooxygenase inhibition in the pial arterioles was confirmed by a 24 +/- 3% decrease in vessel diameter at the baseline (1.2 mM) magnesium concentration. In contrast, cyclooxygenase inhibition with intravenous indomethacin did not attenuate the magnesium-induced cerebrovasodilation. We conclude that in new born piglets magnesium suffusion over the parietal cortex results in a dose-dependent cerebrovasodilation that is most likely not mediated by prostanoids.

  1. Nuclear reactor shield including magnesium oxide

    DOEpatents

    Rouse, Carl A.; Simnad, Massoud T.

    1981-01-01

    An improvement in nuclear reactor shielding of a type used in reactor applications involving significant amounts of fast neutron flux, the reactor shielding including means providing structural support, neutron moderator material, neutron absorber material and other components as described below, wherein at least a portion of the neutron moderator material is magnesium in the form of magnesium oxide either alone or in combination with other moderator materials such as graphite and iron.

  2. 21 CFR 184.1428 - Magnesium hydroxide.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... Specific Substances Affirmed as GRAS § 184.1428 Magnesium hydroxide. (a) Magnesium hydroxide (Mg(OH)2, CAS... Chemicals Codex, 3d Ed. (1981), p. 178, which is incorporated by reference. Copies are available from the... § 170.3(o)(20) of this chapter; a pH control agent as defined in § 170.3(o)(23) of this chapter; and...

  3. Hydrogen in magnesium palladium thin layer structures

    NASA Astrophysics Data System (ADS)

    Kruijtzer, G. L.

    2008-02-01

    In this thesis, the study of hydrogen storage, absorption and desorption in magnesium layers is described. The magnesium layers have a thickness of 50-500 nm and are covered by a palladium layer which acts as a hydrogen dissociation/association catalyst. The study was preformed under ultra high vacuum conditions to avoid oxygen contamination. The main analysis techniques were RBS, ERD and TDS.

  4. Immunological Response to Biodegradable Magnesium Implants

    NASA Astrophysics Data System (ADS)

    Pichler, Karin; Fischerauer, Stefan; Ferlic, Peter; Martinelli, Elisabeth; Brezinsek, Hans-Peter; Uggowitzer, Peter J.; Löffler, Jörg F.; Weinberg, Annelie-Martina

    2014-04-01

    The use of biodegradable magnesium implants in pediatric trauma surgery would render surgical interventions for implant removal after tissue healing unnecessary, thereby preventing stress to the children and reducing therapy costs. In this study, we report on the immunological response to biodegradable magnesium implants—as an important aspect in evaluating biocompatibility—tested in a growing rat model. The focus of this study was to investigate the response of the innate immune system to either fast or slow degrading magnesium pins, which were implanted into the femoral bones of 5-week-old rats. The main alloying element of the fast-degrading alloy (ZX50) was Zn, while it was Y in the slow-degrading implant (WZ21). Our results demonstrate that degrading magnesium implants beneficially influence the immune system, especially in the first postoperative weeks but also during tissue healing and early bone remodeling. However, rodents with WZ21 pins showed a slightly decreased phagocytic ability during bone remodeling when the degradation rate reached its maximum. This may be due to the high release rate of the rare earth-element yttrium, which is potentially toxic. From our results we conclude that magnesium implants have a beneficial effect on the innate immune system but that there are some concerns regarding the use of yttrium-alloyed magnesium implants, especially in pediatric patients.

  5. Research of magnesium phosphosilicate cement

    NASA Astrophysics Data System (ADS)

    Ding, Zhu

    Magnesium phosphosilicate cement (MPSC) is a novel phosphate bonded cement, which consists mainly of magnesia, phosphate and silicate minerals. The traditional magnesium phosphate cements (MPCs) usually composed by ammonium phosphate, and gaseous ammonia will emit during mixing and in service. There is no noxious ammonia released from MPSC, furthermore, it can recycle a large volume of the non-hazardous waste. The goal of this research is to investigate the composition, reaction products, reaction mechanism, microstructure, properties, durability and applications of the MPSC. MPSC sets rapidly and has high early strength. It reacts better with solid industrial waste when compared to Portland cement. Many solid industrial wastes, such as fly ash, steel slag, coal gangue, red coal gangue, red mud, barium-bearing slag, copper slag, silica fume, and ground granulated blast furnace slag, have been used as the main component (40% by weight) in MPSC. The research has found that these aluminosilicate (or ironsilicate, or calciumsilicate) minerals with an amorphous or glass structure can enhance the performance of MPSC. The disorganized internal structure of amorphous materials may make it possess higher reactivity compared to the crystalline phases. Chemical reaction between phosphate and these minerals may form an amorphous gel, which is favorable to the cementing. Borax, boric acid and sodium tripolyphosphate have been used as retardants in the MPSC system. It is found that boric acid has a higher retarding effect on the setting of cement, than borax does. However, sodium polyphosphate accelerates the reaction of MPSC. The hydration of MPSC is exothermic reaction. The heat evolution may prompt hydrates formation, and shorten the setting process. Modern materials characterization techniques, XRD, DSC, TG-DTA FTIR, XPS, MAS-NMR, SEM, TEM, MIP, etc. were used to analyze the phase composition, micro morphology, and microstructure of hardened MPSC. The main hydration product

  6. Magnesium phosphate glass cements with ceramic-type properties

    DOEpatents

    Sugama, Toshifumi; Kukacka, Lawrence E.

    1984-03-13

    Rapid setting magnesium phosphate (Mg glass) cementitious materials consisting of magnesium phosphate cement paste, polyborax and water-saturated aggregate exhibiting rapid setting and high early strength characteristics. The magnesium glass cement is prepared from a cation-leachable powder and a bivalent metallic ion-accepting liquid such as an aqueous solution of diammonium phosphate and ammonium polyphosphate. The cation-leachable powder includes a mixture of two different magnesium oxide powders processed and sized differently which when mixed with the bivalent metallic ion-accepting liquid provides the magnesium glass cement consisting primarily of magnesium ortho phosphate tetrahydrate, with magnesium hydroxide and magnesium ammonium phosphate hexahydrate also present. The polyborax serves as a set-retarder. The resulting magnesium mono- and polyphosphate cements are particularly suitable for use as a cementing matrix in rapid repair systems for deteriorated concrete structures as well as construction materials and surface coatings for fireproof structures.

  7. Magnesium-phosphate-glass cements with ceramic-type properties

    DOEpatents

    Sugama, T.; Kukacka, L.E.

    1982-09-23

    Rapid setting magnesium phosphate (Mg glass) cementitious materials consisting of magnesium phosphate cement paste, polyborax and water-saturated aggregate, exhibits rapid setting and high early strength characteristics. The magnesium glass cement is prepared from a cation-leachable powder and a bivalent metallic ion-accepting liquid such as an aqueous solution of diammonium phosphate and ammonium polyphosphate. The cation-leachable powder includes a mixture of two different magnesium oxide powders processed and sized differently which when mixed with the bivalent metallic ion-accepting liquid provides the magnesium glass cement consisting primarily of magnesium ortho phosphate tetrahydrate, with magnesium hydroxide and magnesium ammonium phosphate hexahydrate also present. The polyborax serves as a set-retarder. The resulting magnesium mono- and polyphosphate cements are particularly suitable for use as a cementing matrix in rapid repair systems for deteriorated concrete structures as well as construction materials and surface coatings for fireproof structures.

  8. Magnesium phosphate glass cements with ceramic-type properties

    SciTech Connect

    Sugama, T.; Kukacka, L.E.

    1984-03-13

    Rapid setting magnesium phosphate (Mg glass) cementitious materials consisting of magnesium phosphate cement paste, polyborax and water-saturated aggregate exhibiting rapid setting and high early strength characteristics. The magnesium glass cement is prepared from a cation-leachable powder and a bivalent metallic ion-accepting liquid such as an aqueous solution of diammonium phosphate and ammonium polyphosphate. The cation-leachable powder includes a mixture of two different magnesium oxide powders processed and sized differently which when mixed with the bivalent metallic ion-accepting liquid provides the magnesium glass cement consisting primarily of magnesium ortho phosphate tetrahydrate, with magnesium hydroxide and magnesium ammonium phosphate hexahydrate also present. The polyborax serves as a set-retarder. The resulting magnesium mono-and polyphosphate cements are particularly suitable for use as a cementing matrix in rapid repair systems for deteriorated concrete structures as well as construction materials and surface coatings for fireproof structures.

  9. Grosnaja ABCs: Magnesium isotope compositions

    NASA Technical Reports Server (NTRS)

    Goswami, J. N.; Srinivasan, G.; Ulyanov, A. A.

    1993-01-01

    Three CAI's from the Grosnaja CV3 chondrite were analyzed for their magnesium isotopic compositions by the ion microprobe. The selected CAI's represent three distinct types: GR4(compact Type A), GR7(Type B) and GR2(Type C). Petrographic studies indicate that all three Grosnaja inclusions were subjected to secondary alterations. The Type A CAI GR4 is primarily composed of melilite with spinel and pyroxene occurring as minor phases. The rim of the inclusion does not exhibit distinct layered structure and secondary alteration products (garnet, Fe-rich olivine and Na-rich plagioclase) are present in some localized areas near the rim region. The average major element compositions of different mineral phases in GR4 are given. Preliminary REE data suggest a depletion of HREE relative to LREE by about a factor of 3 without any clear indication of interelement fractionation. The CAI GR7 has textural and minerological characteristics similar to Type B inclusions. The REE data show a pattern that is similar to Group 6 with enrichment in Eu and Yb. In addition, a depletion of HREE compared to LREE is also evident in this object. Melilite composition shows a broad range of akermanite content (Ak(sub 15-55)). Detailed petrographic study is in progress. GR2 is a anorthite-rich Type C inclusion with large plagioclase laths intergrown with Ti-rich pyroxene. The average plagioclase composition is close to pure anorthite (An99).

  10. Leaf Senescence by Magnesium Deficiency

    PubMed Central

    Tanoi, Keitaro; Kobayashi, Natsuko I.

    2015-01-01

    Magnesium ions (Mg2+) are the second most abundant cations in living plant cells, and they are involved in various functions, including photosynthesis, enzyme catalysis, and nucleic acid synthesis. Low availability of Mg2+ in an agricultural field leads to a decrease in yield, which follows the appearance of Mg-deficient symptoms such as chlorosis, necrotic spots on the leaves, and droop. During the last decade, a variety of physiological and molecular responses to Mg2+ deficiency that potentially link to leaf senescence have been recognized, allowing us to reconsider the mechanisms of Mg2+ deficiency. This review focuses on the current knowledge about the physiological responses to Mg2+ deficiency including a decline in transpiration, accumulation of sugars and starch in source leaves, change in redox states, increased oxidative stress, metabolite alterations, and a decline in photosynthetic activity. In addition, we refer to the molecular responses that are thought to be related to leaf senescence. With these current data, we give an overview of leaf senescence induced by Mg deficiency. PMID:27135350

  11. Magnesium deposition in brain of pregnant patients administered intramuscular magnesium sulphate.

    PubMed

    Pungavkar, Sona

    2014-04-01

    We present three cases of T1 hyperintense signal in the MRI scans of the brains of pregnant patients who were administered magnesium sulphate intramuscularly for control of hypertension during eclampsia. The increase in signal is symmetric and is seen in the globus pallidi of these patients. We postulate it to be secondary to deposition of magnesium in the brain parenchyma. The signal intensity was found to be directly varying according to the level of magnesium in the blood. It decreased over a period of time coming to normalcy after approximately 6months. To the best of our knowledge, this is the first case report which has documented this finding. It has to be determined whether deposition of magnesium in the brain parenchyma could have implications in the use of magnesium sulphate in pregnant patients.

  12. Production of Magnesium by Vacuum Aluminothermic Reduction with Magnesium Aluminate Spinel as a By-Product

    NASA Astrophysics Data System (ADS)

    Wang, Yaowu; You, Jing; Peng, Jianping; Di, Yuezhong

    2016-06-01

    The Pidgeon process currently accounts for 85% of the world's magnesium production. Although the Pidgeon process has been greatly improved over the past 10 years, such production still consumes much energy and material and creates much pollution. The present study investigates the process of producing magnesium by employing vacuum aluminothermic reduction and by using magnesite as material and obtaining magnesium aluminate spinel as a by-product. The results show that compared with the Pidgeon process, producing magnesium by vacuum aluminothermic reduction can save materials by as much as 50%, increase productivity up to 100%, and save energy by more than 50%. It can also reduce CO2 emission by up to 60% and realize zero discharge of waste residue. Vacuum aluminothermic reduction is a highly efficient, low-energy-consumption, and environmentally friendly method of producing magnesium.

  13. 40 CFR 461.60 - Applicability; description of the magnesium subcategory.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... magnesium subcategory. 461.60 Section 461.60 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY... Magnesium Subcategory § 461.60 Applicability; description of the magnesium subcategory. This subpart applies... treatment works from the manufacturing of magnesium anode batteries....

  14. 40 CFR 461.60 - Applicability; description of the magnesium subcategory.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... magnesium subcategory. 461.60 Section 461.60 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY... Magnesium Subcategory § 461.60 Applicability; description of the magnesium subcategory. This subpart applies... treatment works from the manufacturing of magnesium anode batteries....

  15. 40 CFR 461.60 - Applicability; description of the magnesium subcategory.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... magnesium subcategory. 461.60 Section 461.60 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY... Magnesium Subcategory § 461.60 Applicability; description of the magnesium subcategory. This subpart applies... treatment works from the manufacturing of magnesium anode batteries....

  16. Low intracellular magnesium in patients with acute pancreatitis and hypocalcemia.

    PubMed Central

    Ryzen, E.; Rude, R. K.

    1990-01-01

    To determine the role of magnesium deficiency in the pathogenesis of hypocalcemia in acute pancreatitis, we measured magnesium levels in serum and in peripheral blood mononuclear cells in 29 patients with acute pancreatitis, 14 of whom had hypocalcemia and 15 of whom had normal calcium levels. Only six patients had overt hypomagnesemia (serum magnesium less than 0.70 mmol per liter [1.7 mg per dl]). The mean serum magnesium concentration in hypocalcemic patients was not significantly lower than in normocalcemic patients, but the mononuclear cell magnesium content in hypocalcemic patients with pancreatitis was significantly lower than in normocalcemic patients with pancreatitis (P less than .01). The serum magnesium level did not correlate with that of serum calcium or the mononuclear cell magnesium content, but the latter did significantly correlate with the serum calcium concentration (r = .81, P less than .001). Most patients with hypocalcemia had a low intracellular magnesium content. Three normomagnesemic, hypocalcemic patients with alcoholic pancreatitis also underwent low-dose parenteral magnesium tolerance testing and showed increased retention of the magnesium load. We conclude that patients with acute pancreatitis and hypocalcemia commonly have magnesium deficiency despite normal serum magnesium concentrations. Magnesium deficiency may play a significant role in the pathogenesis of hypocalcemia in patients with acute pancreatitis. PMID:2407029

  17. Magnesium and Manganese Content of Halophilic Bacteria

    PubMed Central

    Médicis, Eveline De; Paquette, Jean; Gauthier, Jean-Jacques; Shapcott, Dennis

    1986-01-01

    Magnesium and manganese contents were measured by atomic absorption spectrophotometry in bacteria of several halophilic levels, in Vibrio costicola, a moderately halophilic eubacterium growing in 1 M NaCl, Halobacterium volcanii, a halophilic archaebacterium growing in 2.5 M NaCl, Halobacterium cutirubrum, an extremely halophilic archaebacterium growing in 4 M NaCl, and Escherichia coli, a nonhalophilic eubacterium growing in 0.17 M NaCl. Magnesium and manganese contents varied with the growth phase, being maximal at the early log phase. Magnesium and manganese molalities in cell water were shown to increase with the halophilic character of the logarithmically growing bacteria, from 30 mmol of Mg per kg of cell water and 0.37 mmol of Mn per kg of cell water for E. coli to 102 mmol of Mg per kg of cell water and 1.6 mmol of Mn per kg of cell water for H. cutirubrum. The intracellular concentrations of manganese were determined independently by a radioactive tracer technique in V. costicola and H. volcanii. The values obtained by 54Mn loading represented about 70% of the values obtained by atomic absorption. The increase of magnesium and manganese contents associated with the halophilic character of the bacteria suggests that manganese and magnesium play a role in haloadaptation. Images PMID:16347151

  18. Combustion Synthesis of Magnesium Aluminate

    SciTech Connect

    Kale, M. A.; Joshi, C. P.; Moharil, S. V.

    2011-10-20

    In the system MgO-Al{sub 2}O{sub 3}, three compounds MgAl{sub 2}O{sub 4}, MgAl{sub 6}O{sub 10}(also expressed as-Mg{sub 0.4}Al{sub 2.4}O{sub 4}) and MgAl{sub 26}O{sub 40} are well known. Importance of the first two is well established. Magnesium aluminate (MgAl{sub 2}O{sub 4}) spinel is a technologically important material due to its interesting thermal properties. The MgAl{sub 2}O{sub 4} ceramics also find application as humidity sensors. Apart from the luminescence studies, the interest in MgAl{sub 2}O{sub 4} is due to various applications such as humidity-sensing and PEM fuel cells, TL/OSL dosimetry of the ionizing radiations, white light source. Interest in the MgAl{sub 6}O{sub 10} has aroused due to possible use as a substrate for GaN growth. Attempt was made to synthesize these compounds by the combustion synthesis using metal nitrates as oxidizer and urea as a fuel. Compounds MgAl{sub 2}O{sub 4} and MgAl{sub 6}O{sub 10} were formed in a single step, while MgAl{sub 26}O{sub 40} was not formed by this procedure. Activation of MgAl{sub 6}O{sub 10} by rare earth ions like Ce{sup 3+}, Eu{sup 3+} and Tb{sup 3+} and ns{sup 2} ion Pb{sup 2+} could be achieved. Excitation bands for MgAl{sub 6}O{sub 10} are at slightly shorter wavelengths compared to those reported for MgAl{sub 2}O{sub 4}.

  19. 75 FR 20817 - Magnesium Metal from the People's Republic of China: Preliminary Results of the 2008-2009...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-04-21

    ... FR 76336 (December 16, 2008); and Frontseating Service Valves From the People's Republic of China... Duty Investigation of Pure Magnesium from the Russian Federation, 60 FR 25691 (May 12, 1995). \\2\\ See... Administrative Review, 74 FR 14771 (April 1, 2009). \\3\\ See Initiation of Antidumping and Countervailing...

  20. 76 FR 13355 - Magnesium Metal From the Russian Federation: Notice of Court Decision Not in Harmony With Final...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-03-11

    ... Antidumping Duty Administrative Review, 73 FR 52642 (September 10, 2008) (Final Results). In the Final Results the Department determined that it was appropriate to treat raw magnesium and chlorine gas as co... Review, 75 FR 56989 (September 17, 2010). In the event the CIT's ruling is not appealed or, if...

  1. 77 FR 28570 - Pure Magnesium From the People's Republic of China: Notice of Court Decision Not in Harmony With...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-05-15

    ...On April 25, 2012, the United States Court of International Trade (``CIT'') sustained the Department of Commerce's (``the Department'') final results of redetermination pursuant to voluntary remand of the 2006-2007 antidumping duty administrative review of pure magnesium from the People's Republic of China (``Voluntary Remand Redetermination'').\\1\\ Consistent with the decision of the United......

  2. Comparison of Two High-Dose Magnesium Infusion Regimens in the Treatment of Status Asthmaticus

    PubMed Central

    Vaiyani, Danish

    2016-01-01

    OBJECTIVES: To determine the feasibility and safety of a simplified high-dose magnesium sulfate infusion (sHDMI) for the treatment of status asthmaticus. METHODS: We retrospectively compared 2 different high-dose magnesium sulfate infusion regimens, as adjunctive treatment in status asthmatics, using data that were preciously collected. The initial high-dose, prolonged magnesium infusion (HDMI) regimen consisted of a loading dose of 75 mg/kg (weight ≤ 30 kg) or 50 mg/kg (weight > 30 kg) over a period of 30 to 45 minutes followed by a continuous infusion of 40 mg/kg/hr for an additional 4 hours. This was compared to the sHDMI regimen that consisted of 50 mg/kg/hr for 5 hours. No loading dose was given to the patients in the sHDMI arm. Obese patients were dosed by using ideal body weight. Physiologic parameters (i.e., heart rate, blood pressure, respiratory rate, oxygen saturation) and serum magnesium (SrMg) concentrations were monitored during administration of magnesium sulfate. RESULTS: Nineteen patients receiving the initial HDMI regimen were compared with 10 patients who received the sHDMI regimen. There was no significant difference in SrMg concentrations or physiologic parameters between the 2 dose regimens. CONCLUSIONS: The HDMI and sHDMI regimens both produced SrMg concentrations that are associated with bronchodilation. The safety profile was also similar for the 2 regimens. The unambiguity of sHDMI has the potential to reduce medication errors that are associated with calculation of the loading dose, product preparation, and ultimate administration. PMID:27453701

  3. Ice-melting characteristics of calcium magnesium acetate

    NASA Astrophysics Data System (ADS)

    Schenk, R. U.

    1986-01-01

    The objectives of the study are to determine the pertinent properties of Calcium/Magnesium Acetate and to determine the pH and ratio of calcium to magnesium that provide optimum road deicing characteristics.

  4. Alkalization is responsible for antibacterial effects of corroding magnesium.

    PubMed

    Rahim, Muhammad Imran; Eifler, Rainer; Rais, Bushra; Mueller, Peter P

    2015-11-01

    Magnesium alloys are presently investigated as potential medical implant materials for temporary applications. Magnesium has been reported to have antibacterial activities and could therefore be used to prevent antibiotic treatment-resistant bacterial implant infections. For characterizing the effects of magnesium on infectious bacteria, bioluminescent S. aureus or P. aeruginosa were employed. The proliferation of both types of bacteria was suppressed in the presence of metallic magnesium and also in aqueous magnesium corrosion extracts. Of the two soluble corrosion products, magnesium ions were well tolerated while antibacterial activities correlated with increased pH levels of the supernatants. The alkaline pH alone was sufficient for the antibacterial effects which were completely abolished when the pH of the corrosion supernatants was neutralized. These results demonstrate that pH increases are necessary and sufficient for the antibacterial activity of metallic magnesium. In an animal model magnesium implants showed an enhanced but variable resistance to bacterial colonization.

  5. Intra-carotid cold magnesium sulfate infusion induces selective cerebral hypothermia and neuroprotection in rats with transient middle cerebral artery occlusion.

    PubMed

    Song, Wei; Wu, Yong-Ming; Ji, Zhong; Ji, Ya-Bin; Wang, Sheng-Nan; Pan, Su-Yue

    2013-04-01

    Local hypothermia induced by intra-arterial infusion of cold saline reduces brain injury in ischemic stroke. Administration of magnesium sulfate through the internal carotid artery is also known to reduce ischemic brain damage. The neuroprotective effects of combination therapy with local endovascular hypothermia and intra-carotid magnesium sulfate infusion has not been evaluated. The aim of the study was to determine whether infusion of intra-carotid cold magnesium offers neuroprotective efficacy superior to cold saline infusion alone. Sixty-eight Sprague-Dawley rats were subjected to 3 h of middle cerebral artery occlusion and were randomly divided into six groups: sham-operated group; stroke control group; local cold magnesium infusion group; local cold saline infusion group; local normothermic magnesium infusion group; and local normothermic saline infusion group. Before reperfusion, ischemic rats received local infusion or no treatment. Infarct volume, neurological deficit, and brain water content were evaluated at 48 h after reperfusion. Selective brain hypothermia (33-34 °C) was successfully induced by intra-carotid cold infusion. Local cold saline infusion and local cold magnesium infusion reduced the infarct volumes by 48 % (p < 0.001) and 65 % (p < 0.001), respectively, compared with stroke controls. Brain water content was decreased significantly in animals treated with local cold magnesium infusion. Furthermore, the rats given a local cold magnesium infusion had the best neurological outcome. Local normothermic infusion failed to improve ischemic brain damage. These data suggest that local hypothermia induced by intra-carotid administration of cold magnesium is more effective in reducing acute ischemic damage than infusion of cold saline alone.

  6. Organochlorine formation in magnesium electrowinning cells.

    PubMed

    Deutscher, R L; Cathro, K J

    2001-04-01

    The formation of organochlorines during the electrolytic production of magnesium was investigated using a laboratory-scale electrolytic cell having a graphite anode, a liquid aluminium alloy cathode, and a molten chloride electrolyte. The cell was operated at current densities ranging from 3000 to 10,000 A m(-2) and at temperatures ranging from 660 degrees C to 750 degrees C. Organochlorines were adsorbed from the cell off-gases onto silica gel, extracted with hexane, and determined by gas chromatography. All compounds identified were fully chlorinated aliphatic and aromatic compounds, the major components being hexachlorobutadiene, hexachlorobenzene, hexachloroethylene, and octachlorostyrene. The total amount of organochlorines per tonne of magnesium produced decreased with electrolysis time and with current density and increased with operating temperature; it was also dependent on the type of graphite employed. The output of organochlorines varied from 5 to 20 g t(-1) of magnesium. PMID:11297394

  7. A miniaturised isotachophoresis method for magnesium determination.

    PubMed

    Prest, Jeff E; Baldock, Sara J; Fielden, Peter R; Goddard, Nicholas J; Treves Brown, Bernard J

    2009-07-01

    The use of malonic acid as a complexing agent has enabled a new method to be devised to allow the determination of magnesium to be made using miniaturised isotachophoresis. Using a leading electrolyte of 10 mmol L(-1) caesium hydroxide and 2 mmol L(-1) malonic acid at pH 5.1 gave the method a high specificity towards magnesium. Investigations using a poly(methyl methacrylate) chip device with an integrated conductivity detector showed that no interference from calcium, strontium, barium and sodium should occur. The method was found to be linear over the range of magnesium concentrations from 0.625 to 75 mg L(-1) and the limit of detection was calculated to be 0.45 mg L(-1). Separations were demonstrated with water samples but the procedure should also be applicable to more complex sample matrices such as inorganic explosive residues, blood or urine. PMID:19205676

  8. Solubility of magnesium carbonate in natural waters

    USGS Publications Warehouse

    Wells, R.C.

    1915-01-01

    (1) Under atmospheric conditions it appears possible to attain practically the same state in a solution saturated with MgCO33H2O, whether one starts with a solution containing an excess of magnesium bicarbonate or with the pure trihydrate and water, but the adjustment occurs very slowly. The solution finally contains 0.36 g. magnesium and 1.01 g. carbon dioxide per liter at 20??. (2) The solubility found for magnesite, however, is much smaller, viz., 0.02 g. magnesium and 0.07 g. carbon dioxide per liter. (3) Certain natural waters, freely exposed to the atmosphere, appear to be supersaturated with respect to magnesite but none approaches very closely to the point of saturation of the trihydrate MgCO3.3H2O.

  9. Borosilicate glass alteration driven by magnesium carbonates

    NASA Astrophysics Data System (ADS)

    Debure, M.; Frugier, P.; De Windt, L.; Gin, S.

    2012-01-01

    The alteration of simplified synthetic glass, representative of the French reference nuclear glass R7T7, in presence of hydromagnesite has been experimentally investigated and modeled. Magnesium in solution is known to potentially enhance glass alteration; nuclear glass clayed host rocks contain magnesium and can dissolve to maintain the concentration of magnesium in solution. For modeling purposes, it was suitable to study a simple system. Hydromagnesite was therefore chosen as a simple model mineral in order to check the influence of an Mg-rich mineral on glass alteration. Since the models use thermodynamic and kinetic parameters measured in pure water and pH-buffered solutions, changing the solution composition or adding minerals is a key step towards the validation of the modeling assumptions before using the model for predictive purposes. Experiments revealed that glass alteration is enhanced in presence of hydromagnesite. Modeling was performed using the GRAAL model implemented within the CHESS/HYTEC reactive transport code. Modeling proved useful both for explaining the mechanisms involved and quantifying the impact on glass alteration: Mg coming from hydromagnesite dissolution reacts with Si provided by the glass in order to form magnesium silicates. This reaction decreases the pH down to neutral conditions where magnesium silicates are more soluble than at the natural alkali pH imposed by glass or hydromagnesite dissolution. The driving force of the magnesium silicate precipitation is eventually the interdiffusion of alkali within the altered amorphous glass layer as this mechanism consumes protons. The model's ability to describe the concentrations of elements in solution and formed solids whatever the glass/hydromagnesite ratio strongly supports the basic modeling hypothesis.

  10. Role of magnesium in cardiovascular diseases.

    PubMed

    Kolte, Dhaval; Vijayaraghavan, Krishnaswami; Khera, Sahil; Sica, Domenic A; Frishman, William H

    2014-01-01

    Magnesium, the fourth most abundant cation in the human body, is involved in several essential physiological, biochemical, and cellular processes regulating cardiovascular function. It plays a critical role in modulating vascular smooth muscle tone, endothelial cell function, and myocardial excitability and is thus central to the pathogenesis of several cardiovascular disorders such as hypertension, atherosclerosis, coronary artery disease, congestive heart failure, and cardiac arrhythmias. This review discusses the vasodilatory, anti-inflammatory, anti-ischemic, and antiarrhythmic properties of magnesium and its current role in the prevention and treatment of cardiovascular disorders.

  11. SOLID STATE JOINING OF MAGNESIUM TO STEEL

    SciTech Connect

    Jana, Saumyadeep; Hovanski, Yuri; Pilli, Siva Prasad; Field, David P.; Yu, Hao; Pan, Tsung-Yu; Santella, M. L.

    2012-06-04

    Friction stir welding and ultrasonic welding techniques were applied to join automotive magnesium alloys to steel sheet. The effect of tooling and process parameters on the post-weld microstructure, texture and mechanical properties was investigated. Static and dynamic loading were utilized to investigate the joint strength of both cast and wrought magnesium alloys including their susceptibility and degradation under corrosive media. The conditions required to produce joint strengths in excess of 75% of the base metal strength were determined, and the effects of surface coatings, tooling and weld parameters on weld properties are presented.

  12. 40 CFR 721.9513 - Modified magnesium silicate polymer (generic).

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 40 Protection of Environment 31 2014-07-01 2014-07-01 false Modified magnesium silicate polymer... Specific Chemical Substances § 721.9513 Modified magnesium silicate polymer (generic). (a) Chemical... as modified magnesium silicate polymer (PMN P-98-604) is subject to reporting under this section...

  13. 40 CFR 721.9513 - Modified magnesium silicate polymer (generic).

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 40 Protection of Environment 32 2012-07-01 2012-07-01 false Modified magnesium silicate polymer... Specific Chemical Substances § 721.9513 Modified magnesium silicate polymer (generic). (a) Chemical... as modified magnesium silicate polymer (PMN P-98-604) is subject to reporting under this section...

  14. 40 CFR 721.9513 - Modified magnesium silicate polymer (generic).

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 40 Protection of Environment 32 2013-07-01 2013-07-01 false Modified magnesium silicate polymer... Specific Chemical Substances § 721.9513 Modified magnesium silicate polymer (generic). (a) Chemical... as modified magnesium silicate polymer (PMN P-98-604) is subject to reporting under this section...

  15. An electrolytic process for magnesium and its alloys production

    SciTech Connect

    Sharma, R.

    1996-10-01

    The largest amount of magnesium is used for aluminum-magnesium alloy production. The second largest use is in desulfurization of steel. A magnesium {minus}10 weight percent (w/o) aluminum alloy can also be used in both the above processes. Pure magnesium metal is not of much use for structural purposes. However, a magnesium {minus}10 w/o aluminum alloy melt which is also suitable for structural applications, can be produced as a bottom layer in an electrolytic magnesium production cell using a potassium chloride-magnesium chloride electrolyte at {approximately} 750 C. In this situation, the magnesium production process and the cell can be similar to the aluminum production process and its cell. The magnesium-aluminum alloys can be produced by electrolysis at far less cost than these alloys produced from the respective metals. The process can also be used to produce other magnesium alloys for use in the auto industry at comparatively far less cost. The largest increase in the magnesium usage in the future is going to be only in the magnesium alloys sector.

  16. 40 CFR 721.10504 - Surface modified magnesium hydroxide (generic).

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 40 Protection of Environment 32 2013-07-01 2013-07-01 false Surface modified magnesium hydroxide... Specific Chemical Substances § 721.10504 Surface modified magnesium hydroxide (generic). (a) Chemical... as surface modified magnesium hydroxide (PMN P-06-682) is subject to reporting under this section...

  17. 40 CFR 721.10504 - Surface modified magnesium hydroxide (generic).

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 40 Protection of Environment 31 2014-07-01 2014-07-01 false Surface modified magnesium hydroxide... Specific Chemical Substances § 721.10504 Surface modified magnesium hydroxide (generic). (a) Chemical... as surface modified magnesium hydroxide (PMN P-06-682) is subject to reporting under this section...

  18. Preparation of petaloid microspheres of basic magnesium carbonate.

    PubMed

    Ohkubo, Takahiro; Suzuki, Sei; Mitsuhashi, Kohei; Ogura, Taku; Iwanaga, Shinichi; Sakai, Hideki; Koishi, Masumi; Abe, Masahiko

    2007-05-22

    The synthesis of basic magnesium carbonate was examined under ultrasonic irradiation and was performed by the soda ash method using magnesium sulfate and sodium carbonate as starting materials. The particulate product was evaluated using SEM observations. Ultrasonic irradiation in the preparation of basic magnesium carbonate was found to give fine petaloid microspheres of about 3 mum in primary particle size. PMID:17458985

  19. 40 CFR 721.9513 - Modified magnesium silicate polymer (generic).

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Modified magnesium silicate polymer... Specific Chemical Substances § 721.9513 Modified magnesium silicate polymer (generic). (a) Chemical... as modified magnesium silicate polymer (PMN P-98-604) is subject to reporting under this section...

  20. 40 CFR 721.9513 - Modified magnesium silicate polymer (generic).

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 31 2011-07-01 2011-07-01 false Modified magnesium silicate polymer... Specific Chemical Substances § 721.9513 Modified magnesium silicate polymer (generic). (a) Chemical... as modified magnesium silicate polymer (PMN P-98-604) is subject to reporting under this section...

  1. Magnesium Intake and Prevalence of Metabolic Syndrome in Older Adults

    Technology Transfer Automated Retrieval System (TEKTRAN)

    Higher dietary intake of magnesium (Mg) may protect against development of type 2 diabetes. The aim of this study was to examine the association between dietary magnesium intake and metabolic syndrome risk factors in elderly men and women. We examined cross-sectional associations between magnesium i...

  2. Magnesium retention in 12 to 48 month-old children

    Technology Transfer Automated Retrieval System (TEKTRAN)

    In adults, adaptation to changes in magnesium intake is largely due to changes in fractional magnesium absorption and urinary magnesium excretion. We sought to examine whether these homeostatic mechanisms also occur in young children. Children, 12–48 m old, were studied (n=30). They were adapted to ...

  3. The art of magnesium transport.

    PubMed

    de Baaij, Jeroen H F

    2015-01-01

    Patients with hypomagnesemia suffer from a wide range of symptoms including muscle cramps, cardiac arrhythmias and epilepsy. Disturbances in body Mg(2+) homeostasis can often be attributed to increased Mg(2+) excretion by the kidney. Within the kidney, the distal convoluted tubule (DCT) segment determines the final Mg(2+) excretion, since no reabsorption takes place beyond this segment of the nephron. On 21(st) of January 2015, Jeroen de Baaij defended his thesis "The Distal Convoluted Tubule: the Art of Magnesium Transport", in which he aimed to identify new genes involved in Mg(2+) reabsorption in the DCT. This review summarizes the main findings of his graduate research. TRPM6 mediates apical Mg(2+) entry into the DCT cell and is highly regulated by EGF, insulin and pH. ATP and flavagline compounds have been characterized as new regulators of TRPM6 activity, providing novel pathways to target Mg(2+) disturbances. Using isolated primary DCT cells from mice, PCBD1 was identified as a new transcriptional regulator of Mg(2+) transport in the DCT. Indeed, patients with PCBD1 mutations were shown to suffer hypomagnesemia and MODY5-like diabetes. Subsequently, the work presented in the thesis focused on the elucidation of the basolateral Mg(2+) extrusion of the DCT cell. In vivo studies using SLC41A3-knockout mice suggest that SLC41A3 may act as Mg(2+) extrusion mechanism. CNNM2 has long been hypothesized to transport Mg(2+) at the basolateral membrane of the DCT. However, by determining the protein topology and homology modeling of the CBS domains, it was argued that CNNM2 is rather an Mg(2+)-sensing mechanism. Follow-up studies using (25)Mg(2+) isotopes showed that CNNM2 increases Mg(2+) uptake when overexpressed in HEK293 cells. Additionally, by knocking down cnnm2 in zebrafish, CNNM2 was demonstrated to be essential for brain development and Mg(2+) homeostasis. Mutations in CNNM2 were shown to cause hypomagnesemia, seizures and intellectual disability. Altogether

  4. Intravenous magnesium sulphate effect on maternal serum and amniotic fluid cytokines levels in preterm labour patients.

    PubMed

    Mezad, Daphna; Hallak, Mordechai; Huleihel, Mahmoud; Gortzak-Uzan, Limor; Smolin, Ana; Mazor, Moshe

    2002-12-01

    Our objective was to evaluate the effect of intravenous magnesium sulphate administration to patients with preterm labour on maternal serum and amniotic fluid IL-1beta, IL-6, IL-10 and TNFalpha concentrations. Thirty-six patients at 24-34 weeks of singleton gestation, who presented with contractions (> or = 8 in 60 min) had amniocentesis to rule out intrauterine infection. The patients received intravenous MgSO4 for tocolysis. Twenty-six patients had amniocentesis performed before initiation of MgSO4 (controls) while 10 others had the procedure during tocolytic therapy (study patients). Magnesium, IL-1beta, IL-6, TNFalpha and IL-10 concentrations were measured. Study and control groups were statistically compared using Student t test. Mean magnesium levels were significantly higher in the study group (P < 0.01). There were no significant differences between the cytokines levels in maternal serum and in amniotic fluid between the groups. Our results suggest that the mechanism of magnesium as a tocolytic agent may not be mediated via the examined cytokines. PMID:12635880

  5. Administrative Synergy

    ERIC Educational Resources Information Center

    Hewitt, Kimberly Kappler; Weckstein, Daniel K.

    2012-01-01

    One of the biggest obstacles to overcome in creating and sustaining an administrative professional learning community (PLC) is time. Administrators are constantly deluged by the tyranny of the urgent. It is a Herculean task to carve out time for PLCs, but it is imperative to do so. In this article, the authors describe how an administrative PLC…

  6. Magnesium substitution in the structure of orthopedic nanoparticles: A comparison between amorphous magnesium phosphates, calcium magnesium phosphates, and hydroxyapatites.

    PubMed

    Nabiyouni, Maryam; Ren, Yufu; Bhaduri, Sarit B

    2015-01-01

    As biocompatible materials, magnesium phosphates have received a lot of attention for orthopedic applications. During the last decade multiple studies have shown advantages for magnesium phosphate such as lack of cytotoxicity, biocompatibility, strong mechanical properties, and high biodegradability. The present study investigates the role of Mg(+2) and Ca(+2) ions in the structure of magnesium phosphate and calcium phosphate nanoparticles. To directly compare the effect of Mg(+2) and Ca(+2) ions on structure of nanoparticles and their biological behavior, three groups of nanoparticles including amorphous magnesium phosphates (AMPs) which release Mg(+2), calcium magnesium phosphates (CMPs) which release Mg(+2) and Ca(+2), and hydroxyapatites (HAs) which release Ca(+2) were studied. SEM, TEM, XRD, and FTIR were used to evaluate the morphology, crystallinity, and chemical properties of the particles. AMP particles were homogeneous nanospheres, whereas CMPs were combinations of heterogeneous nanorods and nanospheres, and HAs which contained heterogeneous nanosphere particles. Cell compatibility was monitored in all groups to determine the cytotoxicity effect of particles on studied MC3T3-E1 preosteoblasts. AMPs showed significantly higher attachment rate than the HAs after 1 day and both AMPs and CMPs showed significantly higher proliferation rate when compared to HAs after 7days. Gene expression level of osteoblastic markers ALP, COL I, OCN, OPN, RUNX2 were monitored and they were normalized to GAPDH housekeeping gene. Beta actin expression level was monitored as the second housekeeping gene to confirm the accuracy of results. In general, AMPs and CMPs showed higher expression level of osteoblastic genes after 7 days which can further confirm the stimulating role of Mg(+2) and Ca(+2) ions in increasing the proliferation rate, differentiation, and mineralization of MC3T3-E1 preosteoblasts. PMID:25953534

  7. Magnesium substitution in the structure of orthopedic nanoparticles: A comparison between amorphous magnesium phosphates, calcium magnesium phosphates, and hydroxyapatites.

    PubMed

    Nabiyouni, Maryam; Ren, Yufu; Bhaduri, Sarit B

    2015-01-01

    As biocompatible materials, magnesium phosphates have received a lot of attention for orthopedic applications. During the last decade multiple studies have shown advantages for magnesium phosphate such as lack of cytotoxicity, biocompatibility, strong mechanical properties, and high biodegradability. The present study investigates the role of Mg(+2) and Ca(+2) ions in the structure of magnesium phosphate and calcium phosphate nanoparticles. To directly compare the effect of Mg(+2) and Ca(+2) ions on structure of nanoparticles and their biological behavior, three groups of nanoparticles including amorphous magnesium phosphates (AMPs) which release Mg(+2), calcium magnesium phosphates (CMPs) which release Mg(+2) and Ca(+2), and hydroxyapatites (HAs) which release Ca(+2) were studied. SEM, TEM, XRD, and FTIR were used to evaluate the morphology, crystallinity, and chemical properties of the particles. AMP particles were homogeneous nanospheres, whereas CMPs were combinations of heterogeneous nanorods and nanospheres, and HAs which contained heterogeneous nanosphere particles. Cell compatibility was monitored in all groups to determine the cytotoxicity effect of particles on studied MC3T3-E1 preosteoblasts. AMPs showed significantly higher attachment rate than the HAs after 1 day and both AMPs and CMPs showed significantly higher proliferation rate when compared to HAs after 7days. Gene expression level of osteoblastic markers ALP, COL I, OCN, OPN, RUNX2 were monitored and they were normalized to GAPDH housekeeping gene. Beta actin expression level was monitored as the second housekeeping gene to confirm the accuracy of results. In general, AMPs and CMPs showed higher expression level of osteoblastic genes after 7 days which can further confirm the stimulating role of Mg(+2) and Ca(+2) ions in increasing the proliferation rate, differentiation, and mineralization of MC3T3-E1 preosteoblasts.

  8. Direct Hydrogenation Magnesium Boride to Magnesium Borohydride: Demonstration of >11 Weight Percent Reversible Hydrogen Storage

    SciTech Connect

    Severa, Godwin; Ronnebro, Ewa; Jensen, Craig M.

    2010-11-16

    We here for the first time demonstrate direct hydrogenation of magnesium boride, MgB2, to magnesium borohydride, Mg(BH4)2 at 900 bar H2-pressures and 400°C. Upon 14.8wt% hydrogen release, the end-decomposition product of Mg(BH4)2 is MgB2, thus, this is a unique reversible path here obtaining >11wt% H2 which implies promise for a fully reversible hydrogen storage material.

  9. Importance of magnesium chloride repletion after myocardial infarction.

    PubMed

    Sheehan, J

    1989-04-18

    Data pertinent to the role of magnesium deficits in coronary artery disease and myocardial infarction are reviewed. Results of clinical, laboratory and epidemiologic studies indicate an association between magnesium deficiency and a poor prognostic outcome in patients who have had myocardial infarction. It therefore appears to be a reasonable prophylactic measure to monitor closely magnesium status in patients with coronary heart disease and other patients at risk of acute myocardial infarction, and to supplement with magnesium chloride when clinically necessary. In addition, recent studies provide supportive evidence that supplementation of magnesium chloride may reduce the incidence of fatal and nonfatal arrhythmias after an infarct.

  10. Ionic liquid electrolytes for reversible magnesium electrochemistry.

    PubMed

    Kar, Mega; Ma, Zheng; Azofra, Luis Miguel; Chen, Kun; Forsyth, Maria; MacFarlane, Douglas R

    2016-03-14

    Mg has great potential as the basis for a safe, low cost energy storage technology, however, cycling of magnesium is difficult to achieve in most electrolytes. We demonstrate cycling of Mg from a novel alkoxyammonium ionic liquid. DFT calculations highlight the role that Mg coordination with [BH4](-) ions plays in the mechanism.

  11. Preparation of thorium magnesium-zinc reduction

    NASA Technical Reports Server (NTRS)

    Hariharan, A. V.; Knighton, J. B.; Steunenberg, R. K.

    1969-01-01

    Magnesium-zinc reduction of thorium dioxide is used for the preparation of thorium metal. Potential economic advantages of this technique include use of relatively inexpensive reagents for the metal and flux phases, and production of metal of acceptable quality in good yield.

  12. Constitutive Modeling of Magnesium Alloy Sheets

    SciTech Connect

    Lee, M. G.; Piao, K.; Wagoner, R. H.; Lee, J. K.; Chung, K.; Kim, H. Y.

    2007-05-17

    Magnesium alloy sheets have unique mechanical properties: high in-plane anisotropy/asymmetry of yield stress and hardening response, which have not been thoroughly studied. The unusual mechanical behavior of magnesium alloys has been understood by the limited symmetry crystal structure of h.c.p metals and thus by deformation twinning. In this paper, the phenomenological continuum plasticity models considering the unusual plastic behavior of magnesium alloy sheet were developed for a finite element analysis. A new hardening law based on two-surface model was developed to consider the general stress-strain response of metal sheets such as Bauschinger effect, transient behavior and the unusual asymmetry. Three deformation modes observed during the continuous tension/compression tests were mathematically formulated with simplified relations between the state of deformation and their histories. In terms of the anisotropy and asymmetry of the initial yield stress, the Drucker-Prager's pressure dependent yield surface was modified to include the anisotropy of magnesium alloys. Also, characterization procedures of material parameters for the constitutive equations were presented and finally the correlation of simulation with measurements was performed to validate the proposed theory.

  13. Effect of magnesium ion on human osteoblast activity

    PubMed Central

    He, L.Y.; Zhang, X.M.; Liu, B.; Tian, Y.; Ma, W.H.

    2016-01-01

    Magnesium, a promising biodegradable metal, has been reported in several studies to increase bone formation. Although there is some information regarding the concentrations of magnesium ions that affect bone remodeling at a cellular level, little is known about the effect of magnesium ions on cell gap junctions. Therefore, this study aimed to systematically investigate the effects of different concentrations of magnesium on bone cells, and further evaluate its effect on gap junctions of osteoblasts. Cultures of normal human osteoblasts were treated with magnesium ions at concentrations of 1, 2 and 3 mM, for 24, 48 and 72 h. The effects of magnesium ions on viability and function of normal human osteoblasts and on gap junction intercellular communication (GJIC) in osteoblasts were investigated. Magnesium ions induced significant (P<0.05) increases in cell viability, alkaline phosphate activity and osteocalcin levels of human osteoblasts. These stimulatory actions were positively associated with the concentration of magnesium and the time of exposure. Furthermore, the GJIC of osteoblasts was significantly promoted by magnesium ions. In conclusion, this study demonstrated that magnesium ions induced the activity of osteoblasts by enhancing GJIC between cells, and influenced bone formation. These findings may contribute to a better understanding of the influence of magnesium on bone remodeling and to the advance of its application in clinical practice. PMID:27383121

  14. Nanostructured magnesium has fewer detrimental effects on osteoblast function

    PubMed Central

    Weng, Lucy; Webster, Thomas J

    2013-01-01

    Efforts have been made recently to implement nanoscale surface features on magnesium, a biodegradable metal, to increase bone formation. Compared with normal magnesium, nanostructured magnesium has unique characteristics, including increased grain boundary properties, surface to volume ratio, surface roughness, and surface energy, which may influence the initial adsorption of proteins known to promote the function of osteoblasts (bone-forming cells). Previous studies have shown that one way to increase nanosurface roughness on magnesium is to soak the metal in NaOH. However, it has not been determined if degradation of magnesium is altered by creating nanoscale features on its surface to influence osteoblast density. The aim of the present in vitro study was to determine the influence of degradation of nanostructured magnesium, created by soaking in NaOH, on osteoblast density. Our results showed a less detrimental effect of magnesium degradation on osteoblast density when magnesium was treated with NaOH to create nanoscale surface features. The detrimental degradation products of magnesium are of significant concern when considering use of magnesium as an orthopedic implant material, and this study identified a surface treatment, ie, soaking in NaOH to create nanoscale features for magnesium that can improve its use in numerous orthopedic applications. PMID:23674891

  15. Assessment of the magnesium primary production technology. Final report

    SciTech Connect

    Flemings, M.C.; Kenney, G.B.; Sadoway, D.R.; Clark, J.P.; Szekely, J.

    1981-02-01

    At current production levels, direct energy savings achievable in primary magnesium production are 1.2 milliquads of energy per annum. Were magnesium to penetrate the automotive market to an average level of 50 pounds per vehicle, the resultant energy savings at the production stage would be somewhat larger, but the resulting savings in gasoline would conserve an estimated 325 milliquads of energy per year. The principal barrier to more widespread use of magnesium in the immediate future is its price. A price reduction of magnesium of 10% would lead to widespread conversion of aluminum die and permanent mold castings to magnesium. This report addresses the technology of electrolytic and thermic magnesium production and the economics of expanded magnesium production and use.

  16. Magnesium in CKD: more than a calcification inhibitor?

    PubMed

    Floege, Jürgen

    2015-06-01

    Magnesium fulfils important roles in multiple physiological processes. Accordingly, a tight regulation of magnesium homeostasis is essential. Dysregulated magnesium serum levels, in particular hypomagnesaemia, are common in patients with chronic kidney disease (CKD) and have been associated with poor clinical outcomes. In cell culture studies as well as in clinical situations magnesium levels were associated with vascular calcification, cardiovascular disease and altered bone-mineral metabolism. Magnesium has also been linked to diseases such as metabolic syndrome, diabetes, hypertension, fatigue and depression, all of which are common in CKD. The present review summarizes and discusses the latest clinical data on the impact of magnesium and possible effects of higher levels on the health status of patients with CKD, including an outlook on the use of magnesium-based phosphate-binding agents in this context.

  17. Maternal outcomes of magnesium sulphate and diazepam use in women with severe pre-eclampsia and eclampsia in Ethiopia

    PubMed Central

    Kassie, Gizat M.; Negussie, Dereje; Ahmed, Jemal H.

    2013-01-01

    Background Preferred anticonvulsant used to treat and prevent fits in eclampsia currently is magnesium sulphate. Clinical monitoring of tendon reflexes, respiration rate and measuring hourly urine output should be done to ensures safe administration of magnesium sulphate Objective This study was conducted to evaluate maternal outcomes of magnesium sulphate and diazepam use in the management of severe pre-eclampsia and eclampsia in Jimma University Specialized Hospital. Methods A retrospective hospital based cross-sectional comparative study was conducted using data collection format. Data was collected from the hospital delivery care register and patient chart records of all pregnant women who presented with the diagnosis of severe pre-eclampsia and eclampsia in two years and three months period from January, 2010 to April, 2012. Data analysis was done by SPSS version 16.0. A P-value of <0.05 was considered statistically significant in all tests. Results A total of 357 patient charts, 217 from magnesium sulphate and 140 from diazepam treated pregnant women group, were reviewed and analyzed. Three pregnant women from the magnesium sulphate treated group and eleven pregnant women from diazepam treated group had at least one convulsion after taking the drug. Greater proportion of patients in the magnesium sulphate treated group had less than four days postpartum stay as compared to the diazepam treated patients (82.3% versus 66.2%). Seizure occurrence, duration of postpartum hospital stays and birth outcome had a statistically significant association with the type of anticonvulsant used. Conclusions Magnesium sulphate is more effective than diazepam in the management of severe pre-eclamptic and eclamptic pregnant women in terms of seizure prevention, shortening postpartum hospital stay and reducing maternal morbidities. PMID:25035717

  18. The interactive effects of ketamine and magnesium upon depressive-like pathology

    PubMed Central

    Razmjou, Sara; Litteljohn, Darcy; Rudyk, Chris; Syed, Shuaib; Clarke, Melanie; Pentz, Rowan; Dwyer, Zach; Hayley, Shawn

    2016-01-01

    Approximately one-third of patients with major depressive disorders (MDDs) are resistant to current treatment methods, and the majority of cases relapse at some point during therapy. This has resulted in novel treatments being adopted, including subanesthetic doses of ketamine, which affects aberrant neuroplastic circuits, glutamatergic signaling, and the production of brain-derived neurotrophic factor. Ketamine rapidly relieves depressive symptoms in treatment-resistant major depressive disorder patients with effects that last for up to 2 weeks even after a single administration. However, it is also a drug with an abusive potential and can have marked side effects. Hence, this study aimed at enhancing the antidepressant-like effects of ketamine (allowing for lower dosing regimens) by coadministering magnesium hydroaspartate (Mg2+ normally affects the same receptors as ketamine) and also assessed whether an Mg2+-deficient diet would modify the impact of ketamine. It was found that a single 15 mg/kg dose of ketamine did indeed induce rapid antidepressant-like effects in the forced swim test but did not affect brain levels of the brain-derived neurotrophic factor. Contrary to our hypothesis, magnesium administration or deficiency did not influence the impact of ketamine on these outcomes. Thus, these data do not support the use of magnesium as an adjunct agent and instead suggest that further research involving other antidepressant and animal models is required to confirm the present findings.

  19. The interactive effects of ketamine and magnesium upon depressive-like pathology.

    PubMed

    Razmjou, Sara; Litteljohn, Darcy; Rudyk, Chris; Syed, Shuaib; Clarke, Melanie; Pentz, Rowan; Dwyer, Zach; Hayley, Shawn

    2016-01-01

    Approximately one-third of patients with major depressive disorders (MDDs) are resistant to current treatment methods, and the majority of cases relapse at some point during therapy. This has resulted in novel treatments being adopted, including subanesthetic doses of ketamine, which affects aberrant neuroplastic circuits, glutamatergic signaling, and the production of brain-derived neurotrophic factor. Ketamine rapidly relieves depressive symptoms in treatment-resistant major depressive disorder patients with effects that last for up to 2 weeks even after a single administration. However, it is also a drug with an abusive potential and can have marked side effects. Hence, this study aimed at enhancing the antidepressant-like effects of ketamine (allowing for lower dosing regimens) by coadministering magnesium hydroaspartate (Mg(2+) normally affects the same receptors as ketamine) and also assessed whether an Mg(2+)-deficient diet would modify the impact of ketamine. It was found that a single 15 mg/kg dose of ketamine did indeed induce rapid antidepressant-like effects in the forced swim test but did not affect brain levels of the brain-derived neurotrophic factor. Contrary to our hypothesis, magnesium administration or deficiency did not influence the impact of ketamine on these outcomes. Thus, these data do not support the use of magnesium as an adjunct agent and instead suggest that further research involving other antidepressant and animal models is required to confirm the present findings. PMID:27660449

  20. The interactive effects of ketamine and magnesium upon depressive-like pathology

    PubMed Central

    Razmjou, Sara; Litteljohn, Darcy; Rudyk, Chris; Syed, Shuaib; Clarke, Melanie; Pentz, Rowan; Dwyer, Zach; Hayley, Shawn

    2016-01-01

    Approximately one-third of patients with major depressive disorders (MDDs) are resistant to current treatment methods, and the majority of cases relapse at some point during therapy. This has resulted in novel treatments being adopted, including subanesthetic doses of ketamine, which affects aberrant neuroplastic circuits, glutamatergic signaling, and the production of brain-derived neurotrophic factor. Ketamine rapidly relieves depressive symptoms in treatment-resistant major depressive disorder patients with effects that last for up to 2 weeks even after a single administration. However, it is also a drug with an abusive potential and can have marked side effects. Hence, this study aimed at enhancing the antidepressant-like effects of ketamine (allowing for lower dosing regimens) by coadministering magnesium hydroaspartate (Mg2+ normally affects the same receptors as ketamine) and also assessed whether an Mg2+-deficient diet would modify the impact of ketamine. It was found that a single 15 mg/kg dose of ketamine did indeed induce rapid antidepressant-like effects in the forced swim test but did not affect brain levels of the brain-derived neurotrophic factor. Contrary to our hypothesis, magnesium administration or deficiency did not influence the impact of ketamine on these outcomes. Thus, these data do not support the use of magnesium as an adjunct agent and instead suggest that further research involving other antidepressant and animal models is required to confirm the present findings. PMID:27660449

  1. Administrative Ecology

    ERIC Educational Resources Information Center

    McGarity, Augustus C., III; Maulding, Wanda

    2007-01-01

    This article discusses how all four facets of administrative ecology help dispel the claims about the "impossibility" of the superintendency. These are personal ecology, professional ecology, organizational ecology, and community ecology. Using today's superintendency as an administrative platform, current literature describes a preponderance of…

  2. Administrative Support.

    ERIC Educational Resources Information Center

    Doran, Dorothy; And Others

    This guide is intended to assist business education teachers in administrative support courses. The materials presented are based on the Arizona validated occupational competencies and tasks for the occupations of receptionist, secretary, and administrative assistant. Word processing skills have been infused into each of the three sections. The…

  3. Transport of Magnesium by a Bacterial Nramp-Related Gene

    PubMed Central

    Rodionov, Dmitry A.; Freedman, Benjamin G.; Senger, Ryan S.; Winkler, Wade C.

    2014-01-01

    Magnesium is an essential divalent metal that serves many cellular functions. While most divalent cations are maintained at relatively low intracellular concentrations, magnesium is maintained at a higher level (∼0.5–2.0 mM). Three families of transport proteins were previously identified for magnesium import: CorA, MgtE, and MgtA/MgtB P-type ATPases. In the current study, we find that expression of a bacterial protein unrelated to these transporters can fully restore growth to a bacterial mutant that lacks known magnesium transporters, suggesting it is a new importer for magnesium. We demonstrate that this transport activity is likely to be specific rather than resulting from substrate promiscuity because the proteins are incapable of manganese import. This magnesium transport protein is distantly related to the Nramp family of proteins, which have been shown to transport divalent cations but have never been shown to recognize magnesium. We also find gene expression of the new magnesium transporter to be controlled by a magnesium-sensing riboswitch. Importantly, we find additional examples of riboswitch-regulated homologues, suggesting that they are a frequent occurrence in bacteria. Therefore, our aggregate data discover a new and perhaps broadly important path for magnesium import and highlight how identification of riboswitch RNAs can help shed light on new, and sometimes unexpected, functions of their downstream genes. PMID:24968120

  4. Influence factors on the formation of magnesium nanowires prepared by physical vapor deposition

    NASA Astrophysics Data System (ADS)

    Wang, Han; Song, Xiping; You, Li; Zhang, Bei

    2015-12-01

    Magnesium nanowires were successfully prepared by a physical vapor deposition method, and influence factors on the formation of magnesium nanowires were discussed based on the evaporation/deposition temperature, vacuum level, magnesium vapor concentration and deposition time. The results show that the formation of magnesium nanowires occurs within a specific evaporation/deposition temperature range. Magnesium nanowires become thicker and longer and finally convert into magnesium micronparticles with the increase of evaporation temperature or decrease of deposition temperature. The vacuum level also plays a decisive role in the formation of magnesium nanowires that magnesium nanowires can only be prepared in a high vacuum level. The magnesium vapor concentration and deposition time also have significant influences on the formation of magnesium nanowires. A distribution map of magnesium nanowire is set up based on our experimental results and a criterion of supersaturation of magnesium vapors is proposed in the explanation of the formation of magnesium nanowires.

  5. Thermal conductivities of nanostructured magnesium oxide coatings deposited on magnesium alloys by plasma electrolytic oxidation.

    PubMed

    Shen, Xinwei; Nie, Xueyuan; Hu, Henry

    2014-10-01

    The resistances of magnesium alloys to wear, friction and corrosion can be effectively improved by depositing coatings on their surfaces. However, the coatings can also reduce the heat transfer from the coated components to the surroundings (e.g., coated cylinder bores for internal combustion of engine blocks). In this paper, nanostructured magnesium oxides were produced by plasma electrolytic oxidation (PEO) process on the magnesium alloy AJ62 under different current densities. The guarded comparative heat flow method was adopted to measure the thermal conductivities of such coatings which possess gradient nanoscale grain sizes. The aim of the paper is to explore how the current density in the PEO process affects the thermal conductivity of the nanostructured magnesium coatings. The experimental results show that, as the current density rises from 4 to 20 A/mm2, the thermal conductivity has a slight increase from 0.94 to 1.21 W/m x K, which is significantly smaller than that of the corresponding bulk magnesium oxide materials (29.4 W/m x K). This mostly attributed to the variation of the nanoscale grain sizes of the PEO coatings. PMID:25942897

  6. Thermal conductivities of nanostructured magnesium oxide coatings deposited on magnesium alloys by plasma electrolytic oxidation.

    PubMed

    Shen, Xinwei; Nie, Xueyuan; Hu, Henry

    2014-10-01

    The resistances of magnesium alloys to wear, friction and corrosion can be effectively improved by depositing coatings on their surfaces. However, the coatings can also reduce the heat transfer from the coated components to the surroundings (e.g., coated cylinder bores for internal combustion of engine blocks). In this paper, nanostructured magnesium oxides were produced by plasma electrolytic oxidation (PEO) process on the magnesium alloy AJ62 under different current densities. The guarded comparative heat flow method was adopted to measure the thermal conductivities of such coatings which possess gradient nanoscale grain sizes. The aim of the paper is to explore how the current density in the PEO process affects the thermal conductivity of the nanostructured magnesium coatings. The experimental results show that, as the current density rises from 4 to 20 A/mm2, the thermal conductivity has a slight increase from 0.94 to 1.21 W/m x K, which is significantly smaller than that of the corresponding bulk magnesium oxide materials (29.4 W/m x K). This mostly attributed to the variation of the nanoscale grain sizes of the PEO coatings.

  7. The Corrosion of Magnesium and of the Magnesium Aluminum Alloys Containing Manganese

    NASA Technical Reports Server (NTRS)

    Boyer, J A

    1927-01-01

    The extensive use of magnesium and its alloys in aircraft has been seriously handicapped by the uncertainties surrounding their resistance to corrosion. This problem has been given intense study by the American Magnesium Corporation and at the request of the Subcommittee on Materials for Aircraft of the National Advisory Committee for Aeronautics this report was prepared on the corrosion of magnesium. The tentative conclusions drawn from the experimental facts of this investigation are as follows: the overvoltage of pure magnesium is quite high. On immersion in salt water the metal corrodes with the liberation of hydrogen until the film of corrosion product lowers the potential to a critical value. When the potential reaches this value it no longer exceeds the theoretical hydrogen potential plus the overvoltage of the metal. Rapid corrosion consequently ceases. When aluminum is added, especially when in large amounts, the overvoltage is decreased and hydrogen plates out at a much lower potential than with pure magnesium. The addition of small amount of manganese raises the overvoltage back to practically that of pure metal, and the film is again negative.

  8. Enhancements in Magnesium Die Casting Impact Properties

    SciTech Connect

    David Schwam; John F. Wallace; Yulong Zhu; Srinath Viswanathan; Shafik Iskander

    2000-06-30

    The need to produce lighter components in transportation equipment is the main driver in the increasing demand for magnesium castings. In many automotive applications, components can be made of magnesium or aluminum. While being lighter, often times the magnesium parts have lower impact and fatigue properties than the aluminum. The main objective of this study was to identify potential improvements in the impact resistance of magnesium alloys. The most common magnesium alloys in automotive applications are AZ91D, AM50 and AM60. Accordingly, these alloys were selected as the main candidates for the study. Experimental quantities of these alloys were melted in an electrical furnace under a protective atmosphere comprising sulfur hexafluoride, carbon dioxide and dry air. The alloys were cast both in a permanent mold and in a UBE 315 Ton squeeze caster. Extensive evaluation of tensile, impact and fatigue properties was conducted at CWRU on permanent mold and squeeze cast test bars of AZ91, AM60 and AM50. Ultimate tensile strength values between 20ksi and 30ksi were obtained. The respective elongations varied between 25 and 115. the Charpy V-notch impact strength varied between 1.6 ft-lb and 5 ft-lb depending on the alloy and processing conditions. Preliminary bending fatigue evaluation indicates a fatigue limit of 11-12 ksi for AM50 and AM60. This is about 0.4 of the UTS, typical for these alloys. The microstructures of the cast specimens were investigated with optical and scanning electron microscopy. Concomitantly, a study of the fracture toughness in AM60 was conducted at ORNL as part of the study. The results are in line with values published in the literature and are representative of current state of the art in casting magnesium alloys. The experimental results confirm the strong relationship between aluminum content of the alloys and the mechanical properties, in particular the impact strength and the elongation. As the aluminum content increases from about 5

  9. Lithium-aluminum-magnesium electrode composition

    DOEpatents

    Melendres, Carlos A.; Siegel, Stanley

    1978-01-01

    A negative electrode composition is presented for use in a secondary, high-temperature electrochemical cell. The cell also includes a molten salt electrolyte of alkali metal halides or alkaline earth metal halides and a positive electrode including a chalcogen or a metal chalcogenide as the active electrode material. The negative electrode composition includes up to 50 atom percent lithium as the active electrode constituent and a magnesium-aluminum alloy as a structural matrix. Various binary and ternary intermetallic phases of lithium, magnesium, and aluminum are formed but the electrode composition in both its charged and discharged state remains substantially free of the alpha lithium-aluminum phase and exhibits good structural integrity.

  10. Magnesium, a drug of diverse use.

    PubMed

    Akhtar, Mohammad Irfan; Ullah, Hameed; Hamid, Mohammad

    2011-12-01

    Magnesium has evolved as a drug with diverse clinical applications. Mg++ is an important caution and its homeostasis is very important for normal body functioning. The physiological role of Mg is due to its calcium channel blocking properties at smooth muscle, skeletal muscle and conduction system levels. The analgesic properties are due to NMDA receptor blocking action. Mg++ is beneficial in acute Myocardial Infarction, protection during open heart surgery and treatment and prevention of heart rhythm disturbances. Mg has an established role in the management of preeclampsia and eclampsia. Magnesium prevents or controls convulsions by blocking neuromuscular transmission and decreasing the release of acetylcholine at the motor nerve terminals. The use of MgSO4 in treating tetanus and acute asthma is established. In conclusion, Mg is a cost effective, widely used drug with multidisciplinary applications. Its majority of physiological effects are attributed to calcium channel blocking properties. PMID:22355971

  11. Lead magnesium niobate actuator for micropositioning

    DOEpatents

    Swift, Charles D.; Bergum, John W.

    1994-01-01

    An improved lead magnesium niobate actuator is disclosed comprising a cylindrical lead magnesium niobate crystal stack mounted in a cylindrical casing wherein a bias means, such as one or more belleville washers, is located between one end of the crystal stack and a partially closed end of the casing; and adjustment means are provided which bear against the opposite end of the crystal stack, whereby an adjustable compressive force is constantly applied against the crystal stack, whether the crystal stack is actuated in an extended position, or is in an unactuated contracted position. In a preferred embodiment, cooling ports are provided for the circulation of coolant in the actuator to cool the crystal stack, and provision is made for removal and replacement of the crystal stack without disconnecting the actuator from the external device being actuated.

  12. Lead magnesium niobate actuator for micropositioning

    DOEpatents

    Swift, C.D.; Bergum, J.W.

    1994-10-25

    An improved lead magnesium niobate actuator is disclosed comprising a cylindrical lead magnesium niobate crystal stack mounted in a cylindrical casing wherein a bias means, such as one or more belleville washers, is located between one end of the crystal stack and a partially closed end of the casing; and adjustment means are provided which bear against the opposite end of the crystal stack, whereby an adjustable compressive force is constantly applied against the crystal stack, whether the crystal stack is actuated in an extended position, or is in an unactuated contracted position. In a preferred embodiment, cooling ports are provided for the circulation of coolant in the actuator to cool the crystal stack, and provision is made for removal and replacement of the crystal stack without disconnecting the actuator from the external device being actuated. 3 figs.

  13. 21 CFR 184.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ...·Mg(OH)2·5H2O, CAS Reg. No. 39409-82-0) is also known as magnesium carbonate hydroxide. It is a white...), p. 177, which is incorporated by reference. Copies are available from the National Academy Press... as defined in § 170.3(o)(20) of this chapter; a pH control agent as defined in § 170.3(o)(23) of...

  14. 21 CFR 184.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... (molecular formula approximately (MgCO3)4·Mg(OH)2·5H2O, CAS Reg. No. 39409-82-0) is also known as magnesium... Food Chemicals Codex, 3d Ed. (1981), p. 177, which is incorporated by reference. Copies are available... chapter; a nutrient supplement as defined in § 170.3(o)(20) of this chapter; a pH control agent as...

  15. 21 CFR 184.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... (molecular formula approximately (MgCO3)4·Mg(OH)2·5H2O, CAS Reg. No. 39409-82-0) is also known as magnesium... Food Chemicals Codex, 3d Ed. (1981), p. 177, which is incorporated by reference. Copies are available... chapter; a nutrient supplement as defined in § 170.3(o)(20) of this chapter; a pH control agent as...

  16. 21 CFR 184.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... formula approximately (MgCO3)4·Mg(OH)2·5H2O, CAS Reg. No. 39409-82-0) is also known as magnesium carbonate... Chemicals Codex, 3d Ed. (1981), p. 177, which is incorporated by reference. Copies are available from the... as defined in § 170.3(o)(20) of this chapter; a pH control agent as defined in § 170.3(o)(23) of...

  17. 21 CFR 184.1425 - Magnesium carbonate.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... (molecular formula approximately (MgCO3)4·Mg(OH)2·5H2O, CAS Reg. No. 39409-82-0) is also known as magnesium... Food Chemicals Codex, 3d Ed. (1981), p. 177, which is incorporated by reference. Copies are available... chapter; a nutrient supplement as defined in § 170.3(o)(20) of this chapter; a pH control agent as...

  18. Does dietary magnesium modulate blood lipids?

    PubMed

    Singh, R B; Rastogi, S S; Mani, U V; Seth, J; Devi, L

    1991-07-01

    In a randomized, single-blind, controlled study (400 patients aged 25-63 yr; 374 males, 26 females), 206 subjects were administered a magnesium-rich diet, and 194 subjects their usual diet, for 6 wk. Age, sex, body weight, hypertension, hyperlipidemia, smoking, obesity, diuretic therapy, and diabetes were comparable between the two groups, as were laboratory data at entry to the study. Intervention-group A received a significantly higher amount of dietary magnesium and potassium compared to group B, which received its usual diet. After 6 wk, there was a significant fall in total serum cholesterol (228.5 +/- 46.2 mg/dL), LDL cholesterol 146.5 +/- 75.5 mg/dL), and triglyceride (143.8 +/- 40.5 mg/dL) in group A compared to serum cholesterol (242.5 +/- 58.2 mg/dL), LDL cholesterol (157.0 +/- 78.4 mg/dL), and triglyceride (156.5 +/- 60.0 mg/dL) at entry to study, but no such changes in group-B subjects. HDL cholesterol showed a marginal mean decrease of 0.8 mg/dL in group B and a 2.5 mg/dL increase in group A. The changes in blood lipids were consistent with an increased intake of magnesium and with a rise in serum levels. Although a general blood-lipid-reducing effect of such a diet cannot be excluded, it is possible that dietary magnesium may have contributed to the reduction of total serum cholesterol, LDL cholesterol, and triglyceride, and the marginal rise in HDL cholesterol. More studies with longer follow-up periods are needed to confirm this observation. PMID:1718369

  19. Sodium-dependent magnesium uptake by ferret red cells.

    PubMed Central

    Flatman, P W; Smith, L M

    1991-01-01

    1. Magnesium uptake can be measured in ferret red cells incubated in media containing more than 1 mM-magnesium. Uptake is substantially increased if the sodium concentration in the medium is reduced. 2. Magnesium uptake is half-maximally activated by 0.37 mM-external magnesium when the external sodium concentration is 5 mM. Increasing the external sodium concentration increases the magnesium concentration needed to activate the system. 3. Magnesium uptake is increased by reducing the external sodium concentration. Uptake is half-maximum at sodium concentrations of 17, 22 and 62 nM when the external magnesium concentrations are 2, 5 and 10 mM respectively. 4. Replacement of external sodium with choline does not affect the membrane potential of ferret red cells over a 45 min period. 5. Magnesium uptake from media containing 5 mM-sodium is inhibited by amiloride, quinidine and imipramine. It is not affected by ouabain or bumetanide. Vanadate stimulates magnesium uptake but has no effect on magnesium efflux. 6. When cell ATP content is reduced to 19 mumol (1 cell)-1 by incubating cells for 3 h with 2-deoxyglucose, magnesium uptake falls by 50% in the presence of 5 mM-sodium and is completely abolished in the presence of 145 mM-sodium. Some of the inhibition may be due to the increase in intracellular ionized magnesium concentration ([Mg2+]i) from 0.7 to 1.0 mM which occurs under these conditions. 7. Magnesium uptake can be driven against a substantial electrochemical gradient if the external sodium concentration is reduced sufficiently. 8. These findings are discussed in terms of several possible models for magnesium transport. It is concluded that the majority of magnesium uptake observed in low-sodium media is via sodium-magnesium antiport. A small portion of uptake is through a parallel leak pathway. It is believed that the antiport is responsible for maintaining [Mg2+]i below electrochemical equilibrium in these cells at physiological external sodium concentration

  20. A study on factors affecting the degradation of magnesium and a magnesium-yttrium alloy for biomedical applications.

    PubMed

    Johnson, Ian; Liu, Huinan

    2013-01-01

    Controlling degradation of magnesium or its alloys in physiological saline solutions is essential for their potential applications in clinically viable implants. Rapid degradation of magnesium-based materials reduces the mechanical properties of implants prematurely and severely increases alkalinity of the local environment. Therefore, the objective of this study is to investigate the effects of three interactive factors on magnesium degradation, specifically, the addition of yttrium to form a magnesium-yttrium alloy versus pure magnesium, the metallic versus oxide surfaces, and the presence versus absence of physiological salt ions in the immersion solution. In the immersion solution of phosphate buffered saline (PBS), the magnesium-yttrium alloy with metallic surface degraded the slowest, followed by pure magnesium with metallic or oxide surfaces, and the magnesium-yttrium alloy with oxide surface degraded the fastest. However, in deionized (DI) water, the degradation rate showed a different trend. Specifically, pure magnesium with metallic or oxide surfaces degraded the slowest, followed by the magnesium-yttrium alloy with oxide surface, and the magnesium-yttrium alloy with metallic surface degraded the fastest. Interestingly, only magnesium-yttrium alloy with metallic surface degraded slower in PBS than in DI water, while all the other samples degraded faster in PBS than in DI water. Clearly, the results showed that the alloy composition, presence or absence of surface oxide layer, and presence or absence of physiological salt ions in the immersion solution all influenced the degradation rate and mode. Moreover, these three factors showed statistically significant interactions. This study revealed the complex interrelationships among these factors and their respective contributions to degradation for the first time. The results of this study not only improved our understanding of magnesium degradation in physiological environment, but also presented the key

  1. Biodegradable magnesium-hydroxyapatite metal matrix composites.

    PubMed

    Witte, Frank; Feyerabend, Frank; Maier, Petra; Fischer, Jens; Störmer, Michael; Blawert, Carsten; Dietzel, Wolfgang; Hort, Norbert

    2007-04-01

    Recent studies indicate that there is a high demand to design magnesium alloys with adjustable corrosion rates and suitable mechanical properties. An approach to this challenge might be the application of metal matrix composite (MMC) based on magnesium alloys. In this study, a MMC made of magnesium alloy AZ91D as a matrix and hydroxyapatite (HA) particles as reinforcements have been investigated in vitro for mechanical, corrosive and cytocompatible properties. The mechanical properties of the MMC-HA were adjustable by the choice of HA particle size and distribution. Corrosion tests revealed that HA particles stabilised the corrosion rate and exhibited more uniform corrosion attack in artificial sea water and cell solutions. The phase identification showed that all samples contained hcp-Mg, Mg(17)Al(12), and HA before and after immersion. After immersion in artificial sea water CaCO3 was found on MMC-HA surfaces, while no formation of CaCO3 was found after immersion in cell solutions with and without proteins. Co-cultivation of MMC-HA with human bone derived cells (HBDC), cells of an osteoblasts lineage (MG-63) and cells of a macrophage lineage (RAW264.7) revealed that RAW264.7, MG-63 and HBDC adhere, proliferate and survive on the corroding surfaces of MMC-HA. In summary, biodegradable MMC-HA are cytocompatible biomaterials with adjustable mechanical and corrosive properties.

  2. Sea water magnesium fuel cell power supply

    NASA Astrophysics Data System (ADS)

    Hahn, Robert; Mainert, Jan; Glaw, Fabian; Lang, K.-D.

    2015-08-01

    An environmentally friendly magnesium fuel cell system using seawater electrolyte and atmospheric oxygen was tested under practical considerations for use as maritime power supply. The hydrogen rate and therefore the power density of the system were increased by a factor of two by using hydrogen evolution cathodes with a gas separation membrane instead of submerged cathodes without gas separation. Commercial magnesium AZ31 rolled sheet anodes can be dissolved in seawater for hydrogen production, down to a thickness below 100 μm thickness, resulting in hydrogen generation efficiency of the anode of over 80%. A practical specific energy/energy density of the alloy of more than 1200 Wh/kg/3000 Wh/l was achieved when coupled to a fuel cell with atmospheric air breathing cathode. The performance of several AZ31 alloy anodes was tested as well as the influence of temperature, electrolyte concentration and anode - cathode separation. The excess hydrogen produced by the magnesium hydrogen evolving cell, due to the negative difference effect, is proportional to the cell current in case of the AZ31 alloys, which simplifies system control considerably. Stable long-term operation of the system was demonstrated at low pressures which can be maintained in an open-seawater-submerged hydrogen generator.

  3. Adsorption of β-carotene on modified magnesium silicate

    NASA Astrophysics Data System (ADS)

    Sun, Shanshan; Guo, Ning; Fu, Yongfeng

    2016-02-01

    Modified flocculation magnesium silicate is prepared by a hydrothermal process at 120°C for 18 h after adding Al2(SO4)3 into the magnesium silicate gel. Compared with standard magnesium silicate with 328.116 m2 g-1 surface area, this modified magnesium silicate has a bigger BET surface area of 536.803 m2 g-1 and a lower interlayer water content. Modified magnesium silicate exhibits high β-carotene adsorption with a maximum adsorption capacity of 364.96 mg g-1. It is shown that when suspended in organic solvent, this material can be used effectively for carotenoid separation. Furthermore, our results suggest that modified magnesium silicate may be a promising candidate as an absorbent in the decoloring of oil.

  4. Effects of magnesium deficiency--more than skin deep.

    PubMed

    Chandrasekaran, Navin Chandrakanth; Weir, Christopher; Alfraji, Sumaya; Grice, Jeff; Roberts, Michael S; Barnard, Ross T

    2014-10-01

    Dead Sea and magnesium salt therapy are two of the oldest forms of treatment for skin disease and several other disorders, supported by a body of largely anecdotal evidence. In this paper we review possible pathways for penetration of magnesium ions through the epidermis to reach the circulation, in turn replenishing cellular magnesium levels. We also discuss mechanisms for intercellular movement of magnesium ions and possible mechanisms for the interaction between magnesium ions and inflammatory mediators. Upon addition of magnesium ions in vitro, the expression of inflammatory mediators such as tumour necrosis factor α (TNFα) and nuclear factor κβ (NFκβ) is down regulated. Dysregulation of these and other inflammatory mediators has been linked to several inflammatory disorders, including asthma, arthritis, atherosclerosis and neuroinflammation.

  5. Reversible Dehydrogenation of Magnesium Borohydride to Magnesium Triborane in the Solid State Under Moderate Conditions

    SciTech Connect

    Chong, Marina; Karkamkar, Abhijeet J.; Autrey, Thomas; Orimo, Shin-ichi; Jalisatgi, Satish; Jensen, Craig M.

    2011-02-17

    Thermal decomposition of magnesium borohydride, Mg(BH4)2, in the solid state was studied by a combination of PCT, TGA/MS and NMR spectroscopy. Dehydrogenation of Mg(BH4)2 at 200 °C, results in the highly selective formation of magnesium triborane, Mg(B3H8)2. This process is reversible at 250 °C under 120 atm H2. Dehydrogenation at higher temperature, > 300 °C, produces a complex mixture of polyborane species. Solution phase 11B NMR spectra of the hydrolyzed decomposition products reveals the formation of the B3H8 anion, boric acid from hydrolysis of the unstable polyboranes (BnHx) (n = 3-11, x >8), and the closoborane B12H12 dianion as a minor product. A BH condensation mechanism involving metal hydride formation is proposed to explain the limited reversible hydrogen storage in magnesium borohydride.

  6. Impurity control and corrosion resistance of magnesium-aluminum alloy

    SciTech Connect

    Liu, M.; Song, GuangLing

    2013-01-01

    The corrosion resistance of magnesium alloys is very sensitive to the contents of impurity elements such as iron. In this study, a series of diecast AXJ530 magnesium alloy samples were prepared with additions of Mn and Fe. Through a comprehensive phase diagram calculation and corrosion evaluation, the mechanisms for the tolerance limit of Fe in magnesium alloy are discussed. This adds a new dimension to control the alloying impurity in terms of alloying composition design and casting conditions.

  7. Design Considerations of a Condensing System for Vaporized Magnesium

    NASA Technical Reports Server (NTRS)

    Witzke, Walter R; Prok, George M; Keller, Thomas A

    1955-01-01

    The effect of the design characteristics of various condensing chambers on magnesium build-up at the chamber inlet was investigated. The condensing chambers are used in the vapor-condensation process for making magnesium slurries. A complete description of the various chamber designs and the procedure used in testing the chambers is given. The results are evaluated on the basis of clogging and total magnesium distilled per run. Orifice design was also considered.

  8. Initial observations on using magnesium metal in peripheral nerve repair.

    PubMed

    Vennemeyer, J J; Hopkins, T; Hershcovitch, M; Little, K D; Hagen, M C; Minteer, D; Hom, D B; Marra, K; Pixley, S K

    2015-03-01

    Biodegradable magnesium metal filaments placed inside biodegradable nerve conduits might provide the physical guidance support needed to improve the rate and extent of regeneration of peripheral nerves across injury gaps. In this study, we examined basic issues of magnesium metal resorption and biocompatibility by repairing sub-critical size gap injuries (6 mm) in one sciatic nerve of 24 adult male Lewis rats. Separated nerve stumps were connected with poly(caprolactone) nerve conduits, with and without magnesium filaments (0.25 mm diameter, 10 mm length), with two different conduit filler substances (saline and keratin hydrogel). At 6 weeks after implantation, magnesium degradation was examined by micro-computed tomography and histological analyses. Magnesium degradation was significantly greater when the conduits were filled with an acidic keratin hydrogel than with saline (p < 0.05). But magnesium filaments in some animals remained intact for 6 weeks. Using histological and immunocytochemical analyses, good biocompatibility of the magnesium implants was observed at 6 weeks, as shown by good development of regenerating nerve mini-fascicles and only mild inflammation in tissues even after complete degradation of the magnesium. Nerve regeneration was not interrupted by complete magnesium degradation. An initial functional evaluation, determination of size recovery of the gastrocnemius muscle, showed a slight improvement due to magnesium with the saline but not the keratin filler, compared with respective control conduits without magnesium. These results suggest that magnesium filament implants have the potential to improve repair of injured peripheral nerve defects in this rodent model.

  9. Rechargeable Magnesium Batteries: Low-Cost Rechargeable Magnesium Batteries with High Energy Density

    SciTech Connect

    2010-10-01

    BEEST Project: Pellion Technologies is developing rechargeable magnesium batteries that would enable an EV to travel 3 times farther than it could using Li-ion batteries. Prototype magnesium batteries demonstrate excellent electrochemical behavior; delivering thousands of charge cycles with very little fade. Nevertheless, these prototypes have always stored too little energy to be commercially viable. Pellion Technologies is working to overcome this challenge by rapidly screening potential storage materials using proprietary, high-throughput computer models. To date, 12,000 materials have been identified and analyzed. The resulting best materials have been electrochemically tested, yielding several very promising candidates.

  10. Rapid recovery from major depression using magnesium treatment.

    PubMed

    Eby, George A; Eby, Karen L

    2006-01-01

    Major depression is a mood disorder characterized by a sense of inadequacy, despondency, decreased activity, pessimism, anhedonia and sadness where these symptoms severely disrupt and adversely affect the person's life, sometimes to such an extent that suicide is attempted or results. Antidepressant drugs are not always effective and some have been accused of causing an increased number of suicides particularly in young people. Magnesium deficiency is well known to produce neuropathologies. Only 16% of the magnesium found in whole wheat remains in refined flour, and magnesium has been removed from most drinking water supplies, setting a stage for human magnesium deficiency. Magnesium ions regulate calcium ion flow in neuronal calcium channels, helping to regulate neuronal nitric oxide production. In magnesium deficiency, neuronal requirements for magnesium may not be met, causing neuronal damage which could manifest as depression. Magnesium treatment is hypothesized to be effective in treating major depression resulting from intraneuronal magnesium deficits. These magnesium ion neuronal deficits may be induced by stress hormones, excessive dietary calcium as well as dietary deficiencies of magnesium. Case histories are presented showing rapid recovery (less than 7 days) from major depression using 125-300 mg of magnesium (as glycinate and taurinate) with each meal and at bedtime. Magnesium was found usually effective for treatment of depression in general use. Related and accompanying mental illnesses in these case histories including traumatic brain injury, headache, suicidal ideation, anxiety, irritability, insomnia, postpartum depression, cocaine, alcohol and tobacco abuse, hypersensitivity to calcium, short-term memory loss and IQ loss were also benefited. Dietary deficiencies of magnesium, coupled with excess calcium and stress may cause many cases of other related symptoms including agitation, anxiety, irritability, confusion, asthenia, sleeplessness

  11. Role of magnesium in alleviation of aluminium toxicity in plants.

    PubMed

    Bose, Jayakumar; Babourina, Olga; Rengel, Zed

    2011-04-01

    Magnesium is pivotal for activating a large number of enzymes; hence, magnesium plays an important role in numerous physiological and biochemical processes affecting plant growth and development. Magnesium can also ameliorate aluminium phytotoxicity, but literature reports on the dynamics of magnesium homeostasis upon exposure to aluminium are rare. Herein existing knowledge on the magnesium transport mechanisms and homeostasis maintenance in plant cells is critically reviewed. Even though overexpression of magnesium transporters can alleviate aluminium toxicity in plants, the mechanisms governing such alleviation remain obscure. Possible magnesium-dependent mechanisms include (i) better carbon partitioning from shoots to roots; (ii) increased synthesis and exudation of organic acid anions; (iii) enhanced acid phosphatase activity; (iv) maintenance of proton-ATPase activity and cytoplasmic pH regulation; (v) protection against an aluminium-induced cytosolic calcium increase; and (vi) protection against reactive oxygen species. Future research should concentrate on assessing aluminium toxicity and tolerance in plants with overexpressed or antisense magnesium transporters to increase understanding of the aluminium-magnesium interaction.

  12. Magnesium, aluminum and lead in various brain areas

    SciTech Connect

    Zumkley, H.; Bertram, H.P.; Brandt, M.; Roedig, M.; Spieker, C.

    1986-01-01

    Whereas the lead concentrations were increased in brain tissue of patients with chronic alcoholism, the aluminum concentrations remained within the normal range. The magnesium concentrations were found decreased in patients with chronic alcoholism compared to normal controls. The sources for the elevated lead levels seem to be the increased intake of alcohol. The decreased magnesium levels are probably caused by an increased loss of magnesium with the urine, malnutrition, malabsorption, hormonal factors and drugs. Various neurological disorders which often accompanied chronic alcoholism may be caused or aggravated by lead encephalopathy and hypomagnesemia. Therapeutical implications may be the early substitution of magnesium deficiency in chronic alcoholism. 10 references, 5 figures.

  13. Joint solubility of samarium and dysprosium in solid magnesium

    NASA Astrophysics Data System (ADS)

    Rokhlin, L. L.; Dobatkina, T. V.; Lukyanova, E. A.; Korolkova, I. G.; Tarytina, I. E.

    2016-03-01

    The phase compositions of solid Mg-Sm-Dy alloys corresponding to the magnesium-corner region of the phase diagram are studied by optical and scanning electron microscopy, electrical resistivity measurements, and electron microprobe analysis. The obtained results allowed us to determine the joint solubility of samarium and dysprosium in solid magnesium at 500, 400, and 300°C; it decreases with decreasing temperature. The magnesium solid solution is found to be in equilibrium only with the Mg41Sm5 and Mg24Dy5 compounds, which are in equilibrium with the magnesium solid solution in the binary Mg-Sm and Mg-Dy systems.

  14. Magnesium balances and /sup 28/Mg studies in man

    SciTech Connect

    Spencer, H.; Schwartz, R.; Osis, D.

    1988-01-01

    The intestinal absorption of magnesium was determined under strictly controlled dietary conditions in patients with normal renal function and also in patients with chronic renal failure. The average net absorption of magnesium of patients with normal renal function, expressed as percent of the magnesium intake, was 48.5%, while that of patients with chronic renal failure was significantly lower, 17%. Increasing the calcium intake from a low calcium intake of 200 mg/day to different higher intake levels up to 2000 mg/day did not change the magnesium balance nor the net absorption of magnesium of both types of patients. The lack of effect of the higher calcium intake on the absorption of magnesium was confirmed in /sup 28/Mg studies in which an oral dose of /sup 28/Mg, as the chloride, was given. The excretion of the absorbed magnesium into the intestine, the endogenous fecal magnesium, was low. Also, increasing the phosphorus intake up to 2000 mg/day in subjects with normal renal function did not affect the magnesium balance, regardless of the calcium intake.

  15. Improved biological performance of magnesium by micro-arc oxidation

    PubMed Central

    Ma, W.H.; Liu, Y.J.; Wang, W.; Zhang, Y.Z.

    2014-01-01

    Magnesium and its alloys have recently been used in the development of lightweight, biodegradable implant materials. However, the corrosion properties of magnesium limit its clinical application. The purpose of this study was to comprehensively evaluate the degradation behavior and biomechanical properties of magnesium materials treated with micro-arc oxidation (MAO), which is a new promising surface treatment for developing corrosion resistance in magnesium, and to provide a theoretical basis for its further optimization and clinical application. The degradation behavior of MAO-treated magnesium was studied systematically by immersion and electrochemical tests, and its biomechanical performance when exposed to simulated body fluids was evaluated by tensile tests. In addition, the cell toxicity of MAO-treated magnesium samples during the corrosion process was evaluated, and its biocompatibility was investigated under in vivo conditions. The results of this study showed that the oxide coating layers could elevate the corrosion potential of magnesium and reduce its degradation rate. In addition, the MAO-coated sample showed no cytotoxicity and more new bone was formed around it during in vivo degradation. MAO treatment could effectively enhance the corrosion resistance of the magnesium specimen and help to keep its original mechanical properties. The MAO-coated magnesium material had good cytocompatibility and biocompatibility. This technique has an advantage for developing novel implant materials and may potentially be used for future clinical applications. PMID:25517917

  16. Rapid recovery from major depression using magnesium treatment.

    PubMed

    Eby, George A; Eby, Karen L

    2006-01-01

    Major depression is a mood disorder characterized by a sense of inadequacy, despondency, decreased activity, pessimism, anhedonia and sadness where these symptoms severely disrupt and adversely affect the person's life, sometimes to such an extent that suicide is attempted or results. Antidepressant drugs are not always effective and some have been accused of causing an increased number of suicides particularly in young people. Magnesium deficiency is well known to produce neuropathologies. Only 16% of the magnesium found in whole wheat remains in refined flour, and magnesium has been removed from most drinking water supplies, setting a stage for human magnesium deficiency. Magnesium ions regulate calcium ion flow in neuronal calcium channels, helping to regulate neuronal nitric oxide production. In magnesium deficiency, neuronal requirements for magnesium may not be met, causing neuronal damage which could manifest as depression. Magnesium treatment is hypothesized to be effective in treating major depression resulting from intraneuronal magnesium deficits. These magnesium ion neuronal deficits may be induced by stress hormones, excessive dietary calcium as well as dietary deficiencies of magnesium. Case histories are presented showing rapid recovery (less than 7 days) from major depression using 125-300 mg of magnesium (as glycinate and taurinate) with each meal and at bedtime. Magnesium was found usually effective for treatment of depression in general use. Related and accompanying mental illnesses in these case histories including traumatic brain injury, headache, suicidal ideation, anxiety, irritability, insomnia, postpartum depression, cocaine, alcohol and tobacco abuse, hypersensitivity to calcium, short-term memory loss and IQ loss were also benefited. Dietary deficiencies of magnesium, coupled with excess calcium and stress may cause many cases of other related symptoms including agitation, anxiety, irritability, confusion, asthenia, sleeplessness

  17. Influence of the consumption pattern of magnesium from magnesium-rich mineral water on magnesium bioavailability.

    PubMed

    Sabatier, Magalie; Grandvuillemin, Antoine; Kastenmayer, Peter; Aeschliman, Jean-Marc; Bouisset, Florilène; Arnaud, Maurice J; Dumoulin, Gilles; Berthelot, Alain

    2011-08-01

    It is generally considered that the absorption of Mg is inversely related to the ingested dose. The objective of the present study was to determine if the mode of administration (bolus v. consumption throughout the day) could influence Mg bioavailability from Mg-rich natural mineral water comparing the same nutritional Mg amount (126 mg). Using a 2 d cross-over design, twelve healthy men were asked to drink 1·5 litres Mg-rich mineral water either as 2 × 750 ml or 7 × 212 ml throughout the day. Two stable isotopes ((25)Mg and (26)Mg) were used to label the water in order to distinguish both regimens. Fractional apparent Mg absorption was determined by faecal monitoring and Mg retention was determined by measuring urinary excretion of Mg isotopes. Higher Mg absorption (50·7 (SD 12·7) v. 32·4 (SD 8·1) %; P = 0·0007) and retention (47·5 (SD 12·9) v. 29·0 (SD 7·5) %; P = 0·0008) from Mg-rich mineral water were observed when it was consumed in seven servings compared with larger servings. Thus, regular water consumption throughout the day is an effective way to increase Mg bioavailability from Mg-rich mineral water. PMID:21473800

  18. 40 CFR 461.60 - Applicability; description of the magnesium subcategory.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... magnesium subcategory. 461.60 Section 461.60 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) EFFLUENT GUIDELINES AND STANDARDS BATTERY MANUFACTURING POINT SOURCE CATEGORY Magnesium Subcategory § 461.60 Applicability; description of the magnesium subcategory. This subpart applies...

  19. 40 CFR 461.60 - Applicability; description of the magnesium subcategory.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... magnesium subcategory. 461.60 Section 461.60 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) EFFLUENT GUIDELINES AND STANDARDS BATTERY MANUFACTURING POINT SOURCE CATEGORY Magnesium Subcategory § 461.60 Applicability; description of the magnesium subcategory. This subpart applies...

  20. Additive effect of combined application of magnesium and MK-801 on analgesic action of morphine.

    PubMed

    Bujalska-Zadrożny, Magdalena; Duda, Kamila

    2014-01-01

    As previously reported, magnesium ions (Mg(2+)) administered in relatively low doses markedly potentiated opioid analgesia in neuropathic pain, in which the effectiveness of opioids is limited. Considering that Mg(2+) behaves like an N-methyl-D-aspartate receptor antagonist, the effect of this ion on the analgesic action of morphine was compared with that of MK-801. Acute pain was evoked by mechanical or thermal stimuli, whereas neuropathic hyperalgesia was induced by streptozotocin (STZ) administration. Magnesium sulphate (40 mg/kg i.p.) or MK-801 (0.05 mg/kg s.c.) administered alone did not modify the nociceptive threshold to acute stimuli or the streptozotocin hyperalgesia but significantly augmented the analgesic action of morphine (5 mg/kg i.p.). Furthermore, if these drugs (i.e. magnesium sulphate and MK-801) were applied concomitantly, a clear additive effect on the analgesic action of morphine occurred in both models of pain. Possible explanations of these observations are discussed. PMID:24577345

  1. Use of magnesium as a drug in chronic kidney disease

    PubMed Central

    Wilkie, Martin

    2012-01-01

    From chronic kidney disease (CKD) Stage 4 onwards, phosphate binders are needed in many patients to prevent the development of hyperphosphataemia, which can result in disturbed bone and mineral metabolism, cardiovascular disease and secondary hyperparathyroidism. In this review, we re-examine the use of magnesium-containing phosphate binders for patients with CKD, particularly as their use circumvents problems such as calcium loading, aluminum toxicity and the high costs associated with other agents of this class. The use of magnesium hydroxide in the 1980s has been superseded by magnesium carbonate, as the hydroxide salt was associated with poor gastrointestinal tolerability, whereas studies with magnesium carbonate show much better gastrointestinal profiles. The use of combined magnesium- and calcium-based phosphate binder regimens allows a reduction in the calcium load, and magnesium and calcium regimen comparisons show that magnesium may be as effective a phosphate binder as calcium. A large well-designed trial has recently shown that a drug combining calcium acetate and magnesium carbonate was non-inferior in terms of lowering serum phosphate to sevelamer-HCl and had an equally good tolerability profile. Because of the high cost of sevelamer and lanthanum carbonate, the use of magnesium carbonate could be advantageous and drug acquisition cost savings would compensate for the cost of introducing routine magnesium monitoring, if this is thought to be necessary and not performed anyway. Moreover, given the potential cost savings, it may be time to re-investigate magnesium-containing phosphate binders for CKD patients with further well-designed clinical research using vascular end points. PMID:26069822

  2. Magnesium and metabolic syndrome: The role of magnesium in health and disease

    Technology Transfer Automated Retrieval System (TEKTRAN)

    Metabolic syndrome is a constellation of conditions associated with elevated risk of diabetes and cardiovascular disease. Magnesium, the fourth most abundant cation in the human body and required in over 300 enzymatic reactions, has been shown in experimental, observational, and clinical studies to ...

  3. Magnesium Battery Electrolytes in Ionic Liquids

    NASA Astrophysics Data System (ADS)

    Watkins, Tylan Strike

    A lack of adequate energy storage technologies is arguably the greatest hindrance to a modern sustainable energy infrastructure. Chemical energy storage, in the form of batteries, is an obvious solution to the problem. Unfortunately, today's state of the art battery technologies fail to meet the desired metrics for full scale electric grid and/or electric vehicle role out. Considerable effort from scientists and engineers has gone into the pursuit of battery chemistries theoretically capable of far outperforming leading technologies like Li-ion cells. For instance, an anode of the relatively abundant and cheap metal, magnesium, would boost the specific energy by over 4.6 times that of the current Li-ion anode (LiC6). The work presented here explores the compatibility of magnesium electrolytes in TFSI---based ionic liquids with a Mg anode (TFSI = bis(trifluoromethylsulfonyl)imide). Correlations are made between the Mg2+ speciation conditions in bulk solutions (as determined via Raman spectroscopy) and the corresponding electrochemical behavior of the electrolytes. It was found that by creating specific chelating conditions, with an appropriate Mg salt, the desired electrochemical behavior could be obtained, i.e. reversible electrodeposition and dissolution. Removal of TFSI -- contact ion pairs from the Mg2+ solvation shell was found to be essential for reversible electrodeposition. Ionic liquids with polyethylene glycol chains pendent from a parent pyrrolidinium cation were synthesized and used to create the necessary complexes with Mg 2+, from Mg(BH4)2, so that reversible electrodeposition from a purely ionic liquid medium was achieved. The following document discusses findings from several electrochemical experiments on magnesium electrolytes in ionic liquids. Explanations for the failure of many of these systems to produce reversible Mg electrodeposition are provided. The key characteristics of ionic liquid systems that are capable of achieving reversible Mg

  4. Calcium magnesium acetate production and cost reduction

    SciTech Connect

    Leuschner, A.P.

    1988-02-01

    The New York State Energy Research and Development Authority (Energy Authority), Consolidated Edison Company of New York, Inc. (ConEd), the New York State Department of Transportation (NYSDOT), the New York State Thruway Authority (NYSTA), Chevron Chemical Company, the National Corn Growers Association (NCGA), and the Massachusetts Department of Public Works (MDPW) sponsored a research program to develop technology capable of producing Calcium Magnesium Acetate (CMA), an alternative road deicer, at a quality and cost which will allow its increased use. The objectives of this program were to determine the feasibility of: (1) producing CMA from regionally available waste and low grade organic feedstocks via biochemical engineering technologies; (2) operating the fermentation at concentrated product levels to reduce energy requirements and minimize drying process costs; (3) using this production approach to produce an environmentally acceptable CMA product; and (4) using and adapting an existing facility for a CMA commercial demonstration plant. The experimental program included:(1) selection of microorganisms for their ability to grow in the absence of sodium chloride and to tolerate high concentrations of calcium, magnesium, and acetate ions; (2) analysis of waste feedstocks for their potential conversion to acetate; (3) analysis of waste organic material for impurities in CMA that could carry over into the environment; (4) batch experiments to determine pH tolerance, growth in the absence of sodium chloride (NaCl), tolerance to magnesium, calcium and acetate ions, effect of substrate concentration, acid distribution, and acid production; and (5) semi-continuous laboratory scale anaerobic digestion experiments to determine loading rates, conversion efficiencies, and other design data. 67 refs., 33 figs., 66 tabs.

  5. Comparative angioprotective effects of magnesium compounds.

    PubMed

    Kharitonova, Maria; Iezhitsa, Igor; Zheltova, Anastasia; Ozerov, Alexander; Spasov, Alexander; Skalny, Anatoly

    2015-01-01

    Magnesium (Mg) deficiency is implicated in the development of numerous disorders of the cardiovascular system. Moreover, the data regarding the efficacy of different magnesium compounds in the correction of impaired functions due to low magnesium intake are often fragmentary and inconsistent. The aim of this study was to compare the effects of the most bioavailable Mg compounds (Mg l-aspartate, Mg N-acetyltaurate, Mg chloride, Mg sulphate and Mg oxybutyrate) on systemic inflammation and endothelial dysfunction in rats fed a low Mg diet for 74 days. A low Mg diet decreased the Mg concentration in the plasma and erythrocytes, which was accompanied by a reduced concentration of eNOs and increased levels of endothelin-1 level in the serum and impaired endothelium-dependent vasodilatation. These effects increased the concentration of proinflammatory molecules, such as VCAM-1, TNF-α, IL-6 and CRP, indicating the development of systemic inflammation and endothelial dysfunction. The increased total NO level, which estimated from the sum of the nitrate and nitrite concentrations in the serum, may also be considered to be a proinflammatory marker. Two weeks of Mg supplementation partially or fully normalised the ability of the vascular wall to effect adequate endothelium-dependent vasodilatation and reversed the levels of most endothelial dysfunction and inflammatory markers (except CRP) to the mean values of the control group. Mg sulphate had the smallest effect on the endothelin-1, TNF-α and VCAM-1 levels. Mg N-acetyltaurate was significantly more effective in restoring the level of eNOS compared to all other studied compounds, except for Mg oxybutyrate. Taken together, the present findings demonstrate that all Mg compounds equally alleviate endothelial dysfunction and inflammation caused by Mg deficiency. Mg sulphate tended to be the least effective compound.

  6. Fabrication of faceted nanopores in magnesium

    SciTech Connect

    Wu, Shujing; Cao, Fan; Zheng, He; Sheng, Huaping; Liu, Chun; Liu, Yu; Zhao, Dongshan; Wang, Jianbo

    2013-12-09

    In this paper, using high resolution transmission electron microscopy, we showed the fabrication of faceted nanopores with various shapes in magnesium by focused electron beam (e-beam). The characteristics of nanopore shapes and the crystallographic planes corresponding to the edges of the nanopores were discussed in detail. Interestingly, by manipulating the e-beam (e.g., irradiation direction and duration), the nanopore shape and size could be effectively controlled along different directions. Our results provide important insight into the nanopore patterning in metallic materials and are of fundamental importance concerning the relevant applications, such as nanopore-based sensor, etc.

  7. Administrative IT

    ERIC Educational Resources Information Center

    Grayson, Katherine, Ed.

    2006-01-01

    When it comes to Administrative IT solutions and processes, best practices range across the spectrum. Enterprise resource planning (ERP), student information systems (SIS), and tech support are prominent and continuing areas of focus. But widespread change can also be accomplished via the implementation of campuswide document imaging and sharing,…

  8. Database Administrator

    ERIC Educational Resources Information Center

    Moore, Pam

    2010-01-01

    The Internet and electronic commerce (e-commerce) generate lots of data. Data must be stored, organized, and managed. Database administrators, or DBAs, work with database software to find ways to do this. They identify user needs, set up computer databases, and test systems. They ensure that systems perform as they should and add people to the…

  9. ADMINISTRATIVE CLIMATE.

    ERIC Educational Resources Information Center

    BRUCE, ROBERT L.; CARTER, G.L., JR.

    IN THE COOPERATIVE EXTENSION SERVICE, STYLES OF LEADERSHIP PROFOUNDLY AFFECT THE QUALITY OF THE SERVICE RENDERED. ACCORDINGLY, MAJOR INFLUENCES ON ADMINISTRATIVE CLIMATE AND EMPLOYEE PRODUCTIVITY ARE EXAMINED IN ESSAYS ON (1) SOURCES OF JOB SATISFACTION AND DISSATISFACTION, (2) MOTIVATIONAL THEORIES BASED ON JOB-RELATED SATISFACTIONS AND NEEDS,…

  10. Engineering Administration.

    ERIC Educational Resources Information Center

    Naval Personnel Program Support Activity, Washington, DC.

    This book is intended to acquaint naval engineering officers with their duties in the engineering department. Standard shipboard organizations are analyzed in connection with personnel assignments, division operations, and watch systems. Detailed descriptions are included for the administration of directives, ship's bills, damage control, training…

  11. Magnesium sulfate protects fetal skin from intrauterine ischemia reperfusion injury.

    PubMed

    Kaptanoglu, Asli F; Arca, Turkan; Kilinc, Kamer

    2012-09-01

    Intrauterine ischemia-reperfusion (I/R) injury in fetus occurs with multifactorial pathogenesis and results with multiorgan injury including skin. Magnesium has widespread use in obstetric practice. Inn addition to magnesium's tocolytic and neuroprotective properties, it also has free radical reducing effects. The aim of the present study was to demonstrate whether magnesium sulfate could have protective effect on fetal rat skin in intrauterine ischemia-reperfusion (I/R) injury. Fetal skin ischemia was induced by clamping the utero-ovarian arteries bilaterally for 30 min, and reperfusion was achieved by removing the clamps for 60 min in 19-day pregnant rats. Magnesium Sulfate (MgSO(4)) was given to pregnant rats 20 min before I/R injury at the dose of 600 mg/kg in magnesium treatment group. No ischemia reperfusion was applied to control and sham-operated groups. Lipid peroxidation from the skin tissues was determined as thiobarbituric acid reactive substances (TBARS). Myeloperoxidase (MPO) activity was determined for neutrophil activation. The results showed that the levels of TBARS and MPO increased significantly in the fetal rat skin after I/R injury compared to control group. Levels of TBARS and MPO were significantly lower than those of I/R group in Magnesium-treated group. In conclusion, intrauterine ischemia-reperfusion may produce considerable fetal skin injury. Increased TBARS and MPO activity can be inhibited by magnesium treatment. This suggests that magnesium treatment may have protective effect on fetal rat skin in intrauterine I/R injury.

  12. Casting Porosity-Free Grain Refined Magnesium Alloys

    SciTech Connect

    Schwam, David

    2013-08-12

    The objective of this project was to identify the root causes for micro-porosity in magnesium alloy castings and recommend remedies that can be implemented in production. The findings confirm the key role played by utilizing optimal gating and risering practices in minimizing porosity in magnesium castings. 

  13. Magnesium and diltiazem relaxes phenylephrine-precontracted rat aortic rings

    PubMed Central

    Dogan, Mustafa; Peker, Recep O.; Donmez, Soner; Gokalp, Osman

    2012-01-01

    Perioperative vasospasm during cardiovascular surgery is a challenging problem. Several vasodilator agents are frequently utilized for its prevention in surgical practice. Magnesium and diltiazem both have known potential vasorelaxant effects. We planned to compare the efficacy of diltiazem and magnesium in relieving phenylephrine-precontracted rat aortic rings. Ten young adult female Wistar albino rats weighing 230–260 g were used in this study. The aortic rings in the organ bath equilibrated and reached their baseline tension. Precontraction was induced by 0.001 mmol/l phenylephrine and cumulative concentration–relaxation curves were obtained by consecutively increasing the addition of either diltiazem (10−6-0.1 mmol/l) or magnesium (0.1–10 mmol/l). The mean maximal relaxation responses observed by diltiazem and magnesium on separate aortic rings were 90 ± 3 and 53 ± 2%, respectively. The calculated EC50 of diltiazem was 0.01035 mmol/l, whereas the EC50 of magnesium was 4.064 mmol/l (P < 0.05). Both magnesium and diltiazem produced vasorelaxation on phenylephrine-precontracted rat aortic rings in this study, but the potency of diltiazem regarding the EC50 value was significantly higher than that of magnesium. Magnesium could be a candidate together with diltiazem to inhibit vasospasm on arterial grafts during coronary bypass surgery. PMID:22523136

  14. 75 FR 9252 - Magnesium From China and Russia

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-03-01

    ... magnesium (also known as magnesium metal) from China and Russia (70 FR 19928-19931). The Commission is... 207), as most recently amended at 74 FR 2847 (January 16, 2009). \\1\\ No response to this request for... employment statute for Federal employees, and Commission rule 201.15(b) (19 CFR 201.15(b)), 73 FR 24609...

  15. 75 FR 35086 - Magnesium From China and Russia

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-06-21

    ... group responses to its notice of institution (75 FR 9252, March 1, 2010) were adequate.\\1\\ A record of... COMMISSION Magnesium From China and Russia AGENCY: United States International Trade Commission. ACTION... orders on magnesium from China and Russia. SUMMARY: The Commission hereby gives notice that it...

  16. 40 CFR 721.10021 - Magnesium potassium titanium oxide.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... § 721.63 respirator requirements may request to do so under 40 CFR 721.30. Persons whose § 721.30... 40 Protection of Environment 31 2011-07-01 2011-07-01 false Magnesium potassium titanium oxide... Specific Chemical Substances § 721.10021 Magnesium potassium titanium oxide. (a) Chemical substance...

  17. 40 CFR 721.10021 - Magnesium potassium titanium oxide.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... § 721.63 respirator requirements may request to do so under 40 CFR 721.30. Persons whose § 721.30... 40 Protection of Environment 31 2014-07-01 2014-07-01 false Magnesium potassium titanium oxide... Specific Chemical Substances § 721.10021 Magnesium potassium titanium oxide. (a) Chemical substance...

  18. 40 CFR 721.10021 - Magnesium potassium titanium oxide.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... § 721.63 respirator requirements may request to do so under 40 CFR 721.30. Persons whose § 721.30... 40 Protection of Environment 32 2013-07-01 2013-07-01 false Magnesium potassium titanium oxide... Specific Chemical Substances § 721.10021 Magnesium potassium titanium oxide. (a) Chemical substance...

  19. 40 CFR 721.10021 - Magnesium potassium titanium oxide.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... § 721.63 respirator requirements may request to do so under 40 CFR 721.30. Persons whose § 721.30... 40 Protection of Environment 32 2012-07-01 2012-07-01 false Magnesium potassium titanium oxide... Specific Chemical Substances § 721.10021 Magnesium potassium titanium oxide. (a) Chemical substance...

  20. 40 CFR 721.10021 - Magnesium potassium titanium oxide.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... § 721.63 respirator requirements may request to do so under 40 CFR 721.30. Persons whose § 721.30... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Magnesium potassium titanium oxide... Specific Chemical Substances § 721.10021 Magnesium potassium titanium oxide. (a) Chemical substance...

  1. Fogging technique used to coat magnesium with plastic

    NASA Technical Reports Server (NTRS)

    Mroz, T. S.

    1967-01-01

    Cleaning process and a fogging technique facilitate the application of a plastic coating to magnesium plates. The cleaning process removes general organic and inorganic surface impurities, oils and greases, and oxides and carbonates from the magnesium surfaces. The fogging technique produces a thin-filmlike coating in a clean room atmosphere.

  2. Precipitation of plutonium from acidic solutions using magnesium oxide

    SciTech Connect

    Jones, S.A.

    1994-12-05

    Magnesium oxide will be used as a neutralizing agent for acidic plutonium-containing solutions. It is expected that as the magnesium oxide dissolves, the pH of the solution will rise, and plutonium will precipitate. The resulting solid will be tested for suitability to storage. The liquid is expected to contain plutonium levels that meet disposal limit requirements.

  3. Adsorption of oxygen and 1-butene on magnesium ferrite

    SciTech Connect

    Samuilova, O.K.; Kozlova, M.M.; Yagodovskii, V.D.

    1986-08-01

    The kinetics of the adsorption of oxygen and 1-butene on magnesium ferrite was studied. Conductometry and thermal desorption methods were used to investigate the adsorption of oxygen on magnesium ferrite. Two forms of adsorbed oxygen were found. The formation of these forms affects the kinetics of the adsorption of 1-butene.

  4. Biodegradable resistive switching memory based on magnesium difluoride.

    PubMed

    Zhang, Zhiping; Tsang, Melissa; Chen, I-Wei

    2016-08-11

    This study presents a new type of resistive switching memory device that can be used in biodegradable electronic applications. The biodegradable device features magnesium difluoride as the active layer and iron and magnesium as the corresponding electrodes. This is the first report on magnesium difluoride as a resistive switching layer. With on-off ratios larger than one hundred, the device on silicon switches at voltages less than one volt and requires only sub-mA programming current. AC endurance of 10(3) cycles is demonstrated with ±1 V voltage pulses. The switching mechanism is attributed to the formation and rupture of conductive filaments comprising fluoride vacancies in magnesium difluoride. Devices fabricated on a flexible polyethylene terephthalate substrate are tested for functionality, and degradation is subsequently demonstrated in de-ionized water. An additional layer of magnesium difluoride is used to hinder the degradation and extend the lifetime of the device. PMID:27476796

  5. Thermal Stability of Magnesium Silicide/Nickel Contacts

    NASA Astrophysics Data System (ADS)

    de Boor, J.; Droste, D.; Schneider, C.; Janek, J.; Mueller, E.

    2016-06-01

    Magnesium silicide-based materials are a very promising class of thermoelectric materials with excellent potential for thermoelectric waste heat recovery. For the successful application of magnesium silicide-based thermoelectric generators, the development of long-term stable contacts with low contact resistance is as important as material optimization. We have therefore studied the suitability of Ni as a contact material for magnesium silicide. Co-sintering of magnesium silicide and Ni leads to the formation of a stable reaction layer with low electrical resistance. In this paper we show that the contacts retain their low electrical contact resistance after annealing at temperatures up to 823 K for up to 168 h. By employing scanning electron microscope analysis and time-of-flight (ToF)-secondary ion mass spectrometry, we can further show that elemental diffusion is occurring to a very limited extent. This indicates long-term stability under practical operation conditions for magnesium silicide/nickel contacts.

  6. Security assessment of magnesium alloys used as biodegradable implant material.

    PubMed

    Sun, X; Cao, Z Y; Liu, J G; Feng, C

    2015-01-01

    The security risk of magnesium alloys used as biodegradable implant material was evaluated in this study. Dose-response assessment was conducted by using toxicological data from authoritative public health agencies (World Health Organization) and assuming 1~3 years of uniform corrosion. Through modification calculation, the tolerable corrosion rate of biodegradable magnesium alloys in vivo was proposed, which theoretically ensured the bio-safety of the degradation products. The tolerable limits corresponding to various component elements in magnesium alloys were considered separately, although there are deficits in the toxicological data of some component elements. The influence of corrosion on the strength of magnesium alloys was evaluated, which would contribute to the rationally utilization of magnesium alloys as degradable implant materials. This study illustrates that not only toxicological calculations but also mechanical performance should be taken into consideration when developing novel degradable metallic implant.

  7. Thermal Stability of Magnesium Silicide/Nickel Contacts

    NASA Astrophysics Data System (ADS)

    de Boor, J.; Droste, D.; Schneider, C.; Janek, J.; Mueller, E.

    2016-10-01

    Magnesium silicide-based materials are a very promising class of thermoelectric materials with excellent potential for thermoelectric waste heat recovery. For the successful application of magnesium silicide-based thermoelectric generators, the development of long-term stable contacts with low contact resistance is as important as material optimization. We have therefore studied the suitability of Ni as a contact material for magnesium silicide. Co-sintering of magnesium silicide and Ni leads to the formation of a stable reaction layer with low electrical resistance. In this paper we show that the contacts retain their low electrical contact resistance after annealing at temperatures up to 823 K for up to 168 h. By employing scanning electron microscope analysis and time-of-flight (ToF)-secondary ion mass spectrometry, we can further show that elemental diffusion is occurring to a very limited extent. This indicates long-term stability under practical operation conditions for magnesium silicide/nickel contacts.

  8. Antinociceptive potency of aminoglycoside antibiotics and magnesium chloride: a comparative study on models of phasic and incisional pain in rats.

    PubMed

    Prado, W A; Machado Filho, E B

    2002-03-01

    A close relationship exists between calcium concentration in the central nervous system and nociceptive processing. Aminoglycoside antibiotics and magnesium interact with N- and P/Q-type voltage-operated calcium channels. In the present study we compare the antinociceptive potency of intrathecal administration of aminoglycoside antibiotics and magnesium chloride in the tail-flick test and on incisional pain in rats, taken as models of phasic and persistent post-surgical pain, respectively. The order of potency in the tail-flick test was gentamicin (ED50 = 3.34 microg; confidence limits 2.65 and 4.2) > streptomycin (5.68 microg; 3.76 and 8.57) = neomycin (9.22 microg; 6.98 and 12.17) > magnesium (19.49 microg; 11.46 and 33.13). The order of potency to reduce incisional pain was gentamicin (ED50 = 2.06 microg; confidence limits 1.46 and 2.9) > streptomycin (47.86 microg; 26.3 and 87.1) = neomycin (83.17 microg; 51.6 and 133.9). The dose-response curves for each test did not deviate significantly from parallelism. We conclude that neomycin and streptomycin are more potent against phasic pain than against persistent pain, whereas gentamicin is equipotent against both types of pain. Magnesium was less potent than the antibiotics and effective in the tail-flick test only.

  9. Formation of Magnesium Silicates is Limited around Evolved Stars

    NASA Astrophysics Data System (ADS)

    Kimura, Yuki; Nuth, J. A., III

    2009-05-01

    Laboratory experiments suggest that magnesium silicide (Mg2Si) grains could be produced in the hydrogen dominant gas outflow from evolved stars in addition to amorphous oxide minerals. Astronomical observations have shown the existence of abundant silicate grains around evolved stars and we have long realized that most of the silicate grains are amorphous, based on the observed infrared features. Only high mass loss stars show the feature attributed to magnesium-rich crystalline silicate about 10-20 % respect to total silicates, so far. The lower degree of crystallinity observed in silicates formed in outflows of lower mass-loss-rate stars might be caused by the formation of magnesium silicide in this relatively hydrogen-rich environment. As a result of predominant distribution of magnesium into the silicide, the composition of interstellar amorphous silicates could be magnesium poor compared with silicon. Indeed, the chemical composition of isotopically anomalous GEMS (glass with embedded metal and sulfides) is magnesium poor with respect to a forsteritic composition (Floss et al. 2006; Keller & Messenger 2007). Infrared observations suggest that there is little or no crystalline forsterite in interstellar environments while there is an abundance of crystalline forsterite in our Solar System. If the forsterite is a result of the oxidation of interstellar magnesium silicide, then it is clear both why crystalline forsterite is stoichiometric olivine and why the chemical composition of isotopically anomalous GEMS is magnesium poor with respect to a forsteritic composition. In addition, it may also explain why the chemical composition of olivine is iron poor. Unfortunately, magnesium silicide has never been detected via astronomical observation or in the analysis of primitive meteorites. I would suggest that future analysis of meteorites and theoretical calculations could confirm the possibility of the formation of magnesium silicide grains around evolved stars.

  10. Thermochemistry of dense hydrous magnesium silicates

    NASA Technical Reports Server (NTRS)

    Bose, Kunal; Burnley, Pamela; Navrotsky, Alexandra

    1994-01-01

    Recent experimental investigations under mantle conditions have identified a suite of dense hydrous magnesium silicate (DHMS) phases that could be conduits to transport water to at least the 660 km discontinuity via mature, relatively cold, subducting slabs. Water released from successive dehydration of these phases during subduction could be responsible for deep focus earthquakes, mantle metasomatism and a host of other physico-chemical processes central to our understanding of the earth's deep interior. In order to construct a thermodynamic data base that can delineate and predict the stability ranges for DHMS phases, reliable thermochemical and thermophysical data are required. One of the major obstacles in calorimetric studies of phases synthesized under high pressure conditions has been limitation due to the small (less than 5 mg) sample mass. Our refinement of calorimeter techniques now allow precise determination of enthalpies of solution of less than 5 mg samples of hydrous magnesium silicates. For example, high temperature solution calorimetry of natural talc (Mg(0.99) Fe(0.01)Si4O10(OH)2), periclase (MgO) and quartz (SiO2) yield enthalpies of drop solution at 1044 K to be 592.2 (2.2), 52.01 (0.12) and 45.76 (0.4) kJ/mol respectively. The corresponding enthalpy of formation from oxides at 298 K for talc is minus 5908.2 kJ/mol agreeing within 0.1 percent to literature values.

  11. Thermochemistry of dense hydrous magnesium silicates

    NASA Astrophysics Data System (ADS)

    Bose, Kunal; Burnley, Pamela; Navrotsky, Alexandra

    Recent experimental investigations under mantle conditions have identified a suite of dense hydrous magnesium silicate (DHMS) phases that could be conduits to transport water to at least the 660 km discontinuity via mature, relatively cold, subducting slabs. Water released from successive dehydration of these phases during subduction could be responsible for deep focus earthquakes, mantle metasomatism and a host of other physico-chemical processes central to our understanding of the earth's deep interior. In order to construct a thermodynamic data base that can delineate and predict the stability ranges for DHMS phases, reliable thermochemical and thermophysical data are required. One of the major obstacles in calorimetric studies of phases synthesized under high pressure conditions has been limitation due to the small (less than 5 mg) sample mass. Our refinement of calorimeter techniques now allow precise determination of enthalpies of solution of less than 5 mg samples of hydrous magnesium silicates. For example, high temperature solution calorimetry of natural talc (Mg(0.99) Fe(0.01)Si4O10(OH)2), periclase (MgO) and quartz (SiO2) yield enthalpies of drop solution at 1044 K to be 592.2 (2.2), 52.01 (0.12) and 45.76 (0.4) kJ/mol respectively. The corresponding enthalpy of formation from oxides at 298 K for talc is minus 5908.2 kJ/mol agreeing within 0.1 percent to literature values.

  12. A Magnesium-Activated Carbon Hybrid Capacitor

    SciTech Connect

    Yoo, HD; Shterenberg, I; Gofer, Y; Doe, RE; Fischer, CC; Ceder, G; Aurbach, D

    2013-12-11

    Prototype cells of hybrid capacitor were developed, comprising activated carbon (AC) cloth and magnesium (Mg) foil as the positive and negative electrodes, respectively. The electrolyte solution included ether solvent (TBF) and a magnesium organo-halo-aluminate complex 0.25 M Mg2Cl3+-Ph2AlCl2-. In this solution Mg can be deposited/dissolved reversibly for thousands of cycles with high reversibility (100% cycling efficiency). The main barrier for integrating porous AC electrodes with this electrolyte solution was the saturation of the pores with the large ions in the AC prior to reaching the potential limit. This is due to the existence of bulky Mg and Al based ionic complexes consisting Cl, alkyl or aryl (R), and THF ligands. This problem was resolved by adding 0.5 M of lithium chloride (LiCl), thus introducing smaller ionic species to the solution. This Mg hybrid capacitor system demonstrated a stable cycle performance for many thousands of cycles with a specific capacitance of 90 Fg(-1) for the AC positive electrodes along a potential range of 2.4 V. (C) 2014 The Electrochemical Society. All rights reserved.

  13. Blackening of magnesium alloy using femtosecond laser.

    PubMed

    Shi, Haixia; Cui, Zeqin; Wang, Wenxian; Xu, Bingshe; Gong, Dianqing; Zhang, Wei

    2015-09-01

    Magnesium alloy, a potential structural and biodegradable material, has been increasingly attracting attention. In this paper, two structures with enhanced light absorption on an AZ31B magnesium surface are fabricated by femtosecond laser texturing. Laser power and the number of laser pulses are mainly investigated for darkening effect. After irradiation, surface characteristics are analyzed by a scanning electron microscope equipped with an energy dispersive spectrometer and laser scanning confocal microscope. The darkening effect is investigated by a spectrophotometer with an integrating sphere. Microgroove and stripe structures are obtained, which are covered with homogeneous nanoprotrusions and nanoparticles. The main surface chemical composition after laser ablation is MgO. The optimal light absorption in the visible range (wavelength of 400-800 nm) reaches about 98%, which is significantly improved compared with the untreated surface. The enhanced light absorption is mainly attributed to surface structure. Femtosecond laser surface texturing technology offers potential in the application of stealth technology, airborne devices, and biomedicine.

  14. Synthesis of nanoscale magnesium diboride powder

    DOE PAGES

    Finnemore, D. K.; Marzik, J. V.

    2015-12-18

    A procedure has been developed for the preparation of small grained magnesium diboride (MgB2) powder by reacting nanometer size boron powder in a magnesium vapor. Plasma synthesized boron powder that had particle sizes ranging from 20 to 300nm was mixed with millimeter size chunks of Mg by rolling stoichiometric amounts of the powders in a sealed cylindrical container under nitrogen gas. This mixture then was placed in a niobium reaction vessel, evacuated, and sealed by e-beam welding. The vessel was typically heated to approximately 830°C for several hours. The resulting MgB2 particles have a grain size in the 200 nmmore » to 800 nm range. Agglomerates of loosely bound particles could be broken up by light grinding in a mortar and pestle. At 830°C, many particles are composed of several grains grown together so that the average particle size is about twice the average grain size. Furthermore, experiments were conducted primarily with undoped boron powder, but carbon-doped boron powder showed very similar results.« less

  15. Synthesis of nanoscale magnesium diboride powder

    SciTech Connect

    Finnemore, D. K.; Marzik, J. V.

    2015-12-18

    A procedure has been developed for the preparation of small grained magnesium diboride (MgB2) powder by reacting nanometer size boron powder in a magnesium vapor. Plasma synthesized boron powder that had particle sizes ranging from 20 to 300nm was mixed with millimeter size chunks of Mg by rolling stoichiometric amounts of the powders in a sealed cylindrical container under nitrogen gas. This mixture then was placed in a niobium reaction vessel, evacuated, and sealed by e-beam welding. The vessel was typically heated to approximately 830°C for several hours. The resulting MgB2 particles have a grain size in the 200 nm to 800 nm range. Agglomerates of loosely bound particles could be broken up by light grinding in a mortar and pestle. At 830°C, many particles are composed of several grains grown together so that the average particle size is about twice the average grain size. Furthermore, experiments were conducted primarily with undoped boron powder, but carbon-doped boron powder showed very similar results.

  16. Deuterium storage in nanocrystalline magnesium thin films

    NASA Astrophysics Data System (ADS)

    Checchetto, R.; Bazzanella, N.; Miotello, A.; Brusa, R. S.; Zecca, A.; Mengucci, A.

    2004-02-01

    Nanocrystalline magnesium deuteride thin films with the β-MgD2 structure were prepared by vacuum evaporation of hexagonal magnesium (h-Mg) samples and thermal annealing in 0.15 MPa D2 atmosphere at 373 K. Thermal desorption spectroscopy analysis indicated that the rate-limiting step in the deuterium desorption was given by the thermal decomposition of the deuteride phase. The activation energy Δg of the β-MgD2→h-Mg+D2 reaction scaled from 1.13±0.03 eV in 650-nm-thick films to 1.01±0.02 eV in 75-nm-thick films most likely as consequence of different stress and defect level. Positron annihilation spectroscopy analysis of the thin-film samples submitted to deuterium absorption and desorption cycles reveal the presence of a high concentration of void-like defects in the h-Mg layers after the very first decomposition of the β-MgD2 phase, the presence of these open volume defects reduces the D2 absorption capacity of the h-Mg thin film.

  17. Fabrication of multilayer pancakelike basic magnesium carbonate.

    PubMed

    Sun, Jinhe; Jia, Yongzhong; Yan Jing; Yao, Ying; Ma, Jun

    2014-10-01

    The properties of nanomaterials was strongly affected by their microstructures. Here Mg5(CO3)4(OH)2 x 4H2O multilayer pancakelike structures were fabricated successfully by reaction of MgCl2 and Na2CO3 in aqueous solution at 363 K. The growth process of nanostructures was observed by XRD and SEM. Several transition states of multilayer pancakelike basic magnesium carbonates were observed, which help to understand better the formation process of this hierarchical nanostructures. The formation mechanism of Mg5(CO3)4(OH)2 x 4H2O multilayer pancakelike structures was discussed and helical growth was proposed. The amorphous nanoparticles were formed firstly. Then nanopartilces aggregated and oriented assembly under the direction of chemical bonds with the help of water molecules. The multilayer pancakelike basic magnesium carbonates was formed by helical growth of wafers along (100) and (001) direction. The diameter and volume decreased with the increasing concentration of reactants. PMID:25942931

  18. Blackening of magnesium alloy using femtosecond laser.

    PubMed

    Shi, Haixia; Cui, Zeqin; Wang, Wenxian; Xu, Bingshe; Gong, Dianqing; Zhang, Wei

    2015-09-01

    Magnesium alloy, a potential structural and biodegradable material, has been increasingly attracting attention. In this paper, two structures with enhanced light absorption on an AZ31B magnesium surface are fabricated by femtosecond laser texturing. Laser power and the number of laser pulses are mainly investigated for darkening effect. After irradiation, surface characteristics are analyzed by a scanning electron microscope equipped with an energy dispersive spectrometer and laser scanning confocal microscope. The darkening effect is investigated by a spectrophotometer with an integrating sphere. Microgroove and stripe structures are obtained, which are covered with homogeneous nanoprotrusions and nanoparticles. The main surface chemical composition after laser ablation is MgO. The optimal light absorption in the visible range (wavelength of 400-800 nm) reaches about 98%, which is significantly improved compared with the untreated surface. The enhanced light absorption is mainly attributed to surface structure. Femtosecond laser surface texturing technology offers potential in the application of stealth technology, airborne devices, and biomedicine. PMID:26368903

  19. [SIGNIFICANCE OF MAGNESIUM IN PHISIOLOGY AND PATHOLOGY OF THE DIGESTIVE SYSTEM].

    PubMed

    Grigus, Ya I; Mikhaylova, O D; Gorbunov A Yu; Vakhrushev, Ya M

    2015-01-01

    The article describes the physiological role of magnesium in the human body and its importance for metabolic processes. The reasons for the development of magnesium deficiency and hypermagnesaemia and its clinical symptoms are shown. The specialties of magnesium metabolism disturbances in gastroenterological pathology are described. Particular attention paid to the correction of magnesium levels with deviations of its content in the organism.

  20. Synthesis, Crystal Structure, and Electrochemical Properties of a Simple Magnesium Electrolyte for Magnesium/Sulfur Batteries.

    PubMed

    Li, Wanfei; Cheng, Shuang; Wang, Jian; Qiu, Yongcai; Zheng, Zhaozhao; Lin, Hongzhen; Nanda, Sanjay; Ma, Qian; Xu, Yan; Ye, Fangmin; Liu, Meinan; Zhou, Lisha; Zhang, Yuegang

    2016-05-23

    Most simple magnesium salts tend to passivate the Mg metal surface too quickly to function as electrolytes for Mg batteries. In the present work, an electroactive salt [Mg(THF)6 ][AlCl4 ]2 was synthesized and structurally characterized. The Mg electrolyte based on this simple mononuclear salt showed a high Mg cycling efficiency, good anodic stability (2.5 V vs. Mg), and high ionic conductivity (8.5 mS cm(-1) ). Magnesium/sulfur cells employing the as-prepared electrolyte exhibited good cycling performance over 20 cycles in the range of 0.3-2.6 V, thus indicating an electrochemically reversible conversion of S to MgS without severe passivation of the Mg metal electrode surface. PMID:27094220

  1. Reprint of: The history of biodegradable magnesium implants: A review.

    PubMed

    Witte, Frank

    2015-09-01

    Today, more than 200 years after the first production of metallic magnesium by Sir Humphry Davy in 1808, biodegradable magnesium-based metal implants are currently breaking the paradigm in biomaterial science to develop only highly corrosion resistant metals. This groundbreaking approach to temporary metallic implants is one of the latest developments in biomaterials science that is being rediscovered. It is a challenging topic, and several secrets still remain that might revolutionize various biomedical implants currently in clinical use. Magnesium alloys were investigated as implant materials long ago. A very early clinical report was given in 1878 by the physician Edward C. Huse. He used magnesium wires as ligature for bleeding vessels. Magnesium alloys for clinical use were explored during the last two centuries mainly by surgeons with various clinical backgrounds, such as cardiovascular, musculoskeletal and general surgery. Nearly all patients benefited from the treatment with magnesium implants. Although most patients experienced subcutaneous gas cavities caused by rapid implant corrosion, most patients had no pain and almost no infections were observed during the postoperative follow-up. This review critically summarizes the in vitro and in vivo knowledge and experience that has been reported on the use of magnesium and its alloys to advance the field of biodegradable metals.

  2. The history of biodegradable magnesium implants: a review.

    PubMed

    Witte, Frank

    2010-05-01

    Today, more than 200years after the first production of metallic magnesium by Sir Humphry Davy in 1808, biodegradable magnesium-based metal implants are currently breaking the paradigm in biomaterial science to develop only highly corrosion resistant metals. This groundbreaking approach to temporary metallic implants is one of the latest developments in biomaterials science that is being rediscovered. It is a challenging topic, and several secrets still remain that might revolutionize various biomedical implants currently in clinical use. Magnesium alloys were investigated as implant materials long ago. A very early clinical report was given in 1878 by the physician Edward C. Huse. He used magnesium wires as ligature for bleeding vessels. Magnesium alloys for clinical use were explored during the last two centuries mainly by surgeons with various clinical backgrounds, such as cardiovascular, musculoskeletal and general surgery. Nearly all patients benefited from the treatment with magnesium implants. Although most patients experienced subcutaneous gas cavities caused by rapid implant corrosion, most patients had no pain and almost no infections were observed during the postoperative follow-up. This review critically summarizes the in vitro and in vivo knowledge and experience that has been reported on the use of magnesium and its alloys to advance the field of biodegradable metals.

  3. The history of biodegradable magnesium implants: a review.

    PubMed

    Witte, Frank

    2010-05-01

    Today, more than 200years after the first production of metallic magnesium by Sir Humphry Davy in 1808, biodegradable magnesium-based metal implants are currently breaking the paradigm in biomaterial science to develop only highly corrosion resistant metals. This groundbreaking approach to temporary metallic implants is one of the latest developments in biomaterials science that is being rediscovered. It is a challenging topic, and several secrets still remain that might revolutionize various biomedical implants currently in clinical use. Magnesium alloys were investigated as implant materials long ago. A very early clinical report was given in 1878 by the physician Edward C. Huse. He used magnesium wires as ligature for bleeding vessels. Magnesium alloys for clinical use were explored during the last two centuries mainly by surgeons with various clinical backgrounds, such as cardiovascular, musculoskeletal and general surgery. Nearly all patients benefited from the treatment with magnesium implants. Although most patients experienced subcutaneous gas cavities caused by rapid implant corrosion, most patients had no pain and almost no infections were observed during the postoperative follow-up. This review critically summarizes the in vitro and in vivo knowledge and experience that has been reported on the use of magnesium and its alloys to advance the field of biodegradable metals. PMID:20172057

  4. Reprint of: The history of biodegradable magnesium implants: A review.

    PubMed

    Witte, Frank

    2015-09-01

    Today, more than 200 years after the first production of metallic magnesium by Sir Humphry Davy in 1808, biodegradable magnesium-based metal implants are currently breaking the paradigm in biomaterial science to develop only highly corrosion resistant metals. This groundbreaking approach to temporary metallic implants is one of the latest developments in biomaterials science that is being rediscovered. It is a challenging topic, and several secrets still remain that might revolutionize various biomedical implants currently in clinical use. Magnesium alloys were investigated as implant materials long ago. A very early clinical report was given in 1878 by the physician Edward C. Huse. He used magnesium wires as ligature for bleeding vessels. Magnesium alloys for clinical use were explored during the last two centuries mainly by surgeons with various clinical backgrounds, such as cardiovascular, musculoskeletal and general surgery. Nearly all patients benefited from the treatment with magnesium implants. Although most patients experienced subcutaneous gas cavities caused by rapid implant corrosion, most patients had no pain and almost no infections were observed during the postoperative follow-up. This review critically summarizes the in vitro and in vivo knowledge and experience that has been reported on the use of magnesium and its alloys to advance the field of biodegradable metals. PMID:26235343

  5. Prevalence of Thrombocytopenia and Its Association with Serum Magnesium.

    PubMed

    Lu, Leihong; Zhan, Yiqiang; Yu, Jinming; Sui, Lihong

    2016-01-01

    The present study aimed to investigate the prevalence of thrombocytopenia and its association with serum magnesium in a nationally representative cohort. A total of 8478 participants aged 18 years and over were recruited in a cross-sectional survey. Thrombocytopenia was defined as platelet count less than 150 × 10(9)/L. Multivariable logistic regression models were applied to examine the association between serum magnesium and thrombocytopenia. The prevalence of thrombocytopenia in total was 16.5% with 18.8% for men and 14.4% for women (P < 0.0001), respectively. Compared with men in the first quartile of serum magnesium, the odds ratios (ORs) and 95% confidence intervals (CIs) for those in the second, third, and fourth quartiles of serum magnesium were 0.96 (0.75, 1.21), 0.78 (0.62, 0.98), and 0.82 (0.65, 1.04), respectively, after adjusting for multiple confounders. Likewise, the corresponding ORs (95% CIs) were 0.80 (0.63, 1.01), 0.79 (0.62, 0.99), and 0.65 (0.51, 0.84) in women. When serum magnesium was treated as a continuous variable, each one standard deviation increase of magnesium was associated with 12 and 8% lower risk of thrombocytopenia in men and women, respectively. Serum magnesium was inversely associated with thrombocytopenia, and the association was slightly different in men compared with that in women.

  6. Effect of magnesium on the burning characteristics of boron particles

    NASA Astrophysics Data System (ADS)

    Liu, Jian-zhong; Xi, Jian-fei; Yang, Wei-juan; Hu, You-rui; Zhang, Yan-wei; Wang, Yang; Zhou, Jun-hu

    2014-03-01

    Boron is an attractive fuel for propellants and explosives because of its high energy density. However, boron particles are difficult to combust because of inhibiting oxide layers that cover the particles. The use of magnesium as additives has been shown to promote boron oxidation. In this study, laser ignition facility and thermobalance were used to investigate the effect of magnesium on the burning characteristics of boron particles. The influences of magnesium addition on sample combustion flame, boron ignition delay time, boron combustion efficiency and initial temperature of boron oxidation. Results show that all Mg/B samples exhibit the same type of flame structure, i.e., a bright plume surrounded by green radiation which is interpreted as BO2 emission. The combustion flame intensity of a sample increases with the increasing magnesium content of boron particles. An increase in magnesium content results in a decrease and a subsequent increase in boron ignition delay time. (Mg/B)0.2 has a minimum ignition delay time of ~48 ms. Boron combustion efficiency increases with increasing magnesium addition. (Mg/B)0.5 shows a maximum boron combustion efficiency of ~64.2%. Magnesium addition decreases the initial temperature of boron oxidation.

  7. Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus.

    PubMed

    Patel, Bhoomika M; Raghunathan, Suchi; Porwal, Urvashi

    2014-04-01

    We have evaluated the effect of magnesium valproate (210 mg/kg/day, p.o.) in type 2 diabetes induced cardiovascular complications induced by streptozotocin (STZ, 90 mg/kg, i.p.) in neonatal wistar rats. Various biochemical, cardiovascular and hemodynamic parameters were measured at the end of 8 weeks of treatment. STZ produced significant hyperglycaemia, hypoinsulinemia and dyslipidemia, which was prevented by magnesium valproate treatment. STZ produced increase in Creatinine Kinase, C-reactive protein and lactate dehydrogenase levels and treatment with magnesium valproate produced reduction in these levels. STZ produced increase in cardiac and LV hypertrophy index, LV/RV ratio, LV collagen deposition and LV cardiomyocyte diameter which were decreased by magnesium valproate treatment. Magnesium valproate also prevented STZ induced hemodynamic alterations and oxidative stress. These results were further supported by histopathological studies in which magnesium valproate showed marked reduction in fibrosis and cardiac fiber disarray. In conclusion, our data suggests that magnesium valproate is beneficial as an anti-diabetic agent in type-2 diabetes mellitus and also prevents its cardiac complications.

  8. Magnesium Based Materials and their Antimicrobial Activity

    NASA Astrophysics Data System (ADS)

    Robinson, Duane Allan

    The overall goals of this body of work were to characterize the antimicrobial properties of magnesium (Mg) metal and nano-magnesium oxide (nMgO) in vitro, to evaluate the in vitro cytotoxicity of Mg metal, and to incorporate MgO nanoparticles into a polymeric implant coating and evaluate its in vitro antimicrobial properties. In the course of this work it was found that Mg metal, Mg-mesh, and nMgO have in vitro antimicrobial properties that are similar to a bactericidal antibiotic. For Mg metal, the mechanism of this activity appears to be related to an increase in pH (i.e. a more alkaline environment) and not an increase in Mg2+. Given that Mg-mesh is a Mg metal powder, the assumption is that it has the same mechanism of activity as Mg metal. The mechanism of activity for nMgO remains to be elucidated and may be related to a combination of interaction of the nanoparticles with the bacteria and the alkaline pH. It was further demonstrated that supernatants from suspensions of Mg-mesh and nMgO had the same antimicrobial effect as was noted when the particles were used. The supernatant from Mg-mesh and nMgO was also noted to prevent biofilm formation for two Staphylococcus strains. Finally, poly-epsilon-caprolactone (PCL) composites of Mg-mesh (PCL+Mg-mesh) and nMgO (PCL+nMgO) were produced. Coatings applied to screws inhibited growth of Escherichia coli and Pseudomonas aeruginosa and in thin disc format inhibited the growth of Staphylococcus aureus in addition to the E. coli and P. aeruginosa. Pure Mg metal was noted to have some cytotoxic effect on murine fibroblast and osteoblast cell lines, although this effect needs to be characterized further. To address the need for an in vivo model for evaluating implant associated infections, a new closed fracture osteomyelitis model in the femur of the rat was developed. Magnesium, a readily available and inexpensive metal was shown to have antimicrobial properties that appear to be related to its corrosion products and

  9. Meta-analysis of randomized controlled trials on magnesium in addition to beta-blocker for prevention of postoperative atrial arrhythmias after coronary artery bypass grafting

    PubMed Central

    2013-01-01

    Background Atrial arrhythmia (AA) is the most common complication after coronary artery bypass grafting (CABG). Only beta-blockers and amiodarone have been convincingly shown to decrease its incidence. The effectiveness of magnesium on this complication is still controversial. This meta-analysis was performed to evaluate the effect of magnesium as a sole or adjuvant agent in addition to beta-blocker on suppressing postoperative AA after CABG. Methods We searched the PubMed, Medline, ISI Web of Knowledge, Cochrane library databases and online clinical trial database up to May 2012. We used random effects model when there was significant heterogeneity between trials and fixed effects model when heterogeneity was negligible. Results Five randomized controlled trials were identified, enrolling a total of 1251 patients. The combination of magnesium and beta-blocker did not significantly decrease the incidence of postoperative AA after CABG versus beta-blocker alone (odds ratio (OR) 1.12, 95% confidence interval (CI) 0.86-1.47, P = 0.40). Magnesium in addition to beta-blocker did not significantly affect LOS (weighted mean difference −0.14 days of stay, 95% CI −0.58 to 0.29, P = 0.24) or the overall mortality (OR 0.59, 95% CI 0.08-4.56, P = 0.62). However the risk of postoperative adverse events was higher in the combination of magnesium and beta-blocker group than beta-blocker alone (OR 2.80, 95% CI 1.66-4.71, P = 0.0001). Conclusions This meta-analysis offers the more definitive evidence against the prophylactic administration of intravenous magnesium for prevention of AA after CABG when beta-blockers are routinely administered, and shows an association with more adverse events in those people who received magnesium. PMID:23343189

  10. Characteristics of tetrahydrofuran-based electrolytes with magnesium alkoxide additives for rechargeable magnesium batteries

    NASA Astrophysics Data System (ADS)

    Kim, In-Tae; Yamabuki, Kazuhiro; Sumimoto, Michinori; Tsutsumi, Hiromori; Morita, Masayuki; Yoshimoto, Nobuko

    2016-08-01

    The electrochemical behavior of magnesium (Mg) metal was investigated in tetrahydrofuran (THF)-based solutions containing magnesium bromide (MgBr2) and/or magnesium ethoxide (Mg(OEt)2). THF solutions containing a single solute, MgBr2 or Mg(OEt)2, show no visible faradaic current based on Mg deposition and/or dissolution. However, the electrolyte system containing both solutes, MgBr2 + Mg(OEt)2/THF, gives a reversible current response of Mg deposition and dissolution. The ionic structure of the electrolyte system containing the binary solute was examined by infrared (IR) spectroscopy and density functional theory (DFT) calculations. It was confirmed that MgBr2 and Mg(OEt)2 are coordinated (solvated) with THF molecules to form an EtOsbnd Mgsbnd Br·4THF complex. The DFT calculations also suggest the possible formation of μ-complexes for the MgBr2/Mg(OEt)2 binary system in THF. The voltammetric responses at the Pt electrode indicate low overpotential and high coulombic efficiency for Mg deposition and dissolution in THF-based solutions containing suitable molar ratios of MgBr2 and Mg(OEt)2. The constant-current charge-discharge cycling of Mg in MgBr2 + Mg(OEt)2/THF electrolyte also shows low overpotential and good cyclability over 300 cycles.

  11. Biodegradable Magnesium Alloys: A Review of Material Development and Applications

    PubMed Central

    Persaud-Sharma, Dharam; McGoron, Anthony

    2012-01-01

    Magnesium based alloys possess a natural ability to biodegrade due to corrosion when placed within aqueous substances, which is promising for cardiovascular and orthopedic medical device applications. These materials can serve as a temporary scaffold when placed in vivo, which is desirable for treatments when temporary supportive structures are required to assist in the wound healing process. The nature of these materials to degrade is attributed to the high oxidative corrosion rates of magnesium. In this review, a summary is presented for magnesium material development, biocorrosion characteristics, as well as a biological translation for these results. PMID:22408600

  12. Process for converting magnesium fluoride to calcium fluoride

    DOEpatents

    Kreuzmann, A.B.; Palmer, D.A.

    1984-12-21

    This invention is a process for the conversion of magnesium fluoride to calcium fluoride whereby magnesium fluoride is decomposed by heating in the presence of calcium carbonate, calcium oxide or calcium hydroxide. Magnesium fluoride is a by-product of the reduction of uranium tetrafluoride to form uranium metal and has no known commercial use, thus its production creates a significant storage problem. The advantage of this invention is that the quality of calcium fluoride produced is sufficient to be used in the industrial manufacture of anhydrous hydrogen fluoride, steel mill flux or ceramic applications.

  13. Corrosion resistant properties of polyaniline acrylic coating on magnesium alloy

    NASA Astrophysics Data System (ADS)

    Sathiyanarayanan, S.; Azim, S. Syed; Venkatachari, G.

    2006-12-01

    The performance of the paint coating based on acrylic-polyaniline on magnesium alloy ZM 21 has been studied by electrochemical impedance spectroscopy in 0.5% NaCl solution. The polyaniline was prepared by chemical oxidative method of aniline with ammonium persulphate in phosphoric acid medium. The phosphate-doped polyaniline was characterized by FTIR and XRD methods. Acrylic paint containing the phosphate-doped polyaniline was prepared and coated on magnesium ZM 21 alloy. The coating was able to protect the magnesium alloy and no base metal dissolution was noted even after 75 days exposure to sodium chloride solution.

  14. Structural studies of magnesium doped hydroxyapatite coatings after osteoblast culture

    NASA Astrophysics Data System (ADS)

    Mróz, W.; Bombalska, A.; Burdyńska, S.; Jedyński, M.; Prokopiuk, A.; Budner, B.; Ślósarczyk, A.; Zima, A.; Menaszek, E.; Ścisłowska-Czarnecka, A.; Niedzielski, K.

    2010-08-01

    Hydroxyapatite and magnesium modified hydroxyapatite were deposited on nitrited Ti6Al4V substrates by use of pulsed laser deposition technique. Three target materials consisting of non-modified and magnesium modified hydroxyapatite with Mg content of 0.6 wt.% and 1.8 wt.% were ablated using an ArF excimer laser. The obtained coatings were analyzed using X-ray diffraction, FTIR and AFM methods in order to determine the influence of magnesium on their phase and chemical composition, crystallinity, surface morphology and biological properties. Doping with low concentration of Mg does not significantly influence the HA morphology but improves osteoblast adhesion as compared to pure HA.

  15. A lightweight shape-memory magnesium alloy

    NASA Astrophysics Data System (ADS)

    Ogawa, Yukiko; Ando, Daisuke; Sutou, Yuji; Koike, Junichi

    2016-07-01

    Shape-memory alloys (SMAs), which display shape recovery upon heating, as well as superelasticity, offer many technological advantages in various applications. Those distinctive behaviors have been observed in many polycrystalline alloy systems such as nickel titantium (TiNi)–, copper-, iron-, nickel-, cobalt-, and Ti-based alloys but not in lightweight alloys such as magnesium (Mg) and aluminum alloys. Here we present a Mg SMA showing superelasticity of 4.4% at –150°C and shape recovery upon heating. The shape-memory properties are caused by reversible martensitic transformation. This Mg alloy includes lightweight scandium, and its density is about 2 grams per cubic centimeter, which is one-third less than that of practical TiNi SMAs. This finding raises the potential for development and application of lightweight SMAs across a number of industries.

  16. Nanocomposite polymer electrolyte for rechargeable magnesium batteries

    SciTech Connect

    Shao, Yuyan; Rajput, Nav Nidhi; Hu, Jian Z.; Hu, Mary Y.; Liu, Tianbiao L.; Wei, Zhehao; Gu, Meng; Deng, Xuchu; Xu, Suochang; Han, Kee Sung; Wang, Jiulin; Nie, Zimin; Li, Guosheng; Zavadil, K.; Xiao, Jie; Wang, Chong M.; Henderson, Wesley A.; Zhang, Jiguang; Wang, Yong; Mueller, Karl T.; Persson, Kristin A.; Liu, Jun

    2014-12-28

    Nanocomposite polymer electrolytes present new opportunities for rechargeable magnesium batteries. However, few polymer electrolytes have demonstrated reversible Mg deposition/dissolution and those that have still contain volatile liquids such as tetrahydrofuran (THF). In this work, we report a nanocomposite polymer electrolyte based on poly(ethylene oxide) (PEO), Mg(BH4)2 and MgO nanoparticles for rechargeable Mg batteries. Cells with this electrolyte have a high coulombic efficiency of 98% for Mg plating/stripping and a high cycling stability. Through combined experiment-modeling investigations, a correlation between improved solvation of the salt and solvent chain length, chelation and oxygen denticity is established. Following the same trend, the nanocomposite polymer electrolyte is inferred to enhance the dissociation of the salt Mg(BH4)2 and thus improve the electrochemical performance. The insights and design metrics thus obtained may be used in nanocomposite electrolytes for other multivalent systems.

  17. Laser glazing of lanthanum magnesium hexaaluminate

    NASA Astrophysics Data System (ADS)

    Zhang, Yanfei; Wang, Yaomin; Jarligo, Maria Ophelia; Zhong, Xinghua; Li, Qin; Cao, Xueqiang

    2008-08-01

    Lanthanum magnesium hexaalumminate (LMA) is an important candidate for thermal barrier coatings due to its thermal stability and low thermal conductivity. On the other hand, laser glazing method can potentially make thermal barrier coatings impermeable, resistant to corrosion on the surface and porous at bulk. LMA powder was synthesized at 1600 °C by solid-state reaction, pressed into tablet and laser glazed with a 5-kW continuous wave CO2 laser. Dendritic structures were observed on the surface of the laser-glazed specimen. The thicker the tablet, the easier the sample cracks. Cracking during laser glazing is attributed to the low thermal expansion coefficient and large thickness of the sample.

  18. A lightweight shape-memory magnesium alloy.

    PubMed

    Ogawa, Yukiko; Ando, Daisuke; Sutou, Yuji; Koike, Junichi

    2016-07-22

    Shape-memory alloys (SMAs), which display shape recovery upon heating, as well as superelasticity, offer many technological advantages in various applications. Those distinctive behaviors have been observed in many polycrystalline alloy systems such as nickel titantium (TiNi)-, copper-, iron-, nickel-, cobalt-, and Ti-based alloys but not in lightweight alloys such as magnesium (Mg) and aluminum alloys. Here we present a Mg SMA showing superelasticity of 4.4% at -150°C and shape recovery upon heating. The shape-memory properties are caused by reversible martensitic transformation. This Mg alloy includes lightweight scandium, and its density is about 2 grams per cubic centimeter, which is one-third less than that of practical TiNi SMAs. This finding raises the potential for development and application of lightweight SMAs across a number of industries. PMID:27463668

  19. A lightweight shape-memory magnesium alloy

    NASA Astrophysics Data System (ADS)

    Ogawa, Yukiko; Ando, Daisuke; Sutou, Yuji; Koike, Junichi

    2016-07-01

    Shape-memory alloys (SMAs), which display shape recovery upon heating, as well as superelasticity, offer many technological advantages in various applications. Those distinctive behaviors have been observed in many polycrystalline alloy systems such as nickel titantium (TiNi)-, copper-, iron-, nickel-, cobalt-, and Ti-based alloys but not in lightweight alloys such as magnesium (Mg) and aluminum alloys. Here we present a Mg SMA showing superelasticity of 4.4% at -150°C and shape recovery upon heating. The shape-memory properties are caused by reversible martensitic transformation. This Mg alloy includes lightweight scandium, and its density is about 2 grams per cubic centimeter, which is one-third less than that of practical TiNi SMAs. This finding raises the potential for development and application of lightweight SMAs across a number of industries.

  20. Infrared processing of magnesium wrought alloys

    SciTech Connect

    Horton Jr, Joe A; Blue, Craig A; Muth, T; Bowles, Amanda L; Agnew, Sean R

    2005-01-01

    High density infrared (HDI) processing of magnesium alloy sheet allows rapid heat up and cool down and may facilitate a continuous cast/roll process, thereby reducing costs. In a previous study, a plasma arc lamp resulted in an anneal in seconds that compared well to a normal 1 h 500 C anneal. The current study on AZ31 used a bank of quartz infrared lamps both in a lab setting and in a demonstration test at a commercial facility (Manufacturing Sciences, Inc.). Typical reheats and anneals between rolling passes required 2 to 5 minutes for rolling 6 mm sheet down to 1 mm. Tensile tests showed comparable results to normal processing. The near surface microstructure was similar to the center of the sheets. No gross progressive or cumulative effect on mechanical properties was observed from pass to pass. Good surface quality with minimal edge cracking was produced.

  1. The magnesium chelation step in chlorophyll biosynthesis

    SciTech Connect

    Weinstein, J.

    1990-11-01

    In photosynthetic organisms, the biogenesis of energy transducing membranes requires the coordinate synthesis of prosthetic groups, proteins, and various lipids. Two of the major prosthetic groups, chlorophyll and heme, share a common biosynthetic pathway that diverges at the point of metal insertion into protoporphyrin IX (Proto). Insertion of iron leads to the formation of hemes, while insertion of magnesium is the first step unique to chlorophyll formation. This project is directed toward identifying the enzyme(s) responsible for magnesium chelation and elucidating the mechanism which regulates the flux of precursors through the branch point enzymes in isolated chloroplasts. Using intact chloroplasts from greening cucumber cotyledons, we have confirmed the ATP requirement for Mg-Proto formation. Use of non-hydrolyzable ATP analogs, uncouplers and ionophores has led to the conclusions that ATP hydrolysis is necessary, but that this hydrolysis is not linked to the requirement for membrane intactness by transmembrane ion gradients or electrical potentials. The enzyme(s) are flexible with respect to the porphyrin substrate specificity, accepting porphyrins with -vinyl, -ethyl, or -H substituents at the 2 and 4 positions. The activity increases approximately four-fold during greening. Possible physiological feedback inhibitors such as heme, protochlorophyllide, and chlorophyllide had no specific effect on the activity. The activity has now been assayed in barely, corn and peas, with the system from peas almost ten-fold more active than the cucumber system. Work is continuing in pea chloroplasts with the development of a continuous assay and investigation of the feasibility of characterizing an active, organelle-free preparation. 6 figs.

  2. Cell Adhesion on Surface-Functionalized Magnesium.

    PubMed

    Wagener, Victoria; Schilling, Achim; Mainka, Astrid; Hennig, Diana; Gerum, Richard; Kelch, Marie-Luise; Keim, Simon; Fabry, Ben; Virtanen, Sannakaisa

    2016-05-18

    The biocompatibility of commercially pure magnesium-based (cp Mg) biodegradable implants is compromised of strong hydrogen evolution and surface alkalization due to high initial corrosion rates of cp Mg in the physiological environment. To mitigate this problem, the addition of corrosion-retarding alloying elements or coating of implant surfaces has been suggested. In the following work, we explored the effect of organic coatings on long-term cell growth. cp Mg was coated with aminopropyltriehtoxysilane + vitamin C (AV), carbonyldiimidazole (CDI), or stearic acid (SA). All three coatings have been previously suggested to reduce initial corrosion and to enhance protein adsorption and hence cell adhesion on magnesium surfaces. Endothelial cells (DH1+/+) and osteosarcoma cells (MG63) were cultured on coated samples for up to 20 days. To quantify Mg corrosion, electrochemical impedance spectroscopy (EIS) was measured after 1, 3, and 5 days of cell culture. We also investigated the speed of initial cell spreading after seeding using fluorescently labeled fibroblasts (NIH/3T3). Hydrogen evolution after contact with cell culture medium was markedly decreased on AV- and SA-coated Mg compared to uncoated Mg. These coatings also showed improved cell adhesion and spreading after 24 h of culture comparable to tissue-treated plastic surfaces. On AV-coated cp Mg, a confluent layer of endothelial cells formed after 5 days and remained intact for up to 20 days. Together, these data demonstrate that surface coating with AV is a viable strategy for improving long-term biocompatibility of cp Mg-based implants. EIS measurements confirmed that the presence of a confluent cell layer increased the corrosion resistance. PMID:27089250

  3. Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres.

    PubMed

    Momoh, Mumuni A; Kenechukwu, Franklin C; Nnamani, Petra O; Umetiti, Jennifer C

    2015-01-01

    Effective oral insulin delivery has remained a challenge to the pharmaceutical industry. This study was designed to evaluate the effect of magnesium stearate on the properties of insulin-loaded Eudragit® RL 100 entrapped mucoadhesive microspheres. Microspheres containing Eudragit® RL 100, insulin, and varying concentrations of magnesium stearate (agglomeration-preventing agent) were prepared by emulsification-coacervation method and characterized with respect to differential scanning calorimetry (DSC), morphology, particle size, loading efficiency, mucoadhesive and micromeritics properties. The in vitro release of insulin from the microspheres was performed in simulated intestinal fluid (SIF, pH 7.2) while the in vivo hypoglycemic effect was investigated by monitoring the plasma glucose level of the alloxan-induced diabetic rats after oral administration. Stable, spherical, brownish, mucoadhesive, discrete and free flowing insulin-loaded microspheres were formed. While the average particle size and mucoadhesiveness of the microspheres increased with an increase in the proportion of magnesium stearate, loading efficiency generally decreased. After 12 h, microspheres prepared with Eudragit® RL 100: magnesium stearate ratios of 15:1, 15:2, 15:3 and 15:4 released 68.20 ± 1.57, 79.40 ± 1.52, 76.60 ± 1.93 and 70.00 ± 1.00 (%) of insulin, respectively. Reduction in the blood glucose level for the subcutaneously (sc) administered insulin was significantly (p ≤ 0.05) higher than for most of the formulations. However, the blood glucose reduction effect produced by the orally administered insulin-loaded microspheres prepared with four parts of magnesium stearate and fifteen parts of Eudragit® RL 100 after 12 h was equal to that produced by subcutaneously administered insulin solution. The results of this study can suggest that this carrier system could be an alternative for the delivery of insulin.

  4. Efficacy of Magnesium Trihydrate of Ursodeoxycholic Acid and Chenodeoxycholic Acid for Gallstone Dissolution: A Prospective Multicenter Trial

    PubMed Central

    Hyun, Jong Jin; Lee, Hong Sik; Kim, Chang Duck; Dong, Seok Ho; Lee, Seung-Ok; Ryu, Ji Kon; Lee, Don Haeng; Jeong, Seok; Kim, Tae Nyeun; Lee, Jin; Koh, Dong Hee; Park, Eun Taek; Lee, Inseok; Yoo, Byung Moo; Kim, Jin Hong

    2015-01-01

    Background/Aims Cholecystectomy is necessary for the treatment of symptomatic or complicated gallbladder (GB) stones, but oral litholysis with bile acids is an attractive alternative therapeutic option for asymptomatic or mildly symptomatic patients. This study was conducted to evaluate the efficacy of magnesium trihydrate of ursodeoxycholic acid (UDCA) and chenodeoxycholic acid (CDCA) on gallstone dissolution and to investigate improvements in gallstone-related symptoms. Methods A prospective, multicenter, phase 4 clinical study to determine the efficacy of orally administered magnesium trihydrate of UDCA and CDCA was performed from January 2011 to June 2013. The inclusion criteria were GB stone diameter ≤15 mm, GB ejection fraction ≥50%, radiolucency on plain X-ray, and asymptomatic/mildly symptomatic patients. The patients were prescribed one capsule of magnesium trihydrate of UDCA and CDCA at breakfast and two capsules at bedtime for 6 months. The dissolution rate, response rate, and change in symptom score were evaluated. Results A total of 237 subjects were enrolled, and 195 subjects completed the treatment. The dissolution rate was 45.1% and the response rate was 47.2% (92/195) after 6 months of administration of magnesium trihydrate of UDCA and CDCA. Only the stone diameter was significantly associated with the response rate. Both the symptom score and the number of patients with symptoms significantly decreased regardless of stone dissolution. Adverse events necessitating discontinuation of the drug, surgery, or endoscopic management occurred in 2.5% (6/237) of patients. Conclusions Magnesium trihydrate of UDCA and CDCA is a well-tolerated bile acid that showed similar efficacy for gallstone dissolution and improvement of gallstone-related symptoms as that shown in previous studies. PMID:26087862

  5. The influence of magnesium chloride on blood and urine parameters in calcium oxalate stone patients.

    PubMed

    Brundig, P; Berg, W; Schneider, H J

    1981-01-01

    The influence of magnesium chloride on various blood and urine parameters in calcium oxalate stone patients is studied. High dose magnesium therapy was found to increase urinary magnesium concentrations, whereas the oxalic acid concentration is reduced. The experiments support the statements on the role of magnesium in endogenous oxalic acid depression and the inhibition of the intestinal resorption. For urolith prevention it will be necessary to apply high magnesium doses of easily absorbable and well-tolerated medicaments.

  6. Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review

    PubMed Central

    2013-01-01

    trials. Case reports supported an association between iatrogenic overdose of magnesium sulphate and life-threatening consequences. Conclusions Appropriate administration of antenatal magnesium sulphate was not shown to be associated with serious maternal adverse effects, though an increase in 'minor’ adverse effects and treatment cessation was shown. Larger trials are needed to determine optimal regimens, achieving maximal effectiveness with minimal adverse effects, for each antenatal indication for use. Vigilance in the use of magnesium sulphate is essential for women’s safety. PMID:24139447

  7. Ionized magnesium in the planetary nebula NGC 7027

    NASA Technical Reports Server (NTRS)

    Evans, N. J., II; Natta, A.; Russell, R. W.; Wyant, J.; Beckwith, S.

    1984-01-01

    Observations of NGC 7027 are presented for six ionic lines: Mg(+3) (4.48 microns), Mg(+4) (5.61 microns), H(0) (4.05 and 7.46 microns), Ne(+5) (7.64 microns), and Ar(+5) (4.53 microns). The magnesium lines are consistent with the measurements of Russell, Soifer, and Willner (1977), and the hydrogen lines are consistent with the line strengths predicted from the radio flux. Upper limits were obtained for the neon and argon lines. The abundance of magnesium in the central part of the nebula is highly uncertain because the fine-structure collision strengths are poorly known. The strong gradient of magnesium abundance from the inner to the outer portions of the nebula derived by Pequignot and Stasinska (1980) could be an artifact of this uncertainty. A brief analysis of the effective stellar temperature derived from the magnesium line ratios is given.

  8. Constitutive modelling of magnesium alloy sheets under strain path changes

    NASA Astrophysics Data System (ADS)

    Lee, Jinwoo; Lee, Young-Seon; Lee, Myoung-Gyu; Kim, Daeyong

    2016-08-01

    In this study, a continuum-based approach for the description of the plastic hardening behavior of magnesium alloy sheets subjected to non-proportional strain path changes is discussed. The constitutive model is based on an anisotropic distortional yield function combining a stable component and a fluctuating component. The stable component initiates the yield criterion that characterizes the typical strength differential between tension and compression in magnesium alloys at room temperature. The evolution of the fluctuating component is reformulated based on its cubic metal counterpart to represent the deformation nature of magnesium alloys that consist of slip and twin dominant modes. The model is not formulated with a kinematic hardening rule, but it reasonably reproduces complex features of the stress-strain responses under the load reversal in magnesium alloy sheet: i.e., asymmetric hardening behavior under tension and compression, sigmoidal nature of hardening curve during monotonic compression and compression followed by tension, strong anisotropy etc.

  9. Magnesium-zinc reduction is effective in preparation of metals

    NASA Technical Reports Server (NTRS)

    Knighton, J. B.; Steuneberg, R. K.

    1967-01-01

    Uranium, thorium, and plutonium are effectively prepared by magnesium-zinc reduction, using uranium oxides, thorium dioxide, and plutonium dioxide as starting materials. This technique is also useful in performing reduction of metals such as zirconium and titanium.

  10. POURING IRON FROM ELECTRIC FURNACE INTO BULL LADLE AFTER MAGNESIUM ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    POURING IRON FROM ELECTRIC FURNACE INTO BULL LADLE AFTER MAGNESIUM HAD BEEN ADDED TO GENERATE DUCTILE IRON WHEN IT COOLS IN THE MOLD. - Southern Ductile Casting Company, Casting, 2217 Carolina Avenue, Bessemer, Jefferson County, AL

  11. Topologically ordered magnesium-biopolymer hybrid composite structures.

    PubMed

    Oosterbeek, Reece N; Seal, Christopher K; Staiger, Mark P; Hyland, Margaret M

    2015-01-01

    Magnesium and its alloys are intriguing as possible biodegradable biomaterials due to their unique combination of biodegradability and high specific mechanical properties. However, uncontrolled biodegradation of magnesium during implantation remains a major challenge in spite of the use of alloying and protective coatings. In this study, a hybrid composite structure of magnesium metal and a biopolymer was fabricated as an alternative approach to control the corrosion rate of magnesium. A multistep process that combines metal foam production and injection molding was developed to create a hybrid composite structure that is topologically ordered in all three dimensions. Preliminary investigations of the mechanical properties and corrosion behavior exhibited by the hybrid Mg-polymer composite structures suggest a new potential approach to the development of Mg-based biomedical devices.

  12. Magnesium for Treatment of Reversible Cerebral Vasoconstriction Syndrome

    PubMed Central

    Mijalski, Christina; Dakay, Katarina; Miller-Patterson, Cameron; Saad, Ali; Silver, Brian

    2015-01-01

    We describe 2 cases of reversible cerebral vasoconstriction syndrome (RCVS) with refractory headache aborted by intravenous magnesium. Case 1 is a 53-year-old woman with subarachnoid hemorrhage due to RCVS presented with refractory headache and persistent vasospasm, despite aggressive treatment with calcium channel blockers (CCBs) and systemic corticosteroids. Subsequently, she experienced dramatic relief of symptoms with intravenous magnesium therapy. She continued oral maintenance therapy and remained symptom free. Case 2 is a 71-year-old female with bilateral temporo-occipital infarcts due to RCVS, presented with refractory headache and persistent vasospasm on transcranial Doppler (TCD), despite aggressive treatment with CCBs. She experienced dramatic relief of symptoms with intravenous magnesium and resolution of vasospasm on TCD. Magnesium may be beneficial for the treatment of refractory headaches in patients with RCVS. Future studies are needed to determine whether it should be considered as a first-line agent. PMID:27366294

  13. Clumped-isotope thermometry of magnesium carbonates in ultramafic rocks

    NASA Astrophysics Data System (ADS)

    García del Real, Pablo; Maher, Kate; Kluge, Tobias; Bird, Dennis K.; Brown, Gordon E.; John, Cédric M.

    2016-11-01

    Magnesium carbonate minerals produced by reaction of H2O-CO2 with ultramafic rocks occur in a wide range of paragenetic and tectonic settings and can thus provide insights into a variety of geologic processes, including (1) deposition of ore-grade, massive-vein cryptocrystalline magnesite; (2) formation of hydrous magnesium carbonates in weathering environments; and (3) metamorphic carbonate alteration of ultramafic rocks. However, the application of traditional geochemical and isotopic methods to infer temperatures of mineralization, the nature of mineralizing fluids, and the mechanisms controlling the transformation of dissolved CO2 into magnesium carbonates in these settings is difficult because the fluids are usually not preserved. Clumped-isotope compositions of magnesium carbonates provide a means to determine primary mineralization or (re)equilibration temperature, which permits the reconstruction of geologic processes that govern magnesium carbonate formation. We first provide an evaluation of the acid fractionation correction for magnesium carbonates using synthetic magnesite and hydromagnesite, along with natural metamorphic magnesite and low-temperature hydromagnesite precipitated within a mine adit. We show that the acid fractionation correction for magnesium carbonates is virtually indistinguishable from other carbonate acid fractionation corrections given current mass spectrometer resolution and error. In addition, we employ carbonate clumped-isotope thermometry on natural magnesium carbonates from various geologic environments and tectonic settings. Cryptocrystalline magnesite vein deposits from California (Red Mountain magnesite mine), Austria (Kraubath locality), Turkey (Tutluca mine, Eskişehir district) and Iran (Derakht-Senjed deposit) exhibit broadly uniform Δ47 compositions that yield apparent clumped-isotope temperatures that average 23.7 ± 5.0 °C. Based on oxygen isotope thermometry, these clumped-isotope temperatures suggest

  14. Al-TiH2 Composite Foams Magnesium Alloy

    NASA Astrophysics Data System (ADS)

    Prasada Rao, A. K.; Oh, Y. S.; Ain, W. Q.; A, Azhari; Basri, S. N.; Kim, N. J.

    2016-02-01

    The work presented here in describes the synthesis of aluminum based titanium-hydride particulate composite by casting method and its foaming behavior of magnesium alloy. Results obtained indicate that the Al-10TiH2 composite can be synthesized successfully by casting method. Further, results also reveal that closed-cell magnesium alloy foam can be synthesized by using Al-10TiH2 composite as a foaming agent.

  15. In vivo decomposition study of coated magnesium alloys

    NASA Astrophysics Data System (ADS)

    White, Desiree; Piersma, Tyler; Lecronier, David; Cheng, Xingguo; Rabago-Smith, Montserrat

    2010-04-01

    In the last decade, magnesium has resurged as an important biomaterial. Its mechanical properties are very similar to natural bone, and it degrades in vivo to non toxic substances. Unfortunately, corrosion of pure magnesium in vivo is rapid, thus coated alloys that decrease its corrosion could be used as implants in orthopedics. This presentation will describe the degradation results in cell cultures and in rats.

  16. In vitro decomposition study of coated magnesium alloys

    NASA Astrophysics Data System (ADS)

    Piersma, Tyler; White, Desiree; Cheng, Xinggou; Rabago-Smith, Montserrat; Lecronier, David

    2010-04-01

    In the last decade, magnesium has resurged as an important biomaterial. It's mechanical properties are very similar to natural bone, and it degrades in vivo to non toxic substances. Unfortunately, corrosion of pure magnesium in vivo is rapid, thus coated alloys that decrease it's corrosion could be used as implants in orthopedics. This presentation will describe the degradation results in a simulated body fluid (SBF).

  17. Lithium and magnesium isotopes fractionation by zone melting

    NASA Astrophysics Data System (ADS)

    Akimov, D. V.; Egorov, N. B.; Dyachenko, A. N.; Pustovalova, M. P.; Podoinikov, I. R.

    2016-06-01

    The process of changing isotopic composition of the lithium and magnesium salts was studied by using the process of zone melting. It was founded in the paper that the process of separation of the lithium isotopes is more effective than for magnesium isotopes when the conditions of process were the same. The coefficients of isotopes separation were calculated and have the next value: α = 1.006 for 26Mg isotope and α = 1.0022 for 6Li isotope.

  18. Physicochemical action of potassium-magnesium citrate in nephrolithiasis

    NASA Technical Reports Server (NTRS)

    Pak, C. Y.; Koenig, K.; Khan, R.; Haynes, S.; Padalino, P.

    1992-01-01

    Effect of potassium-magnesium citrate on urinary biochemistry and crystallization of stone-forming salts was compared with that of potassium citrate at same dose of potassium in five normal subjects and five patients with calcium nephrolithiasis. Compared to the placebo phase, urinary pH rose significantly from 6.06 +/- 0.27 to 6.48 +/- 0.36 (mean +/- SD, p less than 0.0167) during treatment with potassium citrate (50 mEq/day for 7 days) and to 6.68 +/- 0.31 during therapy with potassium-magnesium citrate (containing 49 mEq K, 24.5 mEq Mg, and 73.5 mEq citrate per day). Urinary pH was significantly higher during potassium-magnesium citrate than during potassium citrate therapy. Thus, the amount of undissociated uric acid declined from 118 +/- 61 mg/day during the placebo phase to 68 +/- 54 mg/day during potassium citrate treatment and, more prominently, to 41 +/- 46 mg/day during potassium-magnesium citrate therapy. Urinary magnesium rose significantly from 102 +/- 25 to 146 +/- 37 mg/day during potassium-magnesium citrate therapy but not during potassium citrate therapy. Urinary citrate rose more prominently during potassium-magnesium citrate therapy (to 1027 +/- 478 mg/day from 638 +/- 252 mg/day) than during potassium citrate treatment (to 932 +/- 297 mg/day). Consequently, urinary saturation (activity product) of calcium oxalate declined significantly (from 1.49 x 10(-8) to 1.03 x 10(-8) M2) during potassium-magnesium citrate therapy and marginally (to 1.14 x 10(-8) M2) during potassium citrate therapy.(ABSTRACT TRUNCATED AT 250 WORDS).

  19. Formation of chemically bonded ceramics with magnesium dihydrogen phosphate binder

    DOEpatents

    Wagh, Arun S.; Jeong, Seung-Young

    2004-08-17

    A new method for combining magnesium oxide, MgO, and magnesium dihydrogen phosphate to form an inexpensive compactible ceramic to stabilize very low solubility metal oxides, ashes, swarfs, and other iron or metal-based additives, to create products and waste forms which can be poured or dye cast, and to reinforce and strengthen the ceramics formed by the addition of fibers to the initial ceramic mixture.

  20. Influence of magnesium on insulin resistance in obese women.

    PubMed

    Cruz, Kyria Jayanne Clímaco; de Oliveira, Ana Raquel Soares; Pinto, Denise Pereira; Morais, Jennifer Beatriz Silva; Lima, Fabiana da Silva; Colli, Célia; Torres-Leal, Francisco Leonardo; Marreiro, Dilina do Nascimento

    2014-09-01

    The present study evaluated the influence of magnesium on insulin resistance in obese women. A case-control study involving 114 women on the age between 20 and 50 years old, divided into two groups: control (eutrophic women, n = 59) and case (obese women, n = 55). The analysis of magnesium intake was carried out through the 3-day food record and also NutWin software version 1.5. The plasma, erythrocyte, and urinary magnesium concentrations were determined by flame atomic absorption spectrophotometry. The determinations of serum glucose and serum insulin were performed by enzymatic colorimetric method and chemiluminescence, respectively. The insulin resistance was assessed by homeostasis model assessment insulin resistance (HOMA-IR). The mean values of magnesium intake were lower than those recommended, without difference between groups (p > 0.05). All the patients who were evaluated showed adequate mean concentrations of magnesium in the plasma and erythrocyte. The urinary excretion of this mineral was lower than the reference values in both groups and did not show significant difference (p > 0.05). The values of serum glucose, serum insulin, and HOMA-IR were higher in obese women compared to the control group. A negative correlation was observed between erythrocyte magnesium and glycemic parameters (p < 0.05). Obese patients take in foods with low dietary magnesium content, and they show hypomagnesuria as a compensatory mechanism to keep the plasma concentration of this mineral in adequate levels. The correlation between the erythrocyte magnesium concentration and the parameters of glycemic control suggests the influence of this mineral on the index of insulin resistance in obese women.

  1. Multi-functional magnesium alloys containing interstitial oxygen atoms.

    PubMed

    Kang, H; Choi, H J; Kang, S W; Shin, S E; Choi, G S; Bae, D H

    2016-03-15

    A new class of magnesium alloys has been developed by dissolving large amounts of oxygen atoms into a magnesium lattice (Mg-O alloys). The oxygen atoms are supplied by decomposing titanium dioxide nanoparticles in a magnesium melt at 720 °C; the titanium is then completely separated out from the magnesium melt after solidification. The dissolved oxygen atoms are located at the octahedral sites of magnesium, which expand the magnesium lattice. These alloys possess ionic and metallic bonding characteristics, providing outstanding mechanical and functional properties. A Mg-O-Al casting alloy made in this fashion shows superior mechanical performance, chemical resistance to corrosion, and thermal conductivity. Furthermore, a similar Mg-O-Zn wrought alloy shows high elongation to failure (>50%) at room temperature, because the alloy plastically deforms with only multiple slips in the sub-micrometer grains (<300 nm) surrounding the larger grains (~15 μm). The metal/non-metal interstitial alloys are expected to open a new paradigm in commercial alloy design.

  2. Sol - Gel synthesis and characterization of magnesium peroxide nanoparticles

    NASA Astrophysics Data System (ADS)

    Jaison, J.; Ashok raja, C.; Balakumar, S.; Chan, Y. S.

    2015-04-01

    Magnesium peroxide is an excellent source of oxygen in agriculture applications, for instance it is used in waste management as a material for soil bioremediation to remove contaminants from polluted underground water, biological wastes treatment to break down hydrocarbon, etc. In the present study, sol-gel synthesis of magnesium peroxide (MgO2) nanoparticles is reported. Magnesium peroxide is odourless; fine peroxide which releases oxygen when reacts with water. During the sol-gel synthesis, the magnesium malonate intermediate is formed which was then calcinated to obtain MgO2 nanoparticles. The synthesized nanoparticles were characterized using Thermo gravimetric -Differential Thermal Analysis (TG- DTA), X-Ray Diffraction studies (XRD) and High Resolution Transmission Electron Microscope (HRTEM). Our study provides a clear insight that the formation of magnesium malonate during the synthesis was due to the reaction between magnesium acetate, oxalic acid and ethanol. In our study, we can conclude that the calcination temperature has a strong influence on particle size, morphology, monodispersity and the chemistry of the particles.

  3. Synthesis of magnesium aluminate spinel by periclase and alumina chlorination

    SciTech Connect

    Orosco, Pablo; Barbosa, Lucía; Ruiz, María del Carmen

    2014-11-15

    Highlights: • Use of chlorination for the synthesis of magnesium aluminate spinel. • The reagents used were alumina, periclase and chlorine. • Isothermal and non-isothermal assays were performed in air and Cl{sub 2}–N{sub 2} flows. • The chlorination produced magnesium aluminate spinel at 700 °C. • Selectivity of the chlorination reaction to obtain spinel is very high. - Abstract: A pyrometallurgical route for the synthesis of magnesium aluminate spinel by thermal treatment of a mechanical mixture containing 29 wt% MgO (periclase) and 71 wt% Al{sub 2}O{sub 3} (alumina) in chlorine atmosphere was developed and the results were compared with those obtained by calcining the same mixture of oxides in air atmosphere. Isothermal and non-isothermal assays were performed in an experimental piece of equipment adapted to work in corrosive atmospheres. Both reagents and products were analyzed by differential thermal analysis (DTA), X-ray diffraction (XRD) and X-ray fluorescence (XRF). Thermal treatment in Cl{sub 2} atmosphere of the MgO–Al{sub 2}O{sub 3} mixture produces magnesium aluminate spinel at 700 °C, while in air, magnesium spinel is generated at 930 °C. The synthesis reaction of magnesium aluminate spinel was complete at 800 °C.

  4. Multi-functional magnesium alloys containing interstitial oxygen atoms

    PubMed Central

    Kang, H.; Choi, H. J.; Kang, S. W.; Shin, S. E.; Choi, G. S.; Bae, D. H.

    2016-01-01

    A new class of magnesium alloys has been developed by dissolving large amounts of oxygen atoms into a magnesium lattice (Mg-O alloys). The oxygen atoms are supplied by decomposing titanium dioxide nanoparticles in a magnesium melt at 720 °C; the titanium is then completely separated out from the magnesium melt after solidification. The dissolved oxygen atoms are located at the octahedral sites of magnesium, which expand the magnesium lattice. These alloys possess ionic and metallic bonding characteristics, providing outstanding mechanical and functional properties. A Mg-O-Al casting alloy made in this fashion shows superior mechanical performance, chemical resistance to corrosion, and thermal conductivity. Furthermore, a similar Mg-O-Zn wrought alloy shows high elongation to failure (>50%) at room temperature, because the alloy plastically deforms with only multiple slips in the sub-micrometer grains (<300 nm) surrounding the larger grains (~15 μm). The metal/non-metal interstitial alloys are expected to open a new paradigm in commercial alloy design. PMID:26976372

  5. Magnesium in Disease Prevention and Overall Health12

    PubMed Central

    Volpe, Stella Lucia

    2013-01-01

    Magnesium is the fourth most abundant mineral and the second most abundant intracellular divalent cation and has been recognized as a cofactor for >300 metabolic reactions in the body. Some of the processes in which magnesium is a cofactor include, but are not limited to, protein synthesis, cellular energy production and storage, reproduction, DNA and RNA synthesis, and stabilizing mitochondrial membranes. Magnesium also plays a critical role in nerve transmission, cardiac excitability, neuromuscular conduction, muscular contraction, vasomotor tone, blood pressure, and glucose and insulin metabolism. Because of magnesium’s many functions within the body, it plays a major role in disease prevention and overall health. Low levels of magnesium have been associated with a number of chronic diseases including migraine headaches, Alzheimer’s disease, cerebrovascular accident (stroke), hypertension, cardiovascular disease, and type 2 diabetes mellitus. Good food sources of magnesium include unrefined (whole) grains, spinach, nuts, legumes, and white potatoes (tubers). This review presents recent research in the areas of magnesium and chronic disease, with the goal of emphasizing magnesium’s role in disease prevention and overall health. PMID:23674807

  6. Multi-functional magnesium alloys containing interstitial oxygen atoms

    NASA Astrophysics Data System (ADS)

    Kang, H.; Choi, H. J.; Kang, S. W.; Shin, S. E.; Choi, G. S.; Bae, D. H.

    2016-03-01

    A new class of magnesium alloys has been developed by dissolving large amounts of oxygen atoms into a magnesium lattice (Mg-O alloys). The oxygen atoms are supplied by decomposing titanium dioxide nanoparticles in a magnesium melt at 720 °C the titanium is then completely separated out from the magnesium melt after solidification. The dissolved oxygen atoms are located at the octahedral sites of magnesium, which expand the magnesium lattice. These alloys possess ionic and metallic bonding characteristics, providing outstanding mechanical and functional properties. A Mg-O-Al casting alloy made in this fashion shows superior mechanical performance, chemical resistance to corrosion, and thermal conductivity. Furthermore, a similar Mg-O-Zn wrought alloy shows high elongation to failure (>50%) at room temperature, because the alloy plastically deforms with only multiple slips in the sub-micrometer grains (<300 nm) surrounding the larger grains (~15 μm). The metal/non-metal interstitial alloys are expected to open a new paradigm in commercial alloy design.

  7. Production and Refining of Magnesium Metal from Turkey Originating Dolomite

    NASA Astrophysics Data System (ADS)

    Demiray, Yeliz; Yücel, Onuralp

    2012-06-01

    In this study crown magnesium produced from Turkish calcined dolomite by the Pigeon Process was refined and corrosion tests were applied. By using factsage thermodynamic program metalothermic reduction behavior of magnesium oxide and silicate formation structure during this reaction were investigated. After thermodynamic studies were completed, calcination of dolomite and it's metalothermic reduction at temperatures of 1473 K, 1523 K and within a vacuum (varied from 20 to 200 Pa) and refining of crown magnesium was studied. Different flux compositions consisting of MgCl2, KCl, CaCl2, MgO, CaF2, NaCl, and SiO2 with and without B2O3 additions were selected for the refining process. These tests were carried out at 963 K for 15, 30 and 45 minutes setting time. Considerable amount of iron was transferred into the sludge phase and its amount decreased from 0.08% to 0.027%. This refined magnesium was suitable for the production of various magnesium alloys. As a result of decreasing iron content, minimum corrosion rate of refined magnesium was obtained 2.35 g/m2/day. The results are compared with previous studies.

  8. Potential renovascular hypertension, space missions, and the role of magnesium.

    PubMed

    Rowe, William J

    2009-01-01

    Space flight (SF) and dust inhalation in habitats cause hypertension whereas in SF (alone) there is no consistent hypertension but reduced diurnal blood pressure (BP) variation instead. Current pharmaceutical subcutaneous delivery systems are inadequate and there is impairment in the absorption, metabolism, excretion, and deterioration of some pharmaceuticals. Data obtained from the National Aeronautics and Space Administration through the Freedom of Information Act shows that Irwin returned from his 12-day Apollo 15 mission in 1971 and was administered a bicycle stress test. With just three minutes of exercise, his BP was >275/125 mm Hg (heart rate of only 130 beats per minute). There was no acute renal insult. Irwin's apparent spontaneous remission is suggested to be related to the increase of a protective vasodilator, and his atrial natriuretic peptide (ANP) reduced with SF because of reduced plasma volume. With invariable malabsorption and loss of bone/muscle storage sites, there are significant (P < 0.0001) reductions of magnesium (Mg) required for ANP synthesis and release. Reductions of Mg and ANP can trigger pronounced angiotensin (200%), endothelin, and catecholamine elevations (clearly shown in recent years) and vicious cycles between the latter and Mg deficits. There is proteinuria, elevated creatinine, and reduced renal concentrating ability with the potential for progressive inflammatory and oxidative stress-induced renal disease and hypertension with vicious cycles. After SF, animals show myocardial endothelial injuries and increased vascular resistance of extremities in humans. Even without dust, hypertension might eventually develop from renovascular hypertension during very long missions. Without sufficient endothelial protection from pharmaceuticals, a comprehensive gene research program should begin now. PMID:21694921

  9. Potential renovascular hypertension, space missions, and the role of magnesium.

    PubMed

    Rowe, William J

    2009-01-01

    Space flight (SF) and dust inhalation in habitats cause hypertension whereas in SF (alone) there is no consistent hypertension but reduced diurnal blood pressure (BP) variation instead. Current pharmaceutical subcutaneous delivery systems are inadequate and there is impairment in the absorption, metabolism, excretion, and deterioration of some pharmaceuticals. Data obtained from the National Aeronautics and Space Administration through the Freedom of Information Act shows that Irwin returned from his 12-day Apollo 15 mission in 1971 and was administered a bicycle stress test. With just three minutes of exercise, his BP was >275/125 mm Hg (heart rate of only 130 beats per minute). There was no acute renal insult. Irwin's apparent spontaneous remission is suggested to be related to the increase of a protective vasodilator, and his atrial natriuretic peptide (ANP) reduced with SF because of reduced plasma volume. With invariable malabsorption and loss of bone/muscle storage sites, there are significant (P < 0.0001) reductions of magnesium (Mg) required for ANP synthesis and release. Reductions of Mg and ANP can trigger pronounced angiotensin (200%), endothelin, and catecholamine elevations (clearly shown in recent years) and vicious cycles between the latter and Mg deficits. There is proteinuria, elevated creatinine, and reduced renal concentrating ability with the potential for progressive inflammatory and oxidative stress-induced renal disease and hypertension with vicious cycles. After SF, animals show myocardial endothelial injuries and increased vascular resistance of extremities in humans. Even without dust, hypertension might eventually develop from renovascular hypertension during very long missions. Without sufficient endothelial protection from pharmaceuticals, a comprehensive gene research program should begin now.

  10. Potential renovascular hypertension, space missions, and the role of magnesium

    PubMed Central

    Rowe, William J

    2009-01-01

    Space flight (SF) and dust inhalation in habitats cause hypertension whereas in SF (alone) there is no consistent hypertension but reduced diurnal blood pressure (BP) variation instead. Current pharmaceutical subcutaneous delivery systems are inadequate and there is impairment in the absorption, metabolism, excretion, and deterioration of some pharmaceuticals. Data obtained from the National Aeronautics and Space Administration through the Freedom of Information Act shows that Irwin returned from his 12-day Apollo 15 mission in 1971 and was administered a bicycle stress test. With just three minutes of exercise, his BP was >275/125 mm Hg (heart rate of only 130 beats per minute). There was no acute renal insult. Irwin’s apparent spontaneous remission is suggested to be related to the increase of a protective vasodilator, and his atrial natriuretic peptide (ANP) reduced with SF because of reduced plasma volume. With invariable malabsorption and loss of bone/muscle storage sites, there are significant (P < 0.0001) reductions of magnesium (Mg) required for ANP synthesis and release. Reductions of Mg and ANP can trigger pronounced angiotensin (200%), endothelin, and catecholamine elevations (clearly shown in recent years) and vicious cycles between the latter and Mg deficits. There is proteinuria, elevated creatinine, and reduced renal concentrating ability with the potential for progressive inflammatory and oxidative stress-induced renal disease and hypertension with vicious cycles. After SF, animals show myocardial endothelial injuries and increased vascular resistance of extremities in humans. Even without dust, hypertension might eventually develop from renovascular hypertension during very long missions. Without sufficient endothelial protection from pharmaceuticals, a comprehensive gene research program should begin now. PMID:21694921

  11. CO2 laser welding of magnesium alloys

    NASA Astrophysics Data System (ADS)

    Dhahri, Mohammed; Masse, Jean Eric; Mathieu, J. F.; Barreau, Gerard; Autric, Michel L.

    2000-02-01

    Metallic alloys with a low mass density can be considered to be basic materials in aeronautic and automotive industry. Magnesium alloys have better properties than aluminum alloys in respect of their low density and high resistance to traction. The main problems of magnesium alloy welding are the inflammability, the crack formation and the appearance of porosity during the solidification. The laser tool is efficient to overcome the difficulties of manufacturing by conventional processing. Besides, the laser processing mainly using shielding gases allows an effective protection of the metal against the action of oxygen and a small heat affected zone. In this paper, we present experimental results about 5 kW CO2 laser welding of 4 mm-thick magnesium alloy plates provided by Eurocopter France. The focused laser beam has about 0.15 mm of diameter. We have investigated the following sample: WE43, alloy recommended in aeronautic and space applications, is constituted with Mg, Y, Zr, rare earth. More ductile, it can be used at high temperatures until 250 degrees Celsius for times longer than 5000 hours without effects on its mechanical properties. A sample of RZ5 (French Norm: GZ4TR, United States Norm ZE41) is composed of Mg, Zn, Zr, La, rare earth. This alloy has excellent properties of foundry and it allows to the realization of components with complex form. Also, it has a good resistance and important properties of tightness. The parameters of the process were optimized in the following fields: laser power: 2 to 5 kW, welding speed: 1 to 4.5 m/min, focal position: -3 mm to +3 mm below or on the top of the metal surface, shielding gas: helium with a flow of 10 to 60 l/min at 4 bars. Metallurgical analyses and mechanical control are made (macroscopic structure, microscopic structure, interpretations of the structures and localization of possible defects, analyse phases, chemical composition, hardness, tensile test etc.) to understand the parameters influence of welding

  12. Short time effect of Chemiron (a combination iron preparation), single iron, and different magnesium salts on plasma. Magnesium concentration during early pregnancy in Nigerian women. A preliminary report.

    PubMed

    Ajayi, G O; Fadiran, E O

    1998-01-01

    Maternal magnesium requirements increase during pregnancy because of the synthesis of new tissue--both fetal and maternal. Magnesium takes part in almost 300 enzymatic reactions in the human body and regulates membrane permeability and protein bio-synthesis by promoting initiation and dissociation factors. The absorption velocity of magnesium differs from one tissue to another in animal experiments. It is highest in the liver, kidney, heart and is low in skeletal muscle, the brain and erythrocytes. It obeys and follows the Michaelis-Menten Kinetic law. 15 mmol of magnesium is consumed daily depending on the types of food takenin. The main sources of magnesium are vegetables and meats. Many Nigerian women are not able to afford enough of these. The amount of magnesium reabsorbed depends on the magnesium intake and not on magnesium needed which is about 10-40% of the intake. In this study, we examined the short-term effect of magnesium asphat HCL (614.18 mgMG), magnesium diasporal (magnesium citrate 610 mg + magnesium laevalitat 30 mg = 100 mg magnesium = 8.2 mval), ferrous gluconate (300 mg) plus folic acid and chemiron, a new combination hematinic agent (ferrous fumarate 300 mg, folic acid 5 mg, vitamin B12 10 mg, vitamin C 25 mg, magnesium sulfate 0.3 mg and zinc sulfate 0.3 mg) on plasma magnesium concentration during early pregnancy in Nigerian women. Significant increases of plasma magnesium concentrations were found in these groups (magnesium asphat HCL, 0.83 +/- 0.12 to 0.96 +/- 0.14 mmol/l, magnesium diasporal 0.843 +/- 0.14 to 0.891 +/- 0.14 mmol/l and chemiron 0.848 +/- to 0.866 +/- 0.16 mmol/l after five days. The ferrous gluconate and folic acid treated group showed no significant changes. This study shows that a chemiron supplement leads to increased magnesium plasma levels whereas ferrous gluconate and folic acid do not. These results suggest that the low level of magnesium is a normal physiological adjustment of pregnancy and that iron supplementation

  13. Removal of organic magnesium in coccolithophore calcite

    NASA Astrophysics Data System (ADS)

    Blanco-Ameijeiras, S.; Lebrato, M.; Stoll, H. M.; Iglesias-Rodriguez, M. D.; Méndez-Vicente, A.; Sett, S.; Müller, M. N.; Oschlies, A.; Schulz, K. G.

    2012-07-01

    Coccolithophore calcite refers to the plates of calcium carbonate (CaCO3) produced by the calcifying phytoplankton, coccolithophores. The empirical study of the elemental composition has a great potential in the development of paleoproxies. However, the difficulties to separate coccolithophore carbonates from organic phases hamper the investigation of coccoliths magnesium to calcium ratios (Mg/Ca) in biogeochemical studies. Magnesium (Mg) is found in organic molecules in the cells at concentrations up to 400 times higher than in inorganically precipitated calcite in present-day seawater. The aim of this study was to optimize a reliable procedure for organic Mg removal from coccolithophore samples to ensure reproducibility in measurements of inorganic Mg in calcite. Two baseline methods comprising organic matter oxidations with (1) bleach and (2) hydrogen peroxide (H2O2) were tested on synthetic pellets, prepared by mixing reagent grade CaCO3 with organic matter from the non-calcifying marine algae Chlorella autotrophica and measured with an ICP-AES (inductively coupled plasma-atomic emission spectrometer). Our results show that treatments with a reductive solution [using hydroxylamine-hydrochloride (NH2OH·HCl + NH4OH)] followed by three consecutive oxidations (using H2O2) yielded the best cleaning efficiencies, removing >99% of organic Mg in 24 h. P/Ca and Fe/Ca were used as indicators for organic contamination in the treated material. The optimized protocol was tested in dried coccolithophore pellets from batch cultures of Emiliania huxleyi, Calcidiscus leptoporus and Gephyrocapsa oceanica. Mg/Ca of treated coccolithophores were 0.151 ± 0.018, 0.220 ± 0.040, and 0.064 ± 0.023 mmol/mol, respectively. Comparison with Mg/Ca literature coccolith values, suggests a tight dependence on modern seawater Mg/Ca, which changes as a consequence of different seawater origins (<10%). The reliable determination of Mg/Ca and Sr/Ca, and the low levels of organic contamination

  14. Magnesium absorption from mineral water decreases with increasing quantities of magnesium per serving in rats.

    PubMed

    Nakamura, Eri; Tai, Hideyuki; Uozumi, Yoshinobu; Nakagawa, Koji; Matsui, Tohru

    2012-01-01

    It is hypothesized that magnesium (Mg) absorption from mineral water is affected by the concentration of Mg in the water, the consumption pattern, and the volume consumed per serving. The present study examined the effect of serving volume and consumption pattern of artificial mineral water (AMW) and Mg concentration on Mg absorption in rats. Magnesium in AMW was labeled with magnesium-25 as a tracer. Each group consisted of 6 or 7 rats. In experiment 1, the rats received 1 mL of AMW containing 200 mg Mg/L at 4 times, 400 mg Mg/L twice, or 800 mg Mg/L at 1 time. In experiment 2, the rats received 1 mL of AMW containing 200 mg Mg/L or 0.25 mL of AMW containing 800 mg Mg/L at 4 times or 1 mL of AMW containing 800 mg Mg/L at 1 time. The absorption of Mg decreased with increasing Mg concentrations in the same serving volume of AMW with different serving frequencies. When the AMW containing 800 mg Mg/L was portioned into 4 servings, Mg absorption increased to the level of absorption in the group exposed to AMW containing 200 mg Mg/L served at the same frequency. These results suggest that the Mg concentration and the volume of AMW do not affect Mg absorption per se, but Mg absorption from AMW decreases when the amount of Mg in each serving is increased. Thus, frequent consumption is preferable for mineral water rich in Mg when the total consumption of mineral water is the same.

  15. Recycling of Magnesium Alloy Employing Refining and Solid Oxide Membrane (SOM) Electrolysis

    NASA Astrophysics Data System (ADS)

    Guan, Xiaofei; Zink, Peter A.; Pal, Uday B.; Powell, Adam C.

    2013-04-01

    Pure magnesium was recycled from partially oxidized 50.5 wt pct Mg-Al scrap alloy and AZ91 Mg alloy (9 wt pct Al, 1 wt pct Zn). Refining experiments were performed using a eutectic mixture of MgF2-CaF2 molten salt (flux). During the experiments, potentiodynamic scans were performed to determine the electrorefining potentials for magnesium dissolution and magnesium bubble nucleation in the flux. The measured electrorefining potential for magnesium bubble nucleation increased over time as the magnesium content inside the magnesium alloy decreased. Potentiostatic holds and electrochemical impedance spectroscopy were employed to measure the electronic and ionic resistances of the flux. The electronic resistivity of the flux varied inversely with the magnesium solubility. Up to 100 pct of the magnesium was refined from the Mg-Al scrap alloy by dissolving magnesium and its oxide into the flux followed by argon-assisted evaporation of dissolved magnesium and subsequently condensing the magnesium vapor. Solid oxide membrane electrolysis was also employed in the system to enable additional magnesium recovery from magnesium oxide in the partially oxidized Mg-Al scrap. In an experiment employing AZ91 Mg alloy, only the refining step was carried out. The calculated refining yield of magnesium from the AZ91 alloy was near 100 pct.

  16. Magnesium Toxicity-Induced Ileus in a Postpartum Patient Treated for Preeclampsia With Magnesium Sulphate

    PubMed Central

    Al-Shoha, Mohammad; Klair, Jagpal S.; Girotra, Mohit

    2015-01-01

    Hypermagnesemia is a rare and under-recognized cause of paralytic ileus. We report a case of a 21-year-old primigravida who was managed aggressively for preeclampsia and presented with postpartum paralytic ileus. Detailed history was employed to consider hypermagnesemia-induced ileus as the working diagnosis, and the patient improved with correction of the electrolyte imbalance. Hypermagnesemia-induced lethargy, decreased reflexes, muscle weakness, flaccid paralysis, respiratory muscle paralysis, and cardiac arrest are well-described; however, intestinal smooth muscle dysfunction leading to paralytic ileus has never been reported in the setting of magnesium use for peripartum preeclampsia management. PMID:26203447

  17. Layered materials with improved magnesium intercalation for rechargeable magnesium ion cells

    DOEpatents

    Doe, Robert Ellis; Downie, Craig Michael; Fischer, Christopher; Lane, George Hamilton; Morgan, Dane; Nevin, Josh; Ceder, Gerbrand; Persson, Kristin Aslaug; Eaglesham, David

    2015-10-27

    Electrochemical devices which incorporate cathode materials that include layered crystalline compounds for which a structural modification has been achieved which increases the diffusion rate of multi-valent ions into and out of the cathode materials. Examples in which the layer spacing of the layered electrode materials is modified to have a specific spacing range such that the spacing is optimal for diffusion of magnesium ions are presented. An electrochemical cell comprised of a positive intercalation electrode, a negative metal electrode, and a separator impregnated with a nonaqeuous electrolyte solution containing multi-valent ions and arranged between the positive electrode and the negative electrode active material is described.

  18. Layered materials with improved magnesium intercalation for rechargeable magnesium ion cells

    DOEpatents

    Doe, Robert Ellis; Downie, Craig Michael; Fischer, Christopher; Lane, George Hamilton; Morgan, Dane; Nevin, Josh; Ceder, Gerbrand; Persson, Kristin Aslaug; Eaglesham, David

    2016-07-26

    Electrochemical devices which incorporate cathode materials that include layered crystalline compounds for which a structural modification has been achieved which increases the diffusion rate of multi-valent ions into and out of the cathode materials. Examples in which the layer spacing of the layered electrode materials is modified to have a specific spacing range such that the spacing is optimal for diffusion of magnesium ions are presented. An electrochemical cell comprised of a positive intercalation electrode, a negative metal electrode, and a separator impregnated with a nonaqueous electrolyte solution containing multi-valent ions and arranged between the positive electrode and the negative electrode active material is described.

  19. Layered materials with improved magnesium intercalation for rechargeable magnesium ion cells

    DOEpatents

    Doe, Robert E.; Downie, Craig M.; Fischer, Christopher; Lane, George H.; Morgan, Dane; Nevin, Josh; Ceder, Gerbrand; Persson, Kristin A.; Eaglesham, David

    2016-01-19

    Electrochemical devices which incorporate cathode materials that include layered crystalline compounds for which a structural modification has been achieved which increases the diffusion rate of multi-valent ions into and out of the cathode materials. Examples in which the layer spacing of the layered electrode materials is modified to have a specific spacing range such that the spacing is optimal for diffusion of magnesium ions are presented. An electrochemical cell comprised of a positive intercalation electrode, a negative metal electrode, and a separator impregnated with a nonaqueous electrolyte solution containing multi-valent ions and arranged between the positive electrode and the negative electrode active material is described.

  20. Weakening of ice by magnesium perchlorate hydrate

    USGS Publications Warehouse

    Lenferinka, Hendrick J.; Durhama, William B.; Sternb, Laura A.; Patharec, Asmin V.

    2013-01-01

    We show that perchlorate hydrates, which have been detected at high circumpolar martian latitudes, have a dramatic effect upon the rheological behavior of polycrystalline water ice under conditions applicable to the North Polar Layered Deposits (NPLD). We conducted subsolidus creep tests on mixtures of ice and magnesium perchlorate hydrate, Mg(ClO4)2·6H2O (MP6), of 0.02, 0.05, 0.10, and 0.47 volume fraction MP6. We found these mixtures to be increasingly weak with increasing MP6 content. For mixtures with ⩽0.10 volume fraction MP6, we resolved a stress exponent of n ≈ 2 at low stresses transitioning to n ≈ 4 above 10 MPa. Scanning electron microscopy of deformed specimens revealed MP6 to be distributed as an interconnected film between ice grains. These results suggest that grain boundary sliding (GBS) may be enhanced with respect to pure ice. As the enhancement of GBS is expected in polycrystalline aggregates containing a few percent melt or otherwise weak material distributed along grain boundaries, the observed n ≈ 2 is consistent with the mutual accommodation of basal slip and GBS. If ice containing trace concentrations of MP6 is also much weaker than pure ice at low stresses, flow in the NPLD could be significantly enhanced, particularly at the warmer basal temperatures associated with higher martian obliquities.

  1. Magnesium molybdate catalyst for oxidation of butane

    SciTech Connect

    Khazai, B.; Vrieland, G.E.; Murchison, C.B.

    1993-12-31

    Magnesia supported molybdenum oxide has been shown to exhibit catalytic activity in the partial oxidation of butane to 1,3-butadiene. This reaction is carried out in the absence of gaseous oxygen and the catalyst is regenerated by contacting with air in a separate step. The authors have been investigating the use of transport bed technology for this reaction as the relatively short time intervals involved between regenerations (order of seconds) require rapid cycling of the reaction/reoxidation steps for a continuous process. To meet the attrition criteria the authors have developed a multiphase catalyst system based on a dispersion of molybdenum oxide on a magnesia/magnesium aluminate substrate. Hardness is provided by a gamma alumina matrix which displays Davison attrition numbers of 1-5. The catalyst which shows conversions of 35-40% and selectivities to C4 olefins of approximately 80% in a pulsed reactor has been characterized by a variety of techniques. This paper will present data on the catalyst properties and will discuss phase development during synthesis.

  2. The magnesium chelation step in chlorophyll biosynthesis

    SciTech Connect

    Weinstein, J.D.

    1991-01-01

    The biogenesis of energy transducing membranes requires the coordinate synthesis of prosthetic groups, proteins and lipids. Two of the major prosthetic groups, chlorophyll and heme, share a common biosynthetic pathway that diverges at the point of metal insertion into protoporphyrin IX. Insertion of iron leads to heme, while insertion of magnesium leads to chlorophyll. The Mg-chelatase from intact cucumber chloroplasts has been characterized with regard to substrate specificity, regulation, ATP requirement, and a requirement for intact chloroplasts. Mg-chelatase was isolated from maize, barley and peas and characterized in order to circumvent the intact chloroplast requirement of cucumber Mg-chelatase. Pea Mg-chelatase activity is higher than cucumber Mg-chelatase activity, and lacks the requirement for intact chloroplasts. Studies on isolated pea Mg-chelatase have shown more cofactors are required for the reaction than are seen with ferrochelatase, indicating a greater opportunity for regulatory control of this pathway. Two of the cofactors are proteins, and there appears to be a requirement for a protease-sensitive component which is outside the outer envelope. We are developing a continuous spectrophotometric assay for Mg-chelatase activity, and an assay for free heme which has shown heme efflux from intact chloroplasts. 18 refs. (MHB)

  3. Buffer-regulated biocorrosion of pure magnesium.

    PubMed

    Kirkland, Nicholas T; Waterman, Jay; Birbilis, Nick; Dias, George; Woodfield, Tim B F; Hartshorn, Richard M; Staiger, Mark P

    2012-02-01

    Magnesium (Mg) alloys are being actively investigated as potential load-bearing orthopaedic implant materials due to their biodegradability in vivo. With Mg biomaterials at an early stage in their development, the screening of alloy compositions for their biodegradation rate, and hence biocompatibility, is reliant on cost-effective in vitro methods. The use of a buffer to control pH during in vitro biodegradation is recognised as critically important as this seeks to mimic pH control as it occurs naturally in vivo. The two different types of in vitro buffer system available are based on either (i) zwitterionic organic compounds or (ii) carbonate buffers within a partial-CO(2) atmosphere. This study investigated the influence of the buffering system itself on the in vitro corrosion of Mg. It was found that the less realistic zwitterion-based buffer did not form the same corrosion layers as the carbonate buffer, and was potentially affecting the behaviour of the hydrated oxide layer that forms on Mg in all aqueous environments. Consequently it was recommended that Mg in vitro experiments use the more biorealistic carbonate buffering system when possible.

  4. Overview: recognizing the problem of magnesium deficiency

    SciTech Connect

    Seelig, M.S.

    1988-01-01

    The magnesium content of the usual American diet is less than the recommended dietary allowance. Excesses of some macro- and micro-nutrients interact with Mg, increasing its requirements. Marginal deficiency of Mg is not associated with hypomagnesemia, is not characterized by typical manifestations, as is thus difficult to diagnose. Serum or plasma Mg levels are held within narrow limits unless tissue levels are very low, or renal function is poor. Vulnerability to Mg deficiency increases during growth and development, pregnancy, when under physical or psychological stress, and during illness or its treatment that interferes with absorption or causes loss of Mg. Evidence of biochemical changes of early Mg deficiency is rarely sought, although the roles of Mg in many enzyme systems are recognized. The effects of Mg deficiency on metabolism, even in disorders caused by vitamin dependencies in which Mg is a co-factor, are largely unexplored. Deficiency of Mg is diagnosed confidently when the laboratory reports hypomagnesemia in patients with convulsions or arrhythmias. Without these signs, Mg levels are not often ordered, even in the presence of neuromuscular irritability such as respond to Mg repletion. Because Mg supplementation or Mg-sparing drugs protect against premature or ectopic heart beats and sudden death, to which diuretic-treated hypertensive patients are at risk, it is increasingly being advised that their Mg status be determined.

  5. Nanoconfined water in magnesium-rich phyllosilicates.

    SciTech Connect

    Nenoff, Tina Maria; Durkin, Justin S.; Daemen, Luke L.; Ockwig, Nathan W.; Cygan, Randall Timothy; Greathouse, Jeffery A.

    2009-10-01

    Inelastic neutron scattering, density functional theory, ab initio molecular dynamics, and classical molecular dynamics were used to examine the behavior of nanoconfined water in palygorskite and sepiolite. These complementary methods provide a strong basis to illustrate and correlate the significant differences observed in the spectroscopic signatures of water in two unique clay minerals. Distortions of silicate tetrahedra in the smaller-pore palygorskite exhibit a limited number of hydrogen bonds having relatively short bond lengths. In contrast, without the distorted silicate tetrahedra, an increased number of hydrogen bonds are observed in the larger-pore sepiolite with corresponding longer bond distances. Because there is more hydrogen bonding at the pore interface in sepiolite than in palygorskite, we expect librational modes to have higher overall frequencies (i.e., more restricted rotational motions); experimental neutron scattering data clearly illustrates this shift in spectroscopic signatures. Distortions of the silicate tetrahedra in these minerals effectively disrupts hydrogen bonding patterns at the silicate-water interface, and this has a greater impact on the dynamical behavior of nanoconfined water than the actual size of the pore or the presence of coordinatively-unsaturated magnesium edge sites.

  6. K-SHELL PHOTOABSORPTION OF MAGNESIUM IONS

    SciTech Connect

    Hasoğlu, M. F.; Abdel-Naby, Sh. A.; Gatuzz, E.; Mendoza, C.; García, J.; Kallman, T. R.; Gorczyca, T. W.

    2014-09-01

    X-ray photoabsorption cross sections have been computed for all magnesium ions with three or more electrons using the R-matrix method. A comparison with other available data for Mg II-Mg X shows good qualitative agreement in the resultant resonance shapes. However, for the lower ionization stages, and for singly ionized Mg II in particular, the previous R-matrix results overestimate the K-edge position due to the neglect of important orbital relaxation effects, and a global shift downward in photon energy of those cross sections is therefore warranted. We have found that the cross sections for Mg I and Mg II are further complicated by the M-shell (n = 3) occupancy. As a result, the treatment of spectator Auger decay of 1s → np resonances using a method based on multichannel quantum defect theory and an optical potential becomes problematic, making it necessary to implement an alternative, approximate treatment of Auger decay for neutral Mg I. The new cross sections are used to fit the Mg K edge in XMM-Newton spectra of the low-mass X-ray binary GS 1826-238, where most of the interstellar Mg is found to be in ionized form.

  7. Status of Research on Magnesium Oxide Backfill

    SciTech Connect

    PAPENGUTH,HANS W.; KRUMHANSL,JAMES L.; BYNUM,R. VANN; WANG,YIFENG; KELLY,JOHN W.; ANDERSON,HOWARD; NOWAK,E. JAMES

    2000-07-31

    For the WIPP, chemical and physical characteristics of MgO suggest it to be the most beneficial backfill choice, particularly because it has the ability to buffer the aqueous chemical conditions to control actinide volubility. In the current experimental program, the authors are developing a technical basis for taking credit for the complete set of attributes of MgO in geochemical, hydrogeological, and geomechanical technical areas, resulting in an improved conceptual model for the WIPP such as the following. Water uptake by MgO will delay the development of mobile actinides and gas generation by microbes and corrosion. Reduced gas generation will reduce or even eliminate spallings releases. As MgO hydrates, it swells, reducing porosity and permeability, which will inhibit gas flow in the repository, in turn reducing spallings releases. Hydration will also result in a self-sealing mechanism by which water uptake and swelling of MgO adjacent to a groundwater seep cuts off further seepage. Reaction with some groundwaters will produce cementitious materials, which will help to cement waste particles or produce a cohesive solid mass. Larger particles are less likely to be entrained in a spallings release. If sufficient water eventually accumulates in a repository to support microbial gas generation, magnesium carbonate cements will form; also producing good cohesion and strength.

  8. Meteoric Magnesium Ions in the Martian Atmosphere

    NASA Technical Reports Server (NTRS)

    Pesnell, William Dean; Grebowsky, Joseph

    1999-01-01

    From a thorough modeling of the altitude profile of meteoritic ionization in the Martian atmosphere we deduce that a persistent layer of magnesium ions should exist around an altitude of 70 km. Based on current estimates of the meteoroid mass flux density, a peak ion density of about 10(exp 4) ions/cm is predicted. Allowing for the uncertainties in all of the model parameters, this value is probably within an order of magnitude of the correct density. Of these parameters, the peak density is most sensitive to the meteoroid mass flux density which directly determines the ablated line density into a source function for Mg. Unlike the terrestrial case, where the metallic ion production is dominated by charge-exchange of the deposited neutral Mg with the ambient ions, Mg+ in the Martian atmosphere is produced predominantly by photoionization. The low ultraviolet absorption of the Martian atmosphere makes Mars an excellent laboratory in which to study meteoric ablation. Resonance lines not seen in the spectra of terrestrial meteors may be visible to a surface observatory in the Martian highlands.

  9. Potential automotive uses of wrought magnesium alloys

    SciTech Connect

    Gaines, L.; Cuenca, R.; Wu, S.; Stodolsky, F. |

    1996-06-01

    Vehicle weight reduction is one of the major means available to improve automotive fuel efficiency. High-strength steels, aluminum (Al), and polymers are already being used to reduce weight significantly, but substantial additional reductions could be achieved by greater use of low-density magnesium (Mg) and its alloys. Mg alloys are currently used in relatively small quantities for auto parts, generally limited to die castings (e.g., housings). Argonne National Laboratory`s Center for Transportation Research has performed a study for the Lightweight Materials Program within DOE`s Office of Transportation Materials to evaluate the suitability of wrought Mg and its alloys to replace steel/aluminum for automotive structural and sheet applications. Mg sheet could be used in body nonstructural and semi-structural applications, while extrusions could be used in such structural applications as spaceframes. This study identifies high cost as the major barrier to greatly increased Mg use in autos. Two technical R and D areas, novel reduction technology and better hot-forming technology, could enable major cost reductions.

  10. Magnesium induces neuronal apoptosis by suppressing excitability

    PubMed Central

    Dribben, W H; Eisenman, L N; Mennerick, S

    2010-01-01

    In clinical obstetrics, magnesium sulfate (MgSO4) use is widespread, but effects on brain development are unknown. Many agents that depress neuronal excitability increase developmental neuroapoptosis. In this study, we used dissociated cultures of rodent hippocampus to examine the effects of Mg++ on excitability and survival. Mg++-induced caspase-3-associated cell loss at clinically relevant concentrations. Whole-cell patch-clamp techniques measured Mg++ effects on action potential threshold, action potential peak amplitude, spike number and changes in resting membrane potential. Mg++ depolarized action potential threshold, presumably from surface charge screening effects on voltage-gated sodium channels. Mg++ also decreased the number of action potentials in response to fixed current injection without affecting action potential peak amplitude. Surprisingly, Mg++ also depolarized neuronal resting potential in a concentration-dependent manner with a +5.2 mV shift at 10 mM. Voltage ramps suggested that Mg++ blocked a potassium conductance contributing to the resting potential. In spite of this depolarizing effect of Mg++, the net inhibitory effect of Mg++ nearly completely silenced neuronal network activity measured with multielectrode array recordings. We conclude that although Mg++ has complex effects on cellular excitability, the overall inhibitory influence of Mg++ decreases neuronal survival. Taken together with recent in vivo evidence, our results suggest that caution may be warranted in the use of Mg++ in clinical obstetrics and neonatology. PMID:21364668

  11. The Phase Stabilities of Magnesium Hydroxychlorides

    NASA Astrophysics Data System (ADS)

    de Bakker, Jan; LaMarre, Joshua; Peacey, John; Davis, Boyd

    2012-08-01

    This work presents experimental determinations of oxide phase stabilities in the MgCl2-MgO-H2O system. Magnesium hydroxychlorides are compounds with the overall stoichiometry xMgO· yMgCl2· zH2O, which form from the reaction of MgO with MgCl2 brines. They have historically been of importance as the components of Sorel cements; they also have a central role in proposed flowsheets for chloride leaching of laterite nickel ores (among others) and treatment of waste liquors from carnallite processing. A phase diagram of the MgCl2-MgO-H2O system is presented, incorporating both this investigation's results and the values from the literature. Thermochemical values of the 2-form and 3-form hydroxychlorides are estimated from the phase diagram. In addition, a scanning electron microscopy (SEM) micrograph of the hydroxychloride precipitate is presented. The highlights of this article are as follows: Precipitates of stoichiometry xMgO· yMgCl2· zH2O were obtained by adding MgO to MgCl2 solutions.

  12. Fatigue Properties of Cast Magnesium Wheels

    NASA Astrophysics Data System (ADS)

    Li, Zhenming; Luo, Alan A.; Wang, Qigui; Peng, Liming; Zhang, Peng

    2016-08-01

    This paper investigates the fatigue properties and deformation behavior of a newly developed Mg-2.96Nd-0.21Zn-0.39Zr magnesium alloy wheel in both as-cast and T6 conditions. Compared with the as-cast alloy, the T6-treated alloy shows a significant increase in fatigue strength and cyclic stress amplitude. This is believed to be attributed to the change of defect type from porosity to oxides and the increased matrix strength in the T6 (peak-aged) condition. For the as-cast alloy wheel, fatigue failure mainly originated from the cast defects including porosity, oxide film, and inclusion at or near the sample surface. In the T6-treated alloy, however, oxides and inclusions or slip bands initiate the fatigue cracks. Solution treatment appears to reduce or eliminate the shrinkage porosity because of grain growth and dissolution of as-cast eutectic phases in the grain boundaries. The cyclic stress amplitude of the as-cast alloy increases with increasing the number of cycles, while the T6-treated alloy shows cyclic softening after the stress reaches a maximum value. The Coffin-Manson law and Basquin equation can be used to evaluate the life of low cycle fatigue. The developed long crack model and multi-scale fatigue (MSF) models can be used to predict high-cycle fatigue life of the Mg-2.96Nd-0.21Zn-0.39Zr alloys with or without casting defects.

  13. [Pros and cons of magnesium sulfate as a tocolytic].

    PubMed

    Bozhinova, S; Markova, S; Tsvetkov, Ts; Penkov, V; Ivanova, I

    2002-01-01

    Magnesium sulphate (MgSO4) is with a proved effectiveness in cases of praeclampsia/eclampsia, but its use as a tocolytic is discussed in the last few years. That is why we had for an object to study its effect as a tocolytic in cases of abortions and premature labours. The study is prospective and if is made in I-st obstetric clinic of High Medical School--Pleven. Treatment with Cormagnesin was carried out to pregnant women for suppressing the uterine activity. Cormagnesin 200 (1 amp-10 ml) contains 1000 mg MgSO4, and Cormagnesin 400 (1 amp-10 ml) contains 2000 mg MgSO4. The medicine was administered in dosage of 4 or 5 g for 30 min, and after that if there were any uterine contractions the infusion was carried on with additional 5 g MgSO4 for 6 to 12 h. The total dosage was from 4 to 60 g MgSO4. The authors reported on very good effect in cases with pains and increased uterine tone--18 (36.73%), as well as in cases with pains and irregular uterine contractions 5 (10.21%), while the treatment was without any effect in cases with uterine contractions on 15-20 min, increased uterine tone, bleeding and Pelvic score 1-3 points in spite of high dosages of MgSO4 and longer duration of treatment. The authors made the conclusion, that the subjective complaints should not be accepted as an indication for administration of MgSO4, and MgSO4 should be administered in cases with increased uterine tone and irregular uterine contractions. Every genital bleeding and suspicion for placental abruption should be defined more precisely, because lately diagnosed placental abruption and unjustified expectation for suppression of uterine activity by MgSO4, may lead to increase of perinatal morbidity and mortality. In spite of the controversial data about MgSO4 as a tocolytic, its administration is justified and necessary. PMID:12577499

  14. Corrosion prevention of magnesium surfaces via surface conversion treatments using ionic liquids

    DOEpatents

    Qu, Jun; Luo, Huimin

    2016-09-06

    A method for conversion coating a magnesium-containing surface, the method comprising contacting the magnesium-containing surface with an ionic liquid compound under conditions that result in decomposition of the ionic liquid compound to produce a conversion coated magnesium-containing surface having a substantially improved corrosion resistance relative to the magnesium-containing surface before said conversion coating. Also described are the resulting conversion-coated magnesium-containing surface, as well as mechanical components and devices containing the conversion-coated magnesium-containing surface.

  15. [Magnesium, calcium and potassium: "no one was born alone"].

    PubMed

    Rapisarda, Francesco; Portale, Grazia; Ferrario, Silvia; Sessa, Concetto; Aliotta, Roberta; Zanoli, Luca; Fatuzzo, Pasquale

    2016-01-01

    In contrast to other ions, magnesium is treated as an orphan by the body: there are no hormones that have a substantial role in regulating urinary magnesium excretion, and bone, the principal reservoir of magnesium, does not readily exchange with circulating magnesium.The Mg ++ is often overlooked by physicians in the differential diagnosis because it is considered insignificant, but its role is crucial for cells function, first of all neurons and cardiomyocytes. A condition of hypocalcemia associated with hypokalemia, especially in the presence of chronic renal failure, should raise suspicion of a lack of Mg ++.We report the case of an old man of 77 year with kidney transplant for 13 years, treated with cyclosporine, and sodium mycophenolate and steroid who, for about a month, accused impaired balance and walking instability, who fell accidentally down with wrist fracture.Blood tests showed hypocalcemia and hypokalemia, and so we required dosage of serum and urinary magnesium. A significant reduction in the ion plasma concentration was seen, associated to a fraction of excretion inappropriately high in relation to the degree of hypomagnesemia.The cause of this important renal loss is likely attributable to cyclosporine, a drug that has as a side effect the inhibition of the reabsorption of Mg ++ in the distal convoluted tubule. then, oral supplementation was started (244 mg of Mg ++ ion / day), with subsequent normalization, after a few days, not only of magnesiemia, but also in serum calcium and potassium levels, and improvement of neurological symptoms.Hypomagnesaemia is common in patients with renal transplantation in therapy with calcineurin inhibitors ICN, due to the effects of such drugs on the TRPM6 transporter present in the kidney distal convoluted tubule. To prevent complications caused by chronic and severe depletion of magnesium in this particular population, we recommend periodic monitoring of magnesium plasma levels.

  16. Magnesium and Ketamine Gargle and Postoperative Sore Throat

    PubMed Central

    Teymourian, Houman; Mohajerani, Seyed Amir; Farahbod, Alireza

    2015-01-01

    Background: Postoperative sore throat is one of the most common complications after endotracheal intubation. Both Ketamine and magnesium can block N-methyl-D-aspartic acid (NMDA) receptors and provide central and local analgesia. Objectives: To compare the effect of magnesium sulfate and ketamine gargle on the incidence and severity of postoperative sore throat. Patients and Methods: A total of 100 patients candidate for emergency acute appendicitis surgery were enrolled in the study. Patients in ketamine group received ketamine gargle (0.5 mg/kg) and magnesium group received magnesium sulfate gargle (20 mg/kg up to 30 mL dextrose water 20%) 15 minutes before the operation. Patient complaint of postoperative sore throat, and its severity measured by visual analogue scale (VAS) were recorded at baseline in recovery room, and then 2, 4, and 24 hours after operation. Results: There were no significant differences between age, sex, and body mass index (BMI) between two groups of patients. Hemodynamics of patients, including blood pressure, respiratory rate, oxygen saturation %, and conscious state were not significantly different (P > 0.05). Number of patients with sore throat were significantly lower in magnesium group compared to ketamine group at 2 (P = 0.032), 4 (P = 0.02), and 24 hours (P = 0.01) after the operation. Sore throat pain score (VAS) was significantly lower in magnesium group compared to ketamine group at 2 (P = 0.019), 4 (P = 0.028), and 24 hours (P = 0.014) after the operation. Conclusions: Magnesium at low dose decreases sore throat and pain severity more effectively compared to ketamine gargle. PMID:26161316

  17. Atomic layer deposition of magnesium fluoride via bis(ethylcyclopentadienyl)magnesium and anhydrous hydrogen fluoride

    SciTech Connect

    Hennessy, John Jewell, April D.; Greer, Frank; Lee, Michael C.; Nikzad, Shouleh

    2015-01-15

    A new process has been developed to deposit magnesium fluoride (MgF{sub 2}) thin films via atomic layer deposition (ALD) for use as optical coatings in the ultraviolet. MgF{sub 2} was deposited in a showerhead style ALD reactor using bis(ethylcyclopentadienyl)magnesium and anhydrous hydrogen fluoride (HF) as precursors at substrate temperatures from 100 to 250 °C. The use of HF was observed to result in improved morphology and reduced impurity content compared to other reported MgF{sub 2} ALD approaches that use metal fluoride precursors as the fluorine-containing chemistry. Characterization of these films has been performed using spectroscopic ellipsometry, atomic force microscopy, and x-ray photoelectron spectroscopy for material deposited on silicon substrates. Films at all substrate temperatures were transparent at wavelengths down to 190 nm and the low deposition temperature combined with low surface roughness makes these coatings good candidates for a variety of optical applications in the far ultraviolet.

  18. Dry sliding wear behaviour of magnesium oxide and zirconium oxide plasma electrolytic oxidation coated magnesium alloy

    NASA Astrophysics Data System (ADS)

    Bala Srinivasan, P.; Liang, J.; Blawert, C.; Dietzel, W.

    2010-03-01

    Two types of PEO coatings, one consisting of magnesium oxide (MgO) and the other comprising zirconium oxide (ZrO 2) as the main phase composition were produced on AM50 magnesium alloy from alkaline and acidic electrolytes, respectively. The ZrO 2 coating was found to be spongy and thicker with a higher roughness, whilst the relatively more compact MgO coating was having contrasting features. In the dry sliding oscillating wear tests under two different loads viz., 2 N and 5 N, the ZrO 2 coating exhibited a very poor wear resistance. The MgO coating showed an excellent resistance to sliding wear under 2 N load; however, the load bearing capacity of the coating was found to be insufficient to resist the wear damage under 5 N load. The higher specific wear rates of the MgO coating under 5 N load and that of the ZrO 2 coating under 2 N and 5 N loads were attributed to the poor load bearing capacity and a three-body-abrasive wear mechanism.

  19. Cerebrospinal fluid passage of intravenous magnesium sulfate in neurosurgical patients.

    PubMed

    Fuchs-Buder, T; Tramèr, M R; Tassonyi, E

    1997-10-01

    Increasing evidence suggests a neuroprotective potential of magnesium sulfate (MgSO4). Only limited information about the passage of MgSO4 to the cerebrospinal fluid (CSF) is available in neurosurgical patients. However, with regard to the clinical relevance of magnesium's neuroprotective properties, quantitative data about its CSF passage are needed. The present study aims to assess the amount and the time course of magnesium's CSF passage in neurosurgical patients. To this end, 20 patients undergoing general anesthesia for neurosurgery and needing CSF drainage were included. Patients received an i.v. bolus of 60 mg/kg MgSO4. The increase in plasma and CSF magnesium concentration were measured 30, 90, and 240 min after the end of the MgSO4 infusion. These values were compared with the baseline levels taken before the start of the MgSO4 infusion. Thus, each patient served as his or her own control. Values are expressed as means +/- SD. The plasma magnesium levels were measured as follows: baseline, 0.74 +/- 0.12 mM; at 30 min, 1.24 +/- 0.1 mM (p < 0.01); at 90 min, 0.95 +/- 0.15 mM (p < 0.01), and at 240 min, 0.82 +/- 0.14 mM (p < 0.05). The CSF magnesium levels were measured as follows: baseline, 0.95 +/- 0.11 mM; at 30 min, 1.00 +/- 0.15 mM (NS); at 90 min, 1.10 +/- 0.17 mM (p < 0.01); and at 240 min, 1.13 +/- 0.19 mM (p < 0.001). We concluded that a bolus of 60 mg/kg of MgSO4 leads at least after 90 min to a significant increase in the CSF magnesium concentration. Moreover, the increase in plasma and CSF magnesium concentration is not parallel. Thus, plasma magnesium concentration cannot be used to predict the changes in CSF concentrations.

  20. High Strength and Thermally Stable Nanostructured Magnesium Alloys and Nanocomposites

    NASA Astrophysics Data System (ADS)

    Chang, Yuan-Wei

    Magnesium and its alloys are currently in the spotlight of global research because of the need to limit energy consumption and reduce the environmental impact. In particular, their low densities compared to other structural metals make them a very attractive alternative in the automobile and aerospace industries. However, their low strength compared to other structural materials (e.g. Al and steels) has limited their widespread application. This dissertation presents the results of developing and investigation of a high strength nanostructured magnesium-aluminum alloy and composite. The nanostructured magnesium alloy is prepared by cryomilling and consolidated by spark-plasma-sintering. Focused ion beam is used to prepare micropillars with different diameters ranging from 1.5 to 8 mum and micro-compression test is conducted by nanoindenter in order to evaluate the mechanical properties. The yield strength obtained in the present study is around three times higher than conventional magnesium alloys (120 MPa vs. 370 MPa). The yield strength of the nanostructured magnesium alloy is further improved through hot extrusion, resulting in a yield strength of 550 MPa and an ultimate strength of 580 MPa. The nanostructured magnesium alloy exhibits a strong size-dependence, and a significant improvement in strength is observed when the pillar diameter is reduced to below 3.5 mum. The deformation mechanisms of the compressed pillars were characterized using transmission electron microscopy. The size-induced strengthening is attributed to a less number of dislocation sources along with a higher activity of non-basal deformation mechanisms. We have also developed a high strength and thermally stable nanostructured magnesium composite by adding diamantane. A yield strength of 500 MPa is achieved, moreover, excellent thermal stability is demonstrated in the magnesium alloy containing diamantanes. The strength and grain size are thermally stable after annealing at 400°C for 100

  1. Facile and fast fabrication of superhydrophobic surface on magnesium alloy

    NASA Astrophysics Data System (ADS)

    Wang, Zhongwei; Li, Qing; She, Zuxin; Chen, Funan; Li, Longqin; Zhang, Xiaoxu; Zhang, Peng

    2013-04-01

    Superhydrophobic surface has many special functions and is widely investigated by researchers. Magnesium alloy is one of the lightest metal materials among the practice metals. It plays an important role in automobile, airplane and digital product for reducing devices weight. But due to the low standard potential, magnesium alloy has a high chemical activity and easily be corroded. That seriously impedes the application of magnesium alloy. In the process of fabrication a superhydrophobic surface on magnesium alloy, there are two ineluctable problems that must be solved: (1) high chemical activity and (2) the chemical activity is inhomogeneous on surface. In this study, we solved those problems by using the two characters to gain a rough surface on magnesium alloy and obtained a superhydrophobic surface after following modification process. The results show that the as-prepared superhydrophobic surface has obvious anti-corrosion effect in typically corrosive solution and naturally humid air. The delay-icing and self-cleaning effects are also investigated. The presented method is low-cost, fast and has great potential value in large-scale industry production.

  2. Deleterious effects of magnesium intoxication upon the domestic broiler chick

    SciTech Connect

    Lee, S.R.

    1984-01-01

    Dietary levels of 0.6 to 0.8% magnesium in a corn-soy basal were rachitogenic. These rickets appeared most like phosphorus deficiency. Bone Ca/P ratios were numerically quite low implying a lack of transformation from amorphous calcium phosphate to hydroxyapatite. Bone alkaline phosphatase activity was elevated. Additional dietary phosphorus ameliorated, but could not overcome the rachitogenic effects of magnesium. Tibial dyschondroplasia (TD), induced by elevated dietary P, was decreased by high levels of dietary Mg, but with no decrease in plasma phosphorus. Anticoccidial ionophores fed in conjunction with a moderate dietary challenge of Mg (0.48%) produced no clear changes in plasma calcium or Mg, but did interact to reduce body weight. The diarrhea caused by magnesium intoxication is not due to hyperosmotic loads of Mg per se. Rather, Cl was observed to be the major ionic constituent of the gut osmotic load implying different gut ionic fluxes in control versus magnesium intoxicated chicks. These data imply that the cathartic action of Mg is due to hypersecretion of the gut. Effects mediated or modified by the CNS changed in magnesium intoxicated chicks. Such chicks appeared cold and stayed near the heat. When startled, they exhibited extreme avoidance behavior and seizures similar to epilepsy and/or Cl deficiency. Brain tissue Mg content did not concomitantly increase. Whether these effects are due to central signals is unclear.

  3. USAMP Magnesium Powertrain Cast Components: Fundamental research summary

    NASA Astrophysics Data System (ADS)

    Beals, Randy S.; Liu, Zi-Kui; Wayne Jones, J.; Mallick, P. K.; Emadi, Daryoush; Schwam, David; Powell, Bob R.

    2007-08-01

    The Magnesium Powertrain Cast Components (MPCC) Project is an effort, jointly sponsored by the U.S. Department of Energy and the U.S. Automotive Materials Partnership (USAMP), to demonstrate the readiness of magnesium for use in powertrain applications by testing a set the magnesium-intensive engines which were designed, cast, and assembled. A second MPCC goal is to promote new and strengthen existing magnesium scientific research in North America. The project investigated several of the newly developed high-temperature (creep-resistant) magnesium alloys, which will potentially experience service conditions in the temperature range of 150-200°C and about 50-110 MPa in stresses (typical powertrain). However, the mechanical and physical behaviors of these new alloys are not fully understood. This article outlines MPCC-supported fundamental scientific research into the workings of these new alloys. The areas of research are: phase equilibrium and computational thermodynamics, creep deformation mechanisms, corrosion, hot tearing, and alloy recycling.

  4. Maternal Serum Magnesium Level and Low Birth Weight Neonate

    PubMed Central

    Parizadeh, Seyed Mohammadreza; Mohammadzadeh, Ashraf; Farhat, Ahmadshah; Valaee, Laya; Khajedaluee, Mohammad; Faal, Gholamreza

    2013-01-01

    Background: The aim of study was to compare the serum level of magnesium in mothers having low birth weight with those having normal birth weight neonates. Methods: In a case-control study, women who delivered low birth weight neonate (cases), compared with normal birth weight (controls) in serum concentration of magnesium. Blood samples collected within 24 h after delivery. Concentration of magnesium assessed by standard atomic absorption spectro-photometry. Multiple linear regression analysis was performed to control of potential confounding variables. Results: A total of 116 mothers (67 cases and 49 control) were studied. Mothers in two groups did not differ in age, body mass index, and socioeconomic or demographic factors. Maternal magnesium concentration did not differ between two groups 0.86 ± 0.11 m.mol/l versus 0.94 ± 0.22 m.mol/l respectively (P = 0.09). Conclusion: There is no significant difference between serum magnesium levels of low birth weight infants’ mother and normal weight infants’ mother. PMID:24498506

  5. Susceptibility of metallic magnesium implants to bacterial biofilm infections.

    PubMed

    Rahim, Muhammad Imran; Rohde, Manfred; Rais, Bushra; Seitz, Jan-Marten; Mueller, Peter P

    2016-06-01

    Magnesium alloys have promising mechanical and biological properties as biodegradable medical implant materials for temporary applications during bone healing or as vascular stents. Whereas conventional implants are prone to colonization by treatment resistant microbial biofilms in which bacteria are embedded in a protective matrix, magnesium alloys have been reported to act antibacterial in vitro. To permit a basic assessment of antibacterial properties of implant materials in vivo an economic but robust animal model was established. Subcutaneous magnesium implants were inoculated with bacteria in a mouse model. Contrary to the expectations, bacterial activity was enhanced and prolonged in the presence of magnesium implants. Systemic antibiotic treatments were remarkably ineffective, which is a typical property of bacterial biofilms. Biofilm formation was further supported by electron microscopic analyses that revealed highly dense bacterial populations and evidence for the presence of extracellular matrix material. Bacterial agglomerates could be detected not only on the implant surface but also at a limited distance in the peri-implant tissue. Therefore, precautions may be necessary to minimize risks of metallic magnesium-containing implants in prospective clinical applications. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1489-1499, 2016. PMID:26860452

  6. Effects of calcium and magnesium on strontium distribution coefficients

    USGS Publications Warehouse

    Bunde, R.L.; Rosentreter, J.J.; Liszewski, M.J.; Hemming, C.H.; Welhan, J.

    1997-01-01

    The effects of calcium and magnesium on the distribution of strontium between a surficial sediment and simulated wastewater solutions were measured as part of an investigation to determine strontium transport properties of surficial sediment at the Idaho National Engineering Laboratory (INEL), Idaho. The investigation was conducted by the U.S. Geological Survey and Idaho State University, in cooperation with the U.S. Department of Energy. Batch experimental techniques were used to determine strontium linear sorption isotherms and distribution coefficients (K(d)'s) using simulated wastewater solutions prepared at pH 8.0??0.1 with variable concentrations of calcium and magnesium. Strontium linear sorption isotherm K(d)'s ranged from 12??1 to 85??3 ml/g, increasing as the concentration of calcium and magnesium decreased. The concentration of sorbed strontium and the percentage of strontium retained by the sediment were correlated to aqueous concentrations of strontium, calcium, and magnesium. The effect of these cation concentrations on strontium sorption was quantified using multivariate least-squares regression techniques. Analysis of data from these experiments indicates that increased concentrations of calcium and magnesium in wastewater discharged to waste disposal ponds at the INEL increases the availability of strontium for transport beneath the ponds by decreasing strontium sorption to the surficial sediment.

  7. Formability Analysis of Magnesium Alloy Sheet Bulging Using FE Simulation

    NASA Astrophysics Data System (ADS)

    Mac Donald, B. J.; Hunt, D.; Yoshihara, S.; Manabe, K.

    2007-05-01

    There is currently much focus on the application of magnesium alloys to automotive structural components. This has arisen due to the positive environmental aspects associated with use of magnesium alloys such as weight reduction and recycling potential. In recent years many researchers have focused on the application of various forming processes to magnesium alloys. Magnesium alloys would seem highly suitable for sheet forming due to high N and r values, however, in application their formability has been inferior to, for example, aluminium alloys. It has thus been concluded that, when dealing with magnesium alloys, it is difficult to predict formability based on material properties. In order to improve formability and forming accuracy when using Mg alloys it is necessary to build a database and inference system which could decide the optimal forming parameters for complex automotive components. Currently not enough data is available to build such a database due to the limited number of studies available in literature. In this study an experimental analysis of hemispherical bulge forming at elevated temperature was undertaken in order to evaluate formability and hence build a database for forming process design. A finite element model based on the experiment has been built and validated against the experimental results. A ductile failure criterion has been integrated with the FE model and is used to predict the onset of failure. This paper discusses the development and validation of the finite element model with the ductile failure criterion and presents results from the experimental tests and FE simulations.

  8. Metabolic supplementation with orotic acid and magnesium orotate.

    PubMed

    Rosenfeldt, F L

    1998-09-01

    Orotic acid (OA), a naturally occurring substance, is a key intermediate in the biosynthetic pathway of pyrimidines. Previous investigations in the heart suggest that orotate can protect recently infarcted hearts against a further ischemic stress and may be beneficial in certain types of experimental cardiomyopathy. At the Hamburg symposium on magnesium orotate, a number of studies of this form of metabolic supplementation were presented that indicate orotic acid and its magnesium salt have a modest beneficial effect on the myocardium under conditions of stress ranging from myocardial infarction to severe physical exercise. The following conclusions can be drawn: (1) Orotic acid can improve the energy status of the recently infarcted myocardium (rat hearts). (2) Orotic acid may improve myocardial purine and pyrimidine levels by stimulating hepatic release of uridine into the bloodstream, which in turn augments depleted myocardial pyrimidines and purines (rat heart). (3) Orotic acid improves the tolerance of the recently infarcted heart to global ischemia (rats). (4) Magnesium orotate may reduce the severity of chronic myocardial dysfunction and structural damage in cardiomyopathy (cardiomyopathic hamsters). (5) Magnesium orotate may improve exercise tolerance in patients with coronary artery disease and in trained athletes (humans). (6) Magnesium orotate has only a weak inotropic effect, if any, on normal hearts (rats). (7) Further clinical testing is indicated to determine if the effects described could be of significant clinical benefit in the treatment of heart disease. PMID:9794088

  9. Size Effect on Magnesium Alloy Castings

    NASA Astrophysics Data System (ADS)

    Li, Zhenming; Wang, Qigui; Luo, Alan A.; Zhang, Peng; Peng, Liming

    2016-06-01

    The effect of grain size on tensile and fatigue properties has been investigated in cast Mg alloys of Mg-2.98Nd-0.19Zn (1530 μm) and Mg-2.99Nd-0.2Zn-0.51Zr (41 μm). The difference between RB and push-pull fatigue testing was also evaluated in both alloys. The NZ30K05-T6 alloy shows much better tensile strengths (increased by 246 pct in YS and 159 pct in UTS) and fatigue strength (improved by ~80 pct) in comparison with NZ30-T6 alloy. RB fatigue testing results in higher fatigue strength compared with push-pull fatigue testing, mainly due to the stress/strain gradient in the RB specimen cross section. The material with coarse grains could be hardened more in the cyclic loading condition than in the monotonic loading condition, corresponding to the lower σ f and the higher σ f/ σ b or σ f/ σ 0.2 ratio compared to the materials with fine grains. The fatigue crack initiation sites and failure mechanism are mainly determined by the applied stress/strain amplitude. In LCF, fatigue failure mainly originates from the PSBs within the surface or subsurface grains of the samples. In HCF, cyclic deformation and damage irreversibly caused by environment-assisted cyclic slip is the crucial factor to influence the fatigue crack. The Coffin-Manson law and Basquin equation, and the developed MSF models and fatigue strength models can be used to predict fatigue lives and fatigue strengths of cast magnesium alloys.

  10. Effect of magnesium on nerve conduction velocity during regular dialysis treatment

    PubMed Central

    Fleming, Laura W.; Lenman, J. A. R.; Stewart, W. K.

    1972-01-01

    Serial nerve conduction velocities in the peroneal and ulnar nerves have been measured in 10 patients on regular dialysis treatment over a three year period. Each patient alternated between phases on dialysis with magnesium-containing dialysate (1·5-1·7 m-equiv/l.) and phases on `magnesium-free' dialysate (0·2 m-equiv/l.). Plasma magnesium concentrations were high both pre- and post-dialysis during magnesium-containing dialysis, and normal to low on magnesium-free dialysis. All patients had defects in nerve conduction, mainly asymptomatic. Increases in nerve conduction velocity coincided with magnesium-free dialysis, and decreases occurred when the patients reverted to magnesium-containing dialysate. The significance of the correlation by the sign test was P<0·0005. It is concluded that extracellular magnesium levels can influence the rate of nerve conduction in vivo. PMID:4338446

  11. Interactions between aggressive ions and the surface of a magnesium-yttrium alloy.

    PubMed

    Johnson, Ian; Perchy, Daniel; Liu, Huinan

    2012-01-01

    Magnesium alloys possess many desirable properties for biodegradable orthopedic implants. Unfortunately, magnesium degrades too rapidly in vivo. This rapid degradation reduces the alloys' mechanical properties and increases the alkalinity of the local environment. Controlling the degradation rate and mode is an essential step in the development of magnesium based biomaterials. Accomplishing this essential step will require an improved understanding of magnesium alloy degradation. Herein, three interacting factors controlling magnesium degradation were investigated; (1) alloy composition, (2) alloy surface, (3) presence of aggressive ions in the immersion media. The magnesium-yttrium alloy was more susceptible to degradation in water than the high purity magnesium alloy. However, the polished surface magnesium-yttrium alloy had the least susceptibility to degradation in phosphate buffered saline (PBS) among all the sample compositions and surfaces.

  12. Protective effect of magnesium nitrate against neurological disorders provoked by cerebral ischemia in rats.

    PubMed

    Kuzenkov, V S; Krushinskii, A L

    2014-10-01

    The study examined effects of inorganic magnesium agents: magnesium nitrate Mg(NO3)2, magnesium sulfate MgSO4, and magnesium chloride MgCl2 on the development of neurological disorders and mortality in rats resulting from cerebral ischemia provoked by a single-stage bilateral occlusion of the common carotid arteries. The rats were injected with one of examined magnesium preparations (5 mg/1 kg body weight) 1 h prior to or 1-2 sec after occlusion. The control group rats were treated with physiological saline at the same terms. Irrespective of the moment of injection, magnesium nitrate demonstrated significant protective effect on dynamics of neurological disorders and mortality, while similar effects of magnesium sulfate and magnesium chloride were insignificant.

  13. Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study

    Technology Transfer Automated Retrieval System (TEKTRAN)

    OBJECTIVES: The aim of this study was to examine whether magnesium intake is associated with coronary artery calcification (CAC) and abdominal aortic calcification (AAC). BACKGROUND: Animal and cell studies suggest that magnesium may prevent calcification within atherosclerotic plaques underlying c...

  14. Permeation of topically applied Magnesium ions through human skin is facilitated by hair follicles.

    PubMed

    Chandrasekaran, Navin Chandrakanth; Sanchez, Washington Y; Mohammed, Yousuf H; Grice, Jeffrey E; Roberts, Michael S; Barnard, Ross T

    2016-06-01

    Magnesium is an important micronutrient essential for various biological processes and its deficiency has been linked to several inflammatory disorders in humans. Topical magnesium delivery is one of the oldest forms of therapy for skin diseases, for example Dead Sea therapy and Epsom salt baths. Some anecdotal evidence and a few published reports have attributed amelioration of inflammatory skin conditions to the topical application of magnesium. On the other hand, transport of magnesium ions across the protective barrier of skin, the stratum corneum, is contentious. Our primary aim in this study was to estimate the extent of magnesium ion permeation through human skin and the role of hair follicles in facilitating the permeation. Upon topical application of magnesium solution, we found that magnesium penetrates through human stratum corneum and it depends on concentration and time of exposure. We also found that hair follicles make a significant contribution to magnesium penetration. PMID:27624531

  15. Magnesium recycling in the United States in 1998

    USGS Publications Warehouse

    Kramer, Deborah A.

    2001-01-01

    As concern for the environment has grown in recent years, the importance of recycling has become more evident. The more materials that are recycled, the fewer natural resources will be consumed and the fewer waste products will end up in landfills, in the water, and in the air. As one of a series of reports on metals recycling, this report discusses the 1998 flow of magnesium from extraction through its uses with particular emphasis on recycling. In 1998, the recycling rate for magnesium was estimated to be 33 percent?almost 60 percent of the magnesium that was recycled came from new scrap, primarily waste from diecasting operations. The principal source of old scrap was recycled aluminum beverage cans.

  16. Magnesium recycling in the United States in 1998

    USGS Publications Warehouse

    Kramer, Deborah A.

    2002-01-01

    As concern for the environment has grown in recent years, the importance of recycling has become more evident. The more materials that are recycled, the fewer natural resources will be consumed and the fewer waste products will end up in landfills, the water, and the air. As one of a series of reports on metals recycling, this report discusses the 1998 flow of magnesium in the United States from extraction through its uses with particular emphasis on recycling. In 1998, the recycling efficiency for magnesium was estimated to be 33 percent--almost 60 percent of the magnesium that was recycled came from new scrap, primarily waste from die-casting operations. The principal source of old scrap was recycled aluminum beverage cans.

  17. Nanostructured material for advanced energy storage : magnesium battery cathode development.

    SciTech Connect

    Sigmund, Wolfgang M.; Woan, Karran V.; Bell, Nelson Simmons

    2010-11-01

    Magnesium batteries are alternatives to the use of lithium ion and nickel metal hydride secondary batteries due to magnesium's abundance, safety of operation, and lower toxicity of disposal. The divalency of the magnesium ion and its chemistry poses some difficulties for its general and industrial use. This work developed a continuous and fibrous nanoscale network of the cathode material through the use of electrospinning with the goal of enhancing performance and reactivity of the battery. The system was characterized and preliminary tests were performed on the constructed battery cells. We were successful in building and testing a series of electrochemical systems that demonstrated good cyclability maintaining 60-70% of discharge capacity after more than 50 charge-discharge cycles.

  18. Hybrid system for rechargeable magnesium battery with high energy density

    PubMed Central

    Chang, Zheng; Yang, Yaqiong; Wang, Xiaowei; Li, Minxia; Fu, Zhengwen; Wu, Yuping; Holze, Rudolf

    2015-01-01

    One of the main challenges of electrical energy storage (EES) is the development of environmentally friendly battery systems with high safety and high energy density. Rechargeable Mg batteries have been long considered as one highly promising system due to the use of low cost and dendrite-free magnesium metal. The bottleneck for traditional Mg batteries is to achieve high energy density since their output voltage is below 2.0 V. Here, we report a magnesium battery using Mg in Grignard reagent-based electrolyte as the negative electrode, a lithium intercalation compound in aqueous solution as the positive electrode, and a solid electrolyte as a separator. Its average discharge voltage is 2.1 V with stable discharge platform and good cycling life. The calculated energy density based on the two electrodes is high. These findings open another door to rechargeable magnesium batteries. PMID:26173624

  19. The Superheat Phenomenon in the Combustion of Magnesium Particles

    NASA Technical Reports Server (NTRS)

    Shafirovich, E. IA.; Goldshleger, U. I.

    1992-01-01

    Magnesium is known to be a likely fuel for engines that could work in the CO2 atmospheres of Mars and Venus. The present paper reports temperature measurements of magnesium samples during combustion in CO2. The burning sample temperature increases with the decrease in the initial size. The temperature of the 1-mm samples is 300-400 K higher than the boiling point of magnesium. The stability of the superheated drop is explained by the presence of a porous shell on the surface. An attempt has been made to describe vaporization on the superheated drop by the Knudsen-Langmuir equation. During combustion at high-pressure fragment ejection of the flame is observed in high-speed motion pictures. This phenomenon is shown to be connected with the drop superheat. The repeated fracture of the outer shell formed in the flame ensures the complete burnout of metal particles at high pressure.

  20. [Magnesium: the missing link between kidneys and vessels?].

    PubMed

    Tran, Thien-An; Jaques, David; Ponte, Belen

    2016-02-24

    Chronic kidney disease is highly prevalent worldwide and is associated with important cardiovascular morbidity and mortality. The search for new prognostic factors and therapeutic targets is therefore essential. There has been recently an increased interest about magnesium, poorly studied yet in that context. In this article, we review the most recent studies looking at the associations between magnesium, cardiovascular and chronic kidney disease. According to the available data, hypomagnesemia seems to alter negatively cardiovascular and renal prognosis. Maintaining normal magnesium levels could then be protective. However, studied populations are heterogeneous, most of the data is only observational and residual confounding factors still need to be considered. All those issues limit currently any definitive therapeutic recommendations.